{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Analysis of unithood"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This notebook contains most parts of the analysis on unithood, the strength of association between components of concepts."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import utils  # a python module in the same dir as the notebooks\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "CORPUS_NAME = 'genia'\n",
    "MODEL_SPEC = '_min2_l10'\n",
    "FREQ_THRESHOLD = 3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading n-gram model\n",
      "Loading GENIA corpus ... NOTE: 13 files cannot get Constituent annotations!\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 1599/1599 [00:28<00:00, 55.28it/s] \n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "os.chdir(utils.ROOT)  # get to the root directory of the project\n",
    "\n",
    "from datautils import dataio, annotations as anno\n",
    "from stats import ngramcounting\n",
    "\n",
    "# load the corpus\n",
    "print('Loading n-gram model')\n",
    "model = ngramcounting.NgramModel.load_model(CORPUS_NAME, MODEL_SPEC)\n",
    "\n",
    "if CORPUS_NAME.lower() == 'pmc':\n",
    "    corpus = dataio.load_craft_corpus() + dataio.load_genia_corpus()\n",
    "else:\n",
    "    corpus = dataio.load_corpus(CORPUS_NAME.lower())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Question 1: How strong is the association in regular concepts?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Retrieving gold standard concepts ... Skipped 3 concepts not bounded at tokens boundaries.\n"
     ]
    }
   ],
   "source": [
    "# get all continuous concepts\n",
    "\n",
    "from stats import conceptstats\n",
    "cont_concepts = conceptstats.gold_standard_concepts(corpus, discontinuous=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "import nltk\n",
    "concept_bigrams = {bigram for concept in cont_concepts for bigram in nltk.bigrams(concept)}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# now, loop over all bigrams in the n-gram model, measure their association\n",
    "# and note whether they occur in a concept or not\n",
    "\n",
    "data_dict = {'bigram': [], 'in_concept': [],  'pmi': [], 'll': [], 'freq': []}\n",
    "\n",
    "for bigram_pattern, count in model.iterate(2, threshold=FREQ_THRESHOLD,\n",
    "                                           encoded_patterns=True):\n",
    "    \n",
    "    bigram = model.decode_pattern(bigram_pattern)\n",
    "    data_dict['bigram'].append(bigram)\n",
    "    \n",
    "    data_dict['freq'].append(count)\n",
    "    \n",
    "    word_a = bigram_pattern[0]\n",
    "    word_b = bigram_pattern[1]\n",
    "    contingency_table = model.contingency_table(word_a, word_b)\n",
    "    pmi = conceptstats.pointwise_mutual_information(contingency_table)\n",
    "    data_dict['pmi'].append(pmi)\n",
    "    ll = conceptstats.log_likelihood_ratio(contingency_table)\n",
    "    data_dict['ll'].append(ll)\n",
    "    \n",
    "    data_dict['in_concept'].append(bigram in concept_bigrams)\n",
    "\n",
    "\n",
    "data = pd.DataFrame(data_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>bigram</th>\n",
       "      <th>in_concept</th>\n",
       "      <th>pmi</th>\n",
       "      <th>ll</th>\n",
       "      <th>freq</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(of, arsenic)</td>\n",
       "      <td>False</td>\n",
       "      <td>2.522915</td>\n",
       "      <td>19.107739</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(,, similar)</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.347627</td>\n",
       "      <td>0.845113</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(and, secretion)</td>\n",
       "      <td>False</td>\n",
       "      <td>1.365367</td>\n",
       "      <td>15.650506</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(,, implicate)</td>\n",
       "      <td>False</td>\n",
       "      <td>0.638141</td>\n",
       "      <td>2.443953</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(redox, state)</td>\n",
       "      <td>True</td>\n",
       "      <td>6.409419</td>\n",
       "      <td>43.953821</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>(,, dibutyryl)</td>\n",
       "      <td>False</td>\n",
       "      <td>2.295750</td>\n",
       "      <td>12.561360</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>(into, the)</td>\n",
       "      <td>False</td>\n",
       "      <td>1.946253</td>\n",
       "      <td>199.778295</td>\n",
       "      <td>80</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>(and, atopic)</td>\n",
       "      <td>False</td>\n",
       "      <td>2.049704</td>\n",
       "      <td>10.131690</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>(;, 17)</td>\n",
       "      <td>True</td>\n",
       "      <td>4.803986</td>\n",
       "      <td>38.784870</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>(regulator, ,)</td>\n",
       "      <td>False</td>\n",
       "      <td>0.534762</td>\n",
       "      <td>1.514687</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>(il2, ))</td>\n",
       "      <td>True</td>\n",
       "      <td>2.632732</td>\n",
       "      <td>14.314078</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>(activity, for)</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.347553</td>\n",
       "      <td>0.823677</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>(unprimed, cell)</td>\n",
       "      <td>True</td>\n",
       "      <td>3.343949</td>\n",
       "      <td>21.351091</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>(prim, monocyte)</td>\n",
       "      <td>True</td>\n",
       "      <td>5.007124</td>\n",
       "      <td>33.089456</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>(t-cell, determinant)</td>\n",
       "      <td>True</td>\n",
       "      <td>5.115198</td>\n",
       "      <td>42.212634</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>(bob1, ,)</td>\n",
       "      <td>False</td>\n",
       "      <td>2.295750</td>\n",
       "      <td>12.561360</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>(a, dominant)</td>\n",
       "      <td>False</td>\n",
       "      <td>3.028737</td>\n",
       "      <td>100.506588</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>(j, delta)</td>\n",
       "      <td>True</td>\n",
       "      <td>7.436437</td>\n",
       "      <td>120.000595</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>(family, member)</td>\n",
       "      <td>True</td>\n",
       "      <td>5.622606</td>\n",
       "      <td>592.636897</td>\n",
       "      <td>60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>(t-cell, line)</td>\n",
       "      <td>True</td>\n",
       "      <td>4.144713</td>\n",
       "      <td>385.488641</td>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   bigram  in_concept       pmi          ll  freq\n",
       "0           (of, arsenic)       False  2.522915   19.107739     4\n",
       "1            (,, similar)       False -0.347627    0.845113     5\n",
       "2        (and, secretion)       False  1.365367   15.650506    11\n",
       "3          (,, implicate)       False  0.638141    2.443953     6\n",
       "4          (redox, state)        True  6.409419   43.953821     3\n",
       "5          (,, dibutyryl)       False  2.295750   12.561360     3\n",
       "6             (into, the)       False  1.946253  199.778295    80\n",
       "7           (and, atopic)       False  2.049704   10.131690     3\n",
       "8                 (;, 17)        True  4.803986   38.784870     4\n",
       "9          (regulator, ,)       False  0.534762    1.514687     5\n",
       "10               (il2, ))        True  2.632732   14.314078     3\n",
       "11        (activity, for)       False -0.347553    0.823677     5\n",
       "12       (unprimed, cell)        True  3.343949   21.351091     3\n",
       "13       (prim, monocyte)        True  5.007124   33.089456     3\n",
       "14  (t-cell, determinant)        True  5.115198   42.212634     4\n",
       "15              (bob1, ,)       False  2.295750   12.561360     3\n",
       "16          (a, dominant)       False  3.028737  100.506588    21\n",
       "17             (j, delta)        True  7.436437  120.000595     8\n",
       "18       (family, member)        True  5.622606  592.636897    60\n",
       "19         (t-cell, line)        True  4.144713  385.488641    58"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd559d4c50>"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "sns.boxplot(x='in_concept', y='pmi', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd54d21b70>"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.boxplot(x='in_concept', y='ll', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "# we can perform t-tests etc."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "from scipy import stats"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>U-val</th>\n",
       "      <th>tail</th>\n",
       "      <th>p-val</th>\n",
       "      <th>RBC</th>\n",
       "      <th>CLES</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>MWU</th>\n",
       "      <td>72471335.0</td>\n",
       "      <td>two-sided</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.553</td>\n",
       "      <td>0.776</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          U-val       tail  p-val    RBC   CLES\n",
       "MWU  72471335.0  two-sided    0.0 -0.553  0.776"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pingouin\n",
    "pingouin.mwu(data[data['in_concept'] == True]['pmi'],\n",
    "             data[data['in_concept'] == False]['pmi'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>bigram</th>\n",
       "      <th>in_concept</th>\n",
       "      <th>pmi</th>\n",
       "      <th>ll</th>\n",
       "      <th>freq</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8150</th>\n",
       "      <td>(nf-kappa, b)</td>\n",
       "      <td>True</td>\n",
       "      <td>4.989393</td>\n",
       "      <td>1.097984e+04</td>\n",
       "      <td>1077</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15993</th>\n",
       "      <td>(t, cell)</td>\n",
       "      <td>True</td>\n",
       "      <td>3.769280</td>\n",
       "      <td>1.088198e+04</td>\n",
       "      <td>1575</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5990</th>\n",
       "      <td>(transcription, factor)</td>\n",
       "      <td>True</td>\n",
       "      <td>4.508931</td>\n",
       "      <td>8.035224e+03</td>\n",
       "      <td>980</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11134</th>\n",
       "      <td>(of, the)</td>\n",
       "      <td>True</td>\n",
       "      <td>1.517641</td>\n",
       "      <td>6.538910e+03</td>\n",
       "      <td>3705</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5122</th>\n",
       "      <td>(cell, line)</td>\n",
       "      <td>True</td>\n",
       "      <td>3.814526</td>\n",
       "      <td>4.842576e+03</td>\n",
       "      <td>697</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12278</th>\n",
       "      <td>(and, enhancer)</td>\n",
       "      <td>True</td>\n",
       "      <td>-0.000610</td>\n",
       "      <td>4.207667e-06</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8929</th>\n",
       "      <td>(,, constitutive)</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.000756</td>\n",
       "      <td>3.561959e-06</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17896</th>\n",
       "      <td>(cell, at)</td>\n",
       "      <td>False</td>\n",
       "      <td>0.000330</td>\n",
       "      <td>1.559469e-06</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7602</th>\n",
       "      <td>(with, nf-kappa)</td>\n",
       "      <td>False</td>\n",
       "      <td>0.000212</td>\n",
       "      <td>4.532176e-07</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7266</th>\n",
       "      <td>(high, and)</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.000062</td>\n",
       "      <td>3.579771e-08</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>21473 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                        bigram  in_concept       pmi            ll  freq\n",
       "8150             (nf-kappa, b)        True  4.989393  1.097984e+04  1077\n",
       "15993                (t, cell)        True  3.769280  1.088198e+04  1575\n",
       "5990   (transcription, factor)        True  4.508931  8.035224e+03   980\n",
       "11134                (of, the)        True  1.517641  6.538910e+03  3705\n",
       "5122              (cell, line)        True  3.814526  4.842576e+03   697\n",
       "...                        ...         ...       ...           ...   ...\n",
       "12278          (and, enhancer)        True -0.000610  4.207667e-06    10\n",
       "8929         (,, constitutive)       False -0.000756  3.561959e-06     5\n",
       "17896               (cell, at)       False  0.000330  1.559469e-06    13\n",
       "7602          (with, nf-kappa)       False  0.000212  4.532176e-07     9\n",
       "7266               (high, and)       False -0.000062  3.579771e-08     8\n",
       "\n",
       "[21473 rows x 5 columns]"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.sort_values('ll', ascending=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Conclusion: concept bigrams _do_ have higher association."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Question 2: How does it look for bigrams in DC's?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Retrieving gold standard concepts ... Skipped 0 concepts not bounded at tokens boundaries.\n"
     ]
    }
   ],
   "source": [
    "disc_concepts = conceptstats.gold_standard_concepts(corpus, continuous=False,\n",
    "                                                    discontinuous=True)\n",
    "dc_bigrams = {bigram for concept in disc_concepts for bigram in nltk.bigrams(concept)}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# now, loop over all bigrams in the n-gram model, measure their association\n",
    "# and note whether they occur in a concept or not\n",
    "\n",
    "data_dict = {'bigram': [], 'type': [],  'pmi': [], 'll': [], 'freq': []}\n",
    "\n",
    "for bigram_pattern, count in model.iterate(2, threshold=FREQ_THRESHOLD,\n",
    "                                           encoded_patterns=True):\n",
    "    \n",
    "    bigram = model.decode_pattern(bigram_pattern)\n",
    "    data_dict['bigram'].append(bigram)\n",
    "    \n",
    "    data_dict['freq'].append(count)\n",
    "    \n",
    "    word_a = bigram_pattern[0]\n",
    "    word_b = bigram_pattern[1]\n",
    "    contingency_table = model.contingency_table(word_a, word_b)\n",
    "    pmi = conceptstats.pointwise_mutual_information(contingency_table)\n",
    "    data_dict['pmi'].append(pmi)\n",
    "    ll = conceptstats.log_likelihood_ratio(contingency_table)\n",
    "    data_dict['ll'].append(ll)\n",
    "    \n",
    "    if bigram in concept_bigrams:\n",
    "        if bigram in dc_bigrams:\n",
    "            bigram_type = 'both'\n",
    "        else:\n",
    "            bigram_type = 'only_CC'\n",
    "    elif bigram in dc_bigrams:\n",
    "        bigram_type = 'only_DC'\n",
    "    else:\n",
    "        bigram_type = 'neither'\n",
    "    \n",
    "    data_dict['type'].append(bigram_type)\n",
    "\n",
    "\n",
    "data = pd.DataFrame(data_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd54d01dd8>"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.boxplot(x='type', y='pmi', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd548a8ef0>"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.boxplot(x='type', y='ll', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Source</th>\n",
       "      <th>ddof1</th>\n",
       "      <th>H</th>\n",
       "      <th>p-unc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Kruskal</th>\n",
       "      <td>type</td>\n",
       "      <td>3</td>\n",
       "      <td>2958.827</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        Source  ddof1         H  p-unc\n",
       "Kruskal   type      3  2958.827    0.0"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pingouin.kruskal(data, 'll', 'type')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "16"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# However, notice that\n",
    "len(data[data['type'] == 'only_DC'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "786"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# compared to e.g.\n",
    "len(data[data['type'] == 'both'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Question 3: What is the association across the gap?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import defaultdict\n",
    "from itertools import product\n",
    "\n",
    "gap_bigrams = defaultdict(list)\n",
    "cont_bigrams = defaultdict(list)\n",
    "false_bridges = defaultdict(list)\n",
    "dc_sample = {dc for doc in corpus for dc in doc.get_annotations(anno.DiscontinuousConcept)}\n",
    "for dc in dc_sample:\n",
    "    tokens = dc.get_tokens()\n",
    "    norm_concept = dc.normalized_concept()\n",
    "    spanned_tokens = dc.get_spanned_tokens()\n",
    "    non_dc_tokens = set(spanned_tokens).difference(tokens)\n",
    "    for t in non_dc_tokens:\n",
    "        if t.mapped_pos() == 'c':\n",
    "            cc = t\n",
    "            break\n",
    "    for i in range(len(tokens) - 1):\n",
    "        t1, t2 = tokens[i], tokens[i+1]\n",
    "        bigram = norm_concept[i:i + 2]\n",
    "        if t2.span[0] - t1.span[-1] > 2:\n",
    "            gap_bigrams[bigram].append(dc)\n",
    "            for false_friends in product(non_dc_tokens, [t1, t2]):\n",
    "                f1, f2 = sorted(false_friends, key=lambda x: x.span[0])\n",
    "                if f1.span[0] < cc.span[0] < f2.span[0]:\n",
    "                    false_bridge = (f1.lemma(), f2.lemma())\n",
    "                    false_bridges[false_bridge].append(dc)\n",
    "        else:\n",
    "            cont_bigrams[bigram].append(dc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 147,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('monomorphic', 'polymorphic')\n",
      "dies against either \u001b[46m\u001b[30mmonomorphic\u001b[0m or polymorphic \u001b[46m\u001b[30mdeterminants\u001b[0m of class I antigen \n",
      "\n",
      "('tnf', 'pma-')\n",
      "rtial inhibition of \u001b[46m\u001b[30mTNF\u001b[0m -or PMA- \u001b[46m\u001b[30minduced HIV replication\u001b[0m in U1 cells, and no\n",
      "ioxidants inhibited \u001b[46m\u001b[30mTNF\u001b[0m -or PMA-\u001b[46m\u001b[30minduced NF-kappa B activity\u001b[0m in U1 cells, as wel\n",
      "\n",
      "('-', 'induced')\n",
      "rtial inhibition of \u001b[46m\u001b[30mTNF\u001b[0m -or PMA- \u001b[46m\u001b[30minduced HIV replication\u001b[0m in U1 cells, and no\n",
      "ioxidants inhibited \u001b[46m\u001b[30mTNF\u001b[0m -or PMA-\u001b[46m\u001b[30minduced NF-kappa B activity\u001b[0m in U1 cells, as wel\n",
      "\n",
      "(',', 'cell')\n",
      "hocytic, monocytic, \u001b[46m\u001b[30mneuronal\u001b[0m, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "l percentage of the \u001b[46m\u001b[30mCD4+\u001b[0m, CD8+ and CD56+ \u001b[46m\u001b[30mcell populations\u001b[0m in the BM was incre\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "n the commitment to \u001b[46m\u001b[30merythroid\u001b[0m, myeloid and lymphoid \u001b[46m\u001b[30mcell types\u001b[0m is summarized.\n",
      "representing pro-B, \u001b[46m\u001b[30mpre-B\u001b[0m, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      "4- CD8-, CD4+ CD8+, \u001b[46m\u001b[30mCD4+ CD8-\u001b[0m, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "ein was detected in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "ein was detected in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "nes of lymphocytic, \u001b[46m\u001b[30mmonocytic\u001b[0m, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "nes of lymphocytic, \u001b[46m\u001b[30mmonocytic\u001b[0m, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "etween the cells of \u001b[46m\u001b[30mCategories Va\u001b[0m, VI and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      " all the CD4- CD8-, \u001b[46m\u001b[30mCD4+ CD8+\u001b[0m, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      " all the CD4- CD8-, \u001b[46m\u001b[30mCD4+ CD8+\u001b[0m, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "luding HL-60, U937, \u001b[46m\u001b[30mHEL/S\u001b[0m, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "luding HL-60, U937, \u001b[46m\u001b[30mHEL/S\u001b[0m, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "luding HL-60, U937, \u001b[46m\u001b[30mHEL/S\u001b[0m, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "HL-60, U937, HEL/S, \u001b[46m\u001b[30mKU812F\u001b[0m, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "HL-60, U937, HEL/S, \u001b[46m\u001b[30mKU812F\u001b[0m, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "me in the nuclei of \u001b[46m\u001b[30mresting\u001b[0m, activated, and anergized \u001b[46m\u001b[30mcells\u001b[0m. The inducible fact\n",
      "me in the nuclei of \u001b[46m\u001b[30mresting\u001b[0m, activated, and anergized \u001b[46m\u001b[30mcells\u001b[0m. The inducible fact\n",
      "d in the erythroid, \u001b[46m\u001b[30mmegakaryocytic\u001b[0m, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m during normal hemat\n",
      "homas. All cases of \u001b[46m\u001b[30mfollicular\u001b[0m, mixed small and large \u001b[46m\u001b[30mcell lymphomas\u001b[0m showed LAZ3/BCL6 ex\n",
      "937, HEL/S, KU812F, \u001b[46m\u001b[30mK562\u001b[0m, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "ed to as M-TAT/EPO, \u001b[46m\u001b[30mM-TAT/GM-CSF\u001b[0m, and M-TAT/SCF \u001b[46m\u001b[30mcells\u001b[0m, respectively. Hemo\n",
      "ected in erythroid, \u001b[46m\u001b[30mmegakaryocyte\u001b[0m, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      " gene expression in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m. GATA-1 binds to WG\n",
      " gene expression in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m. GATA-1 binds to WG\n",
      "as more abundant in \u001b[46m\u001b[30mU-937\u001b[0m, K-562, and HeLa \u001b[46m\u001b[30mcell extracts\u001b[0m than in Raji, HF, B\n",
      "as more abundant in \u001b[46m\u001b[30mU-937\u001b[0m, K-562, and HeLa \u001b[46m\u001b[30mcell extracts\u001b[0m than in Raji, HF, B\n",
      " from cell lines of \u001b[46m\u001b[30mlymphocytic\u001b[0m, monocytic, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      " from cell lines of \u001b[46m\u001b[30mlymphocytic\u001b[0m, monocytic, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      " from cell lines of \u001b[46m\u001b[30mlymphocytic\u001b[0m, monocytic, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      " differentiation of \u001b[46m\u001b[30mHL-60\u001b[0m, U937 and HEL/S \u001b[46m\u001b[30mcells\u001b[0m. The erythroid diff\n",
      "is expressed in the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m during normal hemat\n",
      "is expressed in the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m during normal hemat\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "tion in H9 T cells, \u001b[46m\u001b[30mmyelomonocytic\u001b[0m, and glial \u001b[46m\u001b[30mcell lines\u001b[0m. In vivo occupancy \n",
      " differentiation of \u001b[46m\u001b[30mHEL\u001b[0m, KU812 and K562 \u001b[46m\u001b[30mcells\u001b[0m, but not the induct\n",
      " nuclei of resting, \u001b[46m\u001b[30mactivated\u001b[0m, and anergized \u001b[46m\u001b[30mcells\u001b[0m. The inducible fact\n",
      "ukocytes of the B-, \u001b[46m\u001b[30mT-\u001b[0m, and NK-\u001b[46m\u001b[30mcell lineages\u001b[0m were treated with e\n",
      " are referred to as \u001b[46m\u001b[30mM-TAT/EPO\u001b[0m, M-TAT/GM-CSF, and M-TAT/SCF \u001b[46m\u001b[30mcells\u001b[0m, respectively. Hemo\n",
      " are referred to as \u001b[46m\u001b[30mM-TAT/EPO\u001b[0m, M-TAT/GM-CSF, and M-TAT/SCF \u001b[46m\u001b[30mcells\u001b[0m, respectively. Hemo\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "SCL is expressed in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte and mast \u001b[46m\u001b[30mcell populations\u001b[0m (the same cell line\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not TUR, \u001b[46m\u001b[30mcells\u001b[0m. Okadaic acid treat\n",
      " abundant in U-937, \u001b[46m\u001b[30mK-562\u001b[0m, and HeLa \u001b[46m\u001b[30mcell extracts\u001b[0m than in Raji, HF, B\n",
      ", leukocytes of the \u001b[46m\u001b[30mB-\u001b[0m, T-, and NK-\u001b[46m\u001b[30mcell lineages\u001b[0m were treated with e\n",
      ", leukocytes of the \u001b[46m\u001b[30mB-\u001b[0m, T-, and NK-\u001b[46m\u001b[30mcell lineages\u001b[0m were treated with e\n",
      "ssion in erythroid, \u001b[46m\u001b[30mmegakaryocyte\u001b[0m, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m. GATA-1 binds to WG\n",
      " lines representing \u001b[46m\u001b[30mpro-B\u001b[0m, pre-B, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      " lines representing \u001b[46m\u001b[30mpro-B\u001b[0m, pre-B, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      "\n",
      "('neuronal', 'glial')\n",
      "hocytic, monocytic, \u001b[46m\u001b[30mneuronal\u001b[0m, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "\n",
      "('erythroid', 'megakaryocytic')\n",
      "progenitors of both \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "h downregulation of \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mtranscription factors\u001b[0m: a novel experiment\n",
      "ownmodulated during \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mterminal maturation\u001b[0m. In immature hemato\n",
      "eins play a role in \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mdifferentiation\u001b[0m.\n",
      "erentiate along the \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mlineages\u001b[0m. We cultured M-TAT \n",
      " and TMD cases have \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mphenotypes\u001b[0m. We also found that\n",
      "fNF-E2 promoter, in \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mlineage cells\u001b[0m, p45 mRNA is transc\n",
      "ation of definitive \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mcells\u001b[0m in vivo. To elucida\n",
      "tion of cells along \u001b[46m\u001b[30merythroid\u001b[0m and/or megakaryocytic \u001b[46m\u001b[30mlineages\u001b[0m, because a signific\n",
      " data indicate that \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mdifferentiation pathways\u001b[0m are closely related\n",
      " and TMD cases have \u001b[46m\u001b[30merythroid\u001b[0m and megakaryocytic \u001b[46m\u001b[30mphenotypes\u001b[0m. These results sugg\n",
      "\n",
      "('+', '+')\n",
      "l percentage of the \u001b[46m\u001b[30mCD4+\u001b[0m, CD8+ and CD56+ \u001b[46m\u001b[30mcell populations\u001b[0m in the BM was incre\n",
      "entage of the CD4+, \u001b[46m\u001b[30mCD8+\u001b[0m and CD56+ \u001b[46m\u001b[30mcell populations\u001b[0m in the BM was incre\n",
      "\n",
      "('cd8', 'cell')\n",
      "l percentage of the \u001b[46m\u001b[30mCD4+\u001b[0m, CD8+ and CD56+ \u001b[46m\u001b[30mcell populations\u001b[0m in the BM was incre\n",
      "\n",
      "('+', 'cd56')\n",
      "l percentage of the \u001b[46m\u001b[30mCD4+\u001b[0m, CD8+ and CD56+ \u001b[46m\u001b[30mcell populations\u001b[0m in the BM was incre\n",
      "entage of the CD4+, \u001b[46m\u001b[30mCD8+\u001b[0m and CD56+ \u001b[46m\u001b[30mcell populations\u001b[0m in the BM was incre\n",
      "\n",
      "('+', 'cell')\n",
      "l percentage of the \u001b[46m\u001b[30mCD4+\u001b[0m, CD8+ and CD56+ \u001b[46m\u001b[30mcell populations\u001b[0m in the BM was incre\n",
      "\n",
      "('fetal', 'erythroid')\n",
      "trated binding of a \u001b[46m\u001b[30mfetal\u001b[0m and erythroid\u001b[46m\u001b[30m-specific protein\u001b[0m. The repressor acti\n",
      "\n",
      "('cre', 'kappab3')\n",
      ", respectively. The \u001b[46m\u001b[30mCRE\u001b[0m and kappaB3 \u001b[46m\u001b[30msites\u001b[0m in region II togeth\n",
      "\n",
      "('human', 'mouse')\n",
      "erum titers against \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mTCF-1 protein\u001b[0m. Wild-type litterma\n",
      "e promoters of both \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mCD19 genes\u001b[0m and was furthermore\n",
      "mRNA and protein in \u001b[46m\u001b[30mnontransformed human\u001b[0m and mouse \u001b[46m\u001b[30mT cells\u001b[0m. Oct-2 was found in\n",
      "mparison of group 1 \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mgenomic sequences\u001b[0m shows high conserva\n",
      "a cells, as well as \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mprimary T lymphocytes\u001b[0m, that this inhibito\n",
      "of the Rhom-2 gene. \u001b[46m\u001b[30mHuman\u001b[0m and mouse \u001b[46m\u001b[30mRhom-2\u001b[0m are highly conserve\n",
      " -4, -5 and -13 and \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mgranulocyte/macrophage-colony stimulating factor\u001b[0m (GM-CSF)]. It conta\n",
      "in various kinds of \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mcells\u001b[0m. Azeptin dose-depen\n",
      "ks proliferation of \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mlymphocytes\u001b[0m. Using a radiolabel\n",
      "mRNA and protein in \u001b[46m\u001b[30mnontransformed\u001b[0m human and \u001b[46m\u001b[30mmouse T cells\u001b[0m. Oct-2 was found in\n",
      "te conserved in the \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mgene\u001b[0m. IL-2 responsivenes\n",
      "s can be found. The \u001b[46m\u001b[30mhuman\u001b[0m and mouse \u001b[46m\u001b[30mGATA3 transcription units\u001b[0m start at a major in\n",
      "\n",
      "('-', 'lipoprotein-lipopeptide-')\n",
      "d divergences among \u001b[46m\u001b[30mlipopolysaccharide (LPS)-\u001b[0m and lipoprotein-lipopeptide-\u001b[46m\u001b[30minduced immune cell signaling events\u001b[0m. Like LPS, purified\n",
      "\n",
      "('b-lymphocyte', 't-lymphocyte')\n",
      "different stages of \u001b[46m\u001b[30mB-lymphocyte\u001b[0m and T-lymphocyte \u001b[46m\u001b[30mdifferentiation\u001b[0m is controlled at th\n",
      "\n",
      "('cd4+', 'cd8+')\n",
      " Oct-2 was found in \u001b[46m\u001b[30mCD4+\u001b[0m and CD8+ \u001b[46m\u001b[30mT cells\u001b[0m prepared from human\n",
      " on 85-90% of human \u001b[46m\u001b[30mCD4+\u001b[0m and CD8+ \u001b[46m\u001b[30mT cells\u001b[0m and on renal cell c\n",
      "ected in individual \u001b[46m\u001b[30mCD4+\u001b[0m and CD8+ \u001b[46m\u001b[30mT cells\u001b[0m infected with EBV. \n",
      "arly transcripts in \u001b[46m\u001b[30mCD4+\u001b[0m and CD8+ \u001b[46m\u001b[30mT lymphocytes\u001b[0m. AIDS-related Epste\n",
      "rative responses of \u001b[46m\u001b[30mpurified CD4+\u001b[0m or CD8+ \u001b[46m\u001b[30mT cells\u001b[0m are suppressed more\n",
      "rative responses of \u001b[46m\u001b[30mpurified\u001b[0m CD4+ or \u001b[46m\u001b[30mCD8+ T cells\u001b[0m are suppressed more\n",
      "ould be detected in \u001b[46m\u001b[30mT rosetting\u001b[0m CD4+ and \u001b[46m\u001b[30mCD8+ T lymphocytes\u001b[0m. Only a few cells s\n",
      "iptional program in \u001b[46m\u001b[30mhomogeneous\u001b[0m CD4+ and \u001b[46m\u001b[30mCD8+ lymphocytes\u001b[0m. Following EBV infe\n",
      " the mitogenesis of \u001b[46m\u001b[30mCD4+\u001b[0m or CD8+ \u001b[46m\u001b[30mcells\u001b[0m. Using electrophore\n",
      "athway may exist in \u001b[46m\u001b[30mCD4+\u001b[0m and CD8+ \u001b[46m\u001b[30mT cell subpopulations\u001b[0m.\n",
      "ould be detected in \u001b[46m\u001b[30mT rosetting CD4+\u001b[0m and CD8+ \u001b[46m\u001b[30mT lymphocytes\u001b[0m. Only a few cells s\n",
      "iptional program in \u001b[46m\u001b[30mhomogeneous CD4+\u001b[0m and CD8+ \u001b[46m\u001b[30mlymphocytes\u001b[0m. Following EBV infe\n",
      "\n",
      "('murine', 'human')\n",
      "xin (TCDD) inhibits \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mB lymphocyte immunoglobulin production\u001b[0m through an unknown \n",
      "hree organisms. The \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mfactors\u001b[0m are abundantly expr\n",
      "e have isolated the \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mcDNAs\u001b[0m which encode a nove\n",
      "\u001b[46m\u001b[30mMurine\u001b[0m and human \u001b[46m\u001b[30mT-lymphocyte GATA-3 factors\u001b[0m mediate transcripti\n",
      ". We infer that the \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mGATA-3 proteins\u001b[0m play a central and \n",
      " initiation site in \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mp40 genes\u001b[0m formed an NF-kappaB\n",
      "ved in human TCF-1. \u001b[46m\u001b[30mMurine\u001b[0m and human \u001b[46m\u001b[30mTCF-1\u001b[0m displayed a 95.5% o\n",
      "mino acid homology. \u001b[46m\u001b[30mRecombinant\u001b[0m murine and \u001b[46m\u001b[30mhuman TCF-1\u001b[0m recognized the same\n",
      "ZF protein (MZF-2). \u001b[46m\u001b[30mMurine\u001b[0m and human \u001b[46m\u001b[30mMZF-2 proteins\u001b[0m consisted of 814 an\n",
      "oforms expressed in \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mT cells\u001b[0m. When expressed in \n",
      "mino acid homology. \u001b[46m\u001b[30mRecombinant murine\u001b[0m and human \u001b[46m\u001b[30mTCF-1\u001b[0m recognized the same\n",
      "observed in several \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mtumor cell lines\u001b[0m. Since the inhibiti\n",
      " initiation site in \u001b[46m\u001b[30mmurine\u001b[0m and human \u001b[46m\u001b[30mp40 promoter regions\u001b[0m could be important \n",
      "\n",
      "('viral', 'host')\n",
      "nteractions between \u001b[46m\u001b[30mviral\u001b[0m and host cellular \u001b[46m\u001b[30mfactors\u001b[0m. Prostaglandin E2 (\n",
      "\n",
      "('viral', 'cellular')\n",
      "nteractions between \u001b[46m\u001b[30mviral\u001b[0m and host cellular \u001b[46m\u001b[30mfactors\u001b[0m. Prostaglandin E2 (\n",
      "t activator of many \u001b[46m\u001b[30mviral\u001b[0m and cellular \u001b[46m\u001b[30mgenes\u001b[0m transcribed by RNA \n",
      "l activator of many \u001b[46m\u001b[30mviral\u001b[0m and cellular \u001b[46m\u001b[30mpromoters\u001b[0m. We found that the \n",
      "e known to regulate \u001b[46m\u001b[30mviral\u001b[0m and cellular \u001b[46m\u001b[30mgenes\u001b[0m. Interleukin-6 (IL-\n",
      "\n",
      "('lpr/lpr', 'cd4(-)')\n",
      "sL up-regulation in \u001b[46m\u001b[30mlpr/lpr\u001b[0m and gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m.\n",
      "\n",
      "('lpr/lpr', 'cd8(-)')\n",
      "sL up-regulation in \u001b[46m\u001b[30mlpr/lpr\u001b[0m and gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m.\n",
      "\n",
      "('lpr/lpr', 'gld/gld')\n",
      "sL up-regulation in \u001b[46m\u001b[30mlpr/lpr\u001b[0m and gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m.\n",
      "CD8(-) T cells from \u001b[46m\u001b[30mlpr/lpr\u001b[0m and gld/gld \u001b[46m\u001b[30mmice\u001b[0m, which have mutatio\n",
      "\n",
      "('g1', 'g2')\n",
      " arrest occurred at \u001b[46m\u001b[30mG1\u001b[0m and G2 \u001b[46m\u001b[30mstages\u001b[0m of the cell cycle, \n",
      "\n",
      "('11p15', '11p13')\n",
      "l translocations to \u001b[46m\u001b[30mhuman chromosomes\u001b[0m 11p15 and \u001b[46m\u001b[30m11p13\u001b[0m. A chromosomal tran\n",
      "\n",
      "('p50/p65-', 'c-rel-')\n",
      " transcription from \u001b[46m\u001b[30mp50/p65-\u001b[0m and c-Rel- \u001b[46m\u001b[30mresponsive promoters\u001b[0m, and that this acti\n",
      "\n",
      "('erythroid', 'nonerythroid')\n",
      "xidase gene between \u001b[46m\u001b[30merythroid\u001b[0m and nonerythroid \u001b[46m\u001b[30mcells\u001b[0m. Coproporphyrinogen\n",
      "of CPO gene between \u001b[46m\u001b[30merythroid\u001b[0m and nonerythroid \u001b[46m\u001b[30mcells\u001b[0m. Copyright 1998 by \n",
      "\n",
      "(',', 'gamma')\n",
      "ect was mediated by \u001b[46m\u001b[30mRA receptors\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m, the expression of \n",
      "ect was mediated by \u001b[46m\u001b[30mRA receptors\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m, the expression of \n",
      "express mRNA of the \u001b[46m\u001b[30mRA receptor\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m. Using retinoids wi\n",
      "express mRNA of the \u001b[46m\u001b[30mRA receptor\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m. Using retinoids wi\n",
      "\n",
      "('alpha', 'gamma')\n",
      "ect was mediated by \u001b[46m\u001b[30mRA receptors\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m, the expression of \n",
      "express mRNA of the \u001b[46m\u001b[30mRA receptor\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m. Using retinoids wi\n",
      "contacts of the two \u001b[46m\u001b[30mIL-4 receptor subunits\u001b[0m alpha and \u001b[46m\u001b[30mgamma\u001b[0m with Janus kinases \n",
      "\n",
      "('beta', 'gamma')\n",
      "ect was mediated by \u001b[46m\u001b[30mRA receptors\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m, the expression of \n",
      "duction through the \u001b[46m\u001b[30mIL-2 receptor (IL-2R)\u001b[0m beta and \u001b[46m\u001b[30mgamma chains\u001b[0m (IL-2R beta and IL-\n",
      "express mRNA of the \u001b[46m\u001b[30mRA receptor\u001b[0m alpha, beta, and \u001b[46m\u001b[30mgamma\u001b[0m. Using retinoids wi\n",
      "duction through the \u001b[46m\u001b[30mIL-2 receptor (IL-2R) beta\u001b[0m and gamma \u001b[46m\u001b[30mchains\u001b[0m (IL-2R beta and IL-\n",
      "alpha)), as well as \u001b[46m\u001b[30mIFN(\u001b[0mbeta) and \u001b[46m\u001b[30mgamma\u001b[0m, results in an incr\n",
      "\n",
      "('mrna', 'protein')\n",
      "compounds inhibited \u001b[46m\u001b[30mIL-2\u001b[0m mRNA and \u001b[46m\u001b[30mprotein levels\u001b[0m in the NFAT-1-linke\n",
      "ing factor (GM-CSF) \u001b[46m\u001b[30mcytoplasmic\u001b[0m mRNA and \u001b[46m\u001b[30mprotein expression\u001b[0m. In addition, when \n",
      "ing factor (GM-CSF) \u001b[46m\u001b[30mcytoplasmic mRNA\u001b[0m and protein \u001b[46m\u001b[30mexpression\u001b[0m. In addition, when \n",
      "pression of IL-2 at \u001b[46m\u001b[30mmRNA\u001b[0m and protein \u001b[46m\u001b[30mlevels\u001b[0m. We analyzed expres\n",
      "sed Stat1 and Stat3 \u001b[46m\u001b[30mmRNA\u001b[0m and protein \u001b[46m\u001b[30mlevels\u001b[0m were detected, resp\n",
      "d NF-kappa B at the \u001b[46m\u001b[30mmRNA\u001b[0m and protein \u001b[46m\u001b[30mlevel\u001b[0m in human monocytes.\n",
      "loride increase the \u001b[46m\u001b[30mvimentin mRNA\u001b[0m and protein \u001b[46m\u001b[30mlevels\u001b[0m in U-937 human prom\n",
      "compounds inhibited \u001b[46m\u001b[30mIL-2 mRNA\u001b[0m and protein \u001b[46m\u001b[30mlevels\u001b[0m in the NFAT-1-linke\n",
      "s were examined for \u001b[46m\u001b[30mNGAL mRNA\u001b[0m and protein \u001b[46m\u001b[30mlevels\u001b[0m, they were found to\n",
      "loride increase the \u001b[46m\u001b[30mvimentin\u001b[0m mRNA and \u001b[46m\u001b[30mprotein levels\u001b[0m in U-937 human prom\n",
      "s were examined for \u001b[46m\u001b[30mNGAL\u001b[0m mRNA and \u001b[46m\u001b[30mprotein levels\u001b[0m, they were found to\n",
      "\n",
      "('(', 'carboxy-')\n",
      " a relatively short \u001b[46m\u001b[30mamino-\u001b[0m (729-766) or \u001b[46m\u001b[30mcarboxy- terminal (940-984) region\u001b[0m of the HBD fragment\n",
      "\n",
      "('729-766', 'carboxy-')\n",
      " a relatively short \u001b[46m\u001b[30mamino-\u001b[0m (729-766) or \u001b[46m\u001b[30mcarboxy- terminal (940-984) region\u001b[0m of the HBD fragment\n",
      "\n",
      "(')', 'carboxy-')\n",
      " a relatively short \u001b[46m\u001b[30mamino-\u001b[0m (729-766) or \u001b[46m\u001b[30mcarboxy- terminal (940-984) region\u001b[0m of the HBD fragment\n",
      " a relatively short \u001b[46m\u001b[30mamino- (729-766)\u001b[0m or carboxy- \u001b[46m\u001b[30mterminal (940-984) region\u001b[0m of the HBD fragment\n",
      "\n",
      "('regulatory', 'catalytic')\n",
      "contribution of the \u001b[46m\u001b[30mregulatory\u001b[0m and catalytic \u001b[46m\u001b[30mdomains\u001b[0m of pp56(lck) to ano\n",
      "\n",
      "('hla-dq', 'dr')\n",
      "ain combinations of \u001b[46m\u001b[30mHLA-DQ\u001b[0m and DR \u001b[46m\u001b[30mhaplotypes\u001b[0m. Dimers encoded by \n",
      "\n",
      "(',', 'lineage')\n",
      " are present in the \u001b[46m\u001b[30mmyeloid\u001b[0m, B-lymphoid, and erythroid \u001b[46m\u001b[30mlineages\u001b[0m, absent in nonhemat\n",
      " are present in the \u001b[46m\u001b[30mmyeloid\u001b[0m, B-lymphoid, and erythroid \u001b[46m\u001b[30mlineages\u001b[0m, absent in nonhemat\n",
      "rmally expressed in \u001b[46m\u001b[30merythroid\u001b[0m, mast and megakaryocyte \u001b[46m\u001b[30mlineages\u001b[0m. Northern analysis \n",
      "n of the erythroid, \u001b[46m\u001b[30mmegakaryocytic\u001b[0m, and basosophilic \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "esenting endocrine, \u001b[46m\u001b[30mfibroblast\u001b[0m, and lymphoid \u001b[46m\u001b[30mlineages\u001b[0m using polyclonal an\n",
      " lines representing \u001b[46m\u001b[30mendocrine\u001b[0m, fibroblast, and lymphoid \u001b[46m\u001b[30mlineages\u001b[0m using polyclonal an\n",
      " lines representing \u001b[46m\u001b[30mendocrine\u001b[0m, fibroblast, and lymphoid \u001b[46m\u001b[30mlineages\u001b[0m using polyclonal an\n",
      "ent in the myeloid, \u001b[46m\u001b[30mB-lymphoid\u001b[0m, and erythroid \u001b[46m\u001b[30mlineages\u001b[0m, absent in nonhemat\n",
      "es specific for the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mastocytic/basophilic \u001b[46m\u001b[30mlineages\u001b[0m, we studied GATA-1 \n",
      "es specific for the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mastocytic/basophilic \u001b[46m\u001b[30mlineages\u001b[0m, we studied GATA-1 \n",
      " for the erythroid, \u001b[46m\u001b[30mmegakaryocytic\u001b[0m, and mastocytic/basophilic \u001b[46m\u001b[30mlineages\u001b[0m, we studied GATA-1 \n",
      "ferentiation of the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and basosophilic \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "ferentiation of the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and basosophilic \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "\n",
      "('myeloid', 'erythroid')\n",
      " are present in the \u001b[46m\u001b[30mmyeloid\u001b[0m, B-lymphoid, and erythroid \u001b[46m\u001b[30mlineages\u001b[0m, absent in nonhemat\n",
      "rowth inhibition of \u001b[46m\u001b[30mnormal bone marrow myeloid\u001b[0m and erythroid progenitor \u001b[46m\u001b[30mcells\u001b[0m. In addition, we de\n",
      "n the regulation of \u001b[46m\u001b[30mnormal myeloid\u001b[0m and erythroid progenitor \u001b[46m\u001b[30mcell growth\u001b[0m. Transactivation st\n",
      "\n",
      "('b-lymphoid', 'lineage')\n",
      " are present in the \u001b[46m\u001b[30mmyeloid\u001b[0m, B-lymphoid, and erythroid \u001b[46m\u001b[30mlineages\u001b[0m, absent in nonhemat\n",
      "\n",
      "('secreting', 'nonsecreting')\n",
      "ed dPRL promoter in \u001b[46m\u001b[30mPRL-secreting\u001b[0m and nonsecreting \u001b[46m\u001b[30mlymphoid cells\u001b[0m, we found that the \n",
      "ed dPRL promoter in \u001b[46m\u001b[30mPRL-\u001b[0msecreting and \u001b[46m\u001b[30mnonsecreting lymphoid cells\u001b[0m, we found that the \n",
      "\n",
      "('inflammatory', 'immunological')\n",
      "matory mediators in \u001b[46m\u001b[30mhuman inflammatory\u001b[0m and immunological \u001b[46m\u001b[30mdiseases\u001b[0m. The regulation of \n",
      "matory mediators in \u001b[46m\u001b[30mhuman\u001b[0m inflammatory and \u001b[46m\u001b[30mimmunological diseases\u001b[0m. The regulation of \n",
      "\n",
      "('interferon', 'factor')\n",
      "terleukin 2 (IL-2), \u001b[46m\u001b[30mgamma interferon\u001b[0m, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "('interferon', 'colony-stimulating')\n",
      "terleukin 2 (IL-2), \u001b[46m\u001b[30mgamma interferon\u001b[0m, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "(',', 'mrna')\n",
      "terleukin 2 (IL-2), \u001b[46m\u001b[30mgamma interferon\u001b[0m, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "induced increase in \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6 or TNF alpha \u001b[46m\u001b[30mmRNA levels\u001b[0m. Furthermore, the p\n",
      "on of the levels of \u001b[46m\u001b[30mleukocyte alkaline phosphatase\u001b[0m, CD11b, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "on of the levels of \u001b[46m\u001b[30mleukocyte alkaline phosphatase\u001b[0m, CD11b, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "on of the levels of \u001b[46m\u001b[30mleukocyte alkaline phosphatase\u001b[0m, CD11b, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "titutive expression \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "titutive expression \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      " with a decrease in \u001b[46m\u001b[30minterleukin 2 (IL-2)\u001b[0m, gamma interferon, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      " with a decrease in \u001b[46m\u001b[30minterleukin 2 (IL-2)\u001b[0m, gamma interferon, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "examined for c-fos, \u001b[46m\u001b[30mc-myc\u001b[0m, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "on of c-fos, c-jun, \u001b[46m\u001b[30mc-myc\u001b[0m, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "on of c-fos, c-jun, \u001b[46m\u001b[30mc-myc\u001b[0m, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "entrations of IL-2, \u001b[46m\u001b[30mIL-1beta\u001b[0m, and IL-6 \u001b[46m\u001b[30mmRNA\u001b[0m, and by the diminis\n",
      "e expression c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "e concentrations of \u001b[46m\u001b[30mIL-2\u001b[0m, IL-1beta, and IL-6 \u001b[46m\u001b[30mmRNA\u001b[0m, and by the diminis\n",
      "e concentrations of \u001b[46m\u001b[30mIL-2\u001b[0m, IL-1beta, and IL-6 \u001b[46m\u001b[30mmRNA\u001b[0m, and by the diminis\n",
      "kaline phosphatase, \u001b[46m\u001b[30mCD11b\u001b[0m, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "kaline phosphatase, \u001b[46m\u001b[30mCD11b\u001b[0m, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "entration of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "entration of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "entration of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "s were examined for \u001b[46m\u001b[30mc-fos\u001b[0m, c-myc, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "s were examined for \u001b[46m\u001b[30mc-fos\u001b[0m, c-myc, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "phosphatase, CD11b, \u001b[46m\u001b[30mCD33\u001b[0m, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "-fos, c-jun, c-myc, \u001b[46m\u001b[30mjunB\u001b[0m, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "\n",
      "('interferon', 'granulocyte-macrophage')\n",
      "terleukin 2 (IL-2), \u001b[46m\u001b[30mgamma interferon\u001b[0m, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "('-dependent', '-independent')\n",
      "icant effect on the \u001b[46m\u001b[30minsulin\u001b[0m-dependent and \u001b[46m\u001b[30m-independent PI 3-kinase activation\u001b[0m. These results indi\n",
      "vity in T cells via \u001b[46m\u001b[30mNF-kappaB\u001b[0m-dependent and \u001b[46m\u001b[30m-independent signaling pathways\u001b[0m. Replication of hum\n",
      "tigens occurred via \u001b[46m\u001b[30mtumor necrosis factor-alpha\u001b[0m-dependent and \u001b[46m\u001b[30m-independent mechanisms\u001b[0m. Our results sugges\n",
      "vity in T cells via \u001b[46m\u001b[30mNF-kappaB-dependent\u001b[0m and -independent \u001b[46m\u001b[30msignaling pathways\u001b[0m. Replication of hum\n",
      "icant effect on the \u001b[46m\u001b[30minsulin-dependent\u001b[0m and -independent \u001b[46m\u001b[30mPI 3-kinase activation\u001b[0m. These results indi\n",
      "\u001b[46m\u001b[30mNF-kappa B-dependent\u001b[0m and -independent \u001b[46m\u001b[30mpathways\u001b[0m of HIV activation i\n",
      "transduced via both \u001b[46m\u001b[30mNF-kappaB-dependent\u001b[0m and -independent \u001b[46m\u001b[30msignaling pathways\u001b[0m. The involvement of\n",
      "\u001b[46m\u001b[30mNF-kappa B\u001b[0m-dependent and \u001b[46m\u001b[30m-independent pathways\u001b[0m of HIV activation i\n",
      "tigens occurred via \u001b[46m\u001b[30mtumor necrosis factor-alpha-dependent\u001b[0m and -independent \u001b[46m\u001b[30mmechanisms\u001b[0m. Our results sugges\n",
      "c-myc expression by \u001b[46m\u001b[30mprotein synthesis-dependent\u001b[0m and -independent \u001b[46m\u001b[30mpathways\u001b[0m in a human T lympho\n",
      "transduced via both \u001b[46m\u001b[30mNF-kappaB\u001b[0m-dependent and \u001b[46m\u001b[30m-independent signaling pathways\u001b[0m. The involvement of\n",
      "c-myc expression by \u001b[46m\u001b[30mprotein synthesis\u001b[0m-dependent and \u001b[46m\u001b[30m-independent pathways\u001b[0m in a human T lympho\n",
      "\n",
      "('-m1', '-m2')\n",
      "human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2\u001b[0m proteins. Moreover,\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "(',', '-m2')\n",
      "human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2\u001b[0m proteins. Moreover,\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('calcineurin-', 'pkc-')\n",
      "cross-talk with the \u001b[46m\u001b[30mcalcineurin-\u001b[0m and PKC- \u001b[46m\u001b[30mdependent signaling systems\u001b[0m.\n",
      "\n",
      "('c-fos', 'c-jun')\n",
      "pression. Levels of \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mtranscripts\u001b[0m remained elevated d\n",
      " blood transfusion, \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mmRNA expression\u001b[0m were analyzed in tw\n",
      "ng to expression of \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mmRNA\u001b[0m. To investigate the\n",
      " lymphocyte maximum \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mexpression\u001b[0m (82+/-6 and 142+/-1\n",
      "umulation of either \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mmessenger RNA\u001b[0m (mRNA) occurred 30 \n",
      "\u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mmRNA expression\u001b[0m in activated cord a\n",
      "omitantly prevented \u001b[46m\u001b[30mTPA-induced\u001b[0m c-fos and \u001b[46m\u001b[30mc-jun gene expression\u001b[0m. (ABSTRACT TRUNCATE\n",
      " down regulation of \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mmRNA\u001b[0m in response to stim\n",
      "riene B4 stimulates \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mgene transcription\u001b[0m and AP-1 binding ac\n",
      "omitantly prevented \u001b[46m\u001b[30mTPA-induced c-fos\u001b[0m and c-jun \u001b[46m\u001b[30mgene expression\u001b[0m. (ABSTRACT TRUNCATE\n",
      "ctivation, both the \u001b[46m\u001b[30mc-fos\u001b[0m and the c-jun \u001b[46m\u001b[30mmRNA expression\u001b[0m was decreased. The \n",
      "ion, as analyzed by \u001b[46m\u001b[30mc-fos\u001b[0m and c-jun \u001b[46m\u001b[30mmRNA expression\u001b[0m, appears similar in\n",
      "\n",
      "('immunoglobulin', 'interleukin-2')\n",
      "in the promoters of \u001b[46m\u001b[30mimmunoglobulin\u001b[0m and interleukin-2 \u001b[46m\u001b[30mgenes\u001b[0m. All tumor cell lin\n",
      "\n",
      "('nf-kappab', 'sre/carg')\n",
      "244, which contains \u001b[46m\u001b[30mNF-kappaB\u001b[0m and SRE/CArG \u001b[46m\u001b[30mmotifs\u001b[0m. PRRII is a T-cell-\n",
      "\n",
      "('virus-encoded', 'cellular')\n",
      " a complex array of \u001b[46m\u001b[30mvirus-encoded\u001b[0m and cellular \u001b[46m\u001b[30mproteins\u001b[0m. Using various cons\n",
      "\n",
      "('tal-1', 'gata-1')\n",
      "ematopoietic cells, \u001b[46m\u001b[30mtal-1\u001b[0m and GATA-1 \u001b[46m\u001b[30mgenes\u001b[0m are coexpressed in \n",
      "\n",
      "('pre-b', 'b')\n",
      "e regulation of the \u001b[46m\u001b[30mpre-B\u001b[0m and B \u001b[46m\u001b[30mlymphocyte-specific mb-1 gene\u001b[0m. Partial amino acid\n",
      "representing pro-B, \u001b[46m\u001b[30mpre-B\u001b[0m, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      "\n",
      "('mast', 'lineage')\n",
      "rmally expressed in \u001b[46m\u001b[30merythroid\u001b[0m, mast and megakaryocyte \u001b[46m\u001b[30mlineages\u001b[0m. Northern analysis \n",
      "\n",
      "('erythroid', 'megakaryocyte')\n",
      "rmally expressed in \u001b[46m\u001b[30merythroid\u001b[0m, mast and megakaryocyte \u001b[46m\u001b[30mlineages\u001b[0m. Northern analysis \n",
      "\n",
      "('c-fos', 'c-myc')\n",
      "e expression of the \u001b[46m\u001b[30mc-fos\u001b[0m and c-myc \u001b[46m\u001b[30mproto-oncogenes\u001b[0m at the transcriptio\n",
      "\n",
      "('b', 'the')\n",
      "similarity with the \u001b[46m\u001b[30mNF kappa B\u001b[0m and the NF-activated T cell \u001b[46m\u001b[30mbinding sites\u001b[0m. We attempted to de\n",
      "\n",
      "('b', 't')\n",
      "similarity with the \u001b[46m\u001b[30mNF kappa B\u001b[0m and the NF-activated T cell \u001b[46m\u001b[30mbinding sites\u001b[0m. We attempted to de\n",
      "n of the factors in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m that regulate its a\n",
      "ctivity of A-MYB in \u001b[46m\u001b[30mB\u001b[0m and not T \u001b[46m\u001b[30mcells\u001b[0m was observed when e\n",
      "normal and leukemic \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcell precursors\u001b[0m and T lymphocytes. \n",
      "lineages, including \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocytes\u001b[0m, granulocytes, and \n",
      "he pp52 promoter in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m and provide the fou\n",
      "clear extracts from \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocytes\u001b[0m revealed a B-cell-s\n",
      "ogenic stimulation. \u001b[46m\u001b[30mResting\u001b[0m B and \u001b[46m\u001b[30mT lymphocytes\u001b[0m contain high levels\n",
      "ion factors. During \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcell differentiation\u001b[0m and proliferation m\n",
      " of ion channels in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocyte activation\u001b[0m is supported by man\n",
      "Stimulation of \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m activates expressio\n",
      "tment step into the \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphoid lineages\u001b[0m.\n",
      "ogenic stimulation. \u001b[46m\u001b[30mResting B\u001b[0m and T \u001b[46m\u001b[30mlymphocytes\u001b[0m contain high levels\n",
      "ortant cytokine for \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocyte function\u001b[0m and mediates its ef\n",
      " are inhibitory for \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m, IgE production, an\n",
      "are not involved in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocyte activation\u001b[0m and mitogenesis.\n",
      "rocesses related to \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcell activation\u001b[0m, the gene expressio\n",
      "ression of c-fos in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcell lines\u001b[0m: implication for c-\n",
      "yperpolarization in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m in a dose-dependent\n",
      "otable exception of \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocytes\u001b[0m. We now report that\n",
      "fos control through \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcell antigen receptors\u001b[0m.\n",
      "are not involved in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocyte\u001b[0m activation and mito\n",
      "ic pp52 promoter in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m. The leukocyte-spec\n",
      "uclear factor(s) in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m necessary for the f\n",
      "genic activation of \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocytes\u001b[0m and display impaire\n",
      "\n",
      "('b', 'cell')\n",
      "similarity with the \u001b[46m\u001b[30mNF kappa B\u001b[0m and the NF-activated T cell \u001b[46m\u001b[30mbinding sites\u001b[0m. We attempted to de\n",
      "\n",
      "('b', 'nf-activated')\n",
      "similarity with the \u001b[46m\u001b[30mNF kappa B\u001b[0m and the NF-activated T cell \u001b[46m\u001b[30mbinding sites\u001b[0m. We attempted to de\n",
      "\n",
      "('mrna', 'virus')\n",
      "otein LIP inhibited \u001b[46m\u001b[30mHIV-1\u001b[0m mRNA and \u001b[46m\u001b[30mvirus production\u001b[0m in activated U1 cel\n",
      "otein LIP inhibited \u001b[46m\u001b[30mHIV-1 mRNA\u001b[0m and virus \u001b[46m\u001b[30mproduction\u001b[0m in activated U1 cel\n",
      "\n",
      "('t', 'natural')\n",
      "notypic analysis of \u001b[46m\u001b[30mpossible T\u001b[0m and natural killer \u001b[46m\u001b[30mcells\u001b[0m in bone marrow. Her\n",
      "notypic analysis of \u001b[46m\u001b[30mpossible\u001b[0m T and \u001b[46m\u001b[30mnatural killer cells\u001b[0m in bone marrow. Her\n",
      "that stimulation of \u001b[46m\u001b[30mhuman T\u001b[0m and natural killer \u001b[46m\u001b[30mcells\u001b[0m with IL-12 induces \n",
      "that stimulation of \u001b[46m\u001b[30mhuman\u001b[0m T and \u001b[46m\u001b[30mnatural killer cells\u001b[0m with IL-12 induces \n",
      "\n",
      "('t', 'killer')\n",
      "notypic analysis of \u001b[46m\u001b[30mpossible T\u001b[0m and natural killer \u001b[46m\u001b[30mcells\u001b[0m in bone marrow. Her\n",
      "that stimulation of \u001b[46m\u001b[30mhuman T\u001b[0m and natural killer \u001b[46m\u001b[30mcells\u001b[0m with IL-12 induces \n",
      "\n",
      "('n-', 'c-')\n",
      "erences between the \u001b[46m\u001b[30mN-\u001b[0m and C- \u001b[46m\u001b[30mterminal SH2 domains\u001b[0m. Wortmannin did not\n",
      "ding activity. Both \u001b[46m\u001b[30mN-\u001b[0m and C-\u001b[46m\u001b[30mterminal residues\u001b[0m of I kappa B alpha \n",
      "\n",
      "('ku812f', 'cell')\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "luding HL-60, U937, \u001b[46m\u001b[30mHEL/S\u001b[0m, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('u937', 'cell')\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      " differentiation of \u001b[46m\u001b[30mHL-60\u001b[0m, U937 and HEL/S \u001b[46m\u001b[30mcells\u001b[0m. The erythroid diff\n",
      "\n",
      "('hel/s', 'cell')\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('hl-60', 'hel')\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('k562', 'cell')\n",
      "mic cells including \u001b[46m\u001b[30mHL-60\u001b[0m, U937, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "luding HL-60, U937, \u001b[46m\u001b[30mHEL/S\u001b[0m, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "HL-60, U937, HEL/S, \u001b[46m\u001b[30mKU812F\u001b[0m, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('homodimer', 'heterodimer')\n",
      "TATs promotes their \u001b[46m\u001b[30mhomodimer\u001b[0m and heterodimer \u001b[46m\u001b[30mformation\u001b[0m and subsequent nucl\n",
      "\n",
      "('glucocorticoid', 'mineralocorticoid')\n",
      "ated: the number of \u001b[46m\u001b[30mglucocorticoid\u001b[0m and mineralocorticoid \u001b[46m\u001b[30mbinding sites\u001b[0m grows in hypertensi\n",
      "-related changes in \u001b[46m\u001b[30mglucocorticoid\u001b[0m and mineralocorticoid \u001b[46m\u001b[30mreceptors\u001b[0m in lymphocytes of h\n",
      "\n",
      "('e-selectin', 'vcam-1')\n",
      "on the half-life of \u001b[46m\u001b[30mE-selectin\u001b[0m or VCAM-1 \u001b[46m\u001b[30mmRNA\u001b[0m. Although NAC reduc\n",
      "\n",
      "('p1', 'p4')\n",
      "e sites overlap the \u001b[46m\u001b[30mP1\u001b[0m, P2, and P4 \u001b[46m\u001b[30mNFAT elements\u001b[0m. To investigate the\n",
      "\n",
      "(',', 'nfat')\n",
      "e sites overlap the \u001b[46m\u001b[30mP1\u001b[0m, P2, and P4 \u001b[46m\u001b[30mNFAT elements\u001b[0m. To investigate the\n",
      "e sites overlap the \u001b[46m\u001b[30mP1\u001b[0m, P2, and P4 \u001b[46m\u001b[30mNFAT elements\u001b[0m. To investigate the\n",
      "tes overlap the P1, \u001b[46m\u001b[30mP2\u001b[0m, and P4 \u001b[46m\u001b[30mNFAT elements\u001b[0m. To investigate the\n",
      "\n",
      "('p2', 'nfat')\n",
      "e sites overlap the \u001b[46m\u001b[30mP1\u001b[0m, P2, and P4 \u001b[46m\u001b[30mNFAT elements\u001b[0m. To investigate the\n",
      "\n",
      "('m-csf', 'c-fms')\n",
      "e detection of both \u001b[46m\u001b[30mM-CSF\u001b[0m and c-fms \u001b[46m\u001b[30mexpression\u001b[0m by cells of the mon\n",
      "\n",
      "('mitogen-', 'stress-')\n",
      "phingomyelinase and \u001b[46m\u001b[30mmitogen-\u001b[0m and stress- \u001b[46m\u001b[30mactivated protein kinases\u001b[0m in T-lymphocyte cel\n",
      "\n",
      "('acidic', 'glutamine-rich')\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous acidic\u001b[0m, proline-rich, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, proline-rich, or \u001b[46m\u001b[30mglutamine-rich activation domain\u001b[0m. ZEBRA activation d\n",
      "\n",
      "('proline-rich', 'activation')\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous acidic\u001b[0m, proline-rich, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "\n",
      "(',', 'activation')\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous acidic\u001b[0m, proline-rich, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous acidic\u001b[0m, proline-rich, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, \u001b[46m\u001b[30mproline-rich\u001b[0m, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, \u001b[46m\u001b[30mproline-rich\u001b[0m, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "\n",
      "('lymphokine', 'receptor')\n",
      "cription of several \u001b[46m\u001b[30mlymphokine\u001b[0m and lymphokine receptor \u001b[46m\u001b[30mgenes\u001b[0m during the competen\n",
      "\n",
      "('lymphokine', 'lymphokine')\n",
      "cription of several \u001b[46m\u001b[30mlymphokine\u001b[0m and lymphokine receptor \u001b[46m\u001b[30mgenes\u001b[0m during the competen\n",
      "\n",
      "('pp-1', 'type')\n",
      "otent inhibitors of \u001b[46m\u001b[30mprotein phosphatase\u001b[0m type 1 (PP-1) and \u001b[46m\u001b[30mtype 2A\u001b[0m (PP-2A), induces th\n",
      "\n",
      "(')', 'type')\n",
      "otent inhibitors of \u001b[46m\u001b[30mprotein phosphatase\u001b[0m type 1 (PP-1) and \u001b[46m\u001b[30mtype 2A\u001b[0m (PP-2A), induces th\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('1', 'type')\n",
      "otent inhibitors of \u001b[46m\u001b[30mprotein phosphatase\u001b[0m type 1 (PP-1) and \u001b[46m\u001b[30mtype 2A\u001b[0m (PP-2A), induces th\n",
      "s harbouring either \u001b[46m\u001b[30mtype 1\u001b[0m or type 2 \u001b[46m\u001b[30mEBV\u001b[0m. The protein was fo\n",
      "\n",
      "('type', 'type')\n",
      "otent inhibitors of \u001b[46m\u001b[30mprotein phosphatase\u001b[0m type 1 (PP-1) and \u001b[46m\u001b[30mtype 2A\u001b[0m (PP-2A), induces th\n",
      " of hypercorticism. \u001b[46m\u001b[30mCorticosteroid\u001b[0m Type I and \u001b[46m\u001b[30mType II receptors\u001b[0m are inversely corre\n",
      " the present study, \u001b[46m\u001b[30mcorticosteroid\u001b[0m Type I and \u001b[46m\u001b[30mType II receptors\u001b[0m in mononuclear leuk\n",
      "nhibit induction of \u001b[46m\u001b[30mIL-1 receptor\u001b[0m type I and \u001b[46m\u001b[30mtype II gene expression\u001b[0m by IL-4 and IL-13 i\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "-1alpha promoter by \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I and \u001b[46m\u001b[30mtype II Tax proteins\u001b[0m. Human T-cell leuke\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('(', 'type')\n",
      "otent inhibitors of \u001b[46m\u001b[30mprotein phosphatase\u001b[0m type 1 (PP-1) and \u001b[46m\u001b[30mtype 2A\u001b[0m (PP-2A), induces th\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('normal', 'dex-resistant')\n",
      "eps in the lysis of \u001b[46m\u001b[30mnormal\u001b[0m and dex-resistant \u001b[46m\u001b[30mCEM cells\u001b[0m, or might serve as \n",
      "\n",
      "('voltage-gated', 'calcium-activated')\n",
      "d reversibly blocks \u001b[46m\u001b[30mvoltage-gated\u001b[0m and calcium-activated \u001b[46m\u001b[30mK+ channels\u001b[0m (KV and KCa, respec\n",
      "\n",
      "('lmp1', 'lmp2b')\n",
      "ven cases; however, \u001b[46m\u001b[30mneither\u001b[0m LMP1 nor \u001b[46m\u001b[30mLMP2B mRNA\u001b[0m was detected in any\n",
      "ven cases; however, \u001b[46m\u001b[30mneither LMP1\u001b[0m nor LMP2B \u001b[46m\u001b[30mmRNA\u001b[0m was detected in any\n",
      "\n",
      "('pyg', 'at')\n",
      " proteins bound the \u001b[46m\u001b[30mPyG\u001b[0m and AT \u001b[46m\u001b[30mboxes\u001b[0m. Mutations in the A\n",
      "\n",
      "('atf1-', 'creb-')\n",
      "IV together support \u001b[46m\u001b[30mATF1-\u001b[0m and CREB-\u001b[46m\u001b[30minduced trans-activation\u001b[0m of the H4 promoter.\n",
      "\n",
      "('severe', 'symptomatic')\n",
      "seven patients with \u001b[46m\u001b[30msevere\u001b[0m and symptomatic \u001b[46m\u001b[30mVKC\u001b[0m for the presence of\n",
      "\n",
      "('m7', 'tmd')\n",
      "st of the blasts in \u001b[46m\u001b[30mM7\u001b[0m and TMD \u001b[46m\u001b[30mcases\u001b[0m have erythroid and \n",
      "\n",
      "('serum', 'tumor')\n",
      "o respond to either \u001b[46m\u001b[30mserum\u001b[0m or tumor \u001b[46m\u001b[30mnecrosis factor alpha\u001b[0m. Therefore, to eval\n",
      "\n",
      "('raf-1', 'mek1')\n",
      "nt caused by active \u001b[46m\u001b[30mRaf-1\u001b[0m and MEK1 \u001b[46m\u001b[30mexpression\u001b[0m. We conclude that t\n",
      "\n",
      "('transcriptional', 'posttranscriptional')\n",
      "\u001b[46m\u001b[30mTranscriptional\u001b[0m and posttranscriptional \u001b[46m\u001b[30mregulation\u001b[0m of erythroid gene e\n",
      "at Epo acts at both \u001b[46m\u001b[30mtranscriptional\u001b[0m and posttranscriptional \u001b[46m\u001b[30mlevels\u001b[0m on the TAL1 locus i\n",
      "\n",
      "(',', 'activity')\n",
      "ivity but not IL-1, \u001b[46m\u001b[30mIL-2\u001b[0m, or IL-4 \u001b[46m\u001b[30mactivity\u001b[0m was present in cult\n",
      "m the medulla. p65, \u001b[46m\u001b[30mp50\u001b[0m, and c-Rel \u001b[46m\u001b[30mactivities\u001b[0m were found in both \n",
      "l effects including \u001b[46m\u001b[30mantitumor\u001b[0m, antiinflammatory, and antiinfectious \u001b[46m\u001b[30mactivities\u001b[0m. Although its preci\n",
      "l effects including \u001b[46m\u001b[30mantitumor\u001b[0m, antiinflammatory, and antiinfectious \u001b[46m\u001b[30mactivities\u001b[0m. Although its preci\n",
      "s from the medulla. \u001b[46m\u001b[30mp65\u001b[0m, p50, and c-Rel \u001b[46m\u001b[30mactivities\u001b[0m were found in both \n",
      "s from the medulla. \u001b[46m\u001b[30mp65\u001b[0m, p50, and c-Rel \u001b[46m\u001b[30mactivities\u001b[0m were found in both \n",
      "ma activity but not \u001b[46m\u001b[30mIL-1\u001b[0m, IL-2, or IL-4 \u001b[46m\u001b[30mactivity\u001b[0m was present in cult\n",
      "ma activity but not \u001b[46m\u001b[30mIL-1\u001b[0m, IL-2, or IL-4 \u001b[46m\u001b[30mactivity\u001b[0m was present in cult\n",
      "ncluding antitumor, \u001b[46m\u001b[30mantiinflammatory\u001b[0m, and antiinfectious \u001b[46m\u001b[30mactivities\u001b[0m. Although its preci\n",
      "\n",
      "('il-2', 'il-4')\n",
      "ivity but not IL-1, \u001b[46m\u001b[30mIL-2\u001b[0m, or IL-4 \u001b[46m\u001b[30mactivity\u001b[0m was present in cult\n",
      " proteins recognize \u001b[46m\u001b[30mIL-2\u001b[0m and IL-4 \u001b[46m\u001b[30mgenes\u001b[0m.\n",
      "\n",
      "('blood', 'nk')\n",
      "e key regulators of \u001b[46m\u001b[30mhuman\u001b[0m peripheral blood T and \u001b[46m\u001b[30mNK cell activation\u001b[0m and differentiation\n",
      "\n",
      "('peripheral', 'nk')\n",
      "e key regulators of \u001b[46m\u001b[30mhuman\u001b[0m peripheral blood T and \u001b[46m\u001b[30mNK cell activation\u001b[0m and differentiation\n",
      "\n",
      "('t', 'nk')\n",
      "e key regulators of \u001b[46m\u001b[30mhuman\u001b[0m peripheral blood T and \u001b[46m\u001b[30mNK cell activation\u001b[0m and differentiation\n",
      "ivation of STATs in \u001b[46m\u001b[30mprimary human\u001b[0m T and \u001b[46m\u001b[30mNK cells\u001b[0m by a variety of spe\n",
      "th fast kinetics in \u001b[46m\u001b[30mT\u001b[0m and NK \u001b[46m\u001b[30mcells\u001b[0m upon IL-2, but not \n",
      "e key regulators of \u001b[46m\u001b[30mhuman peripheral blood T\u001b[0m and NK \u001b[46m\u001b[30mcell activation\u001b[0m and differentiation\n",
      "ymic development of \u001b[46m\u001b[30mT\u001b[0m and NK \u001b[46m\u001b[30mcells\u001b[0m.\n",
      "f STAT complexes in \u001b[46m\u001b[30mprimary human T\u001b[0m and NK \u001b[46m\u001b[30mcells\u001b[0m. Cytokines, IL-2, I\n",
      "f STAT complexes in \u001b[46m\u001b[30mprimary human\u001b[0m T and \u001b[46m\u001b[30mNK cells\u001b[0m. Cytokines, IL-2, I\n",
      "ivation of STATs in \u001b[46m\u001b[30mprimary human T\u001b[0m and NK \u001b[46m\u001b[30mcells\u001b[0m by a variety of spe\n",
      "iated activation of \u001b[46m\u001b[30mT\u001b[0m and NK \u001b[46m\u001b[30mcells\u001b[0m does not involve ex\n",
      "binding patterns in \u001b[46m\u001b[30mT\u001b[0m and NK \u001b[46m\u001b[30mcells\u001b[0m, suggesting that th\n",
      "\n",
      "('stat3-', 'stat5-')\n",
      " in ALL and STAT1-, \u001b[46m\u001b[30mSTAT3-\u001b[0m, and STAT5-\u001b[46m\u001b[30mrelated proteins\u001b[0m were present in nuc\n",
      "\n",
      "(',', 'related')\n",
      " in ALL and STAT1-, \u001b[46m\u001b[30mSTAT3-\u001b[0m, and STAT5-\u001b[46m\u001b[30mrelated proteins\u001b[0m were present in nuc\n",
      "detected in ALL and \u001b[46m\u001b[30mSTAT1-\u001b[0m, STAT3-, and STAT5-\u001b[46m\u001b[30mrelated proteins\u001b[0m were present in nuc\n",
      "detected in ALL and \u001b[46m\u001b[30mSTAT1-\u001b[0m, STAT3-, and STAT5-\u001b[46m\u001b[30mrelated proteins\u001b[0m were present in nuc\n",
      "\n",
      "('fy*a', 'fy*b')\n",
      "d Fyb (coded by the \u001b[46m\u001b[30mFY*A\u001b[0m and FY*B \u001b[46m\u001b[30malleles\u001b[0m), are present on er\n",
      "acterization of the \u001b[46m\u001b[30mFY*A\u001b[0m and FY*B \u001b[46m\u001b[30malleles\u001b[0m, these findings pro\n",
      "\n",
      "('binding', 'transducing')\n",
      ", a recently cloned \u001b[46m\u001b[30mbinding\u001b[0m and signal transducing \u001b[46m\u001b[30mcomponent\u001b[0m of the IL-12R, is e\n",
      "\n",
      "('binding', 'signal')\n",
      ", a recently cloned \u001b[46m\u001b[30mbinding\u001b[0m and signal transducing \u001b[46m\u001b[30mcomponent\u001b[0m of the IL-12R, is e\n",
      "\n",
      "('th1', 'th2')\n",
      "r examination using \u001b[46m\u001b[30mnon-transformed murine Th1\u001b[0m and Th2 \u001b[46m\u001b[30mclones\u001b[0m suggested that a ba\n",
      "tially expressed in \u001b[46m\u001b[30mmurine Th1\u001b[0m and Th2 \u001b[46m\u001b[30mcells\u001b[0m and controls Th2-sp\n",
      "he IL-4 promoter of \u001b[46m\u001b[30mTh1\u001b[0m and Th2 \u001b[46m\u001b[30mcells\u001b[0m. We show that PRE-I\n",
      "r examination using \u001b[46m\u001b[30mnon-transformed murine\u001b[0m Th1 and \u001b[46m\u001b[30mTh2 clones\u001b[0m suggested that a ba\n",
      "n apoptosis in Th0, \u001b[46m\u001b[30mTh1\u001b[0m, and Th2 \u001b[46m\u001b[30mclones\u001b[0m. We also found that\n",
      "une response toward \u001b[46m\u001b[30mTh1\u001b[0m or Th2 \u001b[46m\u001b[30mdifferentiation\u001b[0m. We have examined e\n",
      "press inflammation. \u001b[46m\u001b[30mTh1\u001b[0m and Th2 \u001b[46m\u001b[30meffector functions\u001b[0m and their developme\n",
      "ine is different in \u001b[46m\u001b[30mTh1\u001b[0m and Th2 \u001b[46m\u001b[30mcells\u001b[0m. Our results imply \n",
      "l differences (e.g. \u001b[46m\u001b[30mTh1\u001b[0m or Th2 \u001b[46m\u001b[30mdifferentiation\u001b[0m) in T cell response\n",
      "tially expressed in \u001b[46m\u001b[30mmurine\u001b[0m Th1 and \u001b[46m\u001b[30mTh2 cells\u001b[0m and controls Th2-sp\n",
      "\n",
      "('t', 'b')\n",
      "are not involved in \u001b[46m\u001b[30mhuman\u001b[0m T or \u001b[46m\u001b[30mB cell activation\u001b[0m and proliferation. \n",
      "T cells) complex in \u001b[46m\u001b[30mhuman\u001b[0m T and \u001b[46m\u001b[30mB lymphocytes\u001b[0m. Nuclear factor of \n",
      "on in phorbol ester \u001b[46m\u001b[30mstimulated\u001b[0m T and \u001b[46m\u001b[30mB cell lines\u001b[0m. The minimal region\n",
      "ID was nonrandom in \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m. In addition, X chr\n",
      " expressing CD40 in \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mcell co-cultures\u001b[0m increased from 4.2%\n",
      "er mitogen binding. \u001b[46m\u001b[30mHuman T\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m demonstrate an earl\n",
      "T cells) complex in \u001b[46m\u001b[30mhuman T\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m. Nuclear factor of \n",
      "upon stimulation of \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m via antigen and cyt\n",
      "x formation in both \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mcells\u001b[0m. We therefore propo\n",
      " the choice between \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m. Transgenic mice wi\n",
      "er mitogen binding. \u001b[46m\u001b[30mHuman\u001b[0m T and \u001b[46m\u001b[30mB lymphocytes\u001b[0m demonstrate an earl\n",
      "human monocytes and \u001b[46m\u001b[30mactivated T\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m. Variation in the v\n",
      "ing effects on both \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mcell function\u001b[0m. Our laboratory has\n",
      "human monocytes and \u001b[46m\u001b[30mactivated\u001b[0m T and \u001b[46m\u001b[30mB lymphocytes\u001b[0m. Variation in the v\n",
      "eage choice between \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m is genetically defe\n",
      " differentiation of \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m, natural killer cel\n",
      " of Ag receptors in \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m initiates signal tr\n",
      "nger RNA present in \u001b[46m\u001b[30mhuman\u001b[0m T and \u001b[46m\u001b[30mB lymphocytes\u001b[0m. In vitro transcrip\n",
      "oliferation of both \u001b[46m\u001b[30mT\u001b[0m and, to a lesser extent, B \u001b[46m\u001b[30mcells\u001b[0m. The percentage of \n",
      "t involved in human \u001b[46m\u001b[30mT\u001b[0m or B \u001b[46m\u001b[30mcell\u001b[0m activation and prol\n",
      " NFAT motif in both \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mcells\u001b[0m, indicating that Ju\n",
      "nger RNA present in \u001b[46m\u001b[30mhuman T\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m. In vitro transcrip\n",
      "are not involved in \u001b[46m\u001b[30mhuman T\u001b[0m or B \u001b[46m\u001b[30mcell activation\u001b[0m and proliferation. \n",
      "r is formed in both \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mcells\u001b[0m, but an additional \n",
      "ve. Macrophages and \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m infiltrated the tum\n",
      "s-acting factors of \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m (e.g. NF-kB, NF-AT \n",
      "played by different \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mcell lines\u001b[0m. Moreover, kappa 1-\n",
      "cription factors of \u001b[46m\u001b[30mT\u001b[0m and B \u001b[46m\u001b[30mlymphocytes\u001b[0m--basic research and\n",
      "on in phorbol ester \u001b[46m\u001b[30mstimulated T\u001b[0m and B \u001b[46m\u001b[30mcell lines\u001b[0m. The minimal region\n",
      "\n",
      "('ap1', '-like')\n",
      "cting elements with \u001b[46m\u001b[30mNFkappaB\u001b[0m, AP1 and ETS\u001b[46m\u001b[30m-like binding motifs\u001b[0m have been identifie\n",
      "\n",
      "('nfkappab', 'ets')\n",
      "cting elements with \u001b[46m\u001b[30mNFkappaB\u001b[0m, AP1 and ETS\u001b[46m\u001b[30m-like binding motifs\u001b[0m have been identifie\n",
      "\n",
      "(',', '-like')\n",
      "cting elements with \u001b[46m\u001b[30mNFkappaB\u001b[0m, AP1 and ETS\u001b[46m\u001b[30m-like binding motifs\u001b[0m have been identifie\n",
      "\n",
      "('allergic', 'parasitic')\n",
      "the pathogenesis of \u001b[46m\u001b[30mallergic\u001b[0m and parasitic \u001b[46m\u001b[30mdisorders\u001b[0m. Recently, there ha\n",
      "\n",
      "('molt-4', 'cem')\n",
      " the cell growth of \u001b[46m\u001b[30mMOLT-4\u001b[0m and CEM \u001b[46m\u001b[30mcells\u001b[0m, although all of th\n",
      "normal lymphocytes, \u001b[46m\u001b[30mMOLT-4\u001b[0m and CEM \u001b[46m\u001b[30mcells\u001b[0m exhibited an altere\n",
      "\n",
      "('caccc', 'ccaat')\n",
      "l elements, such as \u001b[46m\u001b[30mCACCC\u001b[0m and CCAAT \u001b[46m\u001b[30mmotifs\u001b[0m. The adult globin e\n",
      "\n",
      "(',', 'site')\n",
      "bind to the NF-AT1, \u001b[46m\u001b[30mAP-1\u001b[0m, and NF-kB \u001b[46m\u001b[30msites\u001b[0m located in the prom\n",
      "ncer containing the \u001b[46m\u001b[30mmuA\u001b[0m, muE3, and muB \u001b[46m\u001b[30msites\u001b[0m is transactivated b\n",
      "ncer containing the \u001b[46m\u001b[30mmuA\u001b[0m, muE3, and muB \u001b[46m\u001b[30msites\u001b[0m is transactivated b\n",
      "rs that bind to the \u001b[46m\u001b[30mNF-AT1\u001b[0m, AP-1, and NF-kB \u001b[46m\u001b[30msites\u001b[0m located in the prom\n",
      "rs that bind to the \u001b[46m\u001b[30mNF-AT1\u001b[0m, AP-1, and NF-kB \u001b[46m\u001b[30msites\u001b[0m located in the prom\n",
      "containing the muA, \u001b[46m\u001b[30mmuE3\u001b[0m, and muB \u001b[46m\u001b[30msites\u001b[0m is transactivated b\n",
      "\n",
      "('ap-1', 'nf-kb')\n",
      "bind to the NF-AT1, \u001b[46m\u001b[30mAP-1\u001b[0m, and NF-kB \u001b[46m\u001b[30msites\u001b[0m located in the prom\n",
      "L-2 promoter or its \u001b[46m\u001b[30mAP-1\u001b[0m, NF-AT, and NF-kB \u001b[46m\u001b[30mmotifs\u001b[0m. Dex inhibited the \n",
      "\n",
      "('1', '2a')\n",
      "id, an inhibitor of \u001b[46m\u001b[30mphosphatases\u001b[0m 1 and \u001b[46m\u001b[30m2A\u001b[0m, did not overcome t\n",
      " human monocytes by \u001b[46m\u001b[30mprotein phosphatase 1\u001b[0m and 2A \u001b[46m\u001b[30minhibitors\u001b[0m. Protein phosphatas\n",
      "id, an inhibitor of \u001b[46m\u001b[30mserine/threonine protein phosphatases\u001b[0m 1 and \u001b[46m\u001b[30m2A\u001b[0m, was associated wit\n",
      " human monocytes by \u001b[46m\u001b[30mprotein phosphatase\u001b[0m 1 and \u001b[46m\u001b[30m2A inhibitors\u001b[0m. Protein phosphatas\n",
      "id, an inhibitor of \u001b[46m\u001b[30mtype 1\u001b[0m and 2A \u001b[46m\u001b[30mprotein phosphatases\u001b[0m, on the regulation \n",
      "e results show that \u001b[46m\u001b[30mprotein phosphatase 1\u001b[0m and 2A \u001b[46m\u001b[30minhibitors\u001b[0m exert multiple effe\n",
      "id, an inhibitor of \u001b[46m\u001b[30mtype\u001b[0m 1 and \u001b[46m\u001b[30m2A phosphatases\u001b[0m, and nuclear extrac\n",
      "e results show that \u001b[46m\u001b[30mprotein phosphatase\u001b[0m 1 and \u001b[46m\u001b[30m2A inhibitors\u001b[0m exert multiple effe\n",
      "id, an inhibitor of \u001b[46m\u001b[30mtype 1\u001b[0m and 2A \u001b[46m\u001b[30mphosphatases\u001b[0m, and nuclear extrac\n",
      " acid suggests that \u001b[46m\u001b[30mprotein phosphatases\u001b[0m 1 and \u001b[46m\u001b[30m2A\u001b[0m (PP1 and PP2A) may \n",
      "id, an inhibitor of \u001b[46m\u001b[30mtype\u001b[0m 1 and \u001b[46m\u001b[30m2A protein phosphatases\u001b[0m, on the regulation \n",
      " and 2A inhibitors. \u001b[46m\u001b[30mProtein phosphatases\u001b[0m 1 and \u001b[46m\u001b[30m2A\u001b[0m are important in re\n",
      "id, an inhibitor of \u001b[46m\u001b[30mphosphatases\u001b[0m 1 and \u001b[46m\u001b[30m2A\u001b[0m, resulted in the in\n",
      "\n",
      "('fetal', 'adult')\n",
      "pressing either the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin developmental program\u001b[0m. In the locus contr\n",
      " work, we show that \u001b[46m\u001b[30mhuman fetal\u001b[0m and adult \u001b[46m\u001b[30merythroid progenitors\u001b[0m are distinct in the\n",
      "olocomplex with the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin gene\u001b[0m.\n",
      " work, we show that \u001b[46m\u001b[30mhuman\u001b[0m fetal and \u001b[46m\u001b[30madult erythroid progenitors\u001b[0m are distinct in the\n",
      "ells expressing the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin program\u001b[0m. In promoter region\n",
      "ells expressing the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin gene program\u001b[0m. To characterize th\n",
      "ed that TPO induced \u001b[46m\u001b[30mfetal\u001b[0m and adult \u001b[46m\u001b[30mHb synthesis\u001b[0m, whereas EPO induce\n",
      " induced embryonic, \u001b[46m\u001b[30mfetal\u001b[0m, and adult \u001b[46m\u001b[30mHb synthesis\u001b[0m. Thus, our data sug\n",
      "ntial dependency of \u001b[46m\u001b[30mfetal\u001b[0m and adult \u001b[46m\u001b[30mB-lymphopoiesis\u001b[0m on this transcripti\n",
      "\n",
      "('fetal', 'the')\n",
      "pressing either the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin developmental program\u001b[0m. In the locus contr\n",
      "olocomplex with the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin gene\u001b[0m.\n",
      "ells expressing the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin program\u001b[0m. In promoter region\n",
      "ells expressing the \u001b[46m\u001b[30mfetal\u001b[0m or the adult \u001b[46m\u001b[30mglobin gene program\u001b[0m. To characterize th\n",
      "\n",
      "('ap-1', 'elf-1')\n",
      "e activities of the \u001b[46m\u001b[30mAP-1\u001b[0m and Elf-1 \u001b[46m\u001b[30msites\u001b[0m in the IL-3 promote\n",
      "\n",
      "('c-jun', 'gst-pi')\n",
      "\u001b[46m\u001b[30mc-Jun\u001b[0m and GST-pi \u001b[46m\u001b[30mexpression\u001b[0m in human plasma cel\n",
      "\n",
      "('jun', 'fo')\n",
      "members of both the \u001b[46m\u001b[30mjun\u001b[0m and fos \u001b[46m\u001b[30mgene families\u001b[0m. These data indicat\n",
      "The role of \u001b[46m\u001b[30mjun\u001b[0m and fos \u001b[46m\u001b[30mgene family members\u001b[0m in 12-O-tetradecano\n",
      "l activation of the \u001b[46m\u001b[30mjun\u001b[0m and fos \u001b[46m\u001b[30mfamily\u001b[0m of proto-oncogenes.\n",
      " motif and that the \u001b[46m\u001b[30mJun\u001b[0m and Fos \u001b[46m\u001b[30mfamilies\u001b[0m of transcription fa\n",
      "yses indicated that \u001b[46m\u001b[30mfunctional Jun\u001b[0m and Fos \u001b[46m\u001b[30mproteins\u001b[0m were present in nuc\n",
      "t the expression of \u001b[46m\u001b[30mjun\u001b[0m and fos \u001b[46m\u001b[30mgene family members\u001b[0m is induced with var\n",
      "urified recombinant \u001b[46m\u001b[30mJun\u001b[0m and Fos \u001b[46m\u001b[30mproteins\u001b[0m failed to bind dire\n",
      "yses indicated that \u001b[46m\u001b[30mfunctional\u001b[0m Jun and \u001b[46m\u001b[30mFos proteins\u001b[0m were present in nuc\n",
      "Regulation of \u001b[46m\u001b[30mjun\u001b[0m and fos \u001b[46m\u001b[30mgene expression\u001b[0m in human monocytes \n",
      "g expression of the \u001b[46m\u001b[30mjun\u001b[0m and fos \u001b[46m\u001b[30mearly response genes\u001b[0m. Low levels of c-ju\n",
      "\n",
      "('tarsal', 'bulbar')\n",
      "e authors evaluated \u001b[46m\u001b[30mtarsal\u001b[0m and bulbar \u001b[46m\u001b[30mconjunctival biopsies\u001b[0m from seven patients\n",
      "ubepithelium of the \u001b[46m\u001b[30mtarsal\u001b[0m and bulbar \u001b[46m\u001b[30mconjunctiva\u001b[0m of patients with VK\n",
      "\n",
      "('beta', 'alpha')\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "induced increase in \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6 or TNF alpha \u001b[46m\u001b[30mmRNA levels\u001b[0m. Furthermore, the p\n",
      "duced expression of \u001b[46m\u001b[30mIL-1 beta\u001b[0m and TNF alpha \u001b[46m\u001b[30mmRNA\u001b[0m in the monocytic TH\n",
      "\n",
      "('-beta', 'gene')\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP alpha\u001b[0m and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('alpha', 'gene')\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('dp', 'gene')\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "(',', 'gene')\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "tion studies on the \u001b[46m\u001b[30mPU.1\u001b[0m, Ikaros and GATA-3 \u001b[46m\u001b[30mgenes\u001b[0m have revealed that \n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "ial response: CREB, \u001b[46m\u001b[30mCTF\u001b[0m, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "ial response: CREB, \u001b[46m\u001b[30mCTF\u001b[0m, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "ial response: CREB, \u001b[46m\u001b[30mCTF\u001b[0m, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "d no effect on p53, \u001b[46m\u001b[30mBax\u001b[0m, or Bak \u001b[46m\u001b[30mgene expression\u001b[0m. Mechanisms for tra\n",
      "nterleukin-2, CD44, \u001b[46m\u001b[30mICAM-1\u001b[0m, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "ences of the CD11a, \u001b[46m\u001b[30mCD11b\u001b[0m, and CD11c \u001b[46m\u001b[30mgene promoters\u001b[0m to identify common \n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      ": CREB, CTF, OTF-1, \u001b[46m\u001b[30mOFT-2\u001b[0m, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "uppress IL-1 alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "uppress IL-1 alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "uppress IL-1 alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "ropic regulators of \u001b[46m\u001b[30mimmunoregulatory\u001b[0m, cytokine and viral \u001b[46m\u001b[30mgene expression\u001b[0m. In this report, we\n",
      "Abnormalities of \u001b[46m\u001b[30mp16\u001b[0m, p15 and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m in recurrent malign\n",
      " alterations in the \u001b[46m\u001b[30mp16\u001b[0m, p15 or CDK4 \u001b[46m\u001b[30mgenes\u001b[0m, whereas homozygous\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins 2\u001b[0m, 3, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins 2\u001b[0m, 3, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins 2\u001b[0m, 3, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "a, IL-1 beta, IL-6, \u001b[46m\u001b[30mIL-8\u001b[0m, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      " the interleukin-2, \u001b[46m\u001b[30mCD44\u001b[0m, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      " the interleukin-2, \u001b[46m\u001b[30mCD44\u001b[0m, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "esponse: CREB, CTF, \u001b[46m\u001b[30mOTF-1\u001b[0m, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "esponse: CREB, CTF, \u001b[46m\u001b[30mOTF-1\u001b[0m, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "bnormalities in the \u001b[46m\u001b[30mp16\u001b[0m, p15 and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m that regulate trans\n",
      "1 alpha, IL-1 beta, \u001b[46m\u001b[30mIL-6\u001b[0m, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "1 alpha, IL-1 beta, \u001b[46m\u001b[30mIL-6\u001b[0m, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "expression of IL-3, \u001b[46m\u001b[30mGM-CSF\u001b[0m, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "de sequences of the \u001b[46m\u001b[30mCD11a\u001b[0m, CD11b, and CD11c \u001b[46m\u001b[30mgene promoters\u001b[0m to identify common \n",
      "de sequences of the \u001b[46m\u001b[30mCD11a\u001b[0m, CD11b, and CD11c \u001b[46m\u001b[30mgene promoters\u001b[0m to identify common \n",
      "ut had no effect on \u001b[46m\u001b[30mp53\u001b[0m, Bax, or Bak \u001b[46m\u001b[30mgene expression\u001b[0m. Mechanisms for tra\n",
      "ut had no effect on \u001b[46m\u001b[30mp53\u001b[0m, Bax, or Bak \u001b[46m\u001b[30mgene expression\u001b[0m. Mechanisms for tra\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "d (3) expression of \u001b[46m\u001b[30mIL-3\u001b[0m, GM-CSF, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "d (3) expression of \u001b[46m\u001b[30mIL-3\u001b[0m, GM-CSF, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP alpha\u001b[0m and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('beta', 'dq')\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('and', 'gene')\n",
      "d in the DNA of the \u001b[46m\u001b[30mDR beta\u001b[0m, DP alpha and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA-1\u001b[0m and -2 or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP alpha\u001b[0m and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "(',', 'sequence')\n",
      "ically to the AP-1, \u001b[46m\u001b[30mAP-2\u001b[0m, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "ns of several other \u001b[46m\u001b[30mhuman\u001b[0m, mouse, and Drosophila \u001b[46m\u001b[30msequences\u001b[0m, defining a subfami\n",
      "ns of several other \u001b[46m\u001b[30mhuman\u001b[0m, mouse, and Drosophila \u001b[46m\u001b[30msequences\u001b[0m, defining a subfami\n",
      "plex formation with \u001b[46m\u001b[30mNF-AT\u001b[0m, AP-1 and CLE0 \u001b[46m\u001b[30msequences\u001b[0m when the cells were\n",
      "everal other human, \u001b[46m\u001b[30mmouse\u001b[0m, and Drosophila \u001b[46m\u001b[30msequences\u001b[0m, defining a subfami\n",
      "specifically to the \u001b[46m\u001b[30mAP-1\u001b[0m, AP-2, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "specifically to the \u001b[46m\u001b[30mAP-1\u001b[0m, AP-2, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "\n",
      "('ap-2', 'nf')\n",
      "ically to the AP-1, \u001b[46m\u001b[30mAP-2\u001b[0m, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "\n",
      "('ap-2', 'b')\n",
      "ically to the AP-1, \u001b[46m\u001b[30mAP-2\u001b[0m, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "\n",
      "('ap-2', 'kappa')\n",
      "ically to the AP-1, \u001b[46m\u001b[30mAP-2\u001b[0m, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "\n",
      "('myeloid', 'cell')\n",
      "n the commitment to \u001b[46m\u001b[30merythroid\u001b[0m, myeloid and lymphoid \u001b[46m\u001b[30mcell types\u001b[0m is summarized.\n",
      "demonstrate that in \u001b[46m\u001b[30mmyeloid\u001b[0m and B cell \u001b[46m\u001b[30mextracts\u001b[0m, PU.1 forms a novel\n",
      "\n",
      "('erythroid', 'lymphoid')\n",
      "n the commitment to \u001b[46m\u001b[30merythroid\u001b[0m, myeloid and lymphoid \u001b[46m\u001b[30mcell types\u001b[0m is summarized.\n",
      "\n",
      "('i', 'type')\n",
      " of hypercorticism. \u001b[46m\u001b[30mCorticosteroid\u001b[0m Type I and \u001b[46m\u001b[30mType II receptors\u001b[0m are inversely corre\n",
      " the present study, \u001b[46m\u001b[30mcorticosteroid\u001b[0m Type I and \u001b[46m\u001b[30mType II receptors\u001b[0m in mononuclear leuk\n",
      "nhibit induction of \u001b[46m\u001b[30mIL-1 receptor\u001b[0m type I and \u001b[46m\u001b[30mtype II gene expression\u001b[0m by IL-4 and IL-13 i\n",
      " the present study, \u001b[46m\u001b[30mcorticosteroid Type I\u001b[0m and Type II \u001b[46m\u001b[30mreceptors\u001b[0m in mononuclear leuk\n",
      "onist (IL-1ra), and \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30mIL-1 receptors\u001b[0m (IL-1R). IFN-gamma \n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "-1alpha promoter by \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I and \u001b[46m\u001b[30mtype II Tax proteins\u001b[0m. Human T-cell leuke\n",
      "c leukaemia gene by \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30minterferons\u001b[0m. The physiological \n",
      "-1alpha promoter by \u001b[46m\u001b[30mhuman T-cell leukemia virus type I\u001b[0m and type II \u001b[46m\u001b[30mTax proteins\u001b[0m. Human T-cell leuke\n",
      "isol. The number of \u001b[46m\u001b[30mType I\u001b[0m and Type II \u001b[46m\u001b[30mreceptors\u001b[0m before the test was\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      " of hypercorticism. \u001b[46m\u001b[30mCorticosteroid Type I\u001b[0m and Type II \u001b[46m\u001b[30mreceptors\u001b[0m are inversely corre\n",
      " The mean number of \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30mreceptors\u001b[0m was significantly l\n",
      "cts of IFN-gamma on \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30mIL-1R gene expression\u001b[0m have not been defin\n",
      "nhibit induction of \u001b[46m\u001b[30mIL-1 receptor type I\u001b[0m and type II \u001b[46m\u001b[30mgene expression\u001b[0m by IL-4 and IL-13 i\n",
      "\n",
      "('e1a-', 'e1b-')\n",
      "able to efficiently \u001b[46m\u001b[30mcross-prime E1A-\u001b[0m and E1B-\u001b[46m\u001b[30mspecific CTLs\u001b[0m following immunizat\n",
      "able to efficiently \u001b[46m\u001b[30mcross-prime\u001b[0m E1A- and \u001b[46m\u001b[30mE1B-specific CTLs\u001b[0m following immunizat\n",
      "e not recognized by \u001b[46m\u001b[30mE1A-\u001b[0m or E1B-\u001b[46m\u001b[30mspecific CTLs\u001b[0m unless the relevant\n",
      "\n",
      "('positively', 'negatively')\n",
      "same arrangement of \u001b[46m\u001b[30mpositively\u001b[0m and negatively \u001b[46m\u001b[30macting sequences\u001b[0m has been conserved \n",
      "\n",
      "('nm23', '-m2')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('-h2', '-m2')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "\n",
      "(',', 'protein')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "Involvement of Rel, \u001b[46m\u001b[30mFos\u001b[0m, and Jun \u001b[46m\u001b[30mproteins\u001b[0m in binding activity\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "Involvement of \u001b[46m\u001b[30mRel\u001b[0m, Fos, and Jun \u001b[46m\u001b[30mproteins\u001b[0m in binding activity\n",
      "Involvement of \u001b[46m\u001b[30mRel\u001b[0m, Fos, and Jun \u001b[46m\u001b[30mproteins\u001b[0m in binding activity\n",
      " chain and activate \u001b[46m\u001b[30mSTAT6\u001b[0m, STAT3 and STAT5 \u001b[46m\u001b[30mproteins\u001b[0m in normal human B c\n",
      "\n",
      "('-h1', 'protein')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('-m1', 'protein')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('nm23', 'protein')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('mouse', 'protein')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23\u001b[0m-H1, \u001b[46m\u001b[30m-H2\u001b[0m, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "(',', 'v')\n",
      "in the tal-1 locus. \u001b[46m\u001b[30mHS\u001b[0m I, IV, and \u001b[46m\u001b[30mV\u001b[0m were exclusively ob\n",
      "in the tal-1 locus. \u001b[46m\u001b[30mHS\u001b[0m I, IV, and \u001b[46m\u001b[30mV\u001b[0m were exclusively ob\n",
      "\n",
      "('i', 'v')\n",
      "in the tal-1 locus. \u001b[46m\u001b[30mHS\u001b[0m I, IV, and \u001b[46m\u001b[30mV\u001b[0m were exclusively ob\n",
      "\n",
      "('iv', 'v')\n",
      "in the tal-1 locus. \u001b[46m\u001b[30mHS\u001b[0m I, IV, and \u001b[46m\u001b[30mV\u001b[0m were exclusively ob\n",
      "\n",
      "('p50', 'p65')\n",
      "appaB sequence. The \u001b[46m\u001b[30mp50\u001b[0m and p65 \u001b[46m\u001b[30mproteins\u001b[0m, constituents of th\n",
      "e expression of the \u001b[46m\u001b[30mp50\u001b[0m and p65 \u001b[46m\u001b[30mNF-kappa B subunits\u001b[0m was also shown to b\n",
      "s of NF-kappa B the \u001b[46m\u001b[30mp50\u001b[0m and RelA (p65) \u001b[46m\u001b[30mproteins\u001b[0m, indicated that the\n",
      "\n",
      "('alpha', 'beta')\n",
      "wnmodulation of the \u001b[46m\u001b[30malpha\u001b[0m and beta \u001b[46m\u001b[30misozymes\u001b[0m of PKC, and abrogat\n",
      " genes encoding the \u001b[46m\u001b[30malpha\u001b[0m and beta \u001b[46m\u001b[30msubunits\u001b[0m of the Pebp2/Cbf tr\n",
      "as not dependent on \u001b[46m\u001b[30mPKC isoenzymes\u001b[0m alpha and \u001b[46m\u001b[30mbeta\u001b[0m as shown by the use\n",
      "ibutable to lack of \u001b[46m\u001b[30mHLA-DQ alpha\u001b[0m or -DQ beta \u001b[46m\u001b[30mtranscription\u001b[0m, because both trans\n",
      " and beta subunits (\u001b[46m\u001b[30mGM-CSFR\u001b[0malpha and \u001b[46m\u001b[30mbeta\u001b[0m) can be induced to \n",
      "ransfected with the \u001b[46m\u001b[30mhuman GM-CSF receptor alpha\u001b[0m and beta \u001b[46m\u001b[30msubunits\u001b[0m (GM-CSFRalpha and b\n",
      "kappa B activity by \u001b[46m\u001b[30mI kappa B alpha\u001b[0m and I kappa B beta \u001b[46m\u001b[30mstability\u001b[0m. Transcription fact\n",
      "D8+ T-PLL expressed \u001b[46m\u001b[30mIL-2Ralpha\u001b[0m and beta \u001b[46m\u001b[30mchains\u001b[0m, and the cells show\n",
      ", which consists of \u001b[46m\u001b[30malpha\u001b[0m and beta \u001b[46m\u001b[30msubunits\u001b[0m. There are at least\n",
      "D8+ T-PLL expressed \u001b[46m\u001b[30mIL-2R\u001b[0malpha and \u001b[46m\u001b[30mbeta chains\u001b[0m, and the cells show\n",
      "ptional activity of \u001b[46m\u001b[30mcore binding factor-\u001b[0malpha (AML1) and \u001b[46m\u001b[30mbeta\u001b[0m subunits on murine \n",
      "eptor proteins, the \u001b[46m\u001b[30mthyroid hormone receptors (TR)\u001b[0m alpha and \u001b[46m\u001b[30mbeta\u001b[0m. Data from cell cul\n",
      "ransfected with the \u001b[46m\u001b[30mhuman GM-CSF receptor\u001b[0m alpha and \u001b[46m\u001b[30mbeta subunits\u001b[0m (GM-CSFRalpha and b\n",
      "hains designated as \u001b[46m\u001b[30malpha\u001b[0m and beta \u001b[46m\u001b[30msubunits\u001b[0m. We have demonstrat\n",
      "\n",
      "('ikaros', 'gata-3')\n",
      "tudies on the PU.1, \u001b[46m\u001b[30mIkaros\u001b[0m and GATA-3 \u001b[46m\u001b[30mgenes\u001b[0m have revealed that \n",
      "\n",
      "('nasal', 'bronchial')\n",
      "om freshly isolated \u001b[46m\u001b[30mnasal\u001b[0m and bronchial \u001b[46m\u001b[30mepithelium\u001b[0m recovered by brushi\n",
      "\n",
      "('immunohistochemical', 'ultrastructural')\n",
      "var leiomyosarcoma. \u001b[46m\u001b[30mImmunohistochemical\u001b[0m and ultrastructural \u001b[46m\u001b[30mstudies\u001b[0m were performed to s\n",
      "\n",
      "('embryonic', 'adult')\n",
      "whereas EPO induced \u001b[46m\u001b[30membryonic\u001b[0m, fetal, and adult \u001b[46m\u001b[30mHb synthesis\u001b[0m. Thus, our data sug\n",
      "\n",
      "('fetal', 'hb')\n",
      "whereas EPO induced \u001b[46m\u001b[30membryonic\u001b[0m, fetal, and adult \u001b[46m\u001b[30mHb synthesis\u001b[0m. Thus, our data sug\n",
      "\n",
      "(',', 'hb')\n",
      "whereas EPO induced \u001b[46m\u001b[30membryonic\u001b[0m, fetal, and adult \u001b[46m\u001b[30mHb synthesis\u001b[0m. Thus, our data sug\n",
      "whereas EPO induced \u001b[46m\u001b[30membryonic\u001b[0m, fetal, and adult \u001b[46m\u001b[30mHb synthesis\u001b[0m. Thus, our data sug\n",
      " induced embryonic, \u001b[46m\u001b[30mfetal\u001b[0m, and adult \u001b[46m\u001b[30mHb synthesis\u001b[0m. Thus, our data sug\n",
      "\n",
      "('-', ')')\n",
      "of cepharanthine on \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)-\u001b[0m and phorbol 12-myristate 13-acetate (PMA)-\u001b[46m\u001b[30minduced HIV-1 replication\u001b[0m in chronically infe\n",
      ". Cotransfection of \u001b[46m\u001b[30mNF-kappa B (p50/p65)-\u001b[0m or AP-1 (c-Jun/c-Fos)- \u001b[46m\u001b[30mexpression vectors\u001b[0m into Jurkat cells w\n",
      "ticoids may inhibit \u001b[46m\u001b[30mconcanavalin A (Con A)-\u001b[0m and phytohemagglutinin (PHA)-\u001b[46m\u001b[30minduced T-cell proliferation\u001b[0m, pokeweed mitogen (\n",
      "at it can stimulate \u001b[46m\u001b[30mgranulocyte-macrophage colony-stimulating factor (GM-CSF)-\u001b[0m or interleukin-3 (IL-3)-\u001b[46m\u001b[30minduced GM colony formation\u001b[0m, but potently inhib\n",
      "e peptide ligand of \u001b[46m\u001b[30mtetanus toxoid (TT)-\u001b[0m and myelin basic protein (MBP)-\u001b[46m\u001b[30mspecific human T cell lines\u001b[0m. The TT-selected T \n",
      "\n",
      "('-', 'pma')\n",
      "of cepharanthine on \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)-\u001b[0m and phorbol 12-myristate 13-acetate (PMA)-\u001b[46m\u001b[30minduced HIV-1 replication\u001b[0m in chronically infe\n",
      "\n",
      "('-', '13-acetate')\n",
      "of cepharanthine on \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)-\u001b[0m and phorbol 12-myristate 13-acetate (PMA)-\u001b[46m\u001b[30minduced HIV-1 replication\u001b[0m in chronically infe\n",
      "\n",
      "('-', '12-myristate')\n",
      "of cepharanthine on \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)-\u001b[0m and phorbol 12-myristate 13-acetate (PMA)-\u001b[46m\u001b[30minduced HIV-1 replication\u001b[0m in chronically infe\n",
      "\n",
      "('-', '-')\n",
      "of cepharanthine on \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)-\u001b[0m and phorbol 12-myristate 13-acetate (PMA)-\u001b[46m\u001b[30minduced HIV-1 replication\u001b[0m in chronically infe\n",
      ". Cotransfection of \u001b[46m\u001b[30mNF-kappa B (p50/p65)-\u001b[0m or AP-1 (c-Jun/c-Fos)- \u001b[46m\u001b[30mexpression vectors\u001b[0m into Jurkat cells w\n",
      "ticoids may inhibit \u001b[46m\u001b[30mconcanavalin A (Con A)-\u001b[0m and phytohemagglutinin (PHA)-\u001b[46m\u001b[30minduced T-cell proliferation\u001b[0m, pokeweed mitogen (\n",
      "at it can stimulate \u001b[46m\u001b[30mgranulocyte-macrophage colony-stimulating factor (GM-CSF)-\u001b[0m or interleukin-3 (IL-3)-\u001b[46m\u001b[30minduced GM colony formation\u001b[0m, but potently inhib\n",
      "e peptide ligand of \u001b[46m\u001b[30mtetanus toxoid (TT)-\u001b[0m and myelin basic protein (MBP)-\u001b[46m\u001b[30mspecific human T cell lines\u001b[0m. The TT-selected T \n",
      "\n",
      "('-', '(')\n",
      "of cepharanthine on \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)-\u001b[0m and phorbol 12-myristate 13-acetate (PMA)-\u001b[46m\u001b[30minduced HIV-1 replication\u001b[0m in chronically infe\n",
      ". Cotransfection of \u001b[46m\u001b[30mNF-kappa B (p50/p65)-\u001b[0m or AP-1 (c-Jun/c-Fos)- \u001b[46m\u001b[30mexpression vectors\u001b[0m into Jurkat cells w\n",
      "ticoids may inhibit \u001b[46m\u001b[30mconcanavalin A (Con A)-\u001b[0m and phytohemagglutinin (PHA)-\u001b[46m\u001b[30minduced T-cell proliferation\u001b[0m, pokeweed mitogen (\n",
      "at it can stimulate \u001b[46m\u001b[30mgranulocyte-macrophage colony-stimulating factor (GM-CSF)-\u001b[0m or interleukin-3 (IL-3)-\u001b[46m\u001b[30minduced GM colony formation\u001b[0m, but potently inhib\n",
      "e peptide ligand of \u001b[46m\u001b[30mtetanus toxoid (TT)-\u001b[0m and myelin basic protein (MBP)-\u001b[46m\u001b[30mspecific human T cell lines\u001b[0m. The TT-selected T \n",
      "\n",
      "('-', 'phorbol')\n",
      "of cepharanthine on \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)-\u001b[0m and phorbol 12-myristate 13-acetate (PMA)-\u001b[46m\u001b[30minduced HIV-1 replication\u001b[0m in chronically infe\n",
      "\n",
      "('l', 'd')\n",
      "eolytic cleavage by \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. We report on a com\n",
      "tion by the enzymes \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. These are prominen\n",
      "\n",
      "(',', 'd')\n",
      "eolytic cleavage by \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. We report on a com\n",
      "eolytic cleavage by \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. We report on a com\n",
      "tion by the enzymes \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. These are prominen\n",
      "tion by the enzymes \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. These are prominen\n",
      "\n",
      "('b', 'd')\n",
      "eolytic cleavage by \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. We report on a com\n",
      "tion by the enzymes \u001b[46m\u001b[30mcathepsin\u001b[0m B, L, and \u001b[46m\u001b[30mD\u001b[0m. These are prominen\n",
      "\n",
      "('il-2-', 'il-12-')\n",
      "erences observed in \u001b[46m\u001b[30mIL-2-\u001b[0m and IL-12-\u001b[46m\u001b[30mstimulated cells\u001b[0m may depend, at leas\n",
      "\n",
      "('n-terminal', 'androgen-binding')\n",
      "ptor flanked by the \u001b[46m\u001b[30mN-terminal\u001b[0m and androgen-binding \u001b[46m\u001b[30mdomains\u001b[0m of the androgen rec\n",
      "\n",
      "('megakaryocytic', 'basosophilic')\n",
      "n of the erythroid, \u001b[46m\u001b[30mmegakaryocytic\u001b[0m, and basosophilic \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "\n",
      "('ferrous', 'ferric')\n",
      "ron (in the form of \u001b[46m\u001b[30mferrous\u001b[0m or ferric \u001b[46m\u001b[30mchloride\u001b[0m and other iron salt\n",
      "\n",
      "('gata', '-3')\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "\n",
      "('-2', '-3')\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "tion. Surprisingly, \u001b[46m\u001b[30mTRAF\u001b[0m1, -2, or \u001b[46m\u001b[30m-3\u001b[0m does not interact w\n",
      "eased expression of \u001b[46m\u001b[30mEgr\u001b[0m-1, -2, and \u001b[46m\u001b[30m-3\u001b[0m. As with egr-3, exp\n",
      "\n",
      "('-1', 'gene')\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA-1\u001b[0m and -2 or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "\n",
      "('or', 'gene')\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA-1\u001b[0m and -2 or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "\n",
      "('gata', 'gene')\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA-1\u001b[0m and -2 or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "\n",
      "('tnf-alpha-', 'pma-')\n",
      "IV-1 replication in \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and PMA-\u001b[46m\u001b[30mstimulated U1 cells\u001b[0m but not in ACH-2 ce\n",
      "ctivation following \u001b[46m\u001b[30mTNF-alpha-\u001b[0m or PMA-\u001b[46m\u001b[30minduced stimulation\u001b[0m of U1 promonocytic \n",
      "\n",
      "('alpha-', 'beta-')\n",
      "ts with findings in \u001b[46m\u001b[30malpha-\u001b[0m and beta- \u001b[46m\u001b[30mherpesvirus systems\u001b[0m (herpes simplex, cy\n",
      "ic genes, including \u001b[46m\u001b[30malpha-\u001b[0m and beta-\u001b[46m\u001b[30mglobin\u001b[0m, band 3, band 4.1, \n",
      "\n",
      "('memory', 'naive')\n",
      "oliferation of both \u001b[46m\u001b[30mmemory\u001b[0m and naive \u001b[46m\u001b[30mT cells subsets\u001b[0m. Taken together, ou\n",
      "appaB alpha in both \u001b[46m\u001b[30mmemory\u001b[0m and naive \u001b[46m\u001b[30mT cells\u001b[0m from the elderly wa\n",
      "of NFkappaB in both \u001b[46m\u001b[30mmemory\u001b[0m and naive \u001b[46m\u001b[30mT cell subsets\u001b[0m, irrespective of th\n",
      "\n",
      "('jun-d', 'expression')\n",
      " transfected c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "\n",
      "('c-fos', 'expression')\n",
      " transfected c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ected c-jun, jun-B, \u001b[46m\u001b[30mjun-D\u001b[0m, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "\n",
      "(',', 'expression')\n",
      " transfected c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      " transfected c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      " transfected c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "nsfection of c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, or jun-D \u001b[46m\u001b[30mexpression vectors\u001b[0m, which augmented GR\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ected c-jun, jun-B, \u001b[46m\u001b[30mjun-D\u001b[0m, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ected c-jun, jun-B, \u001b[46m\u001b[30mjun-D\u001b[0m, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ter transfection of \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, or jun-D \u001b[46m\u001b[30mexpression vectors\u001b[0m, which augmented GR\n",
      "ter transfection of \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, or jun-D \u001b[46m\u001b[30mexpression vectors\u001b[0m, which augmented GR\n",
      "-jun, jun-B, jun-D, \u001b[46m\u001b[30mc-fos\u001b[0m, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "distinct changes in \u001b[46m\u001b[30mP-glycoprotein\u001b[0m, steroid receptors, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "distinct changes in \u001b[46m\u001b[30mP-glycoprotein\u001b[0m, steroid receptors, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "l surface IgM, IgD, \u001b[46m\u001b[30mkappa L chain\u001b[0m, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      " in P-glycoprotein, \u001b[46m\u001b[30msteroid receptors\u001b[0m, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "\n",
      "('jun-b', 'fos-b')\n",
      " transfected c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "\n",
      "('transmembrane', 'intracellular')\n",
      "r (G-CSF-R) and the \u001b[46m\u001b[30mtransmembrane\u001b[0m and intracellular \u001b[46m\u001b[30mdomains\u001b[0m of human IL-7R alph\n",
      "\n",
      "('morphologic', 'cytofluorometry')\n",
      "oclonal antibodies. \u001b[46m\u001b[30mMorphologic\u001b[0m and cytofluorometry \u001b[46m\u001b[30manalysis\u001b[0m established that mo\n",
      "\n",
      "('b', 'not')\n",
      "ctivity of A-MYB in \u001b[46m\u001b[30mB\u001b[0m and not T \u001b[46m\u001b[30mcells\u001b[0m was observed when e\n",
      "\n",
      "('2', '7')\n",
      "ncer. Variants with \u001b[46m\u001b[30mexons\u001b[0m 2 and \u001b[46m\u001b[30m7\u001b[0m deleted were presen\n",
      "R with deletions of \u001b[46m\u001b[30mexons\u001b[0m 2, 5 and \u001b[46m\u001b[30m7\u001b[0m. Variants with exon\n",
      "\n",
      "('factor-alpha', 'interleukin-1')\n",
      "d the expression of \u001b[46m\u001b[30mtumor necrosis factor-alpha\u001b[0m and interleukin-1 beta \u001b[46m\u001b[30mgenes\u001b[0m. These observations\n",
      "\n",
      "('factor-alpha', 'beta')\n",
      "d the expression of \u001b[46m\u001b[30mtumor necrosis factor-alpha\u001b[0m and interleukin-1 beta \u001b[46m\u001b[30mgenes\u001b[0m. These observations\n",
      "\n",
      "('t-cell', 'dendritic')\n",
      "The linkage between \u001b[46m\u001b[30mT-cell\u001b[0m and dendritic cell \u001b[46m\u001b[30mdevelopment\u001b[0m in the mouse thymus\n",
      "\n",
      "('t-cell', 'cell')\n",
      "The linkage between \u001b[46m\u001b[30mT-cell\u001b[0m and dendritic cell \u001b[46m\u001b[30mdevelopment\u001b[0m in the mouse thymus\n",
      "\n",
      "('il-12', 'il-10')\n",
      "system may regulate \u001b[46m\u001b[30mIL-12\u001b[0m and IL-10 \u001b[46m\u001b[30msecretion\u001b[0m and, hence, TH1/TH2\n",
      "\n",
      "('beta-', 'gamma-')\n",
      "lls which expressed \u001b[46m\u001b[30mbeta-\u001b[0m and gamma- \u001b[46m\u001b[30mglobin genes\u001b[0m in the two cell pop\n",
      "nofluorescence with \u001b[46m\u001b[30mbeta-\u001b[0m and gamma-\u001b[46m\u001b[30mspecific antibodies\u001b[0m. The number of gamm\n",
      "\n",
      "('basal', '-inducible')\n",
      "ences necessary for \u001b[46m\u001b[30mbasal\u001b[0m and phorbol 12-myristate 13-acetate-inducible \u001b[46m\u001b[30mtranscription\u001b[0m of the CD69 gene. R\n",
      "\n",
      "('basal', '13-acetate')\n",
      "ences necessary for \u001b[46m\u001b[30mbasal\u001b[0m and phorbol 12-myristate 13-acetate-inducible \u001b[46m\u001b[30mtranscription\u001b[0m of the CD69 gene. R\n",
      "\n",
      "('basal', 'phorbol')\n",
      "ences necessary for \u001b[46m\u001b[30mbasal\u001b[0m and phorbol 12-myristate 13-acetate-inducible \u001b[46m\u001b[30mtranscription\u001b[0m of the CD69 gene. R\n",
      "\n",
      "('basal', '12-myristate')\n",
      "ences necessary for \u001b[46m\u001b[30mbasal\u001b[0m and phorbol 12-myristate 13-acetate-inducible \u001b[46m\u001b[30mtranscription\u001b[0m of the CD69 gene. R\n",
      "\n",
      "('activation', 'growth')\n",
      "ional factor during \u001b[46m\u001b[30mT cell\u001b[0m activation and \u001b[46m\u001b[30mgrowth\u001b[0m.\n",
      "\n",
      "('sla-dr', 'sla-dq')\n",
      "ion of constitutive \u001b[46m\u001b[30mSLA-DR\u001b[0m and SLA-DQ \u001b[46m\u001b[30mexpression\u001b[0m. T-cell proliferati\n",
      " 90% suppression of \u001b[46m\u001b[30mconstitutive SLA-DR\u001b[0m and SLA-DQ \u001b[46m\u001b[30mantigen expression\u001b[0m in 5-8 days. In fun\n",
      " 90% suppression of \u001b[46m\u001b[30mconstitutive\u001b[0m SLA-DR and \u001b[46m\u001b[30mSLA-DQ antigen expression\u001b[0m in 5-8 days. In fun\n",
      "\n",
      "('megakaryocyte', 'lymphoid')\n",
      " No upregulation of \u001b[46m\u001b[30mmegakaryocyte\u001b[0m or lymphoid \u001b[46m\u001b[30mmarkers\u001b[0m occurred. Thus the \n",
      "\n",
      "('a', 'b')\n",
      " splicing generates \u001b[46m\u001b[30mtype A\u001b[0m and B \u001b[46m\u001b[30mtranscripts\u001b[0m that potentially en\n",
      "otypes belonging to \u001b[46m\u001b[30msubgroups\u001b[0m A (Ad12) and \u001b[46m\u001b[30mB (Ad3)\u001b[0m are tumorigenic for\n",
      " splicing generates \u001b[46m\u001b[30mtype\u001b[0m A and \u001b[46m\u001b[30mB transcripts\u001b[0m that potentially en\n",
      " in persistent type \u001b[46m\u001b[30mA\u001b[0m or B \u001b[46m\u001b[30mEpstein-Barr virus infection\u001b[0m. Five healthy human\n",
      "stimulation in both \u001b[46m\u001b[30mtype A\u001b[0m and type B \u001b[46m\u001b[30mEBV carriers\u001b[0m. The RAKFKQLLQ-spec\n",
      "factor PU.1 and the \u001b[46m\u001b[30mMono A\u001b[0m and Mono B \u001b[46m\u001b[30mprotein complexes\u001b[0m act in concert to r\n",
      "lly active dimer of \u001b[46m\u001b[30mcalcineurin A\u001b[0m and B \u001b[46m\u001b[30msubunits\u001b[0m.\n",
      " were infected with \u001b[46m\u001b[30mtype A\u001b[0m and one with type B \u001b[46m\u001b[30mEBV\u001b[0m. Polyclonal and clo\n",
      "entified in primary \u001b[46m\u001b[30mtype A\u001b[0m or type B \u001b[46m\u001b[30mEBV infection\u001b[0m which was sustained\n",
      "lly active dimer of \u001b[46m\u001b[30mcalcineurin\u001b[0m A and \u001b[46m\u001b[30mB subunits\u001b[0m.\n",
      "ic development. The \u001b[46m\u001b[30mPEBP2 alpha A\u001b[0m and PEBP2 alpha B \u001b[46m\u001b[30mgenes\u001b[0m encode the DNA-bind\n",
      "\n",
      "('steroid-sensitive', 'steroid-resistant')\n",
      "on in patients with \u001b[46m\u001b[30msteroid-sensitive\u001b[0m and steroid-resistant \u001b[46m\u001b[30masthma\u001b[0m. BACKGROUND: Glucoc\n",
      "\n",
      "('nk', 't')\n",
      "unction of IL-13 in \u001b[46m\u001b[30mprimary human NK\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m: a comparative stud\n",
      "effects of IL-13 on \u001b[46m\u001b[30mprimary human\u001b[0m NK and \u001b[46m\u001b[30mT cells\u001b[0m have not been well \n",
      "a and STAT3 in both \u001b[46m\u001b[30mNK\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m, consistent with th\n",
      "upon stimulation of \u001b[46m\u001b[30mNK\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m with IL-2, but not \n",
      "effects of IL-13 on \u001b[46m\u001b[30mprimary human NK\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m have not been well \n",
      "unction of IL-13 in \u001b[46m\u001b[30mprimary human\u001b[0m NK and \u001b[46m\u001b[30mT cells\u001b[0m: a comparative stud\n",
      "duced activation of \u001b[46m\u001b[30mNK\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m occurs in the absen\n",
      "ion seen in primary \u001b[46m\u001b[30mNK\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m on direct stimulati\n",
      "RNA accumulation in \u001b[46m\u001b[30mNK\u001b[0m and T \u001b[46m\u001b[30mcells\u001b[0m, whereas only IL-2 \n",
      "ability to regulate \u001b[46m\u001b[30mNK\u001b[0m and T \u001b[46m\u001b[30mcell activation\u001b[0m and that IL-13 is a\n",
      "\n",
      "('pu.1', 'gata-3')\n",
      "tion studies on the \u001b[46m\u001b[30mPU.1\u001b[0m, Ikaros and GATA-3 \u001b[46m\u001b[30mgenes\u001b[0m have revealed that \n",
      "\n",
      "('ikaros', 'gene')\n",
      "tion studies on the \u001b[46m\u001b[30mPU.1\u001b[0m, Ikaros and GATA-3 \u001b[46m\u001b[30mgenes\u001b[0m have revealed that \n",
      "\n",
      "('nf-e2', 'tandem')\n",
      "elements containing \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem GATA \u001b[46m\u001b[30mbinding sites\u001b[0m are required for er\n",
      " Similarly arranged \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem GATA \u001b[46m\u001b[30msites\u001b[0m are present within \n",
      "4 demonstrated that \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem, inverted GATA \u001b[46m\u001b[30mbinding sites\u001b[0m are required for th\n",
      "\n",
      "('nf-e2', 'gata')\n",
      "elements containing \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem GATA \u001b[46m\u001b[30mbinding sites\u001b[0m are required for er\n",
      " Similarly arranged \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem GATA \u001b[46m\u001b[30msites\u001b[0m are present within \n",
      "4 demonstrated that \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem, inverted GATA \u001b[46m\u001b[30mbinding sites\u001b[0m are required for th\n",
      "pothesis that these \u001b[46m\u001b[30mNF-E2\u001b[0m and GATA \u001b[46m\u001b[30msites\u001b[0m are common requirem\n",
      "\n",
      "('anti-inflammatory', 'immunosuppressive')\n",
      "n important role in \u001b[46m\u001b[30manti-inflammatory\u001b[0m and immunosuppressive \u001b[46m\u001b[30meffects\u001b[0m. We have identified\n",
      "ong the most potent \u001b[46m\u001b[30manti-inflammatory\u001b[0m and immunosuppressive \u001b[46m\u001b[30magents\u001b[0m. They inhibit synth\n",
      "\n",
      "('p65-', 'c-rel-')\n",
      "amma inhibits p50-, \u001b[46m\u001b[30mp65-\u001b[0m, and c-Rel-\u001b[46m\u001b[30mmediated transactivation\u001b[0m and/or DNA binding,\n",
      "\n",
      "(',', 'mediated')\n",
      "amma inhibits p50-, \u001b[46m\u001b[30mp65-\u001b[0m, and c-Rel-\u001b[46m\u001b[30mmediated transactivation\u001b[0m and/or DNA binding,\n",
      "d IFN-alpha. IL-2-, \u001b[46m\u001b[30mIL-12-\u001b[0m, and IFN-alpha-\u001b[46m\u001b[30mmediated signaling pathways\u001b[0m were analyzed in pr\n",
      "-12, and IFN-alpha. \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-12-, and IFN-alpha-\u001b[46m\u001b[30mmediated signaling pathways\u001b[0m were analyzed in pr\n",
      "-12, and IFN-alpha. \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-12-, and IFN-alpha-\u001b[46m\u001b[30mmediated signaling pathways\u001b[0m were analyzed in pr\n",
      "pa B gamma inhibits \u001b[46m\u001b[30mp50-\u001b[0m, p65-, and c-Rel-\u001b[46m\u001b[30mmediated transactivation\u001b[0m and/or DNA binding,\n",
      "pa B gamma inhibits \u001b[46m\u001b[30mp50-\u001b[0m, p65-, and c-Rel-\u001b[46m\u001b[30mmediated transactivation\u001b[0m and/or DNA binding,\n",
      "\n",
      "('interleukin-4', 'interleukin-5')\n",
      "e the expression of \u001b[46m\u001b[30minterleukin-4\u001b[0m and interleukin-5 \u001b[46m\u001b[30mgenes\u001b[0m in helper T cells. \n",
      "\n",
      "('pre-b', 'mature')\n",
      "representing pro-B, \u001b[46m\u001b[30mpre-B\u001b[0m, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      "\n",
      "('srf', 'ets')\n",
      "spacing between the \u001b[46m\u001b[30mSRF\u001b[0m and ETS \u001b[46m\u001b[30mmotifs\u001b[0m, appear to account \n",
      "\n",
      "('transcriptional', 'post-transcription')\n",
      "hat HU induces both \u001b[46m\u001b[30mtranscriptional\u001b[0m and post-transcription \u001b[46m\u001b[30mregulation\u001b[0m of c-jun during ery\n",
      "\n",
      "('p50/p65', 'p50/c-rel')\n",
      "yte nuclei as being \u001b[46m\u001b[30mp50/p65\u001b[0m and p50/c-Rel \u001b[46m\u001b[30mcomplexes\u001b[0m. Immunochemical and\n",
      "\n",
      "('neonatal', 'adult')\n",
      "pa B was similar in \u001b[46m\u001b[30mneonatal\u001b[0m and adult \u001b[46m\u001b[30mcells\u001b[0m. These results sugg\n",
      "duction in purified \u001b[46m\u001b[30mneonatal\u001b[0m and adult \u001b[46m\u001b[30mT cells\u001b[0m using polyclonal ac\n",
      "ar translocation in \u001b[46m\u001b[30mneonatal\u001b[0m and adult \u001b[46m\u001b[30mT cells\u001b[0m using the electroph\n",
      "\n",
      "('pyg', 'gc')\n",
      "lements such as the \u001b[46m\u001b[30mPyG\u001b[0m and GC \u001b[46m\u001b[30mboxes\u001b[0m are also necessary \n",
      "\n",
      "('fo', 'jun')\n",
      "Involvement of Rel, \u001b[46m\u001b[30mFos\u001b[0m, and Jun \u001b[46m\u001b[30mproteins\u001b[0m in binding activity\n",
      "nsists of dimers of \u001b[46m\u001b[30mFos\u001b[0m and Jun \u001b[46m\u001b[30mfamily proteins\u001b[0m, was also studied u\n",
      "e activation of the \u001b[46m\u001b[30mfos\u001b[0m and jun \u001b[46m\u001b[30mproteins\u001b[0m of which AP-1 consi\n",
      "\n",
      "('jun-b', 'jun-d')\n",
      "nsfection of c-jun, \u001b[46m\u001b[30mjun-B\u001b[0m, or jun-D \u001b[46m\u001b[30mexpression vectors\u001b[0m, which augmented GR\n",
      "\n",
      "('lef-1', 'ets-1')\n",
      "tif upstream of the \u001b[46m\u001b[30mLEF-1\u001b[0m and Ets-1 \u001b[46m\u001b[30msites\u001b[0m, further augments t\n",
      "\n",
      "('kinase-', 'pkc-')\n",
      "h sIgM and sIgD are \u001b[46m\u001b[30mprotein tyrosine kinase-\u001b[0m and PKC-\u001b[46m\u001b[30mdependent\u001b[0m, but protein kinase\n",
      "\n",
      "('32', '36')\n",
      "f I kappaB alpha on \u001b[46m\u001b[30mserines\u001b[0m 32 and \u001b[46m\u001b[30m36\u001b[0m, all the stimuli th\n",
      " phosphorylation on \u001b[46m\u001b[30mserines\u001b[0m 32 and \u001b[46m\u001b[30m36\u001b[0m. Neither a mutation\n",
      "\n",
      "('transcriptional', 'post-transcriptional')\n",
      " expression by both \u001b[46m\u001b[30mtranscriptional\u001b[0m and post-transcriptional \u001b[46m\u001b[30mmechanisms\u001b[0m. Transient transfec\n",
      "P-1, and found that \u001b[46m\u001b[30mtranscriptional\u001b[0m and post-transcriptional \u001b[46m\u001b[30mmechanisms\u001b[0m could account for i\n",
      "is mediated by both \u001b[46m\u001b[30mtranscriptional\u001b[0m and post-transcriptional \u001b[46m\u001b[30mmechanisms\u001b[0m.\n",
      "\u001b[46m\u001b[30mTranscriptional\u001b[0m and post-transcriptional \u001b[46m\u001b[30mregulation\u001b[0m of c-jun expression\n",
      "\n",
      "('xpb', 'xpd')\n",
      "ns, mutation of the \u001b[46m\u001b[30mXPB\u001b[0m or XPD \u001b[46m\u001b[30mgene\u001b[0m impairs NER, result\n",
      " XPG. Of these, the \u001b[46m\u001b[30mXPB\u001b[0m and XPD \u001b[46m\u001b[30mgenes\u001b[0m encode proteins tha\n",
      "\n",
      "('alpha-', 'delta-')\n",
      "14q11 is a locus of \u001b[46m\u001b[30mT-cell receptor\u001b[0m alpha- and \u001b[46m\u001b[30mdelta-chains\u001b[0m (TCR alpha/delta), \n",
      "14q11 is a locus of \u001b[46m\u001b[30mT-cell receptor alpha-\u001b[0m and delta-\u001b[46m\u001b[30mchains\u001b[0m (TCR alpha/delta), \n",
      "\n",
      "('egr-1', 'kappab3')\n",
      "lear factors to the \u001b[46m\u001b[30mEgr-1\u001b[0m and kappaB3 \u001b[46m\u001b[30msites\u001b[0m, which were identif\n",
      "\n",
      "('cd8-', 'cd8+')\n",
      "4- CD8-, CD4+ CD8+, \u001b[46m\u001b[30mCD4+ CD8-\u001b[0m, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "\n",
      "('cd8-', 'cd4-')\n",
      "4- CD8-, CD4+ CD8+, \u001b[46m\u001b[30mCD4+ CD8-\u001b[0m, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "\n",
      "('fosb/g0s3', 'fos/g0s7')\n",
      "show high levels of \u001b[46m\u001b[30mFOSB/G0S3\u001b[0m and FOS/G0S7 \u001b[46m\u001b[30mmRNAs\u001b[0m, which decline rapi\n",
      "\n",
      "('(', 'b')\n",
      "otypes belonging to \u001b[46m\u001b[30msubgroups\u001b[0m A (Ad12) and \u001b[46m\u001b[30mB (Ad3)\u001b[0m are tumorigenic for\n",
      "\n",
      "('ad12', 'b')\n",
      "otypes belonging to \u001b[46m\u001b[30msubgroups\u001b[0m A (Ad12) and \u001b[46m\u001b[30mB (Ad3)\u001b[0m are tumorigenic for\n",
      "\n",
      "(')', 'b')\n",
      "otypes belonging to \u001b[46m\u001b[30msubgroups\u001b[0m A (Ad12) and \u001b[46m\u001b[30mB (Ad3)\u001b[0m are tumorigenic for\n",
      "on of the cDNAs for \u001b[46m\u001b[30mCN A (catalytic)\u001b[0m and CN B (regulatory) \u001b[46m\u001b[30msubunits\u001b[0m also augments trans\n",
      "-128). Finally, the \u001b[46m\u001b[30mAP-1 (-186 to -176)\u001b[0m and the kappa B \u001b[46m\u001b[30msites\u001b[0m (-206 to -195) resp\n",
      "\n",
      "('il-2-', 'il-7-')\n",
      "into the nucleus of \u001b[46m\u001b[30mIL-2-\u001b[0m or IL-7-\u001b[46m\u001b[30mtreated cells\u001b[0m. The kinetics of th\n",
      "AT5A and STAT5B, to \u001b[46m\u001b[30mIL-2-\u001b[0m and IL-7-\u001b[46m\u001b[30minduced activation\u001b[0m of human peripheral\n",
      "\n",
      "('monkey', 'cotton-top')\n",
      "hich are present in \u001b[46m\u001b[30mowl monkey\u001b[0m and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. The DNA-binding do\n",
      "served among human, \u001b[46m\u001b[30msquirrel monkey\u001b[0m, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "n, squirrel monkey, \u001b[46m\u001b[30mowl monkey\u001b[0m, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "('monkey', 'tamarin')\n",
      "hich are present in \u001b[46m\u001b[30mowl monkey\u001b[0m and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. The DNA-binding do\n",
      "served among human, \u001b[46m\u001b[30msquirrel monkey\u001b[0m, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "n, squirrel monkey, \u001b[46m\u001b[30mowl monkey\u001b[0m, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "('sigm-', 'sigd-')\n",
      "in B104 cells. Both \u001b[46m\u001b[30msIgM-\u001b[0m and sIgD-\u001b[46m\u001b[30mcrosslinking\u001b[0m with antibodies ind\n",
      "pression induced by \u001b[46m\u001b[30msIgM-\u001b[0m and sIgD-\u001b[46m\u001b[30mcrosslinking\u001b[0m was inhibited by H7\n",
      " mRNA expression by \u001b[46m\u001b[30msIgM-\u001b[0m and sIgD-\u001b[46m\u001b[30mcrosslinking\u001b[0m to examine differen\n",
      "\n",
      "('52', '45')\n",
      "o major proteins of \u001b[46m\u001b[30m52\u001b[0m and 45 \u001b[46m\u001b[30mkilodaltons (kD)\u001b[0m copurified with DNA\n",
      "\n",
      "('bclf1', 'bfrf3')\n",
      " Epstein-Barr virus \u001b[46m\u001b[30mBcLF1\u001b[0m and BFRF3 \u001b[46m\u001b[30mpromoters\u001b[0m does not require DN\n",
      "\n",
      "('cytotoxic', 'b')\n",
      "tus influences both \u001b[46m\u001b[30mcytotoxic\u001b[0m and NF-kappa B \u001b[46m\u001b[30mactivation\u001b[0m in natural killer c\n",
      "\n",
      "('cytotoxic', 'nf-kappa')\n",
      "tus influences both \u001b[46m\u001b[30mcytotoxic\u001b[0m and NF-kappa B \u001b[46m\u001b[30mactivation\u001b[0m in natural killer c\n",
      "\n",
      "('fm', 'egr-1')\n",
      "on of IL-3, GM-CSF, \u001b[46m\u001b[30mFMS\u001b[0m and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "\n",
      "('c-jun', 'b')\n",
      "e anti-CD2 pathway, \u001b[46m\u001b[30mc-jun\u001b[0m and jun B \u001b[46m\u001b[30mmRNA expression\u001b[0m was also studied in\n",
      "e expression c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "xpression of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m and jun B \u001b[46m\u001b[30mproto-oncogenes\u001b[0m was studied in phyt\n",
      "\n",
      "('c-jun', 'jun')\n",
      "e anti-CD2 pathway, \u001b[46m\u001b[30mc-jun\u001b[0m and jun B \u001b[46m\u001b[30mmRNA expression\u001b[0m was also studied in\n",
      "xpression of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m and jun B \u001b[46m\u001b[30mproto-oncogenes\u001b[0m was studied in phyt\n",
      "\n",
      "('enhancer', 'promoter')\n",
      "ctivity of IL-2 and \u001b[46m\u001b[30mmetallothionein\u001b[0m enhancer and \u001b[46m\u001b[30mpromoter regions\u001b[0m and transcription f\n",
      "ctivity of IL-2 and \u001b[46m\u001b[30mmetallothionein enhancer\u001b[0m and promoter \u001b[46m\u001b[30mregions\u001b[0m and transcription f\n",
      "\n",
      "('human', 'murine')\n",
      "racts prepared from \u001b[46m\u001b[30mhuman\u001b[0m and murine \u001b[46m\u001b[30mT-ALL cell lines\u001b[0m. Transcriptional ac\n",
      "or complex (BCR) on \u001b[46m\u001b[30mhuman\u001b[0m and murine \u001b[46m\u001b[30mB lymphocytes\u001b[0m. To better understa\n",
      "y mechanisms of the \u001b[46m\u001b[30mhuman\u001b[0m and murine \u001b[46m\u001b[30mTNF genes\u001b[0m are discussed.\n",
      "n a large number of \u001b[46m\u001b[30mcultured\u001b[0m human and \u001b[46m\u001b[30mmurine cell lines\u001b[0m. All three types of\n",
      "ineage. Analysis of \u001b[46m\u001b[30mhuman\u001b[0m and murine \u001b[46m\u001b[30mGATA-3 factors\u001b[0m shows a striking de\n",
      "nserved in both the \u001b[46m\u001b[30mhuman\u001b[0m and murine \u001b[46m\u001b[30minterleukin-2 enhancers\u001b[0m. Within the human e\n",
      "n a large number of \u001b[46m\u001b[30mcultured human\u001b[0m and murine \u001b[46m\u001b[30mcell lines\u001b[0m. All three types of\n",
      "y conserved in both \u001b[46m\u001b[30mhuman\u001b[0m and murine \u001b[46m\u001b[30mGM-CSF genes\u001b[0m. In this report, we\n",
      "\n",
      "(',', 'subsites')\n",
      "epted in any of the \u001b[46m\u001b[30mS2\u001b[0m, S1, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "epted in any of the \u001b[46m\u001b[30mS2\u001b[0m, S1, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "epted in any of the \u001b[46m\u001b[30mS2\u001b[0m, S1, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "d in any of the S2, \u001b[46m\u001b[30mS1\u001b[0m, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "d in any of the S2, \u001b[46m\u001b[30mS1\u001b[0m, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      " any of the S2, S1, \u001b[46m\u001b[30mS1'\u001b[0m, and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "\n",
      "('s1', 'subsites')\n",
      "epted in any of the \u001b[46m\u001b[30mS2\u001b[0m, S1, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "\n",
      "(\"s1'\", 'subsites')\n",
      "epted in any of the \u001b[46m\u001b[30mS2\u001b[0m, S1, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "d in any of the S2, \u001b[46m\u001b[30mS1\u001b[0m, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "\n",
      "('s2', \"s2'\")\n",
      "epted in any of the \u001b[46m\u001b[30mS2\u001b[0m, S1, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "\n",
      "('all-trans', '9-cis')\n",
      "ysis. RESULTS: Both \u001b[46m\u001b[30mall-trans\u001b[0m and 9-cis \u001b[46m\u001b[30mRA\u001b[0m inhibited virus rep\n",
      "HODS: The effect of \u001b[46m\u001b[30mall-trans\u001b[0m and 9-cis \u001b[46m\u001b[30mRA\u001b[0m on HIV-1 production\n",
      "nteractions between \u001b[46m\u001b[30mall-trans\u001b[0m and 9-cis \u001b[46m\u001b[30mRA\u001b[0m and D3 which promot\n",
      "\n",
      "('c-rel', 'v-rel')\n",
      "me family, like the \u001b[46m\u001b[30mc-rel\u001b[0m and v-rel \u001b[46m\u001b[30m(proto)oncogenes\u001b[0m. The dimerization d\n",
      "\n",
      "('nf-kappab', 'sp1')\n",
      "icative capacity of \u001b[46m\u001b[30mNF-kappaB\u001b[0m and Sp1 \u001b[46m\u001b[30mbinding site mutants\u001b[0m of SIVmac is due to\n",
      "n in the absence of \u001b[46m\u001b[30mNF-kappaB\u001b[0m and Sp1 \u001b[46m\u001b[30msites\u001b[0m. This region is res\n",
      "s in the absence of \u001b[46m\u001b[30mNF-kappaB\u001b[0m and Sp1 \u001b[46m\u001b[30mbinding elements\u001b[0m. Ten mutants of the\n",
      "\n",
      "('1st', 'the')\n",
      "ucleotides from the \u001b[46m\u001b[30m1st\u001b[0m and the 2nd \u001b[46m\u001b[30mexon\u001b[0m of the c-myc gene, \n",
      "\n",
      "('1st', '2nd')\n",
      "ucleotides from the \u001b[46m\u001b[30m1st\u001b[0m and the 2nd \u001b[46m\u001b[30mexon\u001b[0m of the c-myc gene, \n",
      "\n",
      "('transcription', 'differentiation')\n",
      "vates expression of \u001b[46m\u001b[30mtranscription\u001b[0m and differentiation \u001b[46m\u001b[30mfactors\u001b[0m. During B and T cel\n",
      "\n",
      "('hiv-1', 'hiv-2')\n",
      "nal activity of the \u001b[46m\u001b[30mHIV-1\u001b[0m and HIV-2 \u001b[46m\u001b[30menhancers\u001b[0m. Taken together, th\n",
      "c activation of the \u001b[46m\u001b[30mHIV-1\u001b[0m and HIV-2 \u001b[46m\u001b[30menhancers\u001b[0m by NF-kappaB (p50 +\n",
      "\n",
      "('0.6', 'kb')\n",
      " mutants containing \u001b[46m\u001b[30m1.3\u001b[0m, 0.6, and 0.2 \u001b[46m\u001b[30mkb 5'-flanking DNA\u001b[0m were incrementally \n",
      "\n",
      "(',', 'kb')\n",
      " mutants containing \u001b[46m\u001b[30m1.3\u001b[0m, 0.6, and 0.2 \u001b[46m\u001b[30mkb 5'-flanking DNA\u001b[0m were incrementally \n",
      " mutants containing \u001b[46m\u001b[30m1.3\u001b[0m, 0.6, and 0.2 \u001b[46m\u001b[30mkb 5'-flanking DNA\u001b[0m were incrementally \n",
      "nts containing 1.3, \u001b[46m\u001b[30m0.6\u001b[0m, and 0.2 \u001b[46m\u001b[30mkb 5'-flanking DNA\u001b[0m were incrementally \n",
      "\n",
      "('1.3', '0.2')\n",
      " mutants containing \u001b[46m\u001b[30m1.3\u001b[0m, 0.6, and 0.2 \u001b[46m\u001b[30mkb 5'-flanking DNA\u001b[0m were incrementally \n",
      "\n",
      "('cell', 'myeloid')\n",
      "lls, activates many \u001b[46m\u001b[30mB cell\u001b[0m and myeloid \u001b[46m\u001b[30mgenes\u001b[0m, and is critical fo\n",
      "\n",
      "('p40', 'p70')\n",
      "n strongly enhanced \u001b[46m\u001b[30mp40\u001b[0m and p70 \u001b[46m\u001b[30mproduction\u001b[0m. Furthermore, trans\n",
      "\n",
      "('aml1', 'beta')\n",
      "nal activation. The \u001b[46m\u001b[30mAML1\u001b[0m and CBF beta \u001b[46m\u001b[30mgenes\u001b[0m that encode CBF eac\n",
      "ptional activity of \u001b[46m\u001b[30mcore binding factor-\u001b[0malpha (AML1) and \u001b[46m\u001b[30mbeta\u001b[0m subunits on murine \n",
      "\n",
      "('aml1', 'cbf')\n",
      "nal activation. The \u001b[46m\u001b[30mAML1\u001b[0m and CBF beta \u001b[46m\u001b[30mgenes\u001b[0m that encode CBF eac\n",
      "\n",
      "('naive', 'memory')\n",
      "replication in both \u001b[46m\u001b[30mnaive\u001b[0m and memory \u001b[46m\u001b[30mT cells\u001b[0m. These studies were\n",
      "ve examined whether \u001b[46m\u001b[30mnaive\u001b[0m and memory \u001b[46m\u001b[30mT lymphocytes\u001b[0m differ in their sen\n",
      "\n",
      "('hematopoietic', 'nonhematopoietic')\n",
      "activity in various \u001b[46m\u001b[30mhematopoietic\u001b[0m and nonhematopoietic \u001b[46m\u001b[30mcell types\u001b[0m. The -1053/+34 cons\n",
      "\n",
      "('mass', '130')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "\n",
      "('120', '130')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "\n",
      "(',', 'kda')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "ing proteins of 85, \u001b[46m\u001b[30m75\u001b[0m, and 54 \u001b[46m\u001b[30mkDa\u001b[0m, whereas in Tax exp\n",
      "binding proteins of \u001b[46m\u001b[30m85\u001b[0m, 75, and 54 \u001b[46m\u001b[30mkDa\u001b[0m, whereas in Tax exp\n",
      "binding proteins of \u001b[46m\u001b[30m85\u001b[0m, 75, and 54 \u001b[46m\u001b[30mkDa\u001b[0m, whereas in Tax exp\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "\n",
      "('40', 'kda')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "\n",
      "('70', 'kda')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "\n",
      "('42', 'kda')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, \u001b[46m\u001b[30m120\u001b[0m, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "\n",
      "('il-2', 'il-12')\n",
      "amma in response to \u001b[46m\u001b[30mIL-2\u001b[0m and IL-12 \u001b[46m\u001b[30mstimulation\u001b[0m, there has as yet b\n",
      "\n",
      "(')', 'il-6')\n",
      "of CMV IE genes and \u001b[46m\u001b[30mIL-6 chloramphenicol acetyl transferase (CAT)\u001b[0m or IL-6 luciferase \u001b[46m\u001b[30mconstructs\u001b[0m were used to study \n",
      "t the expression of \u001b[46m\u001b[30mtumor necrosis factor alpha (TNF-alpha)\u001b[0m and IL-6 \u001b[46m\u001b[30mmRNAs\u001b[0m. In this study, the\n",
      "\n",
      "(')', 'luciferase')\n",
      "of CMV IE genes and \u001b[46m\u001b[30mIL-6 chloramphenicol acetyl transferase (CAT)\u001b[0m or IL-6 luciferase \u001b[46m\u001b[30mconstructs\u001b[0m were used to study \n",
      "\n",
      "('id2', 'id3')\n",
      "Expression of \u001b[46m\u001b[30mId2\u001b[0m and Id3 \u001b[46m\u001b[30mmRNA\u001b[0m in human lymphocyte\n",
      "n the expression of \u001b[46m\u001b[30mId2\u001b[0m and Id3 \u001b[46m\u001b[30mmRNA\u001b[0m in human leukemia/l\n",
      "\n",
      "('positive', 'negative')\n",
      "L-3) is directed by \u001b[46m\u001b[30mpositive\u001b[0m and negative \u001b[46m\u001b[30mcis-acting DNA elements\u001b[0m clustered within 30\n",
      "ing sequences. Both \u001b[46m\u001b[30mpositive\u001b[0m and negative \u001b[46m\u001b[30mregulatory elements\u001b[0m were identified in \n",
      "nteractions between \u001b[46m\u001b[30mmultiple positive\u001b[0m and negative \u001b[46m\u001b[30mtranscriptional regulatory elements\u001b[0m. In this article, t\n",
      "\u001b[46m\u001b[30mPositive\u001b[0m and negative \u001b[46m\u001b[30mregulation\u001b[0m of the composite oc\n",
      "ctional as either a \u001b[46m\u001b[30mpositive\u001b[0m or negative \u001b[46m\u001b[30mregulator\u001b[0m. Electrophoretic mo\n",
      "\u001b[46m\u001b[30mPositive\u001b[0m and negative \u001b[46m\u001b[30mregulation\u001b[0m of granulocyte-macr\n",
      "nteractions between \u001b[46m\u001b[30mmultiple\u001b[0m positive and \u001b[46m\u001b[30mnegative transcriptional regulatory elements\u001b[0m. In this article, t\n",
      "ding sites for both \u001b[46m\u001b[30mpositive\u001b[0m and negative \u001b[46m\u001b[30mregulatory factors\u001b[0m.\n",
      "\n",
      "('htlv-1-infected', 'tax-expressing')\n",
      "icantly elevated in \u001b[46m\u001b[30mHTLV-1-infected\u001b[0m and Tax-expressing \u001b[46m\u001b[30mT-cell lines\u001b[0m. Transfection of ki\n",
      "\n",
      "('-3beta', '-6')\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "\n",
      "(',', '-6')\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "\n",
      "('-3alpha', '-6')\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "\n",
      "('-3gamma', '-6')\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "\n",
      "('-4gamma', '-6')\n",
      " the genes encoding \u001b[46m\u001b[30mhepatocyte nuclear factor\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m. The genes encoding\n",
      "study, we show that \u001b[46m\u001b[30mHNF\u001b[0m-3alpha, -3beta, -3gamma, -4gamma, and \u001b[46m\u001b[30m-6\u001b[0m are expressed in pa\n",
      "\n",
      "('ets', 'nf-kappab/nfat')\n",
      "nding sites for the \u001b[46m\u001b[30mEts\u001b[0m and NF-kappaB/NFAT \u001b[46m\u001b[30mfamilies\u001b[0m of transcription fa\n",
      "mechanisms by which \u001b[46m\u001b[30mEts\u001b[0m and NF-kappaB/NFAT \u001b[46m\u001b[30mproteins\u001b[0m cooperatively regul\n",
      "on between multiple \u001b[46m\u001b[30mEts\u001b[0m and NF-kappaB/NFAT \u001b[46m\u001b[30mproteins\u001b[0m both in vitro and i\n",
      "nteractions between \u001b[46m\u001b[30mEts\u001b[0m and NF-kappaB/NFAT \u001b[46m\u001b[30mproteins\u001b[0m play an important r\n",
      "nteractions between \u001b[46m\u001b[30mEts\u001b[0m and NF-kappaB/NFAT \u001b[46m\u001b[30mproteins\u001b[0m are important in re\n",
      "\n",
      "('il-6', 'gene')\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "uppress IL-1 alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "('beta', 'gene')\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "('il-1', 'gene')\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "('alpha', 'tnf-alpha')\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "('il-8', 'gene')\n",
      "n found to suppress \u001b[46m\u001b[30mIL-1 alpha\u001b[0m, IL-1 beta, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "uppress IL-1 alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "1 alpha, IL-1 beta, \u001b[46m\u001b[30mIL-6\u001b[0m, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "(',', '11p14-15.1')\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      "\n",
      "('6q26-27', '11p14-15.1')\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      "\n",
      "('3q21-24', '11p14-15.1')\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      "\n",
      "('8p12', '11p14-15.1')\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      "\n",
      "('19p13.3', '11p14-15.1')\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      "\n",
      "('1p21-22', '11p14-15.1')\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      "\n",
      "('13q14', '11p14-15.1')\n",
      " are located at the \u001b[46m\u001b[30mhuman chromosomal bands\u001b[0m 6q26-27, 1p21-22, 3q21-24, 8p12, 13q14, 19p13.3 and \u001b[46m\u001b[30m11p14-15.1\u001b[0m, respectively. This\n",
      "\n",
      "('cd8+', 'cell')\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "\n",
      "('cd8-', 'cell')\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      " all the CD4- CD8-, \u001b[46m\u001b[30mCD4+ CD8+\u001b[0m, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "\n",
      "('cd4+', 'cell')\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "detected in all the \u001b[46m\u001b[30mCD4- CD8-\u001b[0m, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      " all the CD4- CD8-, \u001b[46m\u001b[30mCD4+ CD8+\u001b[0m, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "\n",
      "('antigen-', 'camp-')\n",
      "TA-3 site abolished \u001b[46m\u001b[30mantigen-\u001b[0m or cAMP- \u001b[46m\u001b[30mstimulated IL-5 promoter activation\u001b[0m in Th2 cells, ectop\n",
      "\n",
      "('solution', 'crystal')\n",
      " difference between \u001b[46m\u001b[30msolution\u001b[0m and crystal \u001b[46m\u001b[30mstructures\u001b[0m is observed in the \n",
      "\n",
      "('nervous', 'immune')\n",
      "interaction between \u001b[46m\u001b[30mnervous\u001b[0m and immune \u001b[46m\u001b[30msystems\u001b[0m] The problem of the\n",
      "ncentration both in \u001b[46m\u001b[30mnervous\u001b[0m and immune \u001b[46m\u001b[30msystems\u001b[0m. Variation of gluco\n",
      "nd in several other \u001b[46m\u001b[30mnervous\u001b[0m and immune \u001b[46m\u001b[30mtissues\u001b[0m. Peripheral blood m\n",
      "\n",
      "('human', 'drosophila')\n",
      "ns of several other \u001b[46m\u001b[30mhuman\u001b[0m, mouse, and Drosophila \u001b[46m\u001b[30msequences\u001b[0m, defining a subfami\n",
      "\n",
      "('mouse', 'sequence')\n",
      "ns of several other \u001b[46m\u001b[30mhuman\u001b[0m, mouse, and Drosophila \u001b[46m\u001b[30msequences\u001b[0m, defining a subfami\n",
      "\n",
      "('v.cholera.', 'toxin')\n",
      ". Pretreatment with \u001b[46m\u001b[30mB.pertussis\u001b[0m, V.cholera. or C.botulinum \u001b[46m\u001b[30mtoxin\u001b[0m did not influence h\n",
      "\n",
      "('b.pertussis', 'c.botulinum')\n",
      ". Pretreatment with \u001b[46m\u001b[30mB.pertussis\u001b[0m, V.cholera. or C.botulinum \u001b[46m\u001b[30mtoxin\u001b[0m did not influence h\n",
      "\n",
      "(',', 'toxin')\n",
      ". Pretreatment with \u001b[46m\u001b[30mB.pertussis\u001b[0m, V.cholera. or C.botulinum \u001b[46m\u001b[30mtoxin\u001b[0m did not influence h\n",
      "\n",
      "('-12', '-10')\n",
      "d catecholamines on \u001b[46m\u001b[30mhuman interleukin-12\u001b[0m and interleukin-10 \u001b[46m\u001b[30mproduction\u001b[0m: clinical implicati\n",
      "\n",
      "('-12', 'interleukin')\n",
      "d catecholamines on \u001b[46m\u001b[30mhuman interleukin-12\u001b[0m and interleukin-10 \u001b[46m\u001b[30mproduction\u001b[0m: clinical implicati\n",
      "d catecholamines on \u001b[46m\u001b[30mhuman\u001b[0m interleukin-12 and \u001b[46m\u001b[30minterleukin-10 production\u001b[0m: clinical implicati\n",
      "\n",
      "('extracellular', 'transmembrane')\n",
      "s consisting of the \u001b[46m\u001b[30mextracellular\u001b[0m and transmembrane \u001b[46m\u001b[30mdomains\u001b[0m of the erythropoiet\n",
      "tor composed of the \u001b[46m\u001b[30mextracellular\u001b[0m and transmembrane \u001b[46m\u001b[30mregions\u001b[0m of the human type I\n",
      "\n",
      "('antigenic', 'mitogenic')\n",
      " CD4+ T cells after \u001b[46m\u001b[30mantigenic\u001b[0m or mitogenic \u001b[46m\u001b[30mstimulation\u001b[0m. Several cis-acting\n",
      "\n",
      "('ctf', 'nf-kappa')\n",
      "ial response: CREB, \u001b[46m\u001b[30mCTF\u001b[0m, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('otf-1', 'gene')\n",
      "ial response: CREB, \u001b[46m\u001b[30mCTF\u001b[0m, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('ctf', 'b')\n",
      "ial response: CREB, \u001b[46m\u001b[30mCTF\u001b[0m, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('oft-2', 'gene')\n",
      "ial response: CREB, \u001b[46m\u001b[30mCTF\u001b[0m, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "esponse: CREB, CTF, \u001b[46m\u001b[30mOTF-1\u001b[0m, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('neutrophil', 'monocyte')\n",
      "ive rise to optimal \u001b[46m\u001b[30mneutrophil\u001b[0m and monocyte \u001b[46m\u001b[30mdifferentiation\u001b[0m of HL60 cells. The \n",
      "\n",
      "('p15', 'cdk4')\n",
      "rations in the p16, \u001b[46m\u001b[30mp15\u001b[0m or CDK4 \u001b[46m\u001b[30mgenes\u001b[0m, whereas homozygous\n",
      "normalities of p16, \u001b[46m\u001b[30mp15\u001b[0m and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m in recurrent malign\n",
      "alities in the p16, \u001b[46m\u001b[30mp15\u001b[0m and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m that regulate trans\n",
      "\n",
      "('alpha-chain', 'interleukin-2')\n",
      "nscription from the \u001b[46m\u001b[30minterleukin-2 receptor alpha-chain\u001b[0m and interleukin-2 \u001b[46m\u001b[30mgenes\u001b[0m, depending on promo\n",
      "\n",
      "('rat', 'human')\n",
      "ighly homologous to \u001b[46m\u001b[30mrat\u001b[0m and human \u001b[46m\u001b[30mfra-1\u001b[0m. Oligonucleotide pr\n",
      "\n",
      "('diploid', 'tetraploid')\n",
      "a cells with either \u001b[46m\u001b[30mdiploid\u001b[0m or tetraploid \u001b[46m\u001b[30mB cells\u001b[0m (Daudi) results in \n",
      "\n",
      "('mzf-1', 'mzf-2')\n",
      "G-CSF. CONCLUSIONS: \u001b[46m\u001b[30mMZF-1\u001b[0m and MZF-2 \u001b[46m\u001b[30mmRNAs\u001b[0m seem to be produced\n",
      "\n",
      "('allergic', 'neoplastic')\n",
      "certain autoimmune, \u001b[46m\u001b[30mallergic\u001b[0m, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "\n",
      "(',', 'disease')\n",
      "certain autoimmune, \u001b[46m\u001b[30mallergic\u001b[0m, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "certain autoimmune, \u001b[46m\u001b[30mallergic\u001b[0m, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "dividual to certain \u001b[46m\u001b[30mautoimmune\u001b[0m, allergic, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "dividual to certain \u001b[46m\u001b[30mautoimmune\u001b[0m, allergic, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "dividual to certain \u001b[46m\u001b[30mautoimmune\u001b[0m, allergic, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "toimmune, allergic, \u001b[46m\u001b[30minfectious\u001b[0m, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "\n",
      "('infectious', 'disease')\n",
      "certain autoimmune, \u001b[46m\u001b[30mallergic\u001b[0m, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "dividual to certain \u001b[46m\u001b[30mautoimmune\u001b[0m, allergic, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "\n",
      "('egr', 'sp1')\n",
      "in promoter through \u001b[46m\u001b[30mnoncanonical Egr\u001b[0m and Sp1 \u001b[46m\u001b[30mbinding sites\u001b[0m. The interleukin-2 \n",
      "in promoter through \u001b[46m\u001b[30mnoncanonical\u001b[0m Egr and \u001b[46m\u001b[30mSp1 binding sites\u001b[0m. The interleukin-2 \n",
      "\n",
      "('t-cell-', 'b-cell-')\n",
      "Absence of \u001b[46m\u001b[30mT-cell-\u001b[0m and B-cell-\u001b[46m\u001b[30mspecific transcription factors\u001b[0m TCF-1, GATA-3, and \n",
      "\n",
      "('il-12-', 'ifn-alpha-')\n",
      "d IFN-alpha. IL-2-, \u001b[46m\u001b[30mIL-12-\u001b[0m, and IFN-alpha-\u001b[46m\u001b[30mmediated signaling pathways\u001b[0m were analyzed in pr\n",
      "\n",
      "('-', 'ap-1')\n",
      ". Cotransfection of \u001b[46m\u001b[30mNF-kappa B (p50/p65)-\u001b[0m or AP-1 (c-Jun/c-Fos)- \u001b[46m\u001b[30mexpression vectors\u001b[0m into Jurkat cells w\n",
      "\n",
      "('-', 'c-jun/c-fos')\n",
      ". Cotransfection of \u001b[46m\u001b[30mNF-kappa B (p50/p65)-\u001b[0m or AP-1 (c-Jun/c-Fos)- \u001b[46m\u001b[30mexpression vectors\u001b[0m into Jurkat cells w\n",
      "\n",
      "('p2', 'p4')\n",
      "tes overlap the P1, \u001b[46m\u001b[30mP2\u001b[0m, and P4 \u001b[46m\u001b[30mNFAT elements\u001b[0m. To investigate the\n",
      "\n",
      "('expression', 'transcription')\n",
      "nduced increases in \u001b[46m\u001b[30mCD44 mRNA\u001b[0m expression and \u001b[46m\u001b[30mtranscription levels\u001b[0m are shown to occur \n",
      "nduced increases in \u001b[46m\u001b[30mCD44 mRNA expression\u001b[0m and transcription \u001b[46m\u001b[30mlevels\u001b[0m are shown to occur \n",
      "\n",
      "('p50', 'c-rel')\n",
      "m the medulla. p65, \u001b[46m\u001b[30mp50\u001b[0m, and c-Rel \u001b[46m\u001b[30mactivities\u001b[0m were found in both \n",
      "\n",
      "('or', 'proliferation')\n",
      "are not involved in \u001b[46m\u001b[30mhuman T\u001b[0m or B \u001b[46m\u001b[30mcell\u001b[0m activation and \u001b[46m\u001b[30mproliferation\u001b[0m. The involvement of\n",
      "are not involved in \u001b[46m\u001b[30mhuman\u001b[0m T or \u001b[46m\u001b[30mB cell\u001b[0m activation and \u001b[46m\u001b[30mproliferation\u001b[0m. The involvement of\n",
      "\n",
      "('b', 'proliferation')\n",
      "are not involved in \u001b[46m\u001b[30mhuman T\u001b[0m or B \u001b[46m\u001b[30mcell\u001b[0m activation and \u001b[46m\u001b[30mproliferation\u001b[0m. The involvement of\n",
      "\n",
      "('activation', 'proliferation')\n",
      "are not involved in \u001b[46m\u001b[30mhuman T\u001b[0m or B \u001b[46m\u001b[30mcell\u001b[0m activation and \u001b[46m\u001b[30mproliferation\u001b[0m. The involvement of\n",
      "are not involved in \u001b[46m\u001b[30mhuman\u001b[0m T or \u001b[46m\u001b[30mB cell\u001b[0m activation and \u001b[46m\u001b[30mproliferation\u001b[0m. The involvement of\n",
      "\n",
      "('tnf-alpha', 'il-6')\n",
      ". The expression of \u001b[46m\u001b[30mTNF-alpha\u001b[0m and IL-6 \u001b[46m\u001b[30mmRNAs\u001b[0m was also induced. T\n",
      "\n",
      "('igm', 'igd')\n",
      " mouse B cells with \u001b[46m\u001b[30manti-IgM\u001b[0m or IgD \u001b[46m\u001b[30mantibodies\u001b[0m, bacterial lipopoly\n",
      " mouse B cells with \u001b[46m\u001b[30manti-\u001b[0mIgM or \u001b[46m\u001b[30mIgD antibodies\u001b[0m, bacterial lipopoly\n",
      "\n",
      "('tnf-alpha', 'phorbol')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "(',', 'treatment')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('tnf-alpha', ')')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('beta', 'treatment')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('tnf-alpha', 'acetate')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('tnf-alpha', '(')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('tnf-alpha', 'pma')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('tnf-alpha', 'myristate')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('il-1', 'treatment')\n",
      "ility shift assays. \u001b[46m\u001b[30mTNF-alpha\u001b[0m, IL-1 beta and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('osteocalcin', 'osteopontin')\n",
      "of the VDREs of the \u001b[46m\u001b[30mhuman osteocalcin\u001b[0m and the mouse osteopontin \u001b[46m\u001b[30mgene promoters\u001b[0m. A specific, retard\n",
      "\n",
      "('osteocalcin', 'the')\n",
      "of the VDREs of the \u001b[46m\u001b[30mhuman osteocalcin\u001b[0m and the mouse osteopontin \u001b[46m\u001b[30mgene promoters\u001b[0m. A specific, retard\n",
      "\n",
      "('osteocalcin', 'mouse')\n",
      "of the VDREs of the \u001b[46m\u001b[30mhuman osteocalcin\u001b[0m and the mouse osteopontin \u001b[46m\u001b[30mgene promoters\u001b[0m. A specific, retard\n",
      "\n",
      "('nf-kappab', 'ap-1')\n",
      "t least in part via \u001b[46m\u001b[30mNF-kappaB\u001b[0m and AP-1 \u001b[46m\u001b[30mgeneration\u001b[0m, and that this resp\n",
      "\n",
      "(',', '-15')\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "r demonstrated that \u001b[46m\u001b[30mIL\u001b[0m-2, -7, and \u001b[46m\u001b[30m-15\u001b[0m induce multiple STA\n",
      "r demonstrated that \u001b[46m\u001b[30mIL\u001b[0m-2, -7, and \u001b[46m\u001b[30m-15\u001b[0m induce multiple STA\n",
      "\n",
      "('-2', '-15')\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "r demonstrated that \u001b[46m\u001b[30mIL\u001b[0m-2, -7, and \u001b[46m\u001b[30m-15\u001b[0m induce multiple STA\n",
      "\n",
      "('-4', '-15')\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "\n",
      "('-7', '-15')\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "r demonstrated that \u001b[46m\u001b[30mIL\u001b[0m-2, -7, and \u001b[46m\u001b[30m-15\u001b[0m induce multiple STA\n",
      "\n",
      "('-9', '-15')\n",
      "eptor complexes for \u001b[46m\u001b[30mIL\u001b[0m-2, -4, -7, -9, and \u001b[46m\u001b[30m-15\u001b[0m, and the multiple s\n",
      "\n",
      "('inflammatory', 'immune')\n",
      "nhibitory effect on \u001b[46m\u001b[30minflammatory\u001b[0m and immune \u001b[46m\u001b[30mresponses\u001b[0m, and this may be th\n",
      "al role in numerous \u001b[46m\u001b[30minflammatory\u001b[0m and immune \u001b[46m\u001b[30mprocesses\u001b[0m. Interleukin-6 leve\n",
      "fundamental role in \u001b[46m\u001b[30minflammatory\u001b[0m and immune mediated \u001b[46m\u001b[30mreactions\u001b[0m, have been involved\n",
      "the hypothesis that \u001b[46m\u001b[30minflammatory\u001b[0m and immune \u001b[46m\u001b[30mresponses\u001b[0m of monocytes/macrop\n",
      "L-1ra system during \u001b[46m\u001b[30minflammatory\u001b[0m or immune \u001b[46m\u001b[30mprocesses\u001b[0m. Moreover, we provi\n",
      "e in the control of \u001b[46m\u001b[30minflammatory\u001b[0m and immune \u001b[46m\u001b[30mprocesses\u001b[0m, suppress the expre\n",
      "\n",
      "('b', 'sp1')\n",
      " 1, lacking all the \u001b[46m\u001b[30mNF-kappa B\u001b[0m and Sp1 \u001b[46m\u001b[30mbinding sites\u001b[0m present in the nati\n",
      "odifications in the \u001b[46m\u001b[30mNF-kappa B\u001b[0m and/or Sp1 \u001b[46m\u001b[30mbinding sites\u001b[0m. In this study, we \n",
      " or combinations of \u001b[46m\u001b[30mNF-kappa B\u001b[0m and Sp1 \u001b[46m\u001b[30melements\u001b[0m were generated and \n",
      "\n",
      "('proliferation', 'differentiation')\n",
      "n the regulation of \u001b[46m\u001b[30mB cell\u001b[0m proliferation and \u001b[46m\u001b[30mdifferentiation\u001b[0m. B cells were purif\n",
      "n the regulation of \u001b[46m\u001b[30mhuman B cell\u001b[0m proliferation and \u001b[46m\u001b[30mdifferentiation\u001b[0m. Studies with 5' de\n",
      "\n",
      "('anti-inflammatory', 'anti-allergic')\n",
      " therapeutic use as \u001b[46m\u001b[30manti-inflammatory\u001b[0m and anti-allergic\u001b[46m\u001b[30m/hypereosinophilic agents\u001b[0m. We found that trea\n",
      "\n",
      "('aml1-', 'lbf4-')\n",
      "c. Mutations of the \u001b[46m\u001b[30mAML1-\u001b[0m or LBF4-\u001b[46m\u001b[30mbinding sites\u001b[0m had no effect on EB\n",
      "\n",
      "('c-rel', 'p65')\n",
      "\u001b[46m\u001b[30mc-Rel\u001b[0m and p65 \u001b[46m\u001b[30msubunits\u001b[0m bind to an upstream\n",
      "\n",
      "('pkc-', 'ca2+-')\n",
      "GM-CSF gene through \u001b[46m\u001b[30mPKC-\u001b[0m and Ca2+- \u001b[46m\u001b[30msignaling pathways\u001b[0m downstream of T cel\n",
      "\n",
      "('nf-il6', 'nf-kappa')\n",
      "e conclude that the \u001b[46m\u001b[30mNF-IL6\u001b[0m and NF-kappa B \u001b[46m\u001b[30msites\u001b[0m mediate IL-6 induct\n",
      "\n",
      "('nf-il6', 'b')\n",
      "e conclude that the \u001b[46m\u001b[30mNF-IL6\u001b[0m and NF-kappa B \u001b[46m\u001b[30msites\u001b[0m mediate IL-6 induct\n",
      "\n",
      "('pkc-', 'ca(2+)-')\n",
      " phosphorylation by \u001b[46m\u001b[30mPKC-\u001b[0m and Ca(2+)-\u001b[46m\u001b[30mdependent signal transduction pathways\u001b[0m. The Ca(2+)-depende\n",
      "\n",
      "('supershift', 'immunoblot')\n",
      "B, as determined by \u001b[46m\u001b[30msupershift\u001b[0m and immunoblot \u001b[46m\u001b[30manalysis\u001b[0m. As a functional co\n",
      "\n",
      "('fa', 'cd23')\n",
      "vity down-regulates \u001b[46m\u001b[30mFas\u001b[0m and CD23 \u001b[46m\u001b[30mexpression\u001b[0m in B cells. Activat\n",
      "\n",
      "('t-cell', ')')\n",
      "4+, CD8+ and CD56+ [\u001b[46m\u001b[30mpossible T-cell\u001b[0m and natural killer (T/NK) \u001b[46m\u001b[30mpopulations\u001b[0m] in the BM of ST pa\n",
      "\n",
      "('t-cell', 'natural')\n",
      "4+, CD8+ and CD56+ [\u001b[46m\u001b[30mpossible T-cell\u001b[0m and natural killer (T/NK) \u001b[46m\u001b[30mpopulations\u001b[0m] in the BM of ST pa\n",
      "4+, CD8+ and CD56+ [\u001b[46m\u001b[30mpossible\u001b[0m T-cell and \u001b[46m\u001b[30mnatural killer (T/NK) populations\u001b[0m] in the BM of ST pa\n",
      "\n",
      "('t-cell', 't/nk')\n",
      "4+, CD8+ and CD56+ [\u001b[46m\u001b[30mpossible T-cell\u001b[0m and natural killer (T/NK) \u001b[46m\u001b[30mpopulations\u001b[0m] in the BM of ST pa\n",
      "\n",
      "('t-cell', '(')\n",
      "4+, CD8+ and CD56+ [\u001b[46m\u001b[30mpossible T-cell\u001b[0m and natural killer (T/NK) \u001b[46m\u001b[30mpopulations\u001b[0m] in the BM of ST pa\n",
      "\n",
      "('t-cell', 'killer')\n",
      "4+, CD8+ and CD56+ [\u001b[46m\u001b[30mpossible T-cell\u001b[0m and natural killer (T/NK) \u001b[46m\u001b[30mpopulations\u001b[0m] in the BM of ST pa\n",
      "\n",
      "('gamma-globin', 'synthetase')\n",
      "induction by EPO of \u001b[46m\u001b[30mgamma-globin\u001b[0m and erythroid-specific 5-aminolevulinate synthetase \u001b[46m\u001b[30mtranscripts\u001b[0m, resulting in a red\n",
      "\n",
      "('gamma-globin', '5-aminolevulinate')\n",
      "induction by EPO of \u001b[46m\u001b[30mgamma-globin\u001b[0m and erythroid-specific 5-aminolevulinate synthetase \u001b[46m\u001b[30mtranscripts\u001b[0m, resulting in a red\n",
      "\n",
      "('gamma-globin', 'erythroid-specific')\n",
      "induction by EPO of \u001b[46m\u001b[30mgamma-globin\u001b[0m and erythroid-specific 5-aminolevulinate synthetase \u001b[46m\u001b[30mtranscripts\u001b[0m, resulting in a red\n",
      "\n",
      "('t-lymphoid', 'monocytoid')\n",
      "receptors (RARs) in \u001b[46m\u001b[30mT-lymphoid\u001b[0m and monocytoid \u001b[46m\u001b[30mcell lines\u001b[0m. DESIGN AND METHODS\n",
      "\n",
      "('pallidum', 'borrelia')\n",
      " monocytic cells by \u001b[46m\u001b[30mTreponema pallidum\u001b[0m and Borrelia burgdorferi \u001b[46m\u001b[30mlipoproteins\u001b[0m and synthetic lipop\n",
      "\n",
      "('pallidum', 'burgdorferi')\n",
      " monocytic cells by \u001b[46m\u001b[30mTreponema pallidum\u001b[0m and Borrelia burgdorferi \u001b[46m\u001b[30mlipoproteins\u001b[0m and synthetic lipop\n",
      "\n",
      "('human', 'rat')\n",
      "on and apoptosis of \u001b[46m\u001b[30mhuman\u001b[0m and rat \u001b[46m\u001b[30mT lymphocytes\u001b[0m by curcumin, a curr\n",
      "\n",
      "('tumour', 'non')\n",
      "y expressed in both \u001b[46m\u001b[30mtumour\u001b[0m and non tumour \u001b[46m\u001b[30mcells\u001b[0m of A-T and non-A-T \n",
      "\n",
      "('tumour', 'tumour')\n",
      "y expressed in both \u001b[46m\u001b[30mtumour\u001b[0m and non tumour \u001b[46m\u001b[30mcells\u001b[0m of A-T and non-A-T \n",
      "\n",
      "('wild-type', 'class')\n",
      "binding proteins in \u001b[46m\u001b[30mwild-type\u001b[0m and class II-deficient \u001b[46m\u001b[30mB cells\u001b[0m. The X box region i\n",
      "\n",
      "('wild-type', 'ii-deficient')\n",
      "binding proteins in \u001b[46m\u001b[30mwild-type\u001b[0m and class II-deficient \u001b[46m\u001b[30mB cells\u001b[0m. The X box region i\n",
      "\n",
      "('er+', 'er-')\n",
      "ol, E2-treated, and \u001b[46m\u001b[30mTAM-treated\u001b[0m ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "mediated lysis. All \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m tested remained sen\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "ed, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "ol, E2-treated, and \u001b[46m\u001b[30mTAM-treated ER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "\n",
      "('cytoplasmic', 'transmembrane')\n",
      ") receptor) and the \u001b[46m\u001b[30mcytoplasmic\u001b[0m and transmembrane \u001b[46m\u001b[30mdomains\u001b[0m of the IL-4R alpha \n",
      "\n",
      "('initiation', 'elongation')\n",
      " factors, increases \u001b[46m\u001b[30mviral transcription\u001b[0m initiation and \u001b[46m\u001b[30melongation\u001b[0m. Tat also superacti\n",
      "\n",
      "('and', 'er-')\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "\n",
      "(',', 'er-')\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "\n",
      "('tam-treated', 'er-')\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "\n",
      "(',', 'category')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and DFR but not \u001b[46m\u001b[30mCategory III cells\u001b[0m. Cells within each \n",
      "\n",
      "('category', 'not')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and DFR but not \u001b[46m\u001b[30mCategory III cells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('category', 'but')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and DFR but not \u001b[46m\u001b[30mCategory III cells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('vi', 'category')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and DFR but not \u001b[46m\u001b[30mCategory III cells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('category', 'dfr')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and DFR but not \u001b[46m\u001b[30mCategory III cells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('va', 'category')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and DFR but not \u001b[46m\u001b[30mCategory III cells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories Va\u001b[0m, VI and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('homo-', 'hetero')\n",
      "nces through either \u001b[46m\u001b[30mhomo-\u001b[0m or hetero\u001b[46m\u001b[30mdimer formation\u001b[0m. In addition, the p\n",
      "ppa B site and form \u001b[46m\u001b[30mmultiple DNA binding homo-\u001b[0m and hetero\u001b[46m\u001b[30mdimer complexes\u001b[0m in co-renaturation \n",
      "lative formation of \u001b[46m\u001b[30mhomo-\u001b[0m and hetero\u001b[46m\u001b[30mdimers\u001b[0m varies between the \n",
      "ppa B site and form \u001b[46m\u001b[30mmultiple DNA binding\u001b[0m homo- and \u001b[46m\u001b[30mheterodimer complexes\u001b[0m in co-renaturation \n",
      "\n",
      "('bacterial', 'mycobacterial')\n",
      " and LAM, acting as \u001b[46m\u001b[30mbacterial\u001b[0m or mycobacterial \u001b[46m\u001b[30mresponse elements\u001b[0m.\n",
      "\n",
      "('il-13', 'il-4')\n",
      "e expression of the \u001b[46m\u001b[30mIL-13\u001b[0m and IL-4 \u001b[46m\u001b[30mgenes\u001b[0m in a coordinate man\n",
      "\n",
      "('tax-expressing', 'htlv-i-transformed')\n",
      "vation of NF-AT1 in \u001b[46m\u001b[30mTax-expressing\u001b[0m and HTLV-I-transformed \u001b[46m\u001b[30mT cells\u001b[0m results from its de\n",
      "\n",
      "('nfat', 'nf-kappab')\n",
      " results. Authentic \u001b[46m\u001b[30mNFAT\u001b[0m and NF-kappaB \u001b[46m\u001b[30mtargets\u001b[0m did not compete for\n",
      "\n",
      "('tyrosine', 'serine/threonine')\n",
      "rough the action of \u001b[46m\u001b[30mprotein\u001b[0m tyrosine and \u001b[46m\u001b[30mserine/threonine kinases\u001b[0m. We have identified\n",
      "rough the action of \u001b[46m\u001b[30mprotein tyrosine\u001b[0m and serine/threonine \u001b[46m\u001b[30mkinases\u001b[0m. We have identified\n",
      "\n",
      "('b', 'sp-1')\n",
      "rs). Mutagenesis of \u001b[46m\u001b[30mNF kappa B\u001b[0m or Sp-1 \u001b[46m\u001b[30melements\u001b[0m within the LTR resu\n",
      "\n",
      "('bax', 'bak')\n",
      "d no effect on p53, \u001b[46m\u001b[30mBax\u001b[0m, or Bak \u001b[46m\u001b[30mgene expression\u001b[0m. Mechanisms for tra\n",
      "\n",
      "('megakaryocyte', 'cell')\n",
      "ein was detected in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      " gene expression in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m. GATA-1 binds to WG\n",
      "SCL is expressed in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte and mast \u001b[46m\u001b[30mcell populations\u001b[0m (the same cell line\n",
      "\n",
      "('erythroid', 'early')\n",
      "ein was detected in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "\n",
      "('erythroid', 'myeloid')\n",
      "ein was detected in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "\n",
      "('mast', 'cell')\n",
      "ein was detected in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "ected in erythroid, \u001b[46m\u001b[30mmegakaryocyte\u001b[0m, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "\n",
      "('biochemical', 'biological')\n",
      "F2. Analysis of the \u001b[46m\u001b[30mbiochemical\u001b[0m and cell biological \u001b[46m\u001b[30mproperties\u001b[0m of these HSFs revea\n",
      "\n",
      "('biochemical', 'cell')\n",
      "F2. Analysis of the \u001b[46m\u001b[30mbiochemical\u001b[0m and cell biological \u001b[46m\u001b[30mproperties\u001b[0m of these HSFs revea\n",
      "\n",
      "('cell', 'lymphocyte')\n",
      "ctor recruitment in \u001b[46m\u001b[30mhuman\u001b[0m glial cells and \u001b[46m\u001b[30mlymphocytes\u001b[0m. The generation of \n",
      "\n",
      "('glial', 'lymphocyte')\n",
      "ctor recruitment in \u001b[46m\u001b[30mhuman\u001b[0m glial cells and \u001b[46m\u001b[30mlymphocytes\u001b[0m. The generation of \n",
      "\n",
      "('nf-at', 'nf-kb')\n",
      "omoter or its AP-1, \u001b[46m\u001b[30mNF-AT\u001b[0m, and NF-kB \u001b[46m\u001b[30mmotifs\u001b[0m. Dex inhibited the \n",
      "\n",
      "(',', 'motif')\n",
      "omoter or its AP-1, \u001b[46m\u001b[30mNF-AT\u001b[0m, and NF-kB \u001b[46m\u001b[30mmotifs\u001b[0m. Dex inhibited the \n",
      "L-2 promoter or its \u001b[46m\u001b[30mAP-1\u001b[0m, NF-AT, and NF-kB \u001b[46m\u001b[30mmotifs\u001b[0m. Dex inhibited the \n",
      "L-2 promoter or its \u001b[46m\u001b[30mAP-1\u001b[0m, NF-AT, and NF-kB \u001b[46m\u001b[30mmotifs\u001b[0m. Dex inhibited the \n",
      "\n",
      "('myeloid', 'progenitor')\n",
      "rowth inhibition of \u001b[46m\u001b[30mnormal bone marrow myeloid\u001b[0m and erythroid progenitor \u001b[46m\u001b[30mcells\u001b[0m. In addition, we de\n",
      "n the regulation of \u001b[46m\u001b[30mnormal myeloid\u001b[0m and erythroid progenitor \u001b[46m\u001b[30mcell growth\u001b[0m. Transactivation st\n",
      "\n",
      "('cellular', 'viral')\n",
      "A-2 trans-activates \u001b[46m\u001b[30mcellular\u001b[0m and viral \u001b[46m\u001b[30mgenes\u001b[0m like CD23, c-fgr, l\n",
      "tional activator of \u001b[46m\u001b[30mcellular\u001b[0m and viral \u001b[46m\u001b[30mgenes\u001b[0m and plays a crucial\n",
      "mon target for both \u001b[46m\u001b[30mcellular\u001b[0m and viral \u001b[46m\u001b[30manti-apoptotic proteins\u001b[0m. While Bik does not\n",
      "ression of multiple \u001b[46m\u001b[30mcellular\u001b[0m and viral \u001b[46m\u001b[30mgenes\u001b[0m involved in inflamm\n",
      "\n",
      "('monocytic', 'glial')\n",
      "nes of lymphocytic, \u001b[46m\u001b[30mmonocytic\u001b[0m, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "\n",
      "('neuronal', 'cell')\n",
      "nes of lymphocytic, \u001b[46m\u001b[30mmonocytic\u001b[0m, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      " from cell lines of \u001b[46m\u001b[30mlymphocytic\u001b[0m, monocytic, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "\n",
      "('p62c-fos', 'p39c-jun')\n",
      " also observed that \u001b[46m\u001b[30mcytoplasmic\u001b[0m p62c-fos and \u001b[46m\u001b[30mp39c-jun\u001b[0m were present in HL6\n",
      "ls, while levels of \u001b[46m\u001b[30mnuclear\u001b[0m p62c-fos and \u001b[46m\u001b[30mp39c-jun\u001b[0m were constant. Nucl\n",
      "\n",
      "('il-4-', 'ifn-gamma-')\n",
      "an accommodate both \u001b[46m\u001b[30mIL-4-\u001b[0m and IFN-gamma-\u001b[46m\u001b[30mactivated factors\u001b[0m, such as STAT 6 and\n",
      "\n",
      "('icam-1', 'necrosis')\n",
      "nterleukin-2, CD44, \u001b[46m\u001b[30mICAM-1\u001b[0m, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('icam-1', 'tumor')\n",
      "nterleukin-2, CD44, \u001b[46m\u001b[30mICAM-1\u001b[0m, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('icam-1', 'factor')\n",
      "nterleukin-2, CD44, \u001b[46m\u001b[30mICAM-1\u001b[0m, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('va', 'not')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories Va\u001b[0m, VI and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('va', 'but')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories Va\u001b[0m, VI and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('va', 'iii')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories Va\u001b[0m, VI and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('vi', 'cell')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories Va\u001b[0m, VI and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('va', 'dfr')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories Va\u001b[0m, VI and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('cd11b', 'cd11c')\n",
      "ences of the CD11a, \u001b[46m\u001b[30mCD11b\u001b[0m, and CD11c \u001b[46m\u001b[30mgene promoters\u001b[0m to identify common \n",
      "\n",
      "('cd8+', 'cd8+')\n",
      " all the CD4- CD8-, \u001b[46m\u001b[30mCD4+ CD8+\u001b[0m, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "\n",
      "('cd8+', 'cd4-')\n",
      " all the CD4- CD8-, \u001b[46m\u001b[30mCD4+ CD8+\u001b[0m, CD4+ CD8-, and CD4- CD8+ \u001b[46m\u001b[30mcell populations\u001b[0m. The results indica\n",
      "\n",
      "('icam-1', 'gene')\n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      " the interleukin-2, \u001b[46m\u001b[30mCD44\u001b[0m, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('cd44', 'gene')\n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('interleukin-2', 'necrosis')\n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('interleukin-2', 'factor')\n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('interleukin-2', 'tumor')\n",
      "y egr-1 include the \u001b[46m\u001b[30minterleukin-2\u001b[0m, CD44, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('lineage', 'stage')\n",
      "y accounts for both \u001b[46m\u001b[30mlineage\u001b[0m and stage\u001b[46m\u001b[30m-specific expression\u001b[0m of CD20 whereas the\n",
      "\n",
      "('1', '2')\n",
      " region between the \u001b[46m\u001b[30mexons\u001b[0m 1 and \u001b[46m\u001b[30m2\u001b[0m showed that the alt\n",
      "The balance between \u001b[46m\u001b[30mtype\u001b[0m 1 and \u001b[46m\u001b[30m2 T helper cell cytokine production\u001b[0m plays an important \n",
      "The balance between \u001b[46m\u001b[30mtype 1\u001b[0m and 2 \u001b[46m\u001b[30mT helper cell cytokine production\u001b[0m plays an important \n",
      " membrane proteins, \u001b[46m\u001b[30mLMP\u001b[0m1 and \u001b[46m\u001b[30m2\u001b[0m and the BamHI A rig\n",
      "tional enhancers of \u001b[46m\u001b[30mhuman immunodeficiency viruses types\u001b[0m 1 and \u001b[46m\u001b[30m2\u001b[0m (HIV-1 and HIV-2), \n",
      "s harbouring either \u001b[46m\u001b[30mtype 1\u001b[0m or type 2 \u001b[46m\u001b[30mEBV\u001b[0m. The protein was fo\n",
      "\n",
      "('mast', 'myeloid')\n",
      "oid, megakaryocyte, \u001b[46m\u001b[30mmast\u001b[0m and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "\n",
      "('mast', 'early')\n",
      "oid, megakaryocyte, \u001b[46m\u001b[30mmast\u001b[0m and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "\n",
      "('peripheral', 'central')\n",
      " glucocorticoids on \u001b[46m\u001b[30mendogenous glucocorticoid\u001b[0m peripheral and \u001b[46m\u001b[30mcentral function\u001b[0m. Glucocorticoids ar\n",
      " glucocorticoids on \u001b[46m\u001b[30mendogenous glucocorticoid peripheral\u001b[0m and central \u001b[46m\u001b[30mfunction\u001b[0m. Glucocorticoids ar\n",
      "\n",
      "('b', 'activator')\n",
      "strong induction of \u001b[46m\u001b[30mnuclear factor-kappa B\u001b[0m and activator protein-1 \u001b[46m\u001b[30mtranscription factor expression\u001b[0m. Experiments using \n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', 'protein-1')\n",
      "strong induction of \u001b[46m\u001b[30mnuclear factor-kappa B\u001b[0m and activator protein-1 \u001b[46m\u001b[30mtranscription factor expression\u001b[0m. Experiments using \n",
      "\n",
      "('immediate-early', 'early')\n",
      "s expression to the \u001b[46m\u001b[30mimmediate-early\u001b[0m and early \u001b[46m\u001b[30mclasses of viral genes\u001b[0m. Using deletion mut\n",
      "\n",
      "('immune', 'inflammatory')\n",
      "l genes involved in \u001b[46m\u001b[30mimmune\u001b[0m and inflammatory \u001b[46m\u001b[30mresponses\u001b[0m, the authors have a\n",
      "nes involved in the \u001b[46m\u001b[30mimmune\u001b[0m and inflammatory \u001b[46m\u001b[30mresponses\u001b[0m. This transcription\n",
      "y genes involved in \u001b[46m\u001b[30mimmune\u001b[0m and inflammatory \u001b[46m\u001b[30mresponses\u001b[0m, little is known ab\n",
      "lay a major role in \u001b[46m\u001b[30mimmune\u001b[0m and inflammatory \u001b[46m\u001b[30mresponses\u001b[0m. Bacterial lipopoly\n",
      " important roles in \u001b[46m\u001b[30mimmune\u001b[0m and inflammatory \u001b[46m\u001b[30mresponses\u001b[0m by regulating the e\n",
      "f genes involved in \u001b[46m\u001b[30mimmune\u001b[0m and inflammatory \u001b[46m\u001b[30mresponses\u001b[0m. We have reported p\n",
      "\n",
      "('h1285', 'ici')\n",
      "tor, since both the \u001b[46m\u001b[30mantiestrogens\u001b[0m H1285 and \u001b[46m\u001b[30mICI 182,780\u001b[0m effectively inhibit\n",
      "\n",
      "('promoter', 'enhancer')\n",
      "hich is active from \u001b[46m\u001b[30mpromoter\u001b[0m and enhancer \u001b[46m\u001b[30mpositions\u001b[0m. This transactivati\n",
      "emonstrate that the \u001b[46m\u001b[30mhuman GM-CSF\u001b[0m promoter and \u001b[46m\u001b[30menhancer\u001b[0m also encompass bind\n",
      " CACCC sites in the \u001b[46m\u001b[30mH5\u001b[0m promoter and \u001b[46m\u001b[30menhancer\u001b[0m. In contrast, the b\n",
      "\n",
      "('ciita', 'class')\n",
      "issular patterns of \u001b[46m\u001b[30mCIITA\u001b[0m and MHC class II \u001b[46m\u001b[30mgene expression\u001b[0m are tightly correla\n",
      "\n",
      "('ciita', 'ii')\n",
      "issular patterns of \u001b[46m\u001b[30mCIITA\u001b[0m and MHC class II \u001b[46m\u001b[30mgene expression\u001b[0m are tightly correla\n",
      "\n",
      "('ciita', 'mhc')\n",
      "issular patterns of \u001b[46m\u001b[30mCIITA\u001b[0m and MHC class II \u001b[46m\u001b[30mgene expression\u001b[0m are tightly correla\n",
      "\n",
      "('pbgd', 'gata-1')\n",
      "reased stability of \u001b[46m\u001b[30mPBGD\u001b[0m and GATA-1 \u001b[46m\u001b[30mmRNAs\u001b[0m, whereas ACLA did n\n",
      "\n",
      "('tnf-alpha', 'il-1')\n",
      "tream kinase in the \u001b[46m\u001b[30mTNF-alpha\u001b[0m and IL-1 \u001b[46m\u001b[30msignaling pathways\u001b[0m leading to IKKalpha\n",
      "\n",
      "('alpha', 'aml1/eto')\n",
      "enous leukemia with \u001b[46m\u001b[30mPML/RAR alpha\u001b[0m or AML1/ETO \u001b[46m\u001b[30mmRNA\u001b[0m and phenotypic anal\n",
      "\n",
      "('b', 'il-2')\n",
      " the above signals, \u001b[46m\u001b[30mNF kappa B\u001b[0m and IL-2 \u001b[46m\u001b[30mlevels\u001b[0m remain lower than i\n",
      "\n",
      "('mitogen-', 'anti-cd3-')\n",
      "ighly stimulated in \u001b[46m\u001b[30mmitogen-\u001b[0m and anti-CD3-\u001b[46m\u001b[30mtreated peripheral blood lymphocytes\u001b[0m. BLR2-specific mRNA\n",
      "\n",
      "('normal', 'hypopigmented')\n",
      "is was performed on \u001b[46m\u001b[30mnormal\u001b[0m and hypopigmented \u001b[46m\u001b[30mskin samples\u001b[0m obtained from a fem\n",
      "\n",
      "(',', 'b-cell')\n",
      "a was detectable in \u001b[46m\u001b[30mpro-\u001b[0m, pre-, and mature \u001b[46m\u001b[30mB-cell lines\u001b[0m, but not in two pla\n",
      "a was detectable in \u001b[46m\u001b[30mpro-\u001b[0m, pre-, and mature \u001b[46m\u001b[30mB-cell lines\u001b[0m, but not in two pla\n",
      "detectable in pro-, \u001b[46m\u001b[30mpre-\u001b[0m, and mature \u001b[46m\u001b[30mB-cell lines\u001b[0m, but not in two pla\n",
      "\n",
      "('pre-', 'b-cell')\n",
      "a was detectable in \u001b[46m\u001b[30mpro-\u001b[0m, pre-, and mature \u001b[46m\u001b[30mB-cell lines\u001b[0m, but not in two pla\n",
      "\n",
      "('pro-', 'mature')\n",
      "a was detectable in \u001b[46m\u001b[30mpro-\u001b[0m, pre-, and mature \u001b[46m\u001b[30mB-cell lines\u001b[0m, but not in two pla\n",
      "\n",
      "('pma-', 'tnf-')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or \u001b[46m\u001b[30mTNF-\u001b[0minduced, but also co\n",
      "in unstimulated and \u001b[46m\u001b[30mPMA-\u001b[0m or TNF-\u001b[46m\u001b[30mstimulated cells\u001b[0m blocks the function\n",
      "\n",
      "('c-jun', 'c-fos')\n",
      "of c-Jun and c-Fos. \u001b[46m\u001b[30mTruncated\u001b[0m c-Jun and \u001b[46m\u001b[30mc-Fos mutant proteins\u001b[0m including wbJun and\n",
      "nduced increases in \u001b[46m\u001b[30mc-jun\u001b[0m and c-fos \u001b[46m\u001b[30mmRNA levels\u001b[0m in U-937 leukemia c\n",
      "duced expression of \u001b[46m\u001b[30mc-jun\u001b[0m and c-fos \u001b[46m\u001b[30mmessenger RNA\u001b[0m and activator prote\n",
      "n being composed of \u001b[46m\u001b[30mc-jun\u001b[0m and c-fos \u001b[46m\u001b[30mgene products\u001b[0m. In THP-1 cells c-j\n",
      "d expression of the \u001b[46m\u001b[30mc-jun\u001b[0m and c-fos \u001b[46m\u001b[30mearly response genes\u001b[0m. The present work d\n",
      "e expression of the \u001b[46m\u001b[30mproto-oncogenes\u001b[0m c-jun and \u001b[46m\u001b[30mc-fos\u001b[0m. In addition, we lo\n",
      "t: (1) induction of \u001b[46m\u001b[30mc-jun\u001b[0m and c-fos \u001b[46m\u001b[30mexpression\u001b[0m by TPA is regulated\n",
      "of c-Jun and c-Fos. \u001b[46m\u001b[30mTruncated c-Jun\u001b[0m and c-Fos \u001b[46m\u001b[30mmutant proteins\u001b[0m including wbJun and\n",
      "\n",
      "('cis-', 'trans')\n",
      ". Understanding the \u001b[46m\u001b[30mcis-\u001b[0m and trans\u001b[46m\u001b[30macting factors\u001b[0m that regulate the t\n",
      "\n",
      "('surface', 'mrna')\n",
      "y lacked detectable \u001b[46m\u001b[30mCD14\u001b[0m cell surface or \u001b[46m\u001b[30mmRNA expression\u001b[0m. Furthermore, the V\n",
      "y lacked detectable \u001b[46m\u001b[30mCD14 cell surface\u001b[0m or mRNA \u001b[46m\u001b[30mexpression\u001b[0m. Furthermore, the V\n",
      "\n",
      "('cell', 'mrna')\n",
      "y lacked detectable \u001b[46m\u001b[30mCD14\u001b[0m cell surface or \u001b[46m\u001b[30mmRNA expression\u001b[0m. Furthermore, the V\n",
      "\n",
      "('hel/s', 'hel')\n",
      "luding HL-60, U937, \u001b[46m\u001b[30mHEL/S\u001b[0m, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('lps-', 'tnf-alpha-')\n",
      "otein(s) from LAM-, \u001b[46m\u001b[30mLPS-\u001b[0m, or TNF-alpha- \u001b[46m\u001b[30mstimulated THP-1 cells\u001b[0m to the NF-IL6 motif\n",
      "\n",
      "(',', 'stimulated')\n",
      "otein(s) from LAM-, \u001b[46m\u001b[30mLPS-\u001b[0m, or TNF-alpha- \u001b[46m\u001b[30mstimulated THP-1 cells\u001b[0m to the NF-IL6 motif\n",
      "ear protein(s) from \u001b[46m\u001b[30mLAM-\u001b[0m, LPS-, or TNF-alpha- \u001b[46m\u001b[30mstimulated THP-1 cells\u001b[0m to the NF-IL6 motif\n",
      "ear protein(s) from \u001b[46m\u001b[30mLAM-\u001b[0m, LPS-, or TNF-alpha- \u001b[46m\u001b[30mstimulated THP-1 cells\u001b[0m to the NF-IL6 motif\n",
      "\n",
      "('gamma', 'lambda')\n",
      "volume, whereas the \u001b[46m\u001b[30mgamma\u001b[0m and lambda \u001b[46m\u001b[30mgenes\u001b[0m consistently occupi\n",
      "\n",
      "('tnf-alpha-', 'nf-kappab-')\n",
      "tic cells through a \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and NF-kappaB-\u001b[46m\u001b[30mdependent mechanism\u001b[0m. In HIV-infected pa\n",
      "\n",
      "('sp1-', 'pu.1-')\n",
      " combined action of \u001b[46m\u001b[30mSp1-\u001b[0m and PU.1-\u001b[46m\u001b[30mfamily members\u001b[0m.\n",
      "\n",
      "('pro-b-cell', 't-cell')\n",
      "ll line, but not in \u001b[46m\u001b[30mpro-B-cell\u001b[0m or T-cell \u001b[46m\u001b[30mlines\u001b[0m. Mobility shift ass\n",
      "\n",
      "('-65', '-121')\n",
      "us experiments, the \u001b[46m\u001b[30m-70 to -65\u001b[0m and -121 to -103 \u001b[46m\u001b[30mregions\u001b[0m of the CD11c promot\n",
      "eletion of both the \u001b[46m\u001b[30m-70 to -65\u001b[0m and -121 to -103 \u001b[46m\u001b[30mregions\u001b[0m of the CD11c promot\n",
      "\n",
      "('-65', 'to')\n",
      "us experiments, the \u001b[46m\u001b[30m-70 to -65\u001b[0m and -121 to -103 \u001b[46m\u001b[30mregions\u001b[0m of the CD11c promot\n",
      "eletion of both the \u001b[46m\u001b[30m-70 to -65\u001b[0m and -121 to -103 \u001b[46m\u001b[30mregions\u001b[0m of the CD11c promot\n",
      "\n",
      "('-65', '-103')\n",
      "us experiments, the \u001b[46m\u001b[30m-70 to -65\u001b[0m and -121 to -103 \u001b[46m\u001b[30mregions\u001b[0m of the CD11c promot\n",
      "eletion of both the \u001b[46m\u001b[30m-70 to -65\u001b[0m and -121 to -103 \u001b[46m\u001b[30mregions\u001b[0m of the CD11c promot\n",
      "\n",
      "('-dq', '-dp')\n",
      "man class II genes, \u001b[46m\u001b[30mHLA\u001b[0m-DR, -DQ, and \u001b[46m\u001b[30m-DP\u001b[0m. However, the exper\n",
      "\n",
      "(',', '-dp')\n",
      "man class II genes, \u001b[46m\u001b[30mHLA\u001b[0m-DR, -DQ, and \u001b[46m\u001b[30m-DP\u001b[0m. However, the exper\n",
      "man class II genes, \u001b[46m\u001b[30mHLA\u001b[0m-DR, -DQ, and \u001b[46m\u001b[30m-DP\u001b[0m. However, the exper\n",
      "\n",
      "('-dr', '-dp')\n",
      "man class II genes, \u001b[46m\u001b[30mHLA\u001b[0m-DR, -DQ, and \u001b[46m\u001b[30m-DP\u001b[0m. However, the exper\n",
      "wed HLA-DQ, but not \u001b[46m\u001b[30mHLA-DR\u001b[0m or -DP \u001b[46m\u001b[30mtranscription\u001b[0m. Alternatively, ano\n",
      "Q in the absence of \u001b[46m\u001b[30mHLA\u001b[0m-DR and \u001b[46m\u001b[30m-DP\u001b[0m. Several criteria i\n",
      "wed HLA-DQ, but not \u001b[46m\u001b[30mHLA\u001b[0m-DR or \u001b[46m\u001b[30m-DP transcription\u001b[0m. Alternatively, ano\n",
      "\n",
      "('-2', 'il-4')\n",
      "as a key enzyme for \u001b[46m\u001b[30minterleukin (IL)-2\u001b[0m and IL-4 \u001b[46m\u001b[30mpromoter activation\u001b[0m. However, the role \n",
      "\n",
      "('mammalian', 'drosophila')\n",
      "s compared to known \u001b[46m\u001b[30mmammalian\u001b[0m and Drosophila \u001b[46m\u001b[30mhomeodomains\u001b[0m it was found to be \n",
      "\n",
      "('immature', 'mature')\n",
      "ues and 33 cases of \u001b[46m\u001b[30mimmature\u001b[0m and mature \u001b[46m\u001b[30mlymphoid T-cell proliferations\u001b[0m using a sensitive W\n",
      "erance induction in \u001b[46m\u001b[30mimmature\u001b[0m and mature \u001b[46m\u001b[30mT cells\u001b[0m in vivo. Previous s\n",
      "at3-like protein in \u001b[46m\u001b[30mimmature\u001b[0m and mature \u001b[46m\u001b[30mnormal myeloid cells\u001b[0m, StatG. StatG in no\n",
      "\n",
      "('consensus', 'non-consensus')\n",
      " that contains both \u001b[46m\u001b[30mconsensus\u001b[0m and non-consensus \u001b[46m\u001b[30mGAS motifs\u001b[0m, two putative Ets b\n",
      "\n",
      "('lmp1+', 'lmp1-')\n",
      " consisting of both \u001b[46m\u001b[30mLMP1+\u001b[0m and LMP1- \u001b[46m\u001b[30mtumour cells\u001b[0m, suggesting a mixtu\n",
      "\n",
      "(')', ')')\n",
      " gene expression in \u001b[46m\u001b[30mT lymphoblastoid (Jurkat)\u001b[0m and monocytic (U937) \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in prim\n",
      " the breakpoints of \u001b[46m\u001b[30mt(8;21)\u001b[0m and t(3;21) \u001b[46m\u001b[30mmyeloid leukemias\u001b[0m. We examined alpha \n",
      "ar constructs using \u001b[46m\u001b[30mhuman fetal (A gamma-) globin (HBG1)\u001b[0m or simian virus 40 (SV40) \u001b[46m\u001b[30mpromoters\u001b[0m is not enhanced. Th\n",
      "antial decreases in \u001b[46m\u001b[30mmineralocorticoid (MR)\u001b[0m and glucocorticoid receptor (GR) \u001b[46m\u001b[30mlevels\u001b[0m in the hippocampus,\n",
      "okine expression by \u001b[46m\u001b[30mT helper 1 (Th1)\u001b[0m and T helper 2 (Th2) \u001b[46m\u001b[30mcells\u001b[0m is unclear. Previou\n",
      "ent, the effects on \u001b[46m\u001b[30mglucocorticoid receptor (GR)\u001b[0m and methallothionein (MTIIa) \u001b[46m\u001b[30mmRNA expression levels\u001b[0m were examined in pe\n",
      "cytes isolated from \u001b[46m\u001b[30mcorticosteroid-sensitive (CS)\u001b[0m and corticosteroid-resistant (CR) \u001b[46m\u001b[30masthmatic subjects\u001b[0m, which augments leu\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper 0 (Th0)\u001b[0m and 2 (Th2) \u001b[46m\u001b[30msubset\u001b[0m, was originally des\n",
      "the coexpression of \u001b[46m\u001b[30mmyeloid (CD33, CD13, CD15)\u001b[0m and NK cell-associated (CD56) \u001b[46m\u001b[30mantigens\u001b[0m in each case, where\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "cribe the effect of \u001b[46m\u001b[30m383-bp (delta383)\u001b[0m and 99-bp (delta99) \u001b[46m\u001b[30msequences\u001b[0m containing the PYBF\n",
      " can establish both \u001b[46m\u001b[30mnonproductive (latent)\u001b[0m and productive (lytic) \u001b[46m\u001b[30minfections\u001b[0m. Although the CD8+ \n",
      "te the influence of \u001b[46m\u001b[30mserum thyroxine (T4)\u001b[0m and thyrotropin (TSH) \u001b[46m\u001b[30mlevels\u001b[0m on receptor kinetic\n",
      "on of the cDNAs for \u001b[46m\u001b[30mCN A (catalytic)\u001b[0m and CN B (regulatory) \u001b[46m\u001b[30msubunits\u001b[0m also augments trans\n",
      "appaB) in activated \u001b[46m\u001b[30mmemory (CD45RO+)\u001b[0m and naive (CD45RA+) \u001b[46m\u001b[30mT cell subsets\u001b[0m from young and elde\n",
      "ing to analyze both \u001b[46m\u001b[30mIg-silenced (common)\u001b[0m and Ig-expressing (rare) \u001b[46m\u001b[30mhybrids\u001b[0m. Although no single\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum-supplemented (FCS+)\u001b[0m or -nonsupplemented (FCS-) \u001b[46m\u001b[30mculture\u001b[0m treated with satura\n",
      "siently transfected \u001b[46m\u001b[30mhuman (U937)\u001b[0m and murine (J774) \u001b[46m\u001b[30mmonocytic cell lines\u001b[0m. Deletion construct\n",
      "the products of the \u001b[46m\u001b[30mNF-kappa B2 (p100)\u001b[0m and NF-kappa B1 (p105) \u001b[46m\u001b[30mgenes\u001b[0m; (ii) in contrast t\n",
      "\n",
      "(')', 'u937')\n",
      " gene expression in \u001b[46m\u001b[30mT lymphoblastoid (Jurkat)\u001b[0m and monocytic (U937) \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in prim\n",
      "\n",
      "(')', '(')\n",
      " gene expression in \u001b[46m\u001b[30mT lymphoblastoid (Jurkat)\u001b[0m and monocytic (U937) \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in prim\n",
      " the breakpoints of \u001b[46m\u001b[30mt(8;21)\u001b[0m and t(3;21) \u001b[46m\u001b[30mmyeloid leukemias\u001b[0m. We examined alpha \n",
      "ar constructs using \u001b[46m\u001b[30mhuman fetal (A gamma-) globin (HBG1)\u001b[0m or simian virus 40 (SV40) \u001b[46m\u001b[30mpromoters\u001b[0m is not enhanced. Th\n",
      "antial decreases in \u001b[46m\u001b[30mmineralocorticoid (MR)\u001b[0m and glucocorticoid receptor (GR) \u001b[46m\u001b[30mlevels\u001b[0m in the hippocampus,\n",
      "okine expression by \u001b[46m\u001b[30mT helper 1 (Th1)\u001b[0m and T helper 2 (Th2) \u001b[46m\u001b[30mcells\u001b[0m is unclear. Previou\n",
      "ent, the effects on \u001b[46m\u001b[30mglucocorticoid receptor (GR)\u001b[0m and methallothionein (MTIIa) \u001b[46m\u001b[30mmRNA expression levels\u001b[0m were examined in pe\n",
      "cytes isolated from \u001b[46m\u001b[30mcorticosteroid-sensitive (CS)\u001b[0m and corticosteroid-resistant (CR) \u001b[46m\u001b[30masthmatic subjects\u001b[0m, which augments leu\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper 0 (Th0)\u001b[0m and 2 (Th2) \u001b[46m\u001b[30msubset\u001b[0m, was originally des\n",
      "the coexpression of \u001b[46m\u001b[30mmyeloid (CD33, CD13, CD15)\u001b[0m and NK cell-associated (CD56) \u001b[46m\u001b[30mantigens\u001b[0m in each case, where\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "cribe the effect of \u001b[46m\u001b[30m383-bp (delta383)\u001b[0m and 99-bp (delta99) \u001b[46m\u001b[30msequences\u001b[0m containing the PYBF\n",
      " can establish both \u001b[46m\u001b[30mnonproductive (latent)\u001b[0m and productive (lytic) \u001b[46m\u001b[30minfections\u001b[0m. Although the CD8+ \n",
      "te the influence of \u001b[46m\u001b[30mserum thyroxine (T4)\u001b[0m and thyrotropin (TSH) \u001b[46m\u001b[30mlevels\u001b[0m on receptor kinetic\n",
      "on of the cDNAs for \u001b[46m\u001b[30mCN A (catalytic)\u001b[0m and CN B (regulatory) \u001b[46m\u001b[30msubunits\u001b[0m also augments trans\n",
      "appaB) in activated \u001b[46m\u001b[30mmemory (CD45RO+)\u001b[0m and naive (CD45RA+) \u001b[46m\u001b[30mT cell subsets\u001b[0m from young and elde\n",
      "ing to analyze both \u001b[46m\u001b[30mIg-silenced (common)\u001b[0m and Ig-expressing (rare) \u001b[46m\u001b[30mhybrids\u001b[0m. Although no single\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum-supplemented (FCS+)\u001b[0m or -nonsupplemented (FCS-) \u001b[46m\u001b[30mculture\u001b[0m treated with satura\n",
      "siently transfected \u001b[46m\u001b[30mhuman (U937)\u001b[0m and murine (J774) \u001b[46m\u001b[30mmonocytic cell lines\u001b[0m. Deletion construct\n",
      "the products of the \u001b[46m\u001b[30mNF-kappa B2 (p100)\u001b[0m and NF-kappa B1 (p105) \u001b[46m\u001b[30mgenes\u001b[0m; (ii) in contrast t\n",
      "\n",
      "(')', 'monocytic')\n",
      " gene expression in \u001b[46m\u001b[30mT lymphoblastoid (Jurkat)\u001b[0m and monocytic (U937) \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in prim\n",
      "\n",
      "('dependent', '-independent')\n",
      "PKC dependent. Both \u001b[46m\u001b[30mPKC- dependent\u001b[0m and -independent \u001b[46m\u001b[30mactivation\u001b[0m of ERK were sensiti\n",
      "PKC dependent. Both \u001b[46m\u001b[30mPKC-\u001b[0m dependent and \u001b[46m\u001b[30m-independent activation\u001b[0m of ERK were sensiti\n",
      "\n",
      "('i', 'ii')\n",
      " the present study, \u001b[46m\u001b[30mcorticosteroid Type I\u001b[0m and Type II \u001b[46m\u001b[30mreceptors\u001b[0m in mononuclear leuk\n",
      "out 90 degrees with \u001b[46m\u001b[30mhelices\u001b[0m I and \u001b[46m\u001b[30mII\u001b[0m, and constitutes th\n",
      "onist (IL-1ra), and \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30mIL-1 receptors\u001b[0m (IL-1R). IFN-gamma \n",
      "unological markers (\u001b[46m\u001b[30mMHC\u001b[0m I and \u001b[46m\u001b[30mII\u001b[0m).\n",
      "axing enzymes (e.g. \u001b[46m\u001b[30mtopoisomerases\u001b[0m I and \u001b[46m\u001b[30mII\u001b[0m) in nuclear extract\n",
      " two DNA sequences, \u001b[46m\u001b[30msilencers\u001b[0m I and \u001b[46m\u001b[30mII\u001b[0m, and identified a p\n",
      "c leukaemia gene by \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30minterferons\u001b[0m. The physiological \n",
      "-1alpha promoter by \u001b[46m\u001b[30mhuman T-cell leukemia virus type I\u001b[0m and type II \u001b[46m\u001b[30mTax proteins\u001b[0m. Human T-cell leuke\n",
      "onally regulated by \u001b[46m\u001b[30mclass\u001b[0m I and \u001b[46m\u001b[30mII interferons\u001b[0m, which raises the p\n",
      "isol. The number of \u001b[46m\u001b[30mType I\u001b[0m and Type II \u001b[46m\u001b[30mreceptors\u001b[0m before the test was\n",
      " of hypercorticism. \u001b[46m\u001b[30mCorticosteroid Type I\u001b[0m and Type II \u001b[46m\u001b[30mreceptors\u001b[0m are inversely corre\n",
      "igen complexed with \u001b[46m\u001b[30mmajor histocompatibility complex class I\u001b[0m or II \u001b[46m\u001b[30mmolecules\u001b[0m on the surface of a\n",
      " The mean number of \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30mreceptors\u001b[0m was significantly l\n",
      "plex class I or II (\u001b[46m\u001b[30mMHC\u001b[0m I or \u001b[46m\u001b[30mII\u001b[0m) was high, thus est\n",
      "igen complexed with \u001b[46m\u001b[30mmajor histocompatibility complex class\u001b[0m I or \u001b[46m\u001b[30mII molecules\u001b[0m on the surface of a\n",
      "onally regulated by \u001b[46m\u001b[30mclass I\u001b[0m and II \u001b[46m\u001b[30minterferons\u001b[0m, which raises the p\n",
      "r alpha subunit and \u001b[46m\u001b[30mtumor necrosis factor (TNF) receptors\u001b[0m I (p55) and \u001b[46m\u001b[30mII (p75)\u001b[0m were also detected \n",
      "cts of IFN-gamma on \u001b[46m\u001b[30mtype I\u001b[0m and type II \u001b[46m\u001b[30mIL-1R gene expression\u001b[0m have not been defin\n",
      "9 and Leu42-Pro49). \u001b[46m\u001b[30mHelices\u001b[0m I and \u001b[46m\u001b[30mII\u001b[0m are positioned in a\n",
      "h expression of the \u001b[46m\u001b[30mmajor histocompatibility complex class\u001b[0m I or \u001b[46m\u001b[30mII\u001b[0m (MHC I or II) was h\n",
      "inverse relation to \u001b[46m\u001b[30mmajor histocompatibility complex classes\u001b[0m I and \u001b[46m\u001b[30mII\u001b[0m. Using a human TSH \n",
      "nhibit induction of \u001b[46m\u001b[30mIL-1 receptor type I\u001b[0m and type II \u001b[46m\u001b[30mgene expression\u001b[0m by IL-4 and IL-13 i\n",
      "\n",
      "('wild-type', 'dl337-infected')\n",
      "also differ between \u001b[46m\u001b[30mwild-type\u001b[0m and dl337-infected \u001b[46m\u001b[30mcells\u001b[0m. Furthermore, the d\n",
      "\n",
      "('ku812f', 'hel')\n",
      "HL-60, U937, HEL/S, \u001b[46m\u001b[30mKU812F\u001b[0m, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('camp-', 'cgmp-')\n",
      "so by activators of \u001b[46m\u001b[30mcAMP-\u001b[0m and cGMP-\u001b[46m\u001b[30mdependent protein kinases\u001b[0m.\n",
      "\n",
      "('42', '130')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "\n",
      "('120', 'kda')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, \u001b[46m\u001b[30m42\u001b[0m, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "\n",
      "('deletional', 'alanine')\n",
      "87 to 231). Further \u001b[46m\u001b[30mdeletional\u001b[0m and alanine \u001b[46m\u001b[30mmutagenesis\u001b[0m analyses and compar\n",
      "\n",
      "('sp1', 'creb')\n",
      " analyses utilizing \u001b[46m\u001b[30mSp1\u001b[0m and CREB \u001b[46m\u001b[30mbinding site oligonucleotides\u001b[0m demonstrate that Sp\n",
      "\n",
      "('ap1', 'ets')\n",
      "ents with NFkappaB, \u001b[46m\u001b[30mAP1\u001b[0m and ETS\u001b[46m\u001b[30m-like binding motifs\u001b[0m have been identifie\n",
      "\n",
      "('wild-type', 'mutate')\n",
      "differences between \u001b[46m\u001b[30mwild-type\u001b[0m and mutated \u001b[46m\u001b[30mreceptors\u001b[0m in the induction of\n",
      "nduced apoptosis in \u001b[46m\u001b[30mlymphoblastoid T-cell-line-expressing wild-type\u001b[0m and mutated \u001b[46m\u001b[30mCD4 receptors\u001b[0m. We have previously\n",
      "nduced apoptosis in \u001b[46m\u001b[30mlymphoblastoid T-cell-line-expressing\u001b[0m wild-type and \u001b[46m\u001b[30mmutated CD4 receptors\u001b[0m. We have previously\n",
      "ts (kDa). Using the \u001b[46m\u001b[30mwild-type\u001b[0m or mutated \u001b[46m\u001b[30mhuman retinoic acid receptor alpha\u001b[0m as a model, kDa val\n",
      "\n",
      "('coronary', 'carotid')\n",
      "clerotic plaques of \u001b[46m\u001b[30mcoronary\u001b[0m and carotid \u001b[46m\u001b[30marteries\u001b[0m. In the present stu\n",
      "\n",
      "('cdk2', 'id-bhlh')\n",
      "anism through which \u001b[46m\u001b[30mCdk2\u001b[0m and Id-bHLH \u001b[46m\u001b[30mfunctions\u001b[0m are integrated in t\n",
      "\n",
      "('activate', 'inhibitory')\n",
      "\u001b[46m\u001b[30mC-terminal\u001b[0m activating and \u001b[46m\u001b[30minhibitory domains\u001b[0m determine the trans\n",
      "\u001b[46m\u001b[30mC-terminal activating\u001b[0m and inhibitory \u001b[46m\u001b[30mdomains\u001b[0m determine the trans\n",
      " module composed of \u001b[46m\u001b[30mactivating\u001b[0m and inhibitory \u001b[46m\u001b[30msequences\u001b[0m.\n",
      "\n",
      "('triidothyronine', 'thyroxine')\n",
      "nction by measuring \u001b[46m\u001b[30mblood plasma\u001b[0m triidothyronine and \u001b[46m\u001b[30mthyroxine concentration\u001b[0m in 58 bronchial ast\n",
      "nction by measuring \u001b[46m\u001b[30mblood plasma triidothyronine\u001b[0m and thyroxine \u001b[46m\u001b[30mconcentration\u001b[0m in 58 bronchial ast\n",
      "\n",
      "('activate', 'cell')\n",
      "me in the nuclei of \u001b[46m\u001b[30mresting\u001b[0m, activated, and anergized \u001b[46m\u001b[30mcells\u001b[0m. The inducible fact\n",
      "\n",
      "('rest', 'anergized')\n",
      "me in the nuclei of \u001b[46m\u001b[30mresting\u001b[0m, activated, and anergized \u001b[46m\u001b[30mcells\u001b[0m. The inducible fact\n",
      "\n",
      "('b-', 't-')\n",
      " insulin-producing, \u001b[46m\u001b[30mB-\u001b[0m and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "romoter (Zp). Using \u001b[46m\u001b[30mhuman B-\u001b[0m or T-\u001b[46m\u001b[30mcell lines\u001b[0m transfected with Zp\n",
      "ing on its roles in \u001b[46m\u001b[30mB-\u001b[0m and T-\u001b[46m\u001b[30mcell development\u001b[0m and in oncogenesis.\n",
      "romoter (Zp). Using \u001b[46m\u001b[30mhuman\u001b[0m B- or \u001b[46m\u001b[30mT-cell lines\u001b[0m transfected with Zp\n",
      "ribe the defects in \u001b[46m\u001b[30mB-\u001b[0m and T- \u001b[46m\u001b[30mlymphocyte development\u001b[0m in mice carrying ta\n",
      "le of E-proteins in \u001b[46m\u001b[30mB-\u001b[0m and T-\u001b[46m\u001b[30mlymphocyte development\u001b[0m. Department of lymp\n",
      "\n",
      "('male', 'female')\n",
      "olved a group of 60 \u001b[46m\u001b[30mmale\u001b[0m and female \u001b[46m\u001b[30msubjects\u001b[0m who were exposed to\n",
      "\n",
      "('neoplastic', 'normal')\n",
      "scription factor in \u001b[46m\u001b[30mneoplastic\u001b[0m and normal \u001b[46m\u001b[30mB cells\u001b[0m. The myb family of \n",
      "\n",
      "('ca2+', 'cl-')\n",
      "r K+ channel, or on \u001b[46m\u001b[30mlymphocyte\u001b[0m Ca2+ and \u001b[46m\u001b[30mCl- channels\u001b[0m. We propose that di\n",
      "r K+ channel, or on \u001b[46m\u001b[30mlymphocyte Ca2+\u001b[0m and Cl- \u001b[46m\u001b[30mchannels\u001b[0m. We propose that di\n",
      "\n",
      "('pc-3', 'du-145')\n",
      "hway is lost in the \u001b[46m\u001b[30mPC-3\u001b[0m and DU-145 \u001b[46m\u001b[30mcell lines\u001b[0m. This may be an imp\n",
      "\n",
      "('2', 'gamma')\n",
      "1, and for alpha 1, \u001b[46m\u001b[30malpha 2\u001b[0m and gamma \u001b[46m\u001b[30mglobin genes\u001b[0m. These results indi\n",
      "\n",
      "('cat', 'il-6')\n",
      "tivity in both IL-6 \u001b[46m\u001b[30mCAT\u001b[0m and IL-6 luciferase \u001b[46m\u001b[30massays\u001b[0m. A deletion constru\n",
      "\n",
      "('cat', 'luciferase')\n",
      "tivity in both IL-6 \u001b[46m\u001b[30mCAT\u001b[0m and IL-6 luciferase \u001b[46m\u001b[30massays\u001b[0m. A deletion constru\n",
      "\n",
      "(',', '-3')\n",
      "tion. Surprisingly, \u001b[46m\u001b[30mTRAF\u001b[0m1, -2, or \u001b[46m\u001b[30m-3\u001b[0m does not interact w\n",
      "tion. Surprisingly, \u001b[46m\u001b[30mTRAF\u001b[0m1, -2, or \u001b[46m\u001b[30m-3\u001b[0m does not interact w\n",
      "eased expression of \u001b[46m\u001b[30mEgr\u001b[0m-1, -2, and \u001b[46m\u001b[30m-3\u001b[0m. As with egr-3, exp\n",
      "eased expression of \u001b[46m\u001b[30mEgr\u001b[0m-1, -2, and \u001b[46m\u001b[30m-3\u001b[0m. As with egr-3, exp\n",
      "\n",
      "('1', '-3')\n",
      "tion. Surprisingly, \u001b[46m\u001b[30mTRAF\u001b[0m1, -2, or \u001b[46m\u001b[30m-3\u001b[0m does not interact w\n",
      "\n",
      "('-1', '-2')\n",
      "correlated with the \u001b[46m\u001b[30mphase\u001b[0m-1 and \u001b[46m\u001b[30m-2 neutrophil adhesion responses\u001b[0m. Collectively, thes\n",
      "correlated with the \u001b[46m\u001b[30mphase-1\u001b[0m and -2 \u001b[46m\u001b[30mneutrophil adhesion responses\u001b[0m. Collectively, thes\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-2\u001b[0m or GATA-1 and -3 ge\n",
      "\n",
      "(\"5'\", \"3'\")\n",
      " deletion of either \u001b[46m\u001b[30m5'\u001b[0m or 3' \u001b[46m\u001b[30mNF-kappaB sites\u001b[0m reduced IL-1alpha p\n",
      "egulation. Both the \u001b[46m\u001b[30m5'\u001b[0m and 3' \u001b[46m\u001b[30muntranslated regions\u001b[0m of the TNF gene wer\n",
      "\n",
      "('cre', 'po')\n",
      "e (POS). The tandem \u001b[46m\u001b[30mCRE\u001b[0m and POS \u001b[46m\u001b[30msites\u001b[0m are of major functi\n",
      "\n",
      "('platelet', 'granulocyte')\n",
      "to detect red cell, \u001b[46m\u001b[30mplatelet\u001b[0m and granulocyte \u001b[46m\u001b[30mantibodies\u001b[0m of potential clinic\n",
      "\n",
      "('elf-1', 'hmg-i(y)')\n",
      "ted when either the \u001b[46m\u001b[30mElf-1\u001b[0m or the HMG-I(Y) \u001b[46m\u001b[30mbinding site\u001b[0m was mutated. Coexpr\n",
      "\n",
      "('elf-1', 'the')\n",
      "ted when either the \u001b[46m\u001b[30mElf-1\u001b[0m or the HMG-I(Y) \u001b[46m\u001b[30mbinding site\u001b[0m was mutated. Coexpr\n",
      "\n",
      "('monocytic', 'neutrophil')\n",
      "m the eosinophil to \u001b[46m\u001b[30mmonocytic\u001b[0m or neutrophil \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "\n",
      "('-30', '-579')\n",
      " B binding sites at \u001b[46m\u001b[30mpositions\u001b[0m -30, -44, -213, and \u001b[46m\u001b[30m-579\u001b[0m relative to the tra\n",
      "\n",
      "('-213', '-579')\n",
      " B binding sites at \u001b[46m\u001b[30mpositions\u001b[0m -30, -44, -213, and \u001b[46m\u001b[30m-579\u001b[0m relative to the tra\n",
      "\n",
      "(',', '-579')\n",
      " B binding sites at \u001b[46m\u001b[30mpositions\u001b[0m -30, -44, -213, and \u001b[46m\u001b[30m-579\u001b[0m relative to the tra\n",
      " B binding sites at \u001b[46m\u001b[30mpositions\u001b[0m -30, -44, -213, and \u001b[46m\u001b[30m-579\u001b[0m relative to the tra\n",
      " B binding sites at \u001b[46m\u001b[30mpositions\u001b[0m -30, -44, -213, and \u001b[46m\u001b[30m-579\u001b[0m relative to the tra\n",
      "\n",
      "('-44', '-579')\n",
      " B binding sites at \u001b[46m\u001b[30mpositions\u001b[0m -30, -44, -213, and \u001b[46m\u001b[30m-579\u001b[0m relative to the tra\n",
      "\n",
      "('fo', 'fosb')\n",
      "solated cells, both \u001b[46m\u001b[30mFOS\u001b[0m and FOSB \u001b[46m\u001b[30mmRNAs\u001b[0m increase dramatical\n",
      "\n",
      "('vertebral', 'hip')\n",
      "um osteocalcin, and \u001b[46m\u001b[30mvertebral\u001b[0m and hip \u001b[46m\u001b[30mbone density\u001b[0m. We conclude that V\n",
      "\n",
      "('-', 'phytohemagglutinin')\n",
      "ticoids may inhibit \u001b[46m\u001b[30mconcanavalin A (Con A)-\u001b[0m and phytohemagglutinin (PHA)-\u001b[46m\u001b[30minduced T-cell proliferation\u001b[0m, pokeweed mitogen (\n",
      "\n",
      "('-', 'pha')\n",
      "ticoids may inhibit \u001b[46m\u001b[30mconcanavalin A (Con A)-\u001b[0m and phytohemagglutinin (PHA)-\u001b[46m\u001b[30minduced T-cell proliferation\u001b[0m, pokeweed mitogen (\n",
      "\n",
      "('transcript', 'protein')\n",
      "and IL-1 upregulate \u001b[46m\u001b[30mPML transcript\u001b[0m and protein \u001b[46m\u001b[30mexpression\u001b[0m in a time and dose-\n",
      "and IL-1 upregulate \u001b[46m\u001b[30mPML\u001b[0m transcript and \u001b[46m\u001b[30mprotein expression\u001b[0m in a time and dose-\n",
      "\n",
      "('beta-casein', 'irf-1')\n",
      "ide probes from the \u001b[46m\u001b[30mbeta-casein\u001b[0m and IRF-1 \u001b[46m\u001b[30mgene promoters\u001b[0m and the ISRE probe \n",
      "\n",
      "('lymphoid', 'prostatic')\n",
      "interaction between \u001b[46m\u001b[30mlymphoid\u001b[0m and prostatic \u001b[46m\u001b[30mcells\u001b[0m in growth and devel\n",
      "\n",
      "('oct', 'nfat')\n",
      "cooperation between \u001b[46m\u001b[30mOct\u001b[0m and NFAT \u001b[46m\u001b[30mfamily proteins\u001b[0m.\n",
      "ed cooperatively by \u001b[46m\u001b[30mOct\u001b[0m and NFAT \u001b[46m\u001b[30melements\u001b[0m within a DNase I-hy\n",
      "\n",
      "('homodimeric', 'heterodimeric')\n",
      "d STAT 1, either in \u001b[46m\u001b[30mhomodimeric\u001b[0m or heterodimeric \u001b[46m\u001b[30mforms\u001b[0m and the binding of \n",
      "\n",
      "('early', 'early')\n",
      "ol in vivo and that \u001b[46m\u001b[30mimmediate early\u001b[0m and early \u001b[46m\u001b[30mproteins\u001b[0m are frequently the \n",
      "c infection renders \u001b[46m\u001b[30mimmediate early\u001b[0m and early \u001b[46m\u001b[30mproteins\u001b[0m much less immunogen\n",
      "\n",
      "('nfat', 'ap-1')\n",
      "o RE/AP and not the \u001b[46m\u001b[30mNFAT\u001b[0m or AP-1 \u001b[46m\u001b[30msites\u001b[0m. In addition, these\n",
      "-2 promoter and its \u001b[46m\u001b[30mNFAT\u001b[0m or AP-1 \u001b[46m\u001b[30melements\u001b[0m. This activity was \n",
      "\n",
      "('beta', 'tnf')\n",
      "induced increase in \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6 or TNF alpha \u001b[46m\u001b[30mmRNA levels\u001b[0m. Furthermore, the p\n",
      "duced expression of \u001b[46m\u001b[30mIL-1 beta\u001b[0m and TNF alpha \u001b[46m\u001b[30mmRNA\u001b[0m in the monocytic TH\n",
      "\n",
      "('il-6', 'mrna')\n",
      "induced increase in \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6 or TNF alpha \u001b[46m\u001b[30mmRNA levels\u001b[0m. Furthermore, the p\n",
      "\n",
      "('bzlf1', 'brlf1')\n",
      "ll line B95.8. Both \u001b[46m\u001b[30mBZLF1\u001b[0m and BRLF1 \u001b[46m\u001b[30mimmediate-early transcripts\u001b[0m, but not BMLF1 tran\n",
      "\n",
      "('ap-1', 'cle0')\n",
      "rmation with NF-AT, \u001b[46m\u001b[30mAP-1\u001b[0m and CLE0 \u001b[46m\u001b[30msequences\u001b[0m when the cells were\n",
      "\n",
      "('erythroid', 'granulocyte-macrophage')\n",
      "lectively along the \u001b[46m\u001b[30merythroid\u001b[0m or granulocyte-macrophage \u001b[46m\u001b[30mpathway\u001b[0m by differential tre\n",
      "\n",
      "('fibroblast', 'lymphoid')\n",
      "esenting endocrine, \u001b[46m\u001b[30mfibroblast\u001b[0m, and lymphoid \u001b[46m\u001b[30mlineages\u001b[0m using polyclonal an\n",
      "\n",
      "('p65', 'p105')\n",
      "n experiments where \u001b[46m\u001b[30mp65\u001b[0m and p105 \u001b[46m\u001b[30mmRNA levels\u001b[0m were determined, de\n",
      "\n",
      "('pre-', 'mature')\n",
      "detectable in pro-, \u001b[46m\u001b[30mpre-\u001b[0m, and mature \u001b[46m\u001b[30mB-cell lines\u001b[0m, but not in two pla\n",
      "\n",
      "('control', 'infected')\n",
      " were equivalent in \u001b[46m\u001b[30mcontrol\u001b[0m and infected \u001b[46m\u001b[30mcells\u001b[0m. Metabolic labeling\n",
      "\n",
      "('amino-', 'carboxyl-')\n",
      "ing domain, whereas \u001b[46m\u001b[30mamino-\u001b[0m or carboxyl-\u001b[46m\u001b[30mterminal domains\u001b[0m were dispensable. T\n",
      "\n",
      "('ramos', 'jurkat')\n",
      "n of stimulated and \u001b[46m\u001b[30mnonstimulated\u001b[0m Ramos and \u001b[46m\u001b[30mJurkat cells\u001b[0m was studied using c\n",
      "n of stimulated and \u001b[46m\u001b[30mnonstimulated Ramos\u001b[0m and Jurkat \u001b[46m\u001b[30mcells\u001b[0m was studied using c\n",
      "\n",
      "('nf-at', 'il-2')\n",
      "ining the AP-1-TRE, \u001b[46m\u001b[30mNF-AT\u001b[0m, and IL-2 \u001b[46m\u001b[30mpromoter regions\u001b[0m along with IL-2 mRN\n",
      "\n",
      "(',', 'promoter')\n",
      "ining the AP-1-TRE, \u001b[46m\u001b[30mNF-AT\u001b[0m, and IL-2 \u001b[46m\u001b[30mpromoter regions\u001b[0m along with IL-2 mRN\n",
      "ucts containing the \u001b[46m\u001b[30mAP-1-TRE\u001b[0m, NF-AT, and IL-2 \u001b[46m\u001b[30mpromoter regions\u001b[0m along with IL-2 mRN\n",
      "ucts containing the \u001b[46m\u001b[30mAP-1-TRE\u001b[0m, NF-AT, and IL-2 \u001b[46m\u001b[30mpromoter regions\u001b[0m along with IL-2 mRN\n",
      "\n",
      "('osteocalcin', 'urinary')\n",
      "ay. Serum cortisol, \u001b[46m\u001b[30mosteocalcin\u001b[0m and urinary \u001b[46m\u001b[30mcortisol\u001b[0m levels were also de\n",
      "ay. Serum cortisol, \u001b[46m\u001b[30mosteocalcin\u001b[0m and urinary \u001b[46m\u001b[30mcortisol levels\u001b[0m were also determine\n",
      "\n",
      "('megakaryocytic', 'mast')\n",
      "d in the erythroid, \u001b[46m\u001b[30mmegakaryocytic\u001b[0m, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m during normal hemat\n",
      "\n",
      "('small', 'cell')\n",
      "homas. All cases of \u001b[46m\u001b[30mfollicular\u001b[0m, mixed small and large \u001b[46m\u001b[30mcell lymphomas\u001b[0m showed LAZ3/BCL6 ex\n",
      "\n",
      "('mixed', 'cell')\n",
      "homas. All cases of \u001b[46m\u001b[30mfollicular\u001b[0m, mixed small and large \u001b[46m\u001b[30mcell lymphomas\u001b[0m showed LAZ3/BCL6 ex\n",
      "\n",
      "('follicular', 'large')\n",
      "homas. All cases of \u001b[46m\u001b[30mfollicular\u001b[0m, mixed small and large \u001b[46m\u001b[30mcell lymphomas\u001b[0m showed LAZ3/BCL6 ex\n",
      "\n",
      "('il-6', 'tnf')\n",
      "rease in IL-1 beta, \u001b[46m\u001b[30mIL-6\u001b[0m or TNF alpha \u001b[46m\u001b[30mmRNA levels\u001b[0m. Furthermore, the p\n",
      "\n",
      "('il-6', 'alpha')\n",
      "rease in IL-1 beta, \u001b[46m\u001b[30mIL-6\u001b[0m or TNF alpha \u001b[46m\u001b[30mmRNA levels\u001b[0m. Furthermore, the p\n",
      "\n",
      "('ap-1-', 'factor-')\n",
      " revealed that both \u001b[46m\u001b[30mAP-1-\u001b[0m and NF-kappaB factor-\u001b[46m\u001b[30mbinding elements\u001b[0m were involved in co\n",
      "\n",
      "('ap-1-', 'nf-kappab')\n",
      " revealed that both \u001b[46m\u001b[30mAP-1-\u001b[0m and NF-kappaB factor-\u001b[46m\u001b[30mbinding elements\u001b[0m were involved in co\n",
      "\n",
      "('oft-2', 'b')\n",
      ": CREB, CTF, OTF-1, \u001b[46m\u001b[30mOFT-2\u001b[0m, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('oft-2', 'nf-kappa')\n",
      ": CREB, CTF, OTF-1, \u001b[46m\u001b[30mOFT-2\u001b[0m, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "(')', '3')\n",
      " the breakpoints of \u001b[46m\u001b[30mt(8;21)\u001b[0m and t(3;21) \u001b[46m\u001b[30mmyeloid leukemias\u001b[0m. We examined alpha \n",
      "\n",
      "(')', 't')\n",
      " the breakpoints of \u001b[46m\u001b[30mt(8;21)\u001b[0m and t(3;21) \u001b[46m\u001b[30mmyeloid leukemias\u001b[0m. We examined alpha \n",
      "okine expression by \u001b[46m\u001b[30mT helper 1 (Th1)\u001b[0m and T helper 2 (Th2) \u001b[46m\u001b[30mcells\u001b[0m is unclear. Previou\n",
      "\n",
      "(')', ';')\n",
      " the breakpoints of \u001b[46m\u001b[30mt(8;21)\u001b[0m and t(3;21) \u001b[46m\u001b[30mmyeloid leukemias\u001b[0m. We examined alpha \n",
      "\n",
      "(')', '21')\n",
      " the breakpoints of \u001b[46m\u001b[30mt(8;21)\u001b[0m and t(3;21) \u001b[46m\u001b[30mmyeloid leukemias\u001b[0m. We examined alpha \n",
      "\n",
      "('p50-', 'c-rel-')\n",
      " also obtained with \u001b[46m\u001b[30mp50-\u001b[0m and c-Rel-\u001b[46m\u001b[30mselected sequences\u001b[0m. Using either a p50\n",
      "pa B gamma inhibits \u001b[46m\u001b[30mp50-\u001b[0m, p65-, and c-Rel-\u001b[46m\u001b[30mmediated transactivation\u001b[0m and/or DNA binding,\n",
      "\n",
      "('-tre', 'il-2')\n",
      "ucts containing the \u001b[46m\u001b[30mAP-1-TRE\u001b[0m, NF-AT, and IL-2 \u001b[46m\u001b[30mpromoter regions\u001b[0m along with IL-2 mRN\n",
      "\n",
      "('nf-at', 'promoter')\n",
      "ucts containing the \u001b[46m\u001b[30mAP-1-TRE\u001b[0m, NF-AT, and IL-2 \u001b[46m\u001b[30mpromoter regions\u001b[0m along with IL-2 mRN\n",
      "\n",
      "('t-', 'b-')\n",
      "eptor expression in \u001b[46m\u001b[30mhuman T-\u001b[0m and B-\u001b[46m\u001b[30mcell lines\u001b[0m. Regulation of gluc\n",
      " expressed early in \u001b[46m\u001b[30mT-\u001b[0m and B-\u001b[46m\u001b[30mlymphocyte\u001b[0m differentiation.\n",
      "t subpopulations of \u001b[46m\u001b[30mT-\u001b[0m and B- \u001b[46m\u001b[30mlymphocytes\u001b[0m. In myeloid cells, \n",
      "al E(gre) motif. In \u001b[46m\u001b[30mT-\u001b[0m and B-\u001b[46m\u001b[30mcell lines\u001b[0m, the E(gre) motifs \n",
      "eptor expression in \u001b[46m\u001b[30mhuman\u001b[0m T- and \u001b[46m\u001b[30mB-cell lines\u001b[0m. Regulation of gluc\n",
      "\n",
      "('tnf-alpha-', 'i')\n",
      "er demonstrate that \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and calyculin A-induced I kappa B alpha \u001b[46m\u001b[30mdegradation\u001b[0m exhibits similar bu\n",
      "\n",
      "('tnf-alpha-', 'kappa')\n",
      "er demonstrate that \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and calyculin A-induced I kappa B alpha \u001b[46m\u001b[30mdegradation\u001b[0m exhibits similar bu\n",
      "\n",
      "('tnf-alpha-', 'b')\n",
      "er demonstrate that \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and calyculin A-induced I kappa B alpha \u001b[46m\u001b[30mdegradation\u001b[0m exhibits similar bu\n",
      "\n",
      "('tnf-alpha-', 'alpha')\n",
      "er demonstrate that \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and calyculin A-induced I kappa B alpha \u001b[46m\u001b[30mdegradation\u001b[0m exhibits similar bu\n",
      "\n",
      "('tnf-alpha-', 'a-induced')\n",
      "er demonstrate that \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and calyculin A-induced I kappa B alpha \u001b[46m\u001b[30mdegradation\u001b[0m exhibits similar bu\n",
      "\n",
      "('tnf-alpha-', 'calyculin')\n",
      "er demonstrate that \u001b[46m\u001b[30mTNF-alpha-\u001b[0m and calyculin A-induced I kappa B alpha \u001b[46m\u001b[30mdegradation\u001b[0m exhibits similar bu\n",
      "\n",
      "('-', 'hyper')\n",
      "ates. Patients with \u001b[46m\u001b[30movert\u001b[0m hypo -or \u001b[46m\u001b[30mhyperthyroidism\u001b[0m were enrolled in th\n",
      "\n",
      "('hypo', 'hyper')\n",
      "ates. Patients with \u001b[46m\u001b[30movert\u001b[0m hypo -or \u001b[46m\u001b[30mhyperthyroidism\u001b[0m were enrolled in th\n",
      "ates. Patients with \u001b[46m\u001b[30movert hypo\u001b[0m -or hyper\u001b[46m\u001b[30mthyroidism\u001b[0m were enrolled in th\n",
      "ol/microgram RNA in \u001b[46m\u001b[30mhypo\u001b[0m-, eu -and hyper\u001b[46m\u001b[30mthyroid patients\u001b[0m, respectively, corr\n",
      "\n",
      "('rel-a', 'c-rel')\n",
      "\u001b[46m\u001b[30mNuclear\u001b[0m Rel-A and \u001b[46m\u001b[30mc-Rel protein complexes\u001b[0m are differentially \n",
      "\u001b[46m\u001b[30mNuclear Rel-A\u001b[0m and c-Rel \u001b[46m\u001b[30mprotein complexes\u001b[0m are differentially \n",
      "\n",
      "('humoral', 'cellular')\n",
      "of varicella and no \u001b[46m\u001b[30mhumoral\u001b[0m or cellular \u001b[46m\u001b[30mimmunity\u001b[0m to VZV served as na\n",
      "\n",
      "('immune', 'nervous')\n",
      "fection in both the \u001b[46m\u001b[30mimmune\u001b[0m and nervous \u001b[46m\u001b[30msystems\u001b[0m. Electrophoretic mo\n",
      "\n",
      "('nuclear', 'cytoplasmic')\n",
      "acterization of the \u001b[46m\u001b[30mnuclear\u001b[0m and cytoplasmic \u001b[46m\u001b[30mcomponents\u001b[0m of the lymphoid-spe\n",
      "le NFATc protein in \u001b[46m\u001b[30mnuclear\u001b[0m and cytoplasmic \u001b[46m\u001b[30mextracts\u001b[0m from CD16- or phorb\n",
      "\n",
      "('-', 'fas-')\n",
      " mechanisms such as \u001b[46m\u001b[30mtumor necrosis factor (TNF)-\u001b[0m and Fas-\u001b[46m\u001b[30mmediated apoptosis\u001b[0m of transformed or v\n",
      "\n",
      "('haematopoietic', 'solid')\n",
      "-tumour activity in \u001b[46m\u001b[30mhaematopoietic\u001b[0m and solid \u001b[46m\u001b[30mtumours\u001b[0m influence growth an\n",
      "\n",
      "('-h1', '-m2')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('human', '-m2')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23\u001b[0m-M1, and \u001b[46m\u001b[30m-M2 proteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('allergic', 'atopic')\n",
      "n the regulation of \u001b[46m\u001b[30mallergic\u001b[0m and atopic \u001b[46m\u001b[30mimmune responses\u001b[0m. Significant progre\n",
      "\n",
      "('jurkat', 'nc2.10')\n",
      "beta PRDII site. In \u001b[46m\u001b[30mJurkat\u001b[0m and NC2.10 \u001b[46m\u001b[30minduction\u001b[0m with phorbol esters\n",
      "\n",
      "('128', '145')\n",
      "\u001b[46m\u001b[30mTyrosines\u001b[0m 113, 128, and \u001b[46m\u001b[30m145\u001b[0m of SLP-76 are requi\n",
      "\n",
      "(',', '145')\n",
      "\u001b[46m\u001b[30mTyrosines\u001b[0m 113, 128, and \u001b[46m\u001b[30m145\u001b[0m of SLP-76 are requi\n",
      "\u001b[46m\u001b[30mTyrosines\u001b[0m 113, 128, and \u001b[46m\u001b[30m145\u001b[0m of SLP-76 are requi\n",
      "\n",
      "('113', '145')\n",
      "\u001b[46m\u001b[30mTyrosines\u001b[0m 113, 128, and \u001b[46m\u001b[30m145\u001b[0m of SLP-76 are requi\n",
      "\n",
      "('inflammatory', 'mediated')\n",
      "fundamental role in \u001b[46m\u001b[30minflammatory\u001b[0m and immune mediated \u001b[46m\u001b[30mreactions\u001b[0m, have been involved\n",
      "\n",
      "('bacterial', 'viral')\n",
      "s yet unidentified, \u001b[46m\u001b[30mbacterial\u001b[0m or viral \u001b[46m\u001b[30msuperantigen\u001b[0m plays a role in dis\n",
      "\n",
      "('stat1alpha', 'ip-10')\n",
      "jects with elevated \u001b[46m\u001b[30mSTAT1alpha\u001b[0m and IP-10 \u001b[46m\u001b[30mexpression\u001b[0m. Our data suggest t\n",
      "\n",
      "('k562', 'hel')\n",
      "937, HEL/S, KU812F, \u001b[46m\u001b[30mK562\u001b[0m, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('megakaryocyte', 'mast')\n",
      "essed in erythroid, \u001b[46m\u001b[30mmegakaryocyte\u001b[0m and mast \u001b[46m\u001b[30mcell populations\u001b[0m (the same cell line\n",
      "ssion in erythroid, \u001b[46m\u001b[30mmegakaryocyte\u001b[0m, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m. GATA-1 binds to WG\n",
      "\n",
      "('il-1', '(')\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "\n",
      "('il-1', 'alpha')\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "\n",
      "('il-1', 'factor')\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "\n",
      "('il-1', ')')\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "\n",
      "('il-1', 'tumour')\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "\n",
      "('il-1', 'tnf')\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "\n",
      "('il-1', 'necrosis')\n",
      "nt effect of BDP on \u001b[46m\u001b[30mIL-1\u001b[0m and tumour necrosis factor alpha (TNF alpha)\u001b[46m\u001b[30m-induced changes\u001b[0m of gcRs. The effect\n",
      "\n",
      "('hypercortisolemic', 'cortisol-resistant')\n",
      "fection: a study in \u001b[46m\u001b[30mhypercortisolemic\u001b[0m and cortisol-resistant \u001b[46m\u001b[30mpatients\u001b[0m. Immunological stud\n",
      "\n",
      "('differentiation', 'maturation')\n",
      "eristic features of \u001b[46m\u001b[30merythroid\u001b[0m differentiation and \u001b[46m\u001b[30mmaturation\u001b[0m. At the same time t\n",
      "\n",
      "('b', 'carg')\n",
      " -228 that contains \u001b[46m\u001b[30mNF-kappa B\u001b[0m and CArG \u001b[46m\u001b[30mmotifs\u001b[0m was identified. We \n",
      "\n",
      "('70', '130')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, \u001b[46m\u001b[30m70\u001b[0m, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "\n",
      "('gata-1', 'tal-1')\n",
      "ells. We found that \u001b[46m\u001b[30mGATA-1\u001b[0m and tal-1 \u001b[46m\u001b[30mgenes\u001b[0m are coexpressed in \n",
      "\n",
      "('hiv-1', '2')\n",
      "onal effects on the \u001b[46m\u001b[30mHIV-1\u001b[0m and interleukin 2 \u001b[46m\u001b[30mpromoters\u001b[0m. Further evidence s\n",
      "\n",
      "('hiv-1', 'interleukin')\n",
      "onal effects on the \u001b[46m\u001b[30mHIV-1\u001b[0m and interleukin 2 \u001b[46m\u001b[30mpromoters\u001b[0m. Further evidence s\n",
      "\n",
      "(')', '-nonsupplemented')\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum\u001b[0m-supplemented (FCS+) or \u001b[46m\u001b[30m-nonsupplemented (FCS-) culture\u001b[0m treated with satura\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum-supplemented (FCS+)\u001b[0m or -nonsupplemented (FCS-) \u001b[46m\u001b[30mculture\u001b[0m treated with satura\n",
      "\n",
      "('(', '-nonsupplemented')\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum\u001b[0m-supplemented (FCS+) or \u001b[46m\u001b[30m-nonsupplemented (FCS-) culture\u001b[0m treated with satura\n",
      "\n",
      "('fcs+', '-nonsupplemented')\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum\u001b[0m-supplemented (FCS+) or \u001b[46m\u001b[30m-nonsupplemented (FCS-) culture\u001b[0m treated with satura\n",
      "\n",
      "('-supplemented', '-nonsupplemented')\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum\u001b[0m-supplemented (FCS+) or \u001b[46m\u001b[30m-nonsupplemented (FCS-) culture\u001b[0m treated with satura\n",
      "\n",
      "('cd45ra', 'cd45r0')\n",
      " Jurkat T cells and \u001b[46m\u001b[30mprimary CD45RA\u001b[0m and CD45R0 \u001b[46m\u001b[30mCD4+ T cell subsets\u001b[0m isolated from perip\n",
      " Jurkat T cells and \u001b[46m\u001b[30mprimary\u001b[0m CD45RA and \u001b[46m\u001b[30mCD45R0 CD4+ T cell subsets\u001b[0m isolated from perip\n",
      " Jurkat T cells and \u001b[46m\u001b[30mCD45RA\u001b[0m and CD45R0 \u001b[46m\u001b[30mT helper subsets\u001b[0m upon stimulation wi\n",
      "vivo in [corrected] \u001b[46m\u001b[30mCD45RA\u001b[0m and CD45R0 \u001b[46m\u001b[30mT helper subsets\u001b[0m [published erratum \n",
      "\n",
      "('sre-', 'nf-y-')\n",
      "ated function of an \u001b[46m\u001b[30mSRE-\u001b[0m and NF-Y-\u001b[46m\u001b[30mbinding site\u001b[0m.\n",
      "ank, containing the \u001b[46m\u001b[30mSRE-\u001b[0m and NF-Y-\u001b[46m\u001b[30mbinding sites\u001b[0m, mediated a serum r\n",
      "\n",
      "('e2-treated', 'er-')\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated ER+ and \u001b[46m\u001b[30mER- cells\u001b[0m. These in vitro res\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "\n",
      "('m-tat/gm-csf', 'm-tat/scf')\n",
      "ed to as M-TAT/EPO, \u001b[46m\u001b[30mM-TAT/GM-CSF\u001b[0m, and M-TAT/SCF \u001b[46m\u001b[30mcells\u001b[0m, respectively. Hemo\n",
      "\n",
      "(')', '40')\n",
      "ar constructs using \u001b[46m\u001b[30mhuman fetal (A gamma-) globin (HBG1)\u001b[0m or simian virus 40 (SV40) \u001b[46m\u001b[30mpromoters\u001b[0m is not enhanced. Th\n",
      "\n",
      "(')', 'sv40')\n",
      "ar constructs using \u001b[46m\u001b[30mhuman fetal (A gamma-) globin (HBG1)\u001b[0m or simian virus 40 (SV40) \u001b[46m\u001b[30mpromoters\u001b[0m is not enhanced. Th\n",
      "\n",
      "(')', 'virus')\n",
      "ar constructs using \u001b[46m\u001b[30mhuman fetal (A gamma-) globin (HBG1)\u001b[0m or simian virus 40 (SV40) \u001b[46m\u001b[30mpromoters\u001b[0m is not enhanced. Th\n",
      "\n",
      "(')', 'simian')\n",
      "ar constructs using \u001b[46m\u001b[30mhuman fetal (A gamma-) globin (HBG1)\u001b[0m or simian virus 40 (SV40) \u001b[46m\u001b[30mpromoters\u001b[0m is not enhanced. Th\n",
      "\n",
      "(')', 'gr')\n",
      "antial decreases in \u001b[46m\u001b[30mmineralocorticoid (MR)\u001b[0m and glucocorticoid receptor (GR) \u001b[46m\u001b[30mlevels\u001b[0m in the hippocampus,\n",
      "\n",
      "(')', 'receptor')\n",
      "antial decreases in \u001b[46m\u001b[30mmineralocorticoid (MR)\u001b[0m and glucocorticoid receptor (GR) \u001b[46m\u001b[30mlevels\u001b[0m in the hippocampus,\n",
      "\n",
      "(')', 'glucocorticoid')\n",
      "antial decreases in \u001b[46m\u001b[30mmineralocorticoid (MR)\u001b[0m and glucocorticoid receptor (GR) \u001b[46m\u001b[30mlevels\u001b[0m in the hippocampus,\n",
      "\n",
      "('beta', 'tnf-alpha')\n",
      "uppress IL-1 alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m, IL-6, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "('differentiation', 'proliferation')\n",
      "tain transcription, \u001b[46m\u001b[30mdifferentiation\u001b[0m and proliferation \u001b[46m\u001b[30mfactors\u001b[0m. Many of these gene\n",
      "\n",
      "('homo', 'hetero')\n",
      "-box-dependent bHLH \u001b[46m\u001b[30mhomo\u001b[0m -or hetero\u001b[46m\u001b[30mdimer complex formation\u001b[0m in vitro (E.Hara, M\n",
      "\n",
      "('-', 'dimer')\n",
      "-box-dependent bHLH \u001b[46m\u001b[30mhomo\u001b[0m -or hetero\u001b[46m\u001b[30mdimer complex formation\u001b[0m in vitro (E.Hara, M\n",
      "\n",
      "('b-', 'lymphocyte')\n",
      "eins in GH/PRL- and \u001b[46m\u001b[30minsulin-\u001b[0mproducing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "GH/PRL- and insulin-\u001b[46m\u001b[30mproducing\u001b[0m, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      " of Pan proteins in \u001b[46m\u001b[30mGH/PRL-\u001b[0m and insulin-producing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "(',', 'lymphocyte')\n",
      "eins in GH/PRL- and \u001b[46m\u001b[30minsulin-\u001b[0mproducing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "GH/PRL- and insulin-\u001b[46m\u001b[30mproducing\u001b[0m, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      " of Pan proteins in \u001b[46m\u001b[30mGH/PRL-\u001b[0m and insulin-producing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "('producing', 'lymphocyte')\n",
      "eins in GH/PRL- and \u001b[46m\u001b[30minsulin-\u001b[0mproducing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      " of Pan proteins in \u001b[46m\u001b[30mGH/PRL-\u001b[0m and insulin-producing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "('insulin-', 't-')\n",
      "eins in GH/PRL- and \u001b[46m\u001b[30minsulin-\u001b[0mproducing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "('cd14-', 'protein')\n",
      "crophage cells is a \u001b[46m\u001b[30mCD14-\u001b[0m and protein tyrosine phosphorylation-\u001b[46m\u001b[30mdependent event\u001b[0m that may mediate th\n",
      "\n",
      "('cd14-', 'phosphorylation-')\n",
      "crophage cells is a \u001b[46m\u001b[30mCD14-\u001b[0m and protein tyrosine phosphorylation-\u001b[46m\u001b[30mdependent event\u001b[0m that may mediate th\n",
      "\n",
      "('cd14-', 'tyrosine')\n",
      "crophage cells is a \u001b[46m\u001b[30mCD14-\u001b[0m and protein tyrosine phosphorylation-\u001b[46m\u001b[30mdependent event\u001b[0m that may mediate th\n",
      "\n",
      "('bronchial', 'alveolar')\n",
      "on was localized to \u001b[46m\u001b[30mbronchial\u001b[0m and alveolar \u001b[46m\u001b[30mcells\u001b[0m. Electrophoretic mo\n",
      "\n",
      "('ifn-beta', 'ifn-alpha')\n",
      "ility of endogenous \u001b[46m\u001b[30mIFN-beta\u001b[0m and IFN-alpha \u001b[46m\u001b[30mRNA\u001b[0m was also increased \n",
      "\n",
      "('75', '54')\n",
      "ing proteins of 85, \u001b[46m\u001b[30m75\u001b[0m, and 54 \u001b[46m\u001b[30mkDa\u001b[0m, whereas in Tax exp\n",
      "\n",
      "('persistent', 'recurrent')\n",
      "may be one cause of \u001b[46m\u001b[30mpersistent\u001b[0m or recurrent \u001b[46m\u001b[30minflammatory arthritis\u001b[0m.\n",
      "en in patients with \u001b[46m\u001b[30mpersistent\u001b[0m or recurrent \u001b[46m\u001b[30minflammatory arthritis\u001b[0m. The 3H-thymidine u\n",
      "rus is one cause of \u001b[46m\u001b[30mpersistent\u001b[0m or recurrent \u001b[46m\u001b[30minflammatory arthritis\u001b[0m. The assessment of \n",
      "\n",
      "('b-cell-restricted', 'ubiquitous')\n",
      "hough it binds both \u001b[46m\u001b[30mB-cell-restricted\u001b[0m and ubiquitous \u001b[46m\u001b[30mtranscription factors\u001b[0m. Activation of the \n",
      "\n",
      "('hiv-1-', '2-')\n",
      "ts the induction of \u001b[46m\u001b[30mHIV-1-\u001b[0m and interleukin 2-\u001b[46m\u001b[30mdirected gene expression\u001b[0m, and the effect on \n",
      "\n",
      "('hiv-1-', 'interleukin')\n",
      "ts the induction of \u001b[46m\u001b[30mHIV-1-\u001b[0m and interleukin 2-\u001b[46m\u001b[30mdirected gene expression\u001b[0m, and the effect on \n",
      "\n",
      "('-1', '-3')\n",
      "eased expression of \u001b[46m\u001b[30mEgr\u001b[0m-1, -2, and \u001b[46m\u001b[30m-3\u001b[0m. As with egr-3, exp\n",
      "ng GATA-1 and -2 or \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-3 gene products\u001b[0m. This pattern of di\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA-1\u001b[0m and -2 or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "ng GATA-1 and -2 or \u001b[46m\u001b[30mGATA\u001b[0m-1 and \u001b[46m\u001b[30m-3\u001b[0m gene products. This\n",
      "ng GATA-1 and -2 or \u001b[46m\u001b[30mGATA-1\u001b[0m and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "\n",
      "('ifn-alpha', 'ifn-gamma')\n",
      "ages in response to \u001b[46m\u001b[30mIFN-alpha\u001b[0m and IFN-gamma \u001b[46m\u001b[30mstimulation\u001b[0m. We show that IFN-a\n",
      "\n",
      "('macrophage', 'epithelial')\n",
      "amma (IFN-gamma) in \u001b[46m\u001b[30mmacrophage\u001b[0m and epithelial \u001b[46m\u001b[30mcell lines\u001b[0m. We first isolated \n",
      "\n",
      "('ap-1', 'ikaros')\n",
      "lear factors at the \u001b[46m\u001b[30mAP-1\u001b[0m and Ikaros \u001b[46m\u001b[30msites\u001b[0m.\n",
      "\n",
      "('blood', 'pleural')\n",
      "le tumor cells from \u001b[46m\u001b[30mblood\u001b[0m and pleural \u001b[46m\u001b[30meffusions\u001b[0m using a slide assay\n",
      "\n",
      "('exocrine', 'compartment')\n",
      " mainly composed of \u001b[46m\u001b[30mductal\u001b[0m, exocrine and endocrine \u001b[46m\u001b[30mcompartments\u001b[0m. Early buds are cha\n",
      "\n",
      "('ductal', 'endocrine')\n",
      " mainly composed of \u001b[46m\u001b[30mductal\u001b[0m, exocrine and endocrine \u001b[46m\u001b[30mcompartments\u001b[0m. Early buds are cha\n",
      "\n",
      "(',', 'compartment')\n",
      " mainly composed of \u001b[46m\u001b[30mductal\u001b[0m, exocrine and endocrine \u001b[46m\u001b[30mcompartments\u001b[0m. Early buds are cha\n",
      "\n",
      "('igm', 'chain')\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('igm', 'lambda')\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('chain', 'expression')\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('l', 'expression')\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('igm', 'l')\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('igd', 'expression')\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('kappa', 'expression')\n",
      "ased B cell surface \u001b[46m\u001b[30mIgM\u001b[0m, IgD, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "(')', 'pml-rar')\n",
      "al induction of the \u001b[46m\u001b[30mRAR(alpha)\u001b[0m and PML-RAR \u001b[46m\u001b[30mmRNAs\u001b[0m is rapid and it is \n",
      "\n",
      "('papillomavirus-', 'adenovirus-')\n",
      "Oncogenicity of \u001b[46m\u001b[30mhuman\u001b[0m papillomavirus- or \u001b[46m\u001b[30madenovirus-transformed cells\u001b[0m correlates with res\n",
      "Oncogenicity of \u001b[46m\u001b[30mhuman papillomavirus-\u001b[0m or adenovirus-\u001b[46m\u001b[30mtransformed cells\u001b[0m correlates with res\n",
      "\n",
      "('c-mim', 'human')\n",
      " vectors containing \u001b[46m\u001b[30mmyeloid-cell-specific c-mim\u001b[0m and human myeloperoxidase \u001b[46m\u001b[30mpromoters\u001b[0m suggested a role fo\n",
      "\n",
      "('c-mim', 'myeloperoxidase')\n",
      " vectors containing \u001b[46m\u001b[30mmyeloid-cell-specific c-mim\u001b[0m and human myeloperoxidase \u001b[46m\u001b[30mpromoters\u001b[0m suggested a role fo\n",
      "\n",
      "('x', 'y')\n",
      "showed the putative \u001b[46m\u001b[30mX\u001b[0m and Y \u001b[46m\u001b[30mboxes\u001b[0m to be occupied by t\n",
      "\n",
      "('endocrine', 'lymphoid')\n",
      " lines representing \u001b[46m\u001b[30mendocrine\u001b[0m, fibroblast, and lymphoid \u001b[46m\u001b[30mlineages\u001b[0m using polyclonal an\n",
      "\n",
      "('fibroblast', 'lineage')\n",
      " lines representing \u001b[46m\u001b[30mendocrine\u001b[0m, fibroblast, and lymphoid \u001b[46m\u001b[30mlineages\u001b[0m using polyclonal an\n",
      "\n",
      "('myelomonocytic', 'eosinophilic')\n",
      "ically expressed in \u001b[46m\u001b[30mmyelomonocytic\u001b[0m and eosinophilic \u001b[46m\u001b[30mcells\u001b[0m of the hematopoieti\n",
      "\n",
      "('beta', 'tcr')\n",
      "uence motifs in the \u001b[46m\u001b[30mTCR beta\u001b[0m and TCR delta \u001b[46m\u001b[30menhancers\u001b[0m. We have recently i\n",
      "\n",
      "('beta', 'delta')\n",
      "uence motifs in the \u001b[46m\u001b[30mTCR beta\u001b[0m and TCR delta \u001b[46m\u001b[30menhancers\u001b[0m. We have recently i\n",
      "r-bearing mice. The \u001b[46m\u001b[30mTCR alpha beta\u001b[0m or -gamma delta \u001b[46m\u001b[30mchains\u001b[0m bind the peptide li\n",
      "\n",
      "('e-selectin', '-8')\n",
      "ne driven either by \u001b[46m\u001b[30mE-selectin\u001b[0m or interleukin (IL)-8 \u001b[46m\u001b[30mpromoters\u001b[0m or a synthetic NF-k\n",
      "\n",
      "('e-selectin', 'il')\n",
      "ne driven either by \u001b[46m\u001b[30mE-selectin\u001b[0m or interleukin (IL)-8 \u001b[46m\u001b[30mpromoters\u001b[0m or a synthetic NF-k\n",
      "\n",
      "('e-selectin', 'interleukin')\n",
      "ne driven either by \u001b[46m\u001b[30mE-selectin\u001b[0m or interleukin (IL)-8 \u001b[46m\u001b[30mpromoters\u001b[0m or a synthetic NF-k\n",
      "\n",
      "('e-selectin', '(')\n",
      "ne driven either by \u001b[46m\u001b[30mE-selectin\u001b[0m or interleukin (IL)-8 \u001b[46m\u001b[30mpromoters\u001b[0m or a synthetic NF-k\n",
      "\n",
      "('e-selectin', ')')\n",
      "ne driven either by \u001b[46m\u001b[30mE-selectin\u001b[0m or interleukin (IL)-8 \u001b[46m\u001b[30mpromoters\u001b[0m or a synthetic NF-k\n",
      "\n",
      "('-alpha', '-beta1')\n",
      "e the expression of \u001b[46m\u001b[30mTGF\u001b[0m-alpha and \u001b[46m\u001b[30m-beta1\u001b[0m by eosinophils. Eos\n",
      "\n",
      "('low', 'type')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "\n",
      "('capacity', 'type')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "\n",
      "(',', 'type')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('high', 'type')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "\n",
      "('affinity', 'type')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen\u001b[0m type I (high affinity, low capacity) and \u001b[46m\u001b[30mtype II (low affinity, high capacity) binding sites\u001b[0m in human peripheral\n",
      "\n",
      "('megakaryocyte', 'early')\n",
      "ected in erythroid, \u001b[46m\u001b[30mmegakaryocyte\u001b[0m, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "\n",
      "('megakaryocyte', 'myeloid')\n",
      "ected in erythroid, \u001b[46m\u001b[30mmegakaryocyte\u001b[0m, mast and early myeloid \u001b[46m\u001b[30mcell lines\u001b[0m, as well as in seve\n",
      "\n",
      "('4-', '10-')\n",
      "altered spacings. A \u001b[46m\u001b[30m4-\u001b[0m or 10-\u001b[46m\u001b[30mbp insertion\u001b[0m between muE3 and mu\n",
      "\n",
      "('oct1', 'nf-at')\n",
      "ent. Interestingly, \u001b[46m\u001b[30mOct1\u001b[0m and NF-AT \u001b[46m\u001b[30mDNA binding activity\u001b[0m were not affected b\n",
      "\n",
      "('primitive', 'commit')\n",
      "y expressed in both \u001b[46m\u001b[30mmost primitive\u001b[0m and committed progenitors \u001b[46m\u001b[30mcells\u001b[0m, whereas GATA-3 is \n",
      "\n",
      "('primitive', 'progenitor')\n",
      "y expressed in both \u001b[46m\u001b[30mmost primitive\u001b[0m and committed progenitors \u001b[46m\u001b[30mcells\u001b[0m, whereas GATA-3 is \n",
      "\n",
      "('gm-csf', 'il-2')\n",
      "mulatory signal for \u001b[46m\u001b[30mGM-CSF\u001b[0m and IL-2 \u001b[46m\u001b[30mgene transcription\u001b[0m, in that it can coo\n",
      "ed induction of the \u001b[46m\u001b[30mGM-CSF\u001b[0m and IL-2 \u001b[46m\u001b[30mgenes\u001b[0m and that the CLE0 s\n",
      "\n",
      "('hla-dma', 'hla-dmb')\n",
      "\u001b[46m\u001b[30mHLA-DMA\u001b[0m and HLA-DMB \u001b[46m\u001b[30mgene expression\u001b[0m functions through t\n",
      "\n",
      "('basal', 'tax-mediated')\n",
      "d are important for \u001b[46m\u001b[30mbasal\u001b[0m and Tax-mediated \u001b[46m\u001b[30mtranscription\u001b[0m. Using mitogen stim\n",
      "\n",
      "('alpha', '-dq')\n",
      "ibutable to lack of \u001b[46m\u001b[30mHLA-DQ alpha\u001b[0m or -DQ beta \u001b[46m\u001b[30mtranscription\u001b[0m, because both trans\n",
      "ibutable to lack of \u001b[46m\u001b[30mHLA\u001b[0m-DQ alpha or \u001b[46m\u001b[30m-DQ beta transcription\u001b[0m, because both trans\n",
      "\n",
      "('nf-at', 'ap-1')\n",
      " the activities for \u001b[46m\u001b[30mNF-AT\u001b[0m and AP-1 \u001b[46m\u001b[30msites\u001b[0m require two signals\n",
      "\n",
      "('phosphatase', 'receptor')\n",
      "on of the levels of \u001b[46m\u001b[30mleukocyte alkaline phosphatase\u001b[0m, CD11b, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "('cd11b', 'mrna')\n",
      "on of the levels of \u001b[46m\u001b[30mleukocyte alkaline phosphatase\u001b[0m, CD11b, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "('phosphatase', 'g-csf')\n",
      "on of the levels of \u001b[46m\u001b[30mleukocyte alkaline phosphatase\u001b[0m, CD11b, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "('cd33', 'mrna')\n",
      "on of the levels of \u001b[46m\u001b[30mleukocyte alkaline phosphatase\u001b[0m, CD11b, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "kaline phosphatase, \u001b[46m\u001b[30mCD11b\u001b[0m, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "(',', 'clone')\n",
      "n apoptosis in Th0, \u001b[46m\u001b[30mTh1\u001b[0m, and Th2 \u001b[46m\u001b[30mclones\u001b[0m. We also found that\n",
      "vation apoptosis in \u001b[46m\u001b[30mTh0\u001b[0m, Th1, and Th2 \u001b[46m\u001b[30mclones\u001b[0m. We also found that\n",
      "vation apoptosis in \u001b[46m\u001b[30mTh0\u001b[0m, Th1, and Th2 \u001b[46m\u001b[30mclones\u001b[0m. We also found that\n",
      "\n",
      "('p35', 'p40')\n",
      "o covalently linked \u001b[46m\u001b[30mp35\u001b[0m and p40 \u001b[46m\u001b[30mchains\u001b[0m. This pro-inflammat\n",
      "\n",
      "('cytogenetic', 'molecular')\n",
      "e present clinical, \u001b[46m\u001b[30mcytogenetic\u001b[0m, and molecular \u001b[46m\u001b[30mdata\u001b[0m from a new CMPD1/SR\n",
      "\n",
      "(',', 'data')\n",
      "e present clinical, \u001b[46m\u001b[30mcytogenetic\u001b[0m, and molecular \u001b[46m\u001b[30mdata\u001b[0m from a new CMPD1/SR\n",
      "9. Here, we present \u001b[46m\u001b[30mclinical\u001b[0m, cytogenetic, and molecular \u001b[46m\u001b[30mdata\u001b[0m from a new CMPD1/SR\n",
      "9. Here, we present \u001b[46m\u001b[30mclinical\u001b[0m, cytogenetic, and molecular \u001b[46m\u001b[30mdata\u001b[0m from a new CMPD1/SR\n",
      "\n",
      "('only', 'tnf-')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-\u001b[46m\u001b[30minduced\u001b[0m, but also constitut\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also \u001b[46m\u001b[30mconstitutive\u001b[0m, HIV-enhancer activ\n",
      "\n",
      "('pma-', 'induced')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-\u001b[46m\u001b[30minduced\u001b[0m, but also constitut\n",
      "\n",
      "('gata', 'caccc')\n",
      "tracted proteins to \u001b[46m\u001b[30mGATA\u001b[0m and CACCC \u001b[46m\u001b[30msites\u001b[0m in the H5 promoter \n",
      "\n",
      "('myeloid', 'nk')\n",
      "es features of both \u001b[46m\u001b[30mmyeloid\u001b[0m and natural killer (NK) \u001b[46m\u001b[30mcells\u001b[0m. From a consecutive\n",
      " common to both the \u001b[46m\u001b[30mmyeloid\u001b[0m and NK \u001b[46m\u001b[30mcell lineages\u001b[0m; thus we propose th\n",
      "\n",
      "('myeloid', 'killer')\n",
      "es features of both \u001b[46m\u001b[30mmyeloid\u001b[0m and natural killer (NK) \u001b[46m\u001b[30mcells\u001b[0m. From a consecutive\n",
      "\n",
      "('myeloid', '(')\n",
      "es features of both \u001b[46m\u001b[30mmyeloid\u001b[0m and natural killer (NK) \u001b[46m\u001b[30mcells\u001b[0m. From a consecutive\n",
      "\n",
      "('myeloid', ')')\n",
      "es features of both \u001b[46m\u001b[30mmyeloid\u001b[0m and natural killer (NK) \u001b[46m\u001b[30mcells\u001b[0m. From a consecutive\n",
      "\n",
      "('myeloid', 'natural')\n",
      "es features of both \u001b[46m\u001b[30mmyeloid\u001b[0m and natural killer (NK) \u001b[46m\u001b[30mcells\u001b[0m. From a consecutive\n",
      "\n",
      "('buttock', 'thigh')\n",
      " recovered from the \u001b[46m\u001b[30mHSV-2\u001b[0m buttock and \u001b[46m\u001b[30mthigh lesions\u001b[0m of five patients. C\n",
      " recovered from the \u001b[46m\u001b[30mHSV-2 buttock\u001b[0m and thigh \u001b[46m\u001b[30mlesions\u001b[0m of five patients. C\n",
      "\n",
      "('c-rel', 'p105/p50')\n",
      "vation also induced \u001b[46m\u001b[30mc-rel\u001b[0m and p105/p50 \u001b[46m\u001b[30mmRNA synthesis\u001b[0m, but not p65 mRNA w\n",
      "\n",
      "('cytosolic', 'nuclear')\n",
      "demonstrable in the \u001b[46m\u001b[30mcytosolic\u001b[0m and nuclear \u001b[46m\u001b[30mcompartments\u001b[0m; it required betwee\n",
      "\n",
      "('wild-type', 'the')\n",
      " express either the \u001b[46m\u001b[30mwild-type\u001b[0m or the truncated \u001b[46m\u001b[30mER\u001b[0m. This finding may l\n",
      "\n",
      "('wild-type', 'truncate')\n",
      " express either the \u001b[46m\u001b[30mwild-type\u001b[0m or the truncated \u001b[46m\u001b[30mER\u001b[0m. This finding may l\n",
      "\n",
      "('hematopoietic', 'epithelial')\n",
      "nsduction events in \u001b[46m\u001b[30mhematopoietic\u001b[0m and epithelial \u001b[46m\u001b[30mcells\u001b[0m. They are rapidly a\n",
      "\n",
      "('cytokine', 'gene')\n",
      "ropic regulators of \u001b[46m\u001b[30mimmunoregulatory\u001b[0m, cytokine and viral \u001b[46m\u001b[30mgene expression\u001b[0m. In this report, we\n",
      "\n",
      "('immunoregulatory', 'viral')\n",
      "ropic regulators of \u001b[46m\u001b[30mimmunoregulatory\u001b[0m, cytokine and viral \u001b[46m\u001b[30mgene expression\u001b[0m. In this report, we\n",
      "\n",
      "('nk-', 't-cell')\n",
      "\u001b[46m\u001b[30mNasal NK-\u001b[0m and T-cell \u001b[46m\u001b[30mlymphomas\u001b[0m share the same type\n",
      "pt expression. Both \u001b[46m\u001b[30mNK-\u001b[0m and T-cell \u001b[46m\u001b[30msubtypes\u001b[0m are closely associa\n",
      "\n",
      "('nfat', 'oct')\n",
      " of a trimer of the \u001b[46m\u001b[30mNFAT\u001b[0m and Oct \u001b[46m\u001b[30msites\u001b[0m is not sensitive to\n",
      "\n",
      "('p53', 'the')\n",
      "d for c-fos, c-myc, \u001b[46m\u001b[30mp53\u001b[0m and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('p53', 'hybrid')\n",
      "d for c-fos, c-myc, \u001b[46m\u001b[30mp53\u001b[0m and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('p53', 'bcr/abl')\n",
      "d for c-fos, c-myc, \u001b[46m\u001b[30mp53\u001b[0m and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('normal', 'leukemic')\n",
      "erentiation of both \u001b[46m\u001b[30mnormal\u001b[0m and leukemic \u001b[46m\u001b[30mcells\u001b[0m. Its effects are me\n",
      "\n",
      "('cytolytic', 'proliferative')\n",
      "y, IL-13 suppresses \u001b[46m\u001b[30mIL-2-induced NK\u001b[0m cytolytic and \u001b[46m\u001b[30mproliferative activities\u001b[0m although less effic\n",
      "y, IL-13 suppresses \u001b[46m\u001b[30mIL-2-induced NK cytolytic\u001b[0m and proliferative \u001b[46m\u001b[30mactivities\u001b[0m although less effic\n",
      "\n",
      "('delta-', 'kappa-')\n",
      "cific expression of \u001b[46m\u001b[30mdelta-\u001b[0m and kappa-\u001b[46m\u001b[30mopioid receptors\u001b[0m by thymic and perip\n",
      "\n",
      "('e-cdk2-', 'cyclin')\n",
      "equences. Recently, \u001b[46m\u001b[30mcyclin E-Cdk2-\u001b[0m and cyclin A-Cdk2-\u001b[46m\u001b[30mdependent phosphorylation\u001b[0m of a single conserv\n",
      "\n",
      "('e-cdk2-', 'a-cdk2-')\n",
      "equences. Recently, \u001b[46m\u001b[30mcyclin E-Cdk2-\u001b[0m and cyclin A-Cdk2-\u001b[46m\u001b[30mdependent phosphorylation\u001b[0m of a single conserv\n",
      "\n",
      "('ra', 'vitd3')\n",
      "known as to how the \u001b[46m\u001b[30mRA\u001b[0m and VitD3 \u001b[46m\u001b[30mreceptor network\u001b[0m operates in hematop\n",
      "\n",
      "('c-fos', 'jun')\n",
      "nt increase in both \u001b[46m\u001b[30mc-Fos\u001b[0m and Jun \u001b[46m\u001b[30mimmunoreactivity\u001b[0m in contrast to cAMP\n",
      ". The expression of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun and jun B \u001b[46m\u001b[30mproto-oncogenes\u001b[0m was studied in phyt\n",
      "es were observed in \u001b[46m\u001b[30mc-fos\u001b[0m or jun B \u001b[46m\u001b[30mmRNA expression\u001b[0m. However, c-jun mRN\n",
      "\n",
      "('hl-60', 'nb4')\n",
      " differentiation of \u001b[46m\u001b[30mHL-60\u001b[0m and NB4 \u001b[46m\u001b[30mcells\u001b[0m, whereas the combin\n",
      "on and apoptosis of \u001b[46m\u001b[30mHL-60\u001b[0m and NB4 \u001b[46m\u001b[30mcells\u001b[0m, whereas the RAR an\n",
      "\n",
      "('acute', '-')\n",
      "is also involved in \u001b[46m\u001b[30mT- acute\u001b[0m and- chronic \u001b[46m\u001b[30mleukemias\u001b[0m arising in cases of\n",
      "\n",
      "('acute', 'chronic')\n",
      "is also involved in \u001b[46m\u001b[30mT- acute\u001b[0m and- chronic \u001b[46m\u001b[30mleukemias\u001b[0m arising in cases of\n",
      "uding septic shock, \u001b[46m\u001b[30macute\u001b[0m and chronic \u001b[46m\u001b[30minflammation\u001b[0m, and cachexia. Rece\n",
      "was measured during \u001b[46m\u001b[30macute\u001b[0m and chronic \u001b[46m\u001b[30minfection\u001b[0m. The expression lev\n",
      "is also involved in \u001b[46m\u001b[30mT-\u001b[0m acute and- \u001b[46m\u001b[30mchronic leukemias\u001b[0m arising in cases of\n",
      "\n",
      "('sensitive', 'resistant')\n",
      " between six of the \u001b[46m\u001b[30msensitive\u001b[0m and resistant \u001b[46m\u001b[30mpatients\u001b[0m in the clearance of\n",
      "\n",
      "('5a', 'b')\n",
      "uced the binding of \u001b[46m\u001b[30mStat\u001b[0m5a and \u001b[46m\u001b[30mb proteins\u001b[0m to the human GASd e\n",
      "uced the binding of \u001b[46m\u001b[30mStat5a\u001b[0m and b \u001b[46m\u001b[30mproteins\u001b[0m to the human GASd e\n",
      "\n",
      "('cytoplasmic', 'nuclear')\n",
      "DeltaE localized to \u001b[46m\u001b[30mcytoplasmic\u001b[0m and nuclear \u001b[46m\u001b[30mmembranes\u001b[0m, suggesting that in\n",
      "ulation, we studied \u001b[46m\u001b[30mcytoplasmic\u001b[0m and nuclear \u001b[46m\u001b[30msignaling steps\u001b[0m in ALD-treated T ce\n",
      " the existence of a \u001b[46m\u001b[30mcytoplasmic\u001b[0m and/or nuclear \u001b[46m\u001b[30mreceptor\u001b[0m, without explaining\n",
      "\n",
      "('oxidant', 'antioxidant')\n",
      "e activated by both \u001b[46m\u001b[30moxidant\u001b[0m and antioxidant \u001b[46m\u001b[30mstimuli\u001b[0m. However, the mecha\n",
      "ifferentially under \u001b[46m\u001b[30moxidant\u001b[0m and antioxidant \u001b[46m\u001b[30mconditions\u001b[0m.\n",
      "\n",
      "('m-csf', 'fm')\n",
      " expressed both the \u001b[46m\u001b[30mM-CSF\u001b[0m and FMS \u001b[46m\u001b[30mgenes\u001b[0m. No germline change\n",
      "\n",
      "('nf-kappab/nfat', 'ets')\n",
      "ctionally important \u001b[46m\u001b[30mNF-kappaB/NFAT\u001b[0m and Ets \u001b[46m\u001b[30mbinding sites\u001b[0m are present in the \n",
      "\n",
      "('c-fos', 'b')\n",
      "titutive expression \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      ". The expression of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun and jun B \u001b[46m\u001b[30mproto-oncogenes\u001b[0m was studied in phyt\n",
      "es were observed in \u001b[46m\u001b[30mc-fos\u001b[0m or jun B \u001b[46m\u001b[30mmRNA expression\u001b[0m. However, c-jun mRN\n",
      "\n",
      "('c-fos', 'nf')\n",
      "titutive expression \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "\n",
      "('c-fos', 'kappa')\n",
      "titutive expression \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "\n",
      "('c-jun', 'mrna')\n",
      "titutive expression \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "\n",
      "('cd45-', 'lck-')\n",
      "ther, in normal and \u001b[46m\u001b[30mCD45-\u001b[0m or Lck-\u001b[46m\u001b[30mdeficient cell lines\u001b[0m, Fas stimulation re\n",
      "\n",
      "('alpha', '-gamma')\n",
      "r-bearing mice. The \u001b[46m\u001b[30mTCR\u001b[0m alpha beta or \u001b[46m\u001b[30m-gamma delta chains\u001b[0m bind the peptide li\n",
      "\n",
      "('beta', '-gamma')\n",
      "r-bearing mice. The \u001b[46m\u001b[30mTCR\u001b[0m alpha beta or \u001b[46m\u001b[30m-gamma delta chains\u001b[0m bind the peptide li\n",
      "r-bearing mice. The \u001b[46m\u001b[30mTCR alpha beta\u001b[0m or -gamma delta \u001b[46m\u001b[30mchains\u001b[0m bind the peptide li\n",
      "\n",
      "(',', 'family')\n",
      "n of NF-AT, but not \u001b[46m\u001b[30mJun\u001b[0m, Fos, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "n of NF-AT, but not \u001b[46m\u001b[30mJun\u001b[0m, Fos, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "n of NF-AT, but not \u001b[46m\u001b[30mJun\u001b[0m, Fos, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "NF-AT, but not Jun, \u001b[46m\u001b[30mFos\u001b[0m, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "NF-AT, but not Jun, \u001b[46m\u001b[30mFos\u001b[0m, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      ", but not Jun, Fos, \u001b[46m\u001b[30mNF-kappaB\u001b[0m, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n",
      "('nf-kappab', 'family')\n",
      "n of NF-AT, but not \u001b[46m\u001b[30mJun\u001b[0m, Fos, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "NF-AT, but not Jun, \u001b[46m\u001b[30mFos\u001b[0m, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n",
      "('oct', 'family')\n",
      "n of NF-AT, but not \u001b[46m\u001b[30mJun\u001b[0m, Fos, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "NF-AT, but not Jun, \u001b[46m\u001b[30mFos\u001b[0m, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      ", but not Jun, Fos, \u001b[46m\u001b[30mNF-kappaB\u001b[0m, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n",
      "('fo', 'family')\n",
      "n of NF-AT, but not \u001b[46m\u001b[30mJun\u001b[0m, Fos, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n",
      "('jun', 'ets')\n",
      "n of NF-AT, but not \u001b[46m\u001b[30mJun\u001b[0m, Fos, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n",
      "('gata-1', 'sp1')\n",
      "poR expression. The \u001b[46m\u001b[30mGATA-1\u001b[0m and Sp1 \u001b[46m\u001b[30mbinding sites\u001b[0m in this promoter la\n",
      "\n",
      "('gamma', 'mrna')\n",
      " with a decrease in \u001b[46m\u001b[30minterleukin 2 (IL-2)\u001b[0m, gamma interferon, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "('interferon', 'mrna')\n",
      " with a decrease in \u001b[46m\u001b[30minterleukin 2 (IL-2)\u001b[0m, gamma interferon, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "(')', 'factor')\n",
      " with a decrease in \u001b[46m\u001b[30minterleukin 2 (IL-2)\u001b[0m, gamma interferon, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "(')', 'colony-stimulating')\n",
      " with a decrease in \u001b[46m\u001b[30minterleukin 2 (IL-2)\u001b[0m, gamma interferon, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "(')', 'granulocyte-macrophage')\n",
      " with a decrease in \u001b[46m\u001b[30minterleukin 2 (IL-2)\u001b[0m, gamma interferon, and granulocyte-macrophage colony-stimulating factor \u001b[46m\u001b[30mmRNA levels\u001b[0m. We report here tha\n",
      "\n",
      "('b', 'monocyte')\n",
      ", is a regulator of \u001b[46m\u001b[30mhuman\u001b[0m B cell and \u001b[46m\u001b[30mmonocyte functions\u001b[0m. Biologic effects o\n",
      "\n",
      "('cell', 'monocyte')\n",
      ", is a regulator of \u001b[46m\u001b[30mhuman\u001b[0m B cell and \u001b[46m\u001b[30mmonocyte functions\u001b[0m. Biologic effects o\n",
      ", is a regulator of \u001b[46m\u001b[30mhuman B cell\u001b[0m and monocyte \u001b[46m\u001b[30mfunctions\u001b[0m. Biologic effects o\n",
      "\n",
      "('reconstitution', 'cotransfection')\n",
      "e basis of binding, \u001b[46m\u001b[30mreconstitution\u001b[0m and cotransfection \u001b[46m\u001b[30mexperiments\u001b[0m, we propose that ac\n",
      "\n",
      "('calcineurin', 'protein')\n",
      " downregulates both \u001b[46m\u001b[30mcalcineurin\u001b[0m and protein kinase C\u001b[46m\u001b[30m-mediated pathways\u001b[0m for cytokine gene t\n",
      "\n",
      "('calcineurin', 'c')\n",
      " downregulates both \u001b[46m\u001b[30mcalcineurin\u001b[0m and protein kinase C\u001b[46m\u001b[30m-mediated pathways\u001b[0m for cytokine gene t\n",
      "\n",
      "('calcineurin', 'kinase')\n",
      " downregulates both \u001b[46m\u001b[30mcalcineurin\u001b[0m and protein kinase C\u001b[46m\u001b[30m-mediated pathways\u001b[0m for cytokine gene t\n",
      "\n",
      "('b-lymphoid', 'erythroid')\n",
      "ent in the myeloid, \u001b[46m\u001b[30mB-lymphoid\u001b[0m, and erythroid \u001b[46m\u001b[30mlineages\u001b[0m, absent in nonhemat\n",
      "\n",
      "('erythroid', 'mast')\n",
      " gene expression in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m. GATA-1 binds to WG\n",
      "is expressed in the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m during normal hemat\n",
      "SCL is expressed in \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocyte and mast \u001b[46m\u001b[30mcell populations\u001b[0m (the same cell line\n",
      "\n",
      "('-alpha', '-gamma')\n",
      "y both interferons (\u001b[46m\u001b[30minterferon\u001b[0m-alpha and \u001b[46m\u001b[30m-gamma\u001b[0m) and interferon reg\n",
      "\n",
      "('erk1/2', 'p38')\n",
      "onstrated that both \u001b[46m\u001b[30mERK1/2\u001b[0m and p38 \u001b[46m\u001b[30mcascades\u001b[0m play a key role in \n",
      "\n",
      "('alpha', 'il-2')\n",
      "ts in inhibition of \u001b[46m\u001b[30mI kappa B alpha\u001b[0m and IL-2 \u001b[46m\u001b[30mgene expression\u001b[0m, processes dependen\n",
      "\n",
      "('lymphoid', 'monocytic')\n",
      "ulation of c-Fos in \u001b[46m\u001b[30mactivated T lymphoid\u001b[0m and monocytic \u001b[46m\u001b[30mcells\u001b[0m by human immunodefi\n",
      "ulation of c-Fos in \u001b[46m\u001b[30mactivated\u001b[0m T lymphoid and \u001b[46m\u001b[30mmonocytic cells\u001b[0m by human immunodefi\n",
      "\n",
      "('tata', 'caat')\n",
      "te/s and absence of \u001b[46m\u001b[30mTATA\u001b[0m or CAAT \u001b[46m\u001b[30mmotifs\u001b[0m. Transcription is i\n",
      "gene lacks either a \u001b[46m\u001b[30mTATA\u001b[0m or a CAAT \u001b[46m\u001b[30mbox\u001b[0m and transcription i\n",
      "\n",
      "('paternal', 'biallelic')\n",
      "ted observations of \u001b[46m\u001b[30mpaternal\u001b[0m or biallelic \u001b[46m\u001b[30mexpression\u001b[0m of WT1 in fibroblas\n",
      "\n",
      "('calcium-', 'calmodulin-')\n",
      "y controlled by the \u001b[46m\u001b[30mcalcium-\u001b[0m and calmodulin- \u001b[46m\u001b[30mdependent phosphatase\u001b[0m calcineurin. Here w\n",
      "\n",
      "('jun-b', 'expression')\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "ter transfection of \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, or jun-D \u001b[46m\u001b[30mexpression vectors\u001b[0m, which augmented GR\n",
      "\n",
      "('c-jun', 'fos-b')\n",
      "ermore, transfected \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, jun-D, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "\n",
      "('2', '3')\n",
      "ng terminal repeat (\u001b[46m\u001b[30msites\u001b[0m 1, 2, and \u001b[46m\u001b[30m3\u001b[0m) were chosen, in wh\n",
      "cted mutagenesis of \u001b[46m\u001b[30mhuman HSs\u001b[0m 2 and \u001b[46m\u001b[30m3\u001b[0m we have tested the \n",
      "\n",
      "(',', '3')\n",
      "ng terminal repeat (\u001b[46m\u001b[30msites\u001b[0m 1, 2, and \u001b[46m\u001b[30m3\u001b[0m) were chosen, in wh\n",
      "ng terminal repeat (\u001b[46m\u001b[30msites\u001b[0m 1, 2, and \u001b[46m\u001b[30m3\u001b[0m) were chosen, in wh\n",
      "\n",
      "('1', '3')\n",
      "ng terminal repeat (\u001b[46m\u001b[30msites\u001b[0m 1, 2, and \u001b[46m\u001b[30m3\u001b[0m) were chosen, in wh\n",
      "e induction of both \u001b[46m\u001b[30mJak\u001b[0m 1 and \u001b[46m\u001b[30m3\u001b[0m, and STAT 5 activit\n",
      "\n",
      "('cytoskeleton', 'intracellular')\n",
      "pression of several \u001b[46m\u001b[30mcytoskeleton\u001b[0m and intracellular \u001b[46m\u001b[30mproteins\u001b[0m increased as determ\n",
      "\n",
      "('3', '5')\n",
      " from those binding \u001b[46m\u001b[30mTRAFs\u001b[0m 1, 2, 3, and \u001b[46m\u001b[30m5\u001b[0m. When this membrane\n",
      " phosphorylation of \u001b[46m\u001b[30mSTATs\u001b[0m 3 and \u001b[46m\u001b[30m5\u001b[0m (signal transducer \n",
      "\n",
      "(',', '5')\n",
      " from those binding \u001b[46m\u001b[30mTRAFs\u001b[0m 1, 2, 3, and \u001b[46m\u001b[30m5\u001b[0m. When this membrane\n",
      " from those binding \u001b[46m\u001b[30mTRAFs\u001b[0m 1, 2, 3, and \u001b[46m\u001b[30m5\u001b[0m. When this membrane\n",
      " from those binding \u001b[46m\u001b[30mTRAFs\u001b[0m 1, 2, 3, and \u001b[46m\u001b[30m5\u001b[0m. When this membrane\n",
      "\n",
      "('2', '5')\n",
      " from those binding \u001b[46m\u001b[30mTRAFs\u001b[0m 1, 2, 3, and \u001b[46m\u001b[30m5\u001b[0m. When this membrane\n",
      "\n",
      "('1', '5')\n",
      " from those binding \u001b[46m\u001b[30mTRAFs\u001b[0m 1, 2, 3, and \u001b[46m\u001b[30m5\u001b[0m. When this membrane\n",
      "\n",
      "('antigen-', 'cd2')\n",
      "nergism between the \u001b[46m\u001b[30mCD3 antigen-\u001b[0m and CD2 antigen-\u001b[46m\u001b[30mderived signals\u001b[0m. Exploration at the\n",
      "\n",
      "('antigen-', 'antigen-')\n",
      "nergism between the \u001b[46m\u001b[30mCD3 antigen-\u001b[0m and CD2 antigen-\u001b[46m\u001b[30mderived signals\u001b[0m. Exploration at the\n",
      "\n",
      "('activation', 'differentiation')\n",
      "l T lymphocytes, in \u001b[46m\u001b[30mT cell\u001b[0m activation and \u001b[46m\u001b[30mdifferentiation\u001b[0m we created NF-ATp-d\n",
      "\n",
      "('gluco-', 'mineralo')\n",
      "y with captopril on \u001b[46m\u001b[30mgluco-\u001b[0m and mineralo\u001b[46m\u001b[30mcorticoid receptors\u001b[0m of peripheral blood\n",
      "\n",
      "('alpha', '-beta')\n",
      "iated inhibition of \u001b[46m\u001b[30minterleukin-2 receptor alpha\u001b[0m and -beta \u001b[46m\u001b[30msubunit expression\u001b[0m by human T cells. T\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha genes\n",
      "not mRNA levels for \u001b[46m\u001b[30mT cell receptor\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, are increased by i\n",
      "iated inhibition of \u001b[46m\u001b[30minterleukin-2 receptor\u001b[0m alpha and \u001b[46m\u001b[30m-beta subunit expression\u001b[0m by human T cells. T\n",
      "anscription factors \u001b[46m\u001b[30mGABP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m to a dyad symmetry \n",
      "\n",
      "('-', 'thyroidism')\n",
      "ates. Patients with \u001b[46m\u001b[30movert hypo\u001b[0m -or hyper\u001b[46m\u001b[30mthyroidism\u001b[0m were enrolled in th\n",
      "\n",
      "('il-12-', 'mediated')\n",
      "-12, and IFN-alpha. \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-12-, and IFN-alpha-\u001b[46m\u001b[30mmediated signaling pathways\u001b[0m were analyzed in pr\n",
      "\n",
      "('il-2-', 'ifn-alpha-')\n",
      "-12, and IFN-alpha. \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-12-, and IFN-alpha-\u001b[46m\u001b[30mmediated signaling pathways\u001b[0m were analyzed in pr\n",
      "\n",
      "('nf-at', 'nfil-2a')\n",
      "t only the reported \u001b[46m\u001b[30mIL-2 NF-AT\u001b[0m and NFIL-2A \u001b[46m\u001b[30msites\u001b[0m and Ig kappa B site\n",
      "\n",
      "('lymphocyte', 'macrophage')\n",
      " common to both the \u001b[46m\u001b[30mlymphocyte\u001b[0m and macrophage \u001b[46m\u001b[30mreceptor isoforms\u001b[0m. In contrast, the i\n",
      "\n",
      "('alpha', 'i')\n",
      "kappa B activity by \u001b[46m\u001b[30mI kappa B alpha\u001b[0m and I kappa B beta \u001b[46m\u001b[30mstability\u001b[0m. Transcription fact\n",
      "\n",
      "('alpha', 'kappa')\n",
      "kappa B activity by \u001b[46m\u001b[30mI kappa B alpha\u001b[0m and I kappa B beta \u001b[46m\u001b[30mstability\u001b[0m. Transcription fact\n",
      "\n",
      "('alpha', 'b')\n",
      "kappa B activity by \u001b[46m\u001b[30mI kappa B alpha\u001b[0m and I kappa B beta \u001b[46m\u001b[30mstability\u001b[0m. Transcription fact\n",
      "\n",
      "('c-', 'v-')\n",
      "e family (KBF1/p50, \u001b[46m\u001b[30mc-\u001b[0m and v-\u001b[46m\u001b[30mrel\u001b[0m). This mutant also \n",
      "\n",
      "('cd3-epsilon', 'cell')\n",
      "ional motifs in the \u001b[46m\u001b[30mCD3-epsilon\u001b[0m and T cell receptor alpha \u001b[46m\u001b[30menhancers\u001b[0m. CD3-epsilon gene e\n",
      "\n",
      "('cd3-epsilon', 'alpha')\n",
      "ional motifs in the \u001b[46m\u001b[30mCD3-epsilon\u001b[0m and T cell receptor alpha \u001b[46m\u001b[30menhancers\u001b[0m. CD3-epsilon gene e\n",
      "\n",
      "('cd3-epsilon', 't')\n",
      "ional motifs in the \u001b[46m\u001b[30mCD3-epsilon\u001b[0m and T cell receptor alpha \u001b[46m\u001b[30menhancers\u001b[0m. CD3-epsilon gene e\n",
      "\n",
      "('cd3-epsilon', 'receptor')\n",
      "ional motifs in the \u001b[46m\u001b[30mCD3-epsilon\u001b[0m and T cell receptor alpha \u001b[46m\u001b[30menhancers\u001b[0m. CD3-epsilon gene e\n",
      "\n",
      "(')', '2')\n",
      "okine expression by \u001b[46m\u001b[30mT helper 1 (Th1)\u001b[0m and T helper 2 (Th2) \u001b[46m\u001b[30mcells\u001b[0m is unclear. Previou\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper 0 (Th0)\u001b[0m and 2 (Th2) \u001b[46m\u001b[30msubset\u001b[0m, was originally des\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper\u001b[0m 0 (Th0) and \u001b[46m\u001b[30m2 (Th2) subset\u001b[0m, was originally des\n",
      "\n",
      "(')', 'helper')\n",
      "okine expression by \u001b[46m\u001b[30mT helper 1 (Th1)\u001b[0m and T helper 2 (Th2) \u001b[46m\u001b[30mcells\u001b[0m is unclear. Previou\n",
      "\n",
      "(')', 'th2')\n",
      "okine expression by \u001b[46m\u001b[30mT helper 1 (Th1)\u001b[0m and T helper 2 (Th2) \u001b[46m\u001b[30mcells\u001b[0m is unclear. Previou\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper 0 (Th0)\u001b[0m and 2 (Th2) \u001b[46m\u001b[30msubset\u001b[0m, was originally des\n",
      "\n",
      "('h9', 'cem')\n",
      "less efficiently in \u001b[46m\u001b[30mH9\u001b[0m and CEM \u001b[46m\u001b[30mcells\u001b[0m. These studies indi\n",
      "\n",
      "(',', '436')\n",
      "Q2 binding, whereas \u001b[46m\u001b[30mresidues\u001b[0m 431, 433, 434, and \u001b[46m\u001b[30m436\u001b[0m (positions P 1, P2,\n",
      "Q2 binding, whereas \u001b[46m\u001b[30mresidues\u001b[0m 431, 433, 434, and \u001b[46m\u001b[30m436\u001b[0m (positions P 1, P2,\n",
      "Q2 binding, whereas \u001b[46m\u001b[30mresidues\u001b[0m 431, 433, 434, and \u001b[46m\u001b[30m436\u001b[0m (positions P 1, P2,\n",
      "\n",
      "('431', '436')\n",
      "Q2 binding, whereas \u001b[46m\u001b[30mresidues\u001b[0m 431, 433, 434, and \u001b[46m\u001b[30m436\u001b[0m (positions P 1, P2,\n",
      "\n",
      "('434', '436')\n",
      "Q2 binding, whereas \u001b[46m\u001b[30mresidues\u001b[0m 431, 433, 434, and \u001b[46m\u001b[30m436\u001b[0m (positions P 1, P2,\n",
      "\n",
      "('433', '436')\n",
      "Q2 binding, whereas \u001b[46m\u001b[30mresidues\u001b[0m 431, 433, 434, and \u001b[46m\u001b[30m436\u001b[0m (positions P 1, P2,\n",
      "\n",
      "('p50-', 'p65-')\n",
      "ces. Using either a \u001b[46m\u001b[30mp50-\u001b[0m or p65- \u001b[46m\u001b[30mselected kappa B motif\u001b[0m, which displayed di\n",
      "\n",
      "('junb', 'mrna')\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "on of c-fos, c-jun, \u001b[46m\u001b[30mc-myc\u001b[0m, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "entration of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "\n",
      "('c-myc', 'mrna')\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "entration of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "s were examined for \u001b[46m\u001b[30mc-fos\u001b[0m, c-myc, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('c-fos', 'fra-1')\n",
      "he concentration of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "\n",
      "('cd45ro+', 'cd45ra+')\n",
      "kappaB induction in \u001b[46m\u001b[30mCD45RO+\u001b[0m and CD45RA+ \u001b[46m\u001b[30mT cell subsets\u001b[0m during aging. An in\n",
      "\n",
      "('-1', '-2a')\n",
      "cific inhibitors of \u001b[46m\u001b[30mserine/threonine phosphatases\u001b[0m-1 and \u001b[46m\u001b[30m-2A\u001b[0m: okadaic acid and c\n",
      "\n",
      "('clinical', 'molecular')\n",
      " strongly influence \u001b[46m\u001b[30mclinical\u001b[0m and molecular \u001b[46m\u001b[30mremission\u001b[0m. These results stil\n",
      "9. Here, we present \u001b[46m\u001b[30mclinical\u001b[0m, cytogenetic, and molecular \u001b[46m\u001b[30mdata\u001b[0m from a new CMPD1/SR\n",
      "\n",
      "('dna-binding', 'dimerization')\n",
      "ains of E2A and the \u001b[46m\u001b[30mbasic leucine zipper (bZIP) DNA-binding\u001b[0m and protein dimerization \u001b[46m\u001b[30mdomain\u001b[0m of HLF (hepatic leu\n",
      "\n",
      "('dna-binding', 'protein')\n",
      "ains of E2A and the \u001b[46m\u001b[30mbasic leucine zipper (bZIP) DNA-binding\u001b[0m and protein dimerization \u001b[46m\u001b[30mdomain\u001b[0m of HLF (hepatic leu\n",
      "ains of E2A and the \u001b[46m\u001b[30mbasic leucine zipper (bZIP)\u001b[0m DNA-binding and \u001b[46m\u001b[30mprotein dimerization domain\u001b[0m of HLF (hepatic leu\n",
      "\n",
      "('e2a', 'pbx1')\n",
      " from fusion of the \u001b[46m\u001b[30mE2A\u001b[0m and PBX1 \u001b[46m\u001b[30mgenes\u001b[0m following t(1;19) c\n",
      "\n",
      "('2', '15')\n",
      "\u001b[46m\u001b[30mInterleukin\u001b[0m 2 and \u001b[46m\u001b[30m15\u001b[0m activate Stat3alpha\n",
      "\n",
      "('fetal', 'neonatal')\n",
      "ti-CD3 stimulation. \u001b[46m\u001b[30mFetal\u001b[0m and neonatal \u001b[46m\u001b[30mlymphocytes\u001b[0m are relatively resi\n",
      "ion to examine both \u001b[46m\u001b[30mfetal\u001b[0m and term neonatal \u001b[46m\u001b[30mcord bloods\u001b[0m for mRNA expression\n",
      "\n",
      "('aggregation', 'proliferation')\n",
      "om those regulating \u001b[46m\u001b[30mhomotypic\u001b[0m aggregation and \u001b[46m\u001b[30mproliferation\u001b[0m.\n",
      "\n",
      "('lymphocytic', 'monocytic')\n",
      "a B species in most \u001b[46m\u001b[30mT lymphocytic\u001b[0m and monocytic \u001b[46m\u001b[30mcells\u001b[0m, is demonstrated in\n",
      "\n",
      "('mast', 'megakaryocyte')\n",
      "essed in erythroid, \u001b[46m\u001b[30mmast\u001b[0m and megakaryocyte \u001b[46m\u001b[30mlineages\u001b[0m. Northern analysis \n",
      "\n",
      "('megakaryocytic', 'erythroid')\n",
      "erentiation of both \u001b[46m\u001b[30mmegakaryocytic\u001b[0m and erythroid \u001b[46m\u001b[30mlineages\u001b[0m. This cell line sho\n",
      "vestigation of both \u001b[46m\u001b[30mmegakaryocytic\u001b[0m and erythroid \u001b[46m\u001b[30mmaturation\u001b[0m.\n",
      "\n",
      "('lpr', 'gld')\n",
      " normal T cells and \u001b[46m\u001b[30maberrant double-negative lpr\u001b[0m and gld \u001b[46m\u001b[30mT cells\u001b[0m. We previously iden\n",
      "\n",
      "('p53', 'bcl-2')\n",
      " steroid receptors, \u001b[46m\u001b[30mp53\u001b[0m and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "\n",
      "('early', 'late')\n",
      " activities of both \u001b[46m\u001b[30mSV40 early\u001b[0m and late \u001b[46m\u001b[30mpromoters\u001b[0m. Together, these da\n",
      " activities of both \u001b[46m\u001b[30mSV40\u001b[0m early and \u001b[46m\u001b[30mlate promoters\u001b[0m. Together, these da\n",
      "\n",
      "('uv-', 'h2o2-')\n",
      "ptor involvement in \u001b[46m\u001b[30mUV-\u001b[0m and H2O2-\u001b[46m\u001b[30minduced T cell signal transduction\u001b[0m. Several mammalian \n",
      "\n",
      "('nf-at', 'cle0')\n",
      "plex formation with \u001b[46m\u001b[30mNF-AT\u001b[0m, AP-1 and CLE0 \u001b[46m\u001b[30msequences\u001b[0m when the cells were\n",
      "\n",
      "('ap-1', 'sequence')\n",
      "plex formation with \u001b[46m\u001b[30mNF-AT\u001b[0m, AP-1 and CLE0 \u001b[46m\u001b[30msequences\u001b[0m when the cells were\n",
      "\n",
      "('antiproliferative', 'apoptotic')\n",
      "FN-gamma has potent \u001b[46m\u001b[30mantiproliferative\u001b[0m and apoptotic \u001b[46m\u001b[30meffects\u001b[0m in T cells that are\n",
      "\n",
      "('synthetic', 'natural')\n",
      "were incubated with \u001b[46m\u001b[30mvarious\u001b[0m synthetic or \u001b[46m\u001b[30mnatural agonists\u001b[0m or antagonists and \n",
      "were incubated with \u001b[46m\u001b[30mvarious synthetic\u001b[0m or natural \u001b[46m\u001b[30magonists\u001b[0m or antagonists and \n",
      "\n",
      "('mouse', 'drosophila')\n",
      "everal other human, \u001b[46m\u001b[30mmouse\u001b[0m, and Drosophila \u001b[46m\u001b[30msequences\u001b[0m, defining a subfami\n",
      "\n",
      "('nfatp-', 'nfatc-')\n",
      "rshift assays using \u001b[46m\u001b[30mNFATp-\u001b[0m and NFATc- \u001b[46m\u001b[30mspecific antibodies\u001b[0m indicate that NK ce\n",
      "\n",
      "('monocyte', 'lymphocyte')\n",
      "y. In addition, the \u001b[46m\u001b[30mmonocyte\u001b[0m and lymphocyte \u001b[46m\u001b[30mcounts\u001b[0m and the blood estro\n",
      "\n",
      "(\"5'-untranslated\", 'cod')\n",
      "inding sites in the \u001b[46m\u001b[30m5'-untranslated\u001b[0m and proximal coding \u001b[46m\u001b[30mregions\u001b[0m.\n",
      "\n",
      "(\"5'-untranslated\", 'proximal')\n",
      "inding sites in the \u001b[46m\u001b[30m5'-untranslated\u001b[0m and proximal coding \u001b[46m\u001b[30mregions\u001b[0m.\n",
      "\n",
      "('gc2-', 'gd2-')\n",
      "d from lesions. The \u001b[46m\u001b[30mgC2-\u001b[0m and gD2-\u001b[46m\u001b[30mspecific CD4+ clones\u001b[0m had cytotoxic activ\n",
      "\n",
      "('ap-2', 'sp1')\n",
      "containing putative \u001b[46m\u001b[30mAP-2\u001b[0m and Sp1 \u001b[46m\u001b[30mbinding motifs\u001b[0m appears necessary f\n",
      "\n",
      "('die', 'infected')\n",
      "c reticulum (ER) of \u001b[46m\u001b[30mdying\u001b[0m or infected \u001b[46m\u001b[30mcells\u001b[0m. We have tested thi\n",
      "\n",
      "('elbow', 'genital')\n",
      "in samples from the \u001b[46m\u001b[30mpatient's elbow\u001b[0m and genital \u001b[46m\u001b[30mregions\u001b[0m, although there wer\n",
      "in samples from the \u001b[46m\u001b[30mpatient's\u001b[0m elbow and \u001b[46m\u001b[30mgenital regions\u001b[0m, although there wer\n",
      "\n",
      "('alpha', 'alpha')\n",
      "factor binds to the \u001b[46m\u001b[30mDR alpha\u001b[0m and DP alpha \u001b[46m\u001b[30melement\u001b[0m but not to the elem\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP alpha\u001b[0m and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('alpha', 'dp')\n",
      "factor binds to the \u001b[46m\u001b[30mDR alpha\u001b[0m and DP alpha \u001b[46m\u001b[30melement\u001b[0m but not to the elem\n",
      "\n",
      "('mcp-1', 'icam-1')\n",
      "d platelets induced \u001b[46m\u001b[30mMCP-1\u001b[0m and ICAM-1 \u001b[46m\u001b[30mpromoter-dependent transcription\u001b[0m. Liposomal transfec\n",
      "\n",
      "('ebf', 'e47')\n",
      "ctionally important \u001b[46m\u001b[30mEBF\u001b[0m and E47 \u001b[46m\u001b[30mbinding sites\u001b[0m were identified in \n",
      "\n",
      "('heat-', 'cadmium-')\n",
      "on was decreased in \u001b[46m\u001b[30mheat-\u001b[0m and cadmium-\u001b[46m\u001b[30mpretreated cells\u001b[0m in comparison to un\n",
      "\n",
      "('mab', 'cho-cd80')\n",
      "mma were seen after \u001b[46m\u001b[30manti-CD28 mAb\u001b[0m and CHO-CD80 \u001b[46m\u001b[30mstimulation\u001b[0m but to a much lesse\n",
      "\n",
      "(')', 'mtiia')\n",
      "ent, the effects on \u001b[46m\u001b[30mglucocorticoid receptor (GR)\u001b[0m and methallothionein (MTIIa) \u001b[46m\u001b[30mmRNA expression levels\u001b[0m were examined in pe\n",
      "\n",
      "(')', 'methallothionein')\n",
      "ent, the effects on \u001b[46m\u001b[30mglucocorticoid receptor (GR)\u001b[0m and methallothionein (MTIIa) \u001b[46m\u001b[30mmRNA expression levels\u001b[0m were examined in pe\n",
      "\n",
      "('tyrosine', 'serine')\n",
      "STAT5, IL-2 induced \u001b[46m\u001b[30mtyrosine\u001b[0m and serine \u001b[46m\u001b[30mphosphorylation\u001b[0m of STAT1 alpha, whi\n",
      "\n",
      "('first', 'third')\n",
      "cated in either the \u001b[46m\u001b[30mfirst\u001b[0m or the third \u001b[46m\u001b[30mintron\u001b[0m of the CD4 gene, is\n",
      "\n",
      "('first', 'the')\n",
      "cated in either the \u001b[46m\u001b[30mfirst\u001b[0m or the third \u001b[46m\u001b[30mintron\u001b[0m of the CD4 gene, is\n",
      "\n",
      "('il-3-', 'induced')\n",
      "atory effect on the \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-3-, or GM-CSF-\u001b[46m\u001b[30minduced proinflammatory cytokine gene expression\u001b[0m in monocytes provid\n",
      "\n",
      "('il-2-', 'gm-csf-')\n",
      "atory effect on the \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-3-, or GM-CSF-\u001b[46m\u001b[30minduced proinflammatory cytokine gene expression\u001b[0m in monocytes provid\n",
      "\n",
      "(',', 'induced')\n",
      "atory effect on the \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-3-, or GM-CSF-\u001b[46m\u001b[30minduced proinflammatory cytokine gene expression\u001b[0m in monocytes provid\n",
      "atory effect on the \u001b[46m\u001b[30mIL-2-\u001b[0m, IL-3-, or GM-CSF-\u001b[46m\u001b[30minduced proinflammatory cytokine gene expression\u001b[0m in monocytes provid\n",
      "ffect on the IL-2-, \u001b[46m\u001b[30mIL-3-\u001b[0m, or GM-CSF-\u001b[46m\u001b[30minduced proinflammatory cytokine gene expression\u001b[0m in monocytes provid\n",
      "\n",
      "('lymphoid', 'myeloid')\n",
      "/- mice, which lack \u001b[46m\u001b[30mlymphoid\u001b[0m and myeloid \u001b[46m\u001b[30mcells\u001b[0m, expression of Btk \n",
      "iates adhesion with \u001b[46m\u001b[30mlymphoid\u001b[0m and myeloid \u001b[46m\u001b[30mcells\u001b[0m. It is expressed on\n",
      " persistent in many \u001b[46m\u001b[30mlymphoid\u001b[0m and myeloid \u001b[46m\u001b[30mcell types\u001b[0m but can be activate\n",
      "\n",
      "('jun-d', 'fos-b')\n",
      "ected c-jun, jun-B, \u001b[46m\u001b[30mjun-D\u001b[0m, c-fos, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "\n",
      "('ii', 'iii')\n",
      "uclear RNA genes by \u001b[46m\u001b[30mRNA polymerases\u001b[0m II and \u001b[46m\u001b[30mIII\u001b[0m. The proximal seque\n",
      "\n",
      "('rat', 'mouse')\n",
      "tains G0S24 and the \u001b[46m\u001b[30mrat\u001b[0m and mouse \u001b[46m\u001b[30mTIS11 genes\u001b[0m (also known as TTP,\n",
      "alyses performed on \u001b[46m\u001b[30mrat\u001b[0m and mouse \u001b[46m\u001b[30mtissues\u001b[0m have detected ubiqu\n",
      "\n",
      "('genetic', 'neoplastic')\n",
      " with no history of \u001b[46m\u001b[30mgenetic\u001b[0m or neoplastic \u001b[46m\u001b[30mfamilial disorders\u001b[0m. We failed to find \n",
      "\n",
      "('il-1ri', 'il-1rii')\n",
      "endent increases in \u001b[46m\u001b[30mIL-1RI\u001b[0m and IL-1RII \u001b[46m\u001b[30mmRNA levels\u001b[0m. IFN-gamma decrease\n",
      "\n",
      "('il4', 'il13')\n",
      "\u001b[46m\u001b[30mIL4\u001b[0m and IL13 \u001b[46m\u001b[30mreceptors\u001b[0m share the gamma c c\n",
      "\n",
      "('kappa', 'dna')\n",
      " 40-50% decrease in \u001b[46m\u001b[30mAP-1\u001b[0m, NF kappa B, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      "\n",
      "(',', 'dna')\n",
      " 40-50% decrease in \u001b[46m\u001b[30mAP-1\u001b[0m, NF kappa B, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      " 40-50% decrease in \u001b[46m\u001b[30mAP-1\u001b[0m, NF kappa B, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      "% decrease in AP-1, \u001b[46m\u001b[30mNF kappa B\u001b[0m, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      "\n",
      "('nf', 'dna')\n",
      " 40-50% decrease in \u001b[46m\u001b[30mAP-1\u001b[0m, NF kappa B, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      "\n",
      "('ap-1', 'creb')\n",
      " 40-50% decrease in \u001b[46m\u001b[30mAP-1\u001b[0m, NF kappa B, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      "\n",
      "('b', 'dna')\n",
      " 40-50% decrease in \u001b[46m\u001b[30mAP-1\u001b[0m, NF kappa B, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      "\n",
      "('c-myc', 'the')\n",
      "examined for c-fos, \u001b[46m\u001b[30mc-myc\u001b[0m, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('p53', 'mrna')\n",
      "examined for c-fos, \u001b[46m\u001b[30mc-myc\u001b[0m, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "s were examined for \u001b[46m\u001b[30mc-fos\u001b[0m, c-myc, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('c-myc', 'hybrid')\n",
      "examined for c-fos, \u001b[46m\u001b[30mc-myc\u001b[0m, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('c-myc', 'bcr/abl')\n",
      "examined for c-fos, \u001b[46m\u001b[30mc-myc\u001b[0m, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('c-myc', 'fra-1')\n",
      "on of c-fos, c-jun, \u001b[46m\u001b[30mc-myc\u001b[0m, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "\n",
      "('p15', 'gene')\n",
      "Abnormalities of \u001b[46m\u001b[30mp16\u001b[0m, p15 and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m in recurrent malign\n",
      " alterations in the \u001b[46m\u001b[30mp16\u001b[0m, p15 or CDK4 \u001b[46m\u001b[30mgenes\u001b[0m, whereas homozygous\n",
      "bnormalities in the \u001b[46m\u001b[30mp16\u001b[0m, p15 and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m that regulate trans\n",
      "\n",
      "('p16', 'cdk4')\n",
      "Abnormalities of \u001b[46m\u001b[30mp16\u001b[0m, p15 and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m in recurrent malign\n",
      " alterations in the \u001b[46m\u001b[30mp16\u001b[0m, p15 or CDK4 \u001b[46m\u001b[30mgenes\u001b[0m, whereas homozygous\n",
      "bnormalities in the \u001b[46m\u001b[30mp16\u001b[0m, p15 and CDK4 \u001b[46m\u001b[30mgenes\u001b[0m that regulate trans\n",
      "\n",
      "('mouse', 'human')\n",
      "icoid resistance in \u001b[46m\u001b[30mmouse\u001b[0m and human \u001b[46m\u001b[30mlymphoma cells\u001b[0m in culture.\n",
      "ce identity between \u001b[46m\u001b[30mmouse\u001b[0m and human \u001b[46m\u001b[30mBOB.1/OBF.1\u001b[0m. The NH2-terminal 1\n",
      "\n",
      "('agamma-', 'beta-')\n",
      "quences of both the \u001b[46m\u001b[30mAgamma-\u001b[0m and the beta-\u001b[46m\u001b[30mglobin genes\u001b[0m, suggesting a role \n",
      "\n",
      "('agamma-', 'the')\n",
      "quences of both the \u001b[46m\u001b[30mAgamma-\u001b[0m and the beta-\u001b[46m\u001b[30mglobin genes\u001b[0m, suggesting a role \n",
      "\n",
      "('jurkat', '293')\n",
      "IKKbeta into either \u001b[46m\u001b[30mhuman\u001b[0m Jurkat T or \u001b[46m\u001b[30m293 cells\u001b[0m also inhibits NF-ka\n",
      "\n",
      "('t', '293')\n",
      "IKKbeta into either \u001b[46m\u001b[30mhuman\u001b[0m Jurkat T or \u001b[46m\u001b[30m293 cells\u001b[0m also inhibits NF-ka\n",
      "IKKbeta into either \u001b[46m\u001b[30mhuman Jurkat T\u001b[0m or 293 \u001b[46m\u001b[30mcells\u001b[0m also inhibits NF-ka\n",
      "\n",
      "(')', 'cr')\n",
      "cytes isolated from \u001b[46m\u001b[30mcorticosteroid-sensitive (CS)\u001b[0m and corticosteroid-resistant (CR) \u001b[46m\u001b[30masthmatic subjects\u001b[0m, which augments leu\n",
      "\n",
      "(')', 'corticosteroid-resistant')\n",
      "cytes isolated from \u001b[46m\u001b[30mcorticosteroid-sensitive (CS)\u001b[0m and corticosteroid-resistant (CR) \u001b[46m\u001b[30masthmatic subjects\u001b[0m, which augments leu\n",
      "\n",
      "('oct', 'ikaros/lyf-1')\n",
      " contains SP1, ETS, \u001b[46m\u001b[30mOCT\u001b[0m, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "\n",
      "(',', 'transcription')\n",
      " contains SP1, ETS, \u001b[46m\u001b[30mOCT\u001b[0m, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "tivity and contains \u001b[46m\u001b[30mSP1\u001b[0m, ETS, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "tivity and contains \u001b[46m\u001b[30mSP1\u001b[0m, ETS, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "tivity and contains \u001b[46m\u001b[30mSP1\u001b[0m, ETS, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "y and contains SP1, \u001b[46m\u001b[30mETS\u001b[0m, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "y and contains SP1, \u001b[46m\u001b[30mETS\u001b[0m, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "\n",
      "('k-562', 'cell')\n",
      "as more abundant in \u001b[46m\u001b[30mU-937\u001b[0m, K-562, and HeLa \u001b[46m\u001b[30mcell extracts\u001b[0m than in Raji, HF, B\n",
      "\n",
      "('u-937', 'hela')\n",
      "as more abundant in \u001b[46m\u001b[30mU-937\u001b[0m, K-562, and HeLa \u001b[46m\u001b[30mcell extracts\u001b[0m than in Raji, HF, B\n",
      "\n",
      "('autoradiographic', 'immunohistochemical')\n",
      "ects using combined \u001b[46m\u001b[30mautoradiographic\u001b[0m and immunohistochemical \u001b[46m\u001b[30mtechniques\u001b[0m. Lavage T-lymphocyt\n",
      "\n",
      "('phytohemagglutinin-', 'ester-')\n",
      "ssion (about 60% of \u001b[46m\u001b[30mphytohemagglutinin-\u001b[0m and phorbol ester-\u001b[46m\u001b[30mactivated Jurkat cells\u001b[0m) that was dependent\n",
      "\n",
      "('phytohemagglutinin-', 'phorbol')\n",
      "ssion (about 60% of \u001b[46m\u001b[30mphytohemagglutinin-\u001b[0m and phorbol ester-\u001b[46m\u001b[30mactivated Jurkat cells\u001b[0m) that was dependent\n",
      "\n",
      "('ifn-gamma', 'gm-csf')\n",
      "r IL-2 induction of \u001b[46m\u001b[30mIFN-gamma\u001b[0m and GM-CSF \u001b[46m\u001b[30mcytoplasmic mRNA\u001b[0m. In contrast, IL-12\n",
      " is correlated with \u001b[46m\u001b[30mIFN-gamma\u001b[0m and GM-CSF \u001b[46m\u001b[30mgene expression\u001b[0m. These data indicat\n",
      "\n",
      "('basal', '/')\n",
      "f IFN-gamma on both \u001b[46m\u001b[30mbasal\u001b[0m and IL-4/IL-13-induced \u001b[46m\u001b[30mIL-1R gene expression\u001b[0m in primary monocyte\n",
      "\n",
      "('basal', 'il-13')\n",
      "f IFN-gamma on both \u001b[46m\u001b[30mbasal\u001b[0m and IL-4/IL-13-induced \u001b[46m\u001b[30mIL-1R gene expression\u001b[0m in primary monocyte\n",
      "\n",
      "('basal', 'il-4')\n",
      "f IFN-gamma on both \u001b[46m\u001b[30mbasal\u001b[0m and IL-4/IL-13-induced \u001b[46m\u001b[30mIL-1R gene expression\u001b[0m in primary monocyte\n",
      "\n",
      "('basal', '-induced')\n",
      "f IFN-gamma on both \u001b[46m\u001b[30mbasal\u001b[0m and IL-4/IL-13-induced \u001b[46m\u001b[30mIL-1R gene expression\u001b[0m in primary monocyte\n",
      "sulted in augmented \u001b[46m\u001b[30mbasal\u001b[0m and PMA-induced \u001b[46m\u001b[30mpromoter activity\u001b[0m.\n",
      "\n",
      "('matrix', 'nonmatrix')\n",
      "selectively between \u001b[46m\u001b[30mnuclear matrix\u001b[0m and nonmatrix \u001b[46m\u001b[30mcompartments\u001b[0m, consistent with th\n",
      "selectively between \u001b[46m\u001b[30mnuclear\u001b[0m matrix and \u001b[46m\u001b[30mnonmatrix compartments\u001b[0m, consistent with th\n",
      "\n",
      "('anti-cd3-', 'anti-cd28-')\n",
      "ive response of the \u001b[46m\u001b[30manti-CD3-\u001b[0m and anti-CD28-\u001b[46m\u001b[30mtreated Rel-/- T cells\u001b[0m, restores productio\n",
      "\n",
      "('cd40-', 'pervanadate-')\n",
      "lear translocation. \u001b[46m\u001b[30mCD40-\u001b[0m or pervanadate-\u001b[46m\u001b[30mmediated I kappa B tyrosine phosphorylation\u001b[0m was not detected. N\n",
      "\n",
      "('il-10', 'tgf-beta')\n",
      "leotides within the \u001b[46m\u001b[30mIL-10\u001b[0m and TGF-beta \u001b[46m\u001b[30mgene promoters\u001b[0m would link to the e\n",
      "\n",
      "('fetal', 'term')\n",
      "ion to examine both \u001b[46m\u001b[30mfetal\u001b[0m and term neonatal \u001b[46m\u001b[30mcord bloods\u001b[0m for mRNA expression\n",
      "\n",
      "('nk', 'nk3.3')\n",
      "K2 and TYK2 in both \u001b[46m\u001b[30mpreactivated primary\u001b[0m NK and \u001b[46m\u001b[30mNK3.3 cells\u001b[0m. Differential phosp\n",
      "K2 and TYK2 in both \u001b[46m\u001b[30mpreactivated primary NK\u001b[0m and NK3.3 \u001b[46m\u001b[30mcells\u001b[0m. Differential phosp\n",
      "\n",
      "('il-3-', 'gm-csf-')\n",
      "ffect on the IL-2-, \u001b[46m\u001b[30mIL-3-\u001b[0m, or GM-CSF-\u001b[46m\u001b[30minduced proinflammatory cytokine gene expression\u001b[0m in monocytes provid\n",
      "\n",
      "('wild-type', 'human')\n",
      "fectants expressing \u001b[46m\u001b[30mwild-type\u001b[0m or mutant human \u001b[46m\u001b[30mCD40\u001b[0m. Analysis of CD40 c\n",
      "\n",
      "('wild-type', 'mutant')\n",
      "fectants expressing \u001b[46m\u001b[30mwild-type\u001b[0m or mutant human \u001b[46m\u001b[30mCD40\u001b[0m. Analysis of CD40 c\n",
      "nding properties of \u001b[46m\u001b[30mmultimerized\u001b[0m wild-type and \u001b[46m\u001b[30mmutant elements\u001b[0m added upstream to t\n",
      "constructs carrying \u001b[46m\u001b[30mwild-type\u001b[0m or mutant \u001b[46m\u001b[30mLTRs\u001b[0m with modifications \n",
      "nding properties of \u001b[46m\u001b[30mmultimerized wild-type\u001b[0m and mutant \u001b[46m\u001b[30melements\u001b[0m added upstream to t\n",
      "\n",
      "('s1t', 'atl-1k')\n",
      "3 were found in the \u001b[46m\u001b[30mS1T\u001b[0m and ATL-1K \u001b[46m\u001b[30mcell lines\u001b[0m, which are nonprodu\n",
      "\n",
      "('activation', 'mitogenesis')\n",
      "t involved in B and \u001b[46m\u001b[30mT lymphocyte\u001b[0m activation and \u001b[46m\u001b[30mmitogenesis\u001b[0m.\n",
      "are not involved in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocyte\u001b[0m activation and \u001b[46m\u001b[30mmitogenesis\u001b[0m.\n",
      "\n",
      "('cell', 'b')\n",
      "e earliest stage of \u001b[46m\u001b[30mT cell\u001b[0m and B cell \u001b[46m\u001b[30mspecification\u001b[0m. In the adult, howe\n",
      "\n",
      "('cell', 'cell')\n",
      "e earliest stage of \u001b[46m\u001b[30mT cell\u001b[0m and B cell \u001b[46m\u001b[30mspecification\u001b[0m. In the adult, howe\n",
      "\n",
      "('adolescent', 'adult')\n",
      "rapy, especially in \u001b[46m\u001b[30madolescent\u001b[0m and young adult \u001b[46m\u001b[30mpatients\u001b[0m.\n",
      "\n",
      "('adolescent', 'young')\n",
      "rapy, especially in \u001b[46m\u001b[30madolescent\u001b[0m and young adult \u001b[46m\u001b[30mpatients\u001b[0m.\n",
      "\n",
      "('erythroid', 'non-erythroid')\n",
      "Binding of \u001b[46m\u001b[30merythroid\u001b[0m and non-erythroid \u001b[46m\u001b[30mnuclear proteins\u001b[0m to the silencer of \n",
      "nding proteins from \u001b[46m\u001b[30merythroid\u001b[0m and non-erythroid \u001b[46m\u001b[30mcells\u001b[0m could bind to the S\n",
      "\n",
      "('20-methyl-', '20-methyl-23-')\n",
      "ZK157202, which are \u001b[46m\u001b[30m20-methyl-\u001b[0m and 20-methyl-23-\u001b[46m\u001b[30meneanalogues\u001b[0m, respectively, have\n",
      "\n",
      "('mu', 'gamma')\n",
      "e secreted forms of \u001b[46m\u001b[30mmu\u001b[0m and gamma \u001b[46m\u001b[30mmRNA\u001b[0m. The mechanism by w\n",
      "\n",
      "('kinase', 'protease')\n",
      "distinct from known \u001b[46m\u001b[30mkinase\u001b[0m or protease \u001b[46m\u001b[30mpathways\u001b[0m. Activation of TGF-\n",
      "\n",
      "('8;21', '3;21')\n",
      " breakpoints of the \u001b[46m\u001b[30m8;21\u001b[0m and 3;21 \u001b[46m\u001b[30mchromosome translocations\u001b[0m associated with acu\n",
      "\n",
      "('major', 'minor')\n",
      "tream sequence. One \u001b[46m\u001b[30mmajor\u001b[0m and one minor \u001b[46m\u001b[30mtranscription start site\u001b[0m were identified 101\n",
      "\n",
      "('major', 'one')\n",
      "tream sequence. One \u001b[46m\u001b[30mmajor\u001b[0m and one minor \u001b[46m\u001b[30mtranscription start site\u001b[0m were identified 101\n",
      "\n",
      "('cd2', 'cd28')\n",
      "d human T-cells via \u001b[46m\u001b[30mCD2\u001b[0m and CD28 \u001b[46m\u001b[30madhesion molecules\u001b[0m induces and maintai\n",
      "\n",
      "('-', 'thyroid')\n",
      "ogram RNA in hypo-, \u001b[46m\u001b[30meu\u001b[0m -and hyper\u001b[46m\u001b[30mthyroid patients\u001b[0m, respectively, corr\n",
      "ol/microgram RNA in \u001b[46m\u001b[30mhypo\u001b[0m-, eu -and hyper\u001b[46m\u001b[30mthyroid patients\u001b[0m, respectively, corr\n",
      "ol/microgram RNA in \u001b[46m\u001b[30mhypo\u001b[0m-, eu -and hyper\u001b[46m\u001b[30mthyroid patients\u001b[0m, respectively, corr\n",
      "\n",
      "('eu', 'hyper')\n",
      "ogram RNA in hypo-, \u001b[46m\u001b[30meu\u001b[0m -and hyper\u001b[46m\u001b[30mthyroid patients\u001b[0m, respectively, corr\n",
      "\n",
      "(',', 'receptor')\n",
      "served among human, \u001b[46m\u001b[30msquirrel monkey\u001b[0m, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "served among human, \u001b[46m\u001b[30msquirrel monkey\u001b[0m, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "n, squirrel monkey, \u001b[46m\u001b[30mowl monkey\u001b[0m, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "('monkey', 'receptor')\n",
      "served among human, \u001b[46m\u001b[30msquirrel monkey\u001b[0m, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "('owl', 'receptor')\n",
      "served among human, \u001b[46m\u001b[30msquirrel monkey\u001b[0m, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "('-dq', '-dq')\n",
      "ibutable to lack of \u001b[46m\u001b[30mHLA\u001b[0m-DQ alpha or \u001b[46m\u001b[30m-DQ beta transcription\u001b[0m, because both trans\n",
      "\n",
      "('s1', \"s2'\")\n",
      "d in any of the S2, \u001b[46m\u001b[30mS1\u001b[0m, S1', and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "\n",
      "('sp1-', 'ets-')\n",
      "A critical role of \u001b[46m\u001b[30mSp1-\u001b[0m and Ets-\u001b[46m\u001b[30mrelated transcription factors\u001b[0m in maintaining CTL-\n",
      "\n",
      "('e1a', 'e1b')\n",
      " two model Ags, the \u001b[46m\u001b[30mhuman adenovirus type 5 early regions\u001b[0m E1A and \u001b[46m\u001b[30mE1B\u001b[0m. Although both prot\n",
      "\n",
      "('tsg101', 'fhit')\n",
      "ant splicing of the \u001b[46m\u001b[30mTSG101\u001b[0m and FHIT \u001b[46m\u001b[30mgenes\u001b[0m occurs frequently i\n",
      "gs demonstrate that \u001b[46m\u001b[30mtruncated TSG101\u001b[0m and FHIT \u001b[46m\u001b[30mtranscripts\u001b[0m are commonly detect\n",
      "gs demonstrate that \u001b[46m\u001b[30mtruncated\u001b[0m TSG101 and \u001b[46m\u001b[30mFHIT transcripts\u001b[0m are commonly detect\n",
      "\n",
      "('glucocorticoid', 'beta-adrenergic')\n",
      "ith T cells via the \u001b[46m\u001b[30mglucocorticoid\u001b[0m and beta-adrenergic \u001b[46m\u001b[30mreceptors\u001b[0m respectively. When \n",
      "\n",
      "('l428', 'hdlm-1')\n",
      "e rearrangements in \u001b[46m\u001b[30mL428\u001b[0m and HDLM-1 \u001b[46m\u001b[30mcells\u001b[0m, the expression of \n",
      "\n",
      "('basal', 'ra-')\n",
      "ntly suppressed the \u001b[46m\u001b[30mbasal\u001b[0m, PMA-, and RA-\u001b[46m\u001b[30minducible CD23 expression\u001b[0m in a dose-dependent\n",
      "\n",
      "('pma-', 'inducible')\n",
      "ntly suppressed the \u001b[46m\u001b[30mbasal\u001b[0m, PMA-, and RA-\u001b[46m\u001b[30minducible CD23 expression\u001b[0m in a dose-dependent\n",
      "\n",
      "(',', 'inducible')\n",
      "ntly suppressed the \u001b[46m\u001b[30mbasal\u001b[0m, PMA-, and RA-\u001b[46m\u001b[30minducible CD23 expression\u001b[0m in a dose-dependent\n",
      "ntly suppressed the \u001b[46m\u001b[30mbasal\u001b[0m, PMA-, and RA-\u001b[46m\u001b[30minducible CD23 expression\u001b[0m in a dose-dependent\n",
      "ppressed the basal, \u001b[46m\u001b[30mPMA-\u001b[0m, and RA-\u001b[46m\u001b[30minducible CD23 expression\u001b[0m in a dose-dependent\n",
      "\n",
      "('ets', 'ap-1')\n",
      "rated that both the \u001b[46m\u001b[30mEts\u001b[0m and AP-1 \u001b[46m\u001b[30msites\u001b[0m are required for bi\n",
      "\n",
      "('thymic', 'peripheral')\n",
      "opioid receptors by \u001b[46m\u001b[30mthymic\u001b[0m and peripheral \u001b[46m\u001b[30mT lymphocytes\u001b[0m. Since medical trea\n",
      "\n",
      "('monocytic', 'erythroid')\n",
      "opposite effects on \u001b[46m\u001b[30mmonocytic\u001b[0m and erythroid \u001b[46m\u001b[30mdifferentiation\u001b[0m of K562 cells. Spi-\n",
      "\n",
      "('a', 'type')\n",
      "stimulation in both \u001b[46m\u001b[30mtype A\u001b[0m and type B \u001b[46m\u001b[30mEBV carriers\u001b[0m. The RAKFKQLLQ-spec\n",
      " were infected with \u001b[46m\u001b[30mtype A\u001b[0m and one with type B \u001b[46m\u001b[30mEBV\u001b[0m. Polyclonal and clo\n",
      "entified in primary \u001b[46m\u001b[30mtype A\u001b[0m or type B \u001b[46m\u001b[30mEBV infection\u001b[0m which was sustained\n",
      "\n",
      "('xp', 'c')\n",
      "ion for many of the \u001b[46m\u001b[30mXP\u001b[0m and CS \u001b[46m\u001b[30msymptoms\u001b[0m that are difficult \n",
      "\n",
      "('cd68-', 'cd1a-')\n",
      "0 was found only in \u001b[46m\u001b[30mCD68-\u001b[0m and CD1a- \u001b[46m\u001b[30mcells\u001b[0m. Cells with nuclear\n",
      "\n",
      "('dependent', 'independent')\n",
      "of a combination of \u001b[46m\u001b[30mcalcineurin-\u001b[0mdependent and \u001b[46m\u001b[30mindependent pathways\u001b[0m. Both pathways were\n",
      "of a combination of \u001b[46m\u001b[30mcalcineurin-dependent\u001b[0m and independent \u001b[46m\u001b[30mpathways\u001b[0m. Both pathways were\n",
      "\n",
      "('a', 'mono')\n",
      "factor PU.1 and the \u001b[46m\u001b[30mMono A\u001b[0m and Mono B \u001b[46m\u001b[30mprotein complexes\u001b[0m act in concert to r\n",
      "\n",
      "('unstimulated', 'tnf-')\n",
      "dical scavenging in \u001b[46m\u001b[30munstimulated\u001b[0m and PMA- or TNF-\u001b[46m\u001b[30mstimulated cells\u001b[0m blocks the function\n",
      "\n",
      "('unstimulated', 'pma-')\n",
      "dical scavenging in \u001b[46m\u001b[30munstimulated\u001b[0m and PMA- or TNF-\u001b[46m\u001b[30mstimulated cells\u001b[0m blocks the function\n",
      "\n",
      "('unstimulated', 'or')\n",
      "dical scavenging in \u001b[46m\u001b[30munstimulated\u001b[0m and PMA- or TNF-\u001b[46m\u001b[30mstimulated cells\u001b[0m blocks the function\n",
      "\n",
      "('carcinoma', 'lymphoid')\n",
      "a B protein in both \u001b[46m\u001b[30mcarcinoma\u001b[0m and lymphoid \u001b[46m\u001b[30mcells\u001b[0m by two mechanisms: \n",
      "\n",
      "('t', 'proliferation')\n",
      "are not involved in \u001b[46m\u001b[30mhuman\u001b[0m T or \u001b[46m\u001b[30mB cell\u001b[0m activation and \u001b[46m\u001b[30mproliferation\u001b[0m. The involvement of\n",
      "\n",
      "('oct', 'ets')\n",
      "un, Fos, NF-kappaB, \u001b[46m\u001b[30mOct\u001b[0m or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n",
      "('tcr-alpha', 'cd3-epsilon')\n",
      "ional motifs in the \u001b[46m\u001b[30mTCR-alpha\u001b[0m and CD3-epsilon \u001b[46m\u001b[30menhancers\u001b[0m imply an important \n",
      "\n",
      "('viral', 'immune')\n",
      "pa B in response to \u001b[46m\u001b[30mviral\u001b[0m and immune \u001b[46m\u001b[30mstimuli\u001b[0m.\n",
      "\n",
      "('transcription', 'expression')\n",
      "hat is dependent on \u001b[46m\u001b[30mFasL\u001b[0m transcription and \u001b[46m\u001b[30mexpression\u001b[0m. Here we demonstrat\n",
      "Comparison of \u001b[46m\u001b[30mHTLV-I\u001b[0m basal transcription and \u001b[46m\u001b[30mexpression\u001b[0m of CREB/ATF-1/CREM \n",
      "\n",
      "('vp16', 'e1a')\n",
      "ntaining the potent \u001b[46m\u001b[30mVP16\u001b[0m and E1A \u001b[46m\u001b[30mviral transactivation domains\u001b[0m in place of the GR \n",
      "\n",
      "('dna-', 'the')\n",
      "eening assay of the \u001b[46m\u001b[30mDNA-\u001b[0m and the steroid\u001b[46m\u001b[30m-binding region\u001b[0m, none of the treate\n",
      "\n",
      "('dna-', 'steroid')\n",
      "eening assay of the \u001b[46m\u001b[30mDNA-\u001b[0m and the steroid\u001b[46m\u001b[30m-binding region\u001b[0m, none of the treate\n",
      "\n",
      "('d3-', 'acid-')\n",
      "\u001b[46m\u001b[30mVitamin D3-\u001b[0m and retinoic acid-\u001b[46m\u001b[30minduced monocytic differentiation\u001b[0m: interactions betwe\n",
      "\n",
      "('d3-', 'retinoic')\n",
      "\u001b[46m\u001b[30mVitamin D3-\u001b[0m and retinoic acid-\u001b[46m\u001b[30minduced monocytic differentiation\u001b[0m: interactions betwe\n",
      "\n",
      "(')', 'htlv-ii')\n",
      "I tax proteins. The \u001b[46m\u001b[30mhuman T-cell leukemia virus type I (HTLV-I)\u001b[0m and HTLV-II \u001b[46m\u001b[30mTax proteins\u001b[0m are potent transact\n",
      "\n",
      "('n', 'c')\n",
      "gen receptor to the \u001b[46m\u001b[30mN\u001b[0m or C \u001b[46m\u001b[30mterminus\u001b[0m of EBNA2. In promot\n",
      "tion domains at the \u001b[46m\u001b[30mN\u001b[0m and the C \u001b[46m\u001b[30mtermini\u001b[0m. The transcriptiona\n",
      "\n",
      "(',', '6')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, 4, and \u001b[46m\u001b[30m6 genes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, 4, and \u001b[46m\u001b[30m6 genes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, 4, and \u001b[46m\u001b[30m6 genes\u001b[0m. Electrophoretic mo\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "\n",
      "('4', '6')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, 4, and \u001b[46m\u001b[30m6 genes\u001b[0m. Electrophoretic mo\n",
      "blastoma protein by \u001b[46m\u001b[30mcyclin-dependent kinases\u001b[0m 4 and \u001b[46m\u001b[30m6\u001b[0m prevents its intera\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "6, the inhibitor of \u001b[46m\u001b[30mcyclin-dependent-kinase-\u001b[0m4 and \u001b[46m\u001b[30m6\u001b[0m, in tumorigenesis i\n",
      "\n",
      "('2', '6')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, 4, and \u001b[46m\u001b[30m6 genes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins 2\u001b[0m, 3, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "\n",
      "('3', '6')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, 4, and \u001b[46m\u001b[30m6 genes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "ited by addition of \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 3 and \u001b[46m\u001b[30m6\u001b[0m, suggesting that th\n",
      "\n",
      "('ets', 'sp1')\n",
      "NA, tandem pairs of \u001b[46m\u001b[30mEts\u001b[0m and SP1 \u001b[46m\u001b[30mmotifs\u001b[0m, and a lone C/EBP m\n",
      "\n",
      "('antiproliferative', 'differentiate')\n",
      "(OH)2D3) acts as an \u001b[46m\u001b[30mantiproliferative\u001b[0m and differentiating \u001b[46m\u001b[30magent\u001b[0m for the monoblastoi\n",
      "\n",
      "('recombinant', '-m2')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('mouse', '-m2')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('-h2', 'protein')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant human nm23-H1\u001b[0m, -H2, mouse nm23-M1, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('human', 'protein')\n",
      "ls was inhibited by \u001b[46m\u001b[30mrecombinant\u001b[0m human nm23-H1, -H2, \u001b[46m\u001b[30mmouse nm23-M1\u001b[0m, and -M2 \u001b[46m\u001b[30mproteins\u001b[0m. Moreover, both the\n",
      "\n",
      "('nh2-', 'cooh-')\n",
      "n reveals that both \u001b[46m\u001b[30mNH2-\u001b[0m and COOH-\u001b[46m\u001b[30mterminal domains\u001b[0m of BOB.1/OBF.1 cont\n",
      "\n",
      "('oct', 'transcription')\n",
      "tivity and contains \u001b[46m\u001b[30mSP1\u001b[0m, ETS, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "y and contains SP1, \u001b[46m\u001b[30mETS\u001b[0m, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "\n",
      "('sp1', 'ikaros/lyf-1')\n",
      "tivity and contains \u001b[46m\u001b[30mSP1\u001b[0m, ETS, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "\n",
      "('ets', 'transcription')\n",
      "tivity and contains \u001b[46m\u001b[30mSP1\u001b[0m, ETS, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "\n",
      "('distal', 'proximal')\n",
      "ne transcription at \u001b[46m\u001b[30mdistal\u001b[0m and proximal \u001b[46m\u001b[30mpromoter elements\u001b[0m.\n",
      "\n",
      "('p46', 'p54')\n",
      "d activation of the \u001b[46m\u001b[30mp46\u001b[0m and p54 \u001b[46m\u001b[30misoforms\u001b[0m of JNK. Treatment w\n",
      "\n",
      "(')', 'cell-associated')\n",
      "the coexpression of \u001b[46m\u001b[30mmyeloid (CD33, CD13, CD15)\u001b[0m and NK cell-associated (CD56) \u001b[46m\u001b[30mantigens\u001b[0m in each case, where\n",
      "\n",
      "(')', 'nk')\n",
      "the coexpression of \u001b[46m\u001b[30mmyeloid (CD33, CD13, CD15)\u001b[0m and NK cell-associated (CD56) \u001b[46m\u001b[30mantigens\u001b[0m in each case, where\n",
      "\n",
      "(')', 'cd56')\n",
      "the coexpression of \u001b[46m\u001b[30mmyeloid (CD33, CD13, CD15)\u001b[0m and NK cell-associated (CD56) \u001b[46m\u001b[30mantigens\u001b[0m in each case, where\n",
      "\n",
      "('heavy', 'light')\n",
      "he visualization of \u001b[46m\u001b[30mheavy\u001b[0m and light \u001b[46m\u001b[30mchain genes\u001b[0m in B-lymphoid cells\n",
      "motif found in both \u001b[46m\u001b[30mheavy\u001b[0m and kappa light \u001b[46m\u001b[30mchain enhancers\u001b[0m. The complementary \n",
      "if. Activity of the \u001b[46m\u001b[30mimmunoglobulin heavy\u001b[0m and kappa light \u001b[46m\u001b[30mchain gene enhancers\u001b[0m depends on a comple\n",
      "\n",
      "('ap-1-', 'binding')\n",
      "t cooperation among \u001b[46m\u001b[30mNF-kappa B-\u001b[0m, AP-1- and NF-AT-\u001b[46m\u001b[30mbinding sequences\u001b[0m is required for ind\n",
      "\n",
      "('b-', 'nf-at-')\n",
      "t cooperation among \u001b[46m\u001b[30mNF-kappa B-\u001b[0m, AP-1- and NF-AT-\u001b[46m\u001b[30mbinding sequences\u001b[0m is required for ind\n",
      "\n",
      "(',', 'binding')\n",
      "t cooperation among \u001b[46m\u001b[30mNF-kappa B-\u001b[0m, AP-1- and NF-AT-\u001b[46m\u001b[30mbinding sequences\u001b[0m is required for ind\n",
      "\n",
      "('il-1beta', 'il-6')\n",
      "entrations of IL-2, \u001b[46m\u001b[30mIL-1beta\u001b[0m, and IL-6 \u001b[46m\u001b[30mmRNA\u001b[0m, and by the diminis\n",
      "\n",
      "('immunoblot', 'immunofluorescence')\n",
      "n, as determined by \u001b[46m\u001b[30mimmunoblot\u001b[0m and immunofluorescence \u001b[46m\u001b[30massays\u001b[0m. By contrast, the a\n",
      "\n",
      "('c-jun', 'nf')\n",
      "e expression c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "\n",
      "('c-jun', 'kappa')\n",
      "e expression c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, and NF kappa B \u001b[46m\u001b[30mmRNA\u001b[0m is in nucleated fet\n",
      "\n",
      "('ebv-positive', 'ebv-negative')\n",
      "characterization of \u001b[46m\u001b[30mEBV-positive\u001b[0m and EBV-negative \u001b[46m\u001b[30mprimary effusion lymphoma cell lines\u001b[0m harbouring human he\n",
      "receptor profile in \u001b[46m\u001b[30mEBV-positive\u001b[0m and EBV-negative \u001b[46m\u001b[30mBurkitt's lymphoma cell lines\u001b[0m, and these receptor\n",
      "\n",
      "('normal', 'malignant')\n",
      "man monocytes. Both \u001b[46m\u001b[30mnormal\u001b[0m and malignant \u001b[46m\u001b[30mcells\u001b[0m contain ganglioside\n",
      "\n",
      "('ul49', 'ul50')\n",
      "dUTPase, encoded by \u001b[46m\u001b[30mgenes\u001b[0m UL49 and \u001b[46m\u001b[30mUL50\u001b[0m, respectively, are \n",
      "\n",
      "('lymphocytic', 'glial')\n",
      " from cell lines of \u001b[46m\u001b[30mlymphocytic\u001b[0m, monocytic, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "\n",
      "('monocytic', 'cell')\n",
      " from cell lines of \u001b[46m\u001b[30mlymphocytic\u001b[0m, monocytic, neuronal, and glial \u001b[46m\u001b[30mcell origin\u001b[0m have demonstrated d\n",
      "\n",
      "('c-jun', 'jun-d')\n",
      "ter transfection of \u001b[46m\u001b[30mc-jun\u001b[0m, jun-B, or jun-D \u001b[46m\u001b[30mexpression vectors\u001b[0m, which augmented GR\n",
      "\n",
      "('e2f-1', 'dp-1')\n",
      "ss of the activity. \u001b[46m\u001b[30mE2F-1\u001b[0m and DP-1 \u001b[46m\u001b[30mmRNAs\u001b[0m were not detectable\n",
      "\n",
      "('lck/fyn-', 'zap-70-')\n",
      " two interconnected \u001b[46m\u001b[30mLck/Fyn-\u001b[0m or zap-70-\u001b[46m\u001b[30mdependent signaling pathways\u001b[0m. The tyrosine phosp\n",
      "\n",
      "('u937', 'hel')\n",
      "ls including HL-60, \u001b[46m\u001b[30mU937\u001b[0m, HEL/S, KU812F, K562, and HEL \u001b[46m\u001b[30mcells\u001b[0m. Native human eryth\n",
      "\n",
      "('4', 'gene')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins 2\u001b[0m, 3, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "\n",
      "('3', 'gene')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins 2\u001b[0m, 3, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "\n",
      "('tax-expressing', 'human')\n",
      "T cells, NF-AT1, in \u001b[46m\u001b[30mTax-expressing\u001b[0m and type I human T-cell leukemia virus-infected \u001b[46m\u001b[30mhuman T cells\u001b[0m. The tax gene produ\n",
      "\n",
      "('tax-expressing', 'leukemia')\n",
      "T cells, NF-AT1, in \u001b[46m\u001b[30mTax-expressing\u001b[0m and type I human T-cell leukemia virus-infected \u001b[46m\u001b[30mhuman T cells\u001b[0m. The tax gene produ\n",
      "\n",
      "('tax-expressing', 't-cell')\n",
      "T cells, NF-AT1, in \u001b[46m\u001b[30mTax-expressing\u001b[0m and type I human T-cell leukemia virus-infected \u001b[46m\u001b[30mhuman T cells\u001b[0m. The tax gene produ\n",
      "\n",
      "('tax-expressing', 'type')\n",
      "T cells, NF-AT1, in \u001b[46m\u001b[30mTax-expressing\u001b[0m and type I human T-cell leukemia virus-infected \u001b[46m\u001b[30mhuman T cells\u001b[0m. The tax gene produ\n",
      "\n",
      "('tax-expressing', 'virus-infected')\n",
      "T cells, NF-AT1, in \u001b[46m\u001b[30mTax-expressing\u001b[0m and type I human T-cell leukemia virus-infected \u001b[46m\u001b[30mhuman T cells\u001b[0m. The tax gene produ\n",
      "\n",
      "('tax-expressing', 'i')\n",
      "T cells, NF-AT1, in \u001b[46m\u001b[30mTax-expressing\u001b[0m and type I human T-cell leukemia virus-infected \u001b[46m\u001b[30mhuman T cells\u001b[0m. The tax gene produ\n",
      "\n",
      "('hemin-', 'erythropoietin-')\n",
      "e myb expression on \u001b[46m\u001b[30mhemin-\u001b[0m and erythropoietin- \u001b[46m\u001b[30minduced erythroid differentiation\u001b[0m of K562 cells. In o\n",
      "\n",
      "('antitumor', 'antiinfectious')\n",
      "l effects including \u001b[46m\u001b[30mantitumor\u001b[0m, antiinflammatory, and antiinfectious \u001b[46m\u001b[30mactivities\u001b[0m. Although its preci\n",
      "\n",
      "('antiinflammatory', 'activity')\n",
      "l effects including \u001b[46m\u001b[30mantitumor\u001b[0m, antiinflammatory, and antiinfectious \u001b[46m\u001b[30mactivities\u001b[0m. Although its preci\n",
      "\n",
      "('acid', 'lipid')\n",
      "e genes involved in \u001b[46m\u001b[30mfatty acid\u001b[0m and lipid \u001b[46m\u001b[30mmetabolism\u001b[0m. Recently, it was s\n",
      "\n",
      "('finger', 'pou')\n",
      "of the genes in the \u001b[46m\u001b[30mzinc finger\u001b[0m and POU \u001b[46m\u001b[30mfamilies\u001b[0m will lead to a bett\n",
      "\n",
      "('mua', 'mub')\n",
      "cise spacing of the \u001b[46m\u001b[30mmuA\u001b[0m and muB \u001b[46m\u001b[30melements\u001b[0m is due in part to a\n",
      "e core GGAAs of the \u001b[46m\u001b[30mmuA\u001b[0m and muB \u001b[46m\u001b[30msites\u001b[0m are separated by 30\n",
      "ncer containing the \u001b[46m\u001b[30mmuA\u001b[0m, muE3, and muB \u001b[46m\u001b[30msites\u001b[0m is transactivated b\n",
      "\n",
      "('nfatp', 'nfatc')\n",
      "ially targeted both \u001b[46m\u001b[30mNFATp\u001b[0m and NFATc \u001b[46m\u001b[30mfamily members\u001b[0m, inhibiting the tra\n",
      "\n",
      "('gamma', 'delta')\n",
      "characterization of \u001b[46m\u001b[30mPTF\u001b[0m gamma and \u001b[46m\u001b[30mdelta subunits\u001b[0m. Here we describe t\n",
      "characterization of \u001b[46m\u001b[30mPTF gamma\u001b[0m and delta \u001b[46m\u001b[30msubunits\u001b[0m. Here we describe t\n",
      "\n",
      "('gamma-', 'beta-')\n",
      " takes place in the \u001b[46m\u001b[30mgamma-\u001b[0m and beta-\u001b[46m\u001b[30mglobin gene promoters\u001b[0m, and that GT motifs\n",
      "\n",
      "('megakaryocytic', 'lineage')\n",
      "es specific for the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mastocytic/basophilic \u001b[46m\u001b[30mlineages\u001b[0m, we studied GATA-1 \n",
      "ferentiation of the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and basosophilic \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "\n",
      "('erythroid', 'mastocytic/basophilic')\n",
      "es specific for the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mastocytic/basophilic \u001b[46m\u001b[30mlineages\u001b[0m, we studied GATA-1 \n",
      "\n",
      "('oct-', 'nfatp/c-')\n",
      "mpassed overlapping \u001b[46m\u001b[30mOct-\u001b[0m and NFATp/c-\u001b[46m\u001b[30mbinding sites\u001b[0m, which functioned i\n",
      "\n",
      "('immunosuppressive', 'antiviral')\n",
      "evelopment of novel \u001b[46m\u001b[30mimmunosuppressive\u001b[0m and antiviral \u001b[46m\u001b[30mtherapies\u001b[0m.\n",
      "\n",
      "('b', 'creb')\n",
      "% decrease in AP-1, \u001b[46m\u001b[30mNF kappa B\u001b[0m, and CREB \u001b[46m\u001b[30mDNA binding\u001b[0m that was blocked by\n",
      "\n",
      "('cns', 'immune')\n",
      "ication in cells of \u001b[46m\u001b[30mCNS\u001b[0m and immune system \u001b[46m\u001b[30morigin\u001b[0m.\n",
      "\n",
      "('cns', 'system')\n",
      "ication in cells of \u001b[46m\u001b[30mCNS\u001b[0m and immune system \u001b[46m\u001b[30morigin\u001b[0m.\n",
      "\n",
      "('il-8', 'tnf-alpha')\n",
      "a, IL-1 beta, IL-6, \u001b[46m\u001b[30mIL-8\u001b[0m, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "(',', 'dfr')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('category', 'category')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('category', 'iii')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('vi', 'dfr')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('va', 'cell')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, VI and \u001b[46m\u001b[30mDFR\u001b[0m but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "(',', 'antibody')\n",
      "ce assays to detect \u001b[46m\u001b[30mred cell\u001b[0m, platelet and granulocyte \u001b[46m\u001b[30mantibodies\u001b[0m of potential clinic\n",
      "\n",
      "('platelet', 'antibody')\n",
      "ce assays to detect \u001b[46m\u001b[30mred cell\u001b[0m, platelet and granulocyte \u001b[46m\u001b[30mantibodies\u001b[0m of potential clinic\n",
      "\n",
      "('cell', 'granulocyte')\n",
      "ce assays to detect \u001b[46m\u001b[30mred cell\u001b[0m, platelet and granulocyte \u001b[46m\u001b[30mantibodies\u001b[0m of potential clinic\n",
      "e rapidly depressed \u001b[46m\u001b[30mperipheral white blood cell\u001b[0m and granulocyte \u001b[46m\u001b[30mcounts\u001b[0m. As expected, nearl\n",
      "\n",
      "('interleukin', 'interleukin')\n",
      "d catecholamines on \u001b[46m\u001b[30mhuman\u001b[0m interleukin-12 and \u001b[46m\u001b[30minterleukin-10 production\u001b[0m: clinical implicati\n",
      "\n",
      "('biochemical', 'mutagenesis')\n",
      "ull function. Using \u001b[46m\u001b[30mbiochemical\u001b[0m and mutagenesis \u001b[46m\u001b[30manalyses\u001b[0m, we determined that\n",
      "\n",
      "('xp-b', 'xp-d')\n",
      "racts prepared from \u001b[46m\u001b[30mXP-B\u001b[0m and XP-D \u001b[46m\u001b[30mlymphoblastoid cells\u001b[0m exhibited similar t\n",
      "linical symptoms in \u001b[46m\u001b[30mXP-B\u001b[0m or XP-D \u001b[46m\u001b[30mpatients\u001b[0m, and discuss a 'con\n",
      "ate was normal, the \u001b[46m\u001b[30mXP-B\u001b[0m and XP-D \u001b[46m\u001b[30mcells\u001b[0m contained reduced a\n",
      "e conclude that the \u001b[46m\u001b[30mXP-B\u001b[0m and XP-D \u001b[46m\u001b[30mlymphoblastoid cells\u001b[0m do not have impaire\n",
      "\n",
      "('nf-at', 'motif')\n",
      "L-2 promoter or its \u001b[46m\u001b[30mAP-1\u001b[0m, NF-AT, and NF-kB \u001b[46m\u001b[30mmotifs\u001b[0m. Dex inhibited the \n",
      "\n",
      "('il-1beta', 'mrna')\n",
      "e concentrations of \u001b[46m\u001b[30mIL-2\u001b[0m, IL-1beta, and IL-6 \u001b[46m\u001b[30mmRNA\u001b[0m, and by the diminis\n",
      "\n",
      "('il-2', 'il-6')\n",
      "e concentrations of \u001b[46m\u001b[30mIL-2\u001b[0m, IL-1beta, and IL-6 \u001b[46m\u001b[30mmRNA\u001b[0m, and by the diminis\n",
      "\n",
      "('primary', 'secondary')\n",
      " from patients with \u001b[46m\u001b[30mprimary\u001b[0m and secondary \u001b[46m\u001b[30mhyperparathyroidism\u001b[0m. A decreased number\n",
      "IL-10 and IL-13, in \u001b[46m\u001b[30mprimary\u001b[0m and secondary \u001b[46m\u001b[30mstimulations\u001b[0m of spleen cells in \n",
      "e potent APC during \u001b[46m\u001b[30mprimary\u001b[0m and secondary \u001b[46m\u001b[30mimmune responses\u001b[0m. The first objectiv\n",
      "\n",
      "('tpa-', 'okadaic')\n",
      "n of pp70S6K during \u001b[46m\u001b[30mTPA-\u001b[0m or okadaic acid-\u001b[46m\u001b[30minduced monocytic differentiation\u001b[0m. Moreover, rapamyci\n",
      "\n",
      "('tpa-', 'acid-')\n",
      "n of pp70S6K during \u001b[46m\u001b[30mTPA-\u001b[0m or okadaic acid-\u001b[46m\u001b[30minduced monocytic differentiation\u001b[0m. Moreover, rapamyci\n",
      "\n",
      "('hl-60', 'hel/s')\n",
      " differentiation of \u001b[46m\u001b[30mHL-60\u001b[0m, U937 and HEL/S \u001b[46m\u001b[30mcells\u001b[0m. The erythroid diff\n",
      "\n",
      "('p65', 'c-rel')\n",
      "ations suggest that \u001b[46m\u001b[30mp65\u001b[0m and c-Rel \u001b[46m\u001b[30mcomplexes\u001b[0m play distinct roles\n",
      "ssociation with the \u001b[46m\u001b[30mp65\u001b[0m or c-Rel \u001b[46m\u001b[30msubunits\u001b[0m. In addition, we ha\n",
      "s from the medulla. \u001b[46m\u001b[30mp65\u001b[0m, p50, and c-Rel \u001b[46m\u001b[30mactivities\u001b[0m were found in both \n",
      "ve. We next studied \u001b[46m\u001b[30mp65\u001b[0m and c-Rel \u001b[46m\u001b[30mprotein expression\u001b[0m in FDC clusters. p6\n",
      "\n",
      "('b', 'stat')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', 'signal')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', 'transcription')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', ')')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', 'and')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', 'of')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', 'transducer')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('b', '(')\n",
      "RA did not activate \u001b[46m\u001b[30mnuclear factor kappa B\u001b[0m or signal transducer and activator of transcription (STAT) \u001b[46m\u001b[30mactivation pathways\u001b[0m, suggesting that an\n",
      "\n",
      "('dimerization', 'binding')\n",
      " located within the \u001b[46m\u001b[30mdimerization\u001b[0m and DNA binding \u001b[46m\u001b[30mdomains\u001b[0m of c-Jun and c-Fos.\n",
      "\n",
      "('dimerization', 'dna')\n",
      " located within the \u001b[46m\u001b[30mdimerization\u001b[0m and DNA binding \u001b[46m\u001b[30mdomains\u001b[0m of c-Jun and c-Fos.\n",
      "\n",
      "('latently', 'acutely')\n",
      "activate HIV-1 from \u001b[46m\u001b[30mlatently\u001b[0m and acutely \u001b[46m\u001b[30minfected cells\u001b[0m of monocyte/macroph\n",
      "\n",
      "('specific', 'hla-dr-restricted')\n",
      "tinal mucosa. Using \u001b[46m\u001b[30mtetanus toxoid specific\u001b[0m and HLA-DR-restricted \u001b[46m\u001b[30mT lymphocytes\u001b[0m, we show that polar\n",
      "\n",
      "('granulocytic', 'monocytic')\n",
      " the development of \u001b[46m\u001b[30mgranulocytic\u001b[0m and monocytic \u001b[46m\u001b[30mlineages\u001b[0m, transcription fact\n",
      "n capable of either \u001b[46m\u001b[30mgranulocytic\u001b[0m or monocytic \u001b[46m\u001b[30mdifferentiation\u001b[0m after induction wit\n",
      "\n",
      "('antigen', 'cytokine')\n",
      "hose initiated from \u001b[46m\u001b[30mantigen\u001b[0m and cytokine \u001b[46m\u001b[30mreceptors\u001b[0m. In contrast, intro\n",
      "\n",
      "('amino-', 'carboxy-')\n",
      "that generate novel \u001b[46m\u001b[30mamino-\u001b[0m or carboxy-\u001b[46m\u001b[30mterminal sequences\u001b[0m. An isoform lacking\n",
      "\n",
      "('tf', 'other')\n",
      "to induction of the \u001b[46m\u001b[30mTF\u001b[0m and other inflammatory \u001b[46m\u001b[30mgenes\u001b[0m. Enhancement of exp\n",
      "\n",
      "('tf', 'inflammatory')\n",
      "to induction of the \u001b[46m\u001b[30mTF\u001b[0m and other inflammatory \u001b[46m\u001b[30mgenes\u001b[0m. Enhancement of exp\n",
      "\n",
      "('t', 'to')\n",
      "oliferation of both \u001b[46m\u001b[30mT\u001b[0m and, to a lesser extent, B \u001b[46m\u001b[30mcells\u001b[0m. The percentage of \n",
      "\n",
      "('t', ',')\n",
      "oliferation of both \u001b[46m\u001b[30mT\u001b[0m and, to a lesser extent, B \u001b[46m\u001b[30mcells\u001b[0m. The percentage of \n",
      "oliferation of both \u001b[46m\u001b[30mT\u001b[0m and, to a lesser extent, B \u001b[46m\u001b[30mcells\u001b[0m. The percentage of \n",
      "\n",
      "('t', 'less')\n",
      "oliferation of both \u001b[46m\u001b[30mT\u001b[0m and, to a lesser extent, B \u001b[46m\u001b[30mcells\u001b[0m. The percentage of \n",
      "\n",
      "('t', 'extent')\n",
      "oliferation of both \u001b[46m\u001b[30mT\u001b[0m and, to a lesser extent, B \u001b[46m\u001b[30mcells\u001b[0m. The percentage of \n",
      "\n",
      "('t', 'a')\n",
      "oliferation of both \u001b[46m\u001b[30mT\u001b[0m and, to a lesser extent, B \u001b[46m\u001b[30mcells\u001b[0m. The percentage of \n",
      "\n",
      "('x1-', 'x2-')\n",
      " X-box, or only the \u001b[46m\u001b[30mX1-\u001b[0m or X2-\u001b[46m\u001b[30mboxes\u001b[0m of HLA-DRA were rep\n",
      "\n",
      "('ets', 'ikaros/lyf-1')\n",
      "y and contains SP1, \u001b[46m\u001b[30mETS\u001b[0m, OCT, and IKAROS/LYF-1 \u001b[46m\u001b[30mtranscription factor motifs\u001b[0m. All these motifs a\n",
      "\n",
      "('quiescent', 'stimulate')\n",
      "associated genes in \u001b[46m\u001b[30mquiescent\u001b[0m and stimulated \u001b[46m\u001b[30mcells\u001b[0m. We show that the e\n",
      "\n",
      "('megakaryocytic', 'cell')\n",
      "is expressed in the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and mast \u001b[46m\u001b[30mcell lineages\u001b[0m during normal hemat\n",
      "\n",
      "('myeloid', 'b')\n",
      "nantly expressed in \u001b[46m\u001b[30mmyeloid\u001b[0m and B \u001b[46m\u001b[30mcells\u001b[0m, activates many B c\n",
      "demonstrate that in \u001b[46m\u001b[30mmyeloid\u001b[0m and B cell \u001b[46m\u001b[30mextracts\u001b[0m, PU.1 forms a novel\n",
      "\n",
      "('follicular', 'luteal')\n",
      "asured, in both the \u001b[46m\u001b[30mfollicular\u001b[0m and luteal \u001b[46m\u001b[30mphases\u001b[0m of the menstrual cy\n",
      "\n",
      "(',', 'tyrosine')\n",
      "ling molecules. The \u001b[46m\u001b[30mJak1\u001b[0m, Jak2, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "ling molecules. The \u001b[46m\u001b[30mJak1\u001b[0m, Jak2, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "ling molecules. The \u001b[46m\u001b[30mJak1\u001b[0m, Jak2, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "olecules. The Jak1, \u001b[46m\u001b[30mJak2\u001b[0m, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "olecules. The Jak1, \u001b[46m\u001b[30mJak2\u001b[0m, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "es. The Jak1, Jak2, \u001b[46m\u001b[30mJak3\u001b[0m, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "\n",
      "('jak2', 'tyrosine')\n",
      "ling molecules. The \u001b[46m\u001b[30mJak1\u001b[0m, Jak2, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "\n",
      "('jak1', 'fe')\n",
      "ling molecules. The \u001b[46m\u001b[30mJak1\u001b[0m, Jak2, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "\n",
      "('jak3', 'tyrosine')\n",
      "ling molecules. The \u001b[46m\u001b[30mJak1\u001b[0m, Jak2, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "olecules. The Jak1, \u001b[46m\u001b[30mJak2\u001b[0m, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "\n",
      "('basal', 'expression')\n",
      "Comparison of \u001b[46m\u001b[30mHTLV-I\u001b[0m basal transcription and \u001b[46m\u001b[30mexpression\u001b[0m of CREB/ATF-1/CREM \n",
      "\n",
      "('camp', 'camp-phosphodiesterase')\n",
      " AD and findings of \u001b[46m\u001b[30mabnormal cAMP\u001b[0m and cAMP-phosphodiesterase \u001b[46m\u001b[30mactivity\u001b[0m, the elevated GR co\n",
      " AD and findings of \u001b[46m\u001b[30mabnormal\u001b[0m cAMP and \u001b[46m\u001b[30mcAMP-phosphodiesterase activity\u001b[0m, the elevated GR co\n",
      "\n",
      "(',', 'alpha')\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not \u001b[46m\u001b[30malpha\u001b[0m or beta, induces ma\n",
      "\n",
      "('interferon', 'not')\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not \u001b[46m\u001b[30malpha\u001b[0m or beta, induces ma\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not alpha or \u001b[46m\u001b[30mbeta\u001b[0m, induces maturation\n",
      "\n",
      "('gamma', 'alpha')\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not \u001b[46m\u001b[30malpha\u001b[0m or beta, induces ma\n",
      "\n",
      "('5', '7')\n",
      "R with deletions of \u001b[46m\u001b[30mexons\u001b[0m 2, 5 and \u001b[46m\u001b[30m7\u001b[0m. Variants with exon\n",
      "\n",
      "(',', '7')\n",
      "R with deletions of \u001b[46m\u001b[30mexons\u001b[0m 2, 5 and \u001b[46m\u001b[30m7\u001b[0m. Variants with exon\n",
      "\n",
      "('myelomonocytic', 'glia')\n",
      "gulatory element in \u001b[46m\u001b[30mmyelomonocytic\u001b[0m and glia \u001b[46m\u001b[30mcell lines\u001b[0m. In vivo protein-DN\n",
      "\n",
      "('ap-1', 'nf-il6')\n",
      "with a reduction of \u001b[46m\u001b[30mAP-1\u001b[0m and NF-IL6 \u001b[46m\u001b[30mbinding activity\u001b[0m whereas IL-10 only \n",
      "\n",
      "('cd2', 'cd25')\n",
      "ulated, whereas the \u001b[46m\u001b[30mCD2\u001b[0m and CD25 \u001b[46m\u001b[30mreceptors\u001b[0m are increased. When\n",
      "\n",
      "('allergic', 'disease')\n",
      "dividual to certain \u001b[46m\u001b[30mautoimmune\u001b[0m, allergic, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "\n",
      "('autoimmune', 'neoplastic')\n",
      "dividual to certain \u001b[46m\u001b[30mautoimmune\u001b[0m, allergic, infectious, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "\n",
      "(',', 'specific')\n",
      "OCA-B is a tissue-, \u001b[46m\u001b[30mpromoter-\u001b[0m, and factor-\u001b[46m\u001b[30mspecific coactivator\u001b[0m and that OCA-B may \n",
      "est that OCA-B is a \u001b[46m\u001b[30mtissue-\u001b[0m, promoter-, and factor-\u001b[46m\u001b[30mspecific coactivator\u001b[0m and that OCA-B may \n",
      "est that OCA-B is a \u001b[46m\u001b[30mtissue-\u001b[0m, promoter-, and factor-\u001b[46m\u001b[30mspecific coactivator\u001b[0m and that OCA-B may \n",
      "\n",
      "('promoter-', 'factor-')\n",
      "OCA-B is a tissue-, \u001b[46m\u001b[30mpromoter-\u001b[0m, and factor-\u001b[46m\u001b[30mspecific coactivator\u001b[0m and that OCA-B may \n",
      "\n",
      "('ap-1', 'nf-at')\n",
      "ranscription of its \u001b[46m\u001b[30mAP-1\u001b[0m and NF-AT \u001b[46m\u001b[30mtransactivating pathways\u001b[0m. Under the same con\n",
      "\n",
      "('protein', '6')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "\n",
      "('2', 'gene')\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, \u001b[46m\u001b[30m3\u001b[0m, 4, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "membrane protein-1, \u001b[46m\u001b[30mEBV nuclear proteins\u001b[0m 2, 3, \u001b[46m\u001b[30m4\u001b[0m, and 6 \u001b[46m\u001b[30mgenes\u001b[0m. Electrophoretic mo\n",
      "\n",
      "('0.6', '0.2')\n",
      "nts containing 1.3, \u001b[46m\u001b[30m0.6\u001b[0m, and 0.2 \u001b[46m\u001b[30mkb 5'-flanking DNA\u001b[0m were incrementally \n",
      "\n",
      "('cd11c', 'cd11b')\n",
      "n activation of the \u001b[46m\u001b[30mCD11c\u001b[0m and CD11b \u001b[46m\u001b[30mpromoters\u001b[0m in vivo.\n",
      "\n",
      "('atopic', 'nonatopic')\n",
      "ensive screening of \u001b[46m\u001b[30matopic\u001b[0m and nonatopic \u001b[46m\u001b[30mindividuals\u001b[0m and may provide a c\n",
      "\n",
      "('unstimulated', '13-acetate/phytohemagglutinin-stimulated')\n",
      "reporter plasmid in \u001b[46m\u001b[30munstimulated\u001b[0m and 12-O-tetradecanoylphorbol 13-acetate/phytohemagglutinin-stimulated \u001b[46m\u001b[30mhuman Jurkat T cells\u001b[0m. In contrast, the p\n",
      "\n",
      "('unstimulated', '12-o-tetradecanoylphorbol')\n",
      "reporter plasmid in \u001b[46m\u001b[30munstimulated\u001b[0m and 12-O-tetradecanoylphorbol 13-acetate/phytohemagglutinin-stimulated \u001b[46m\u001b[30mhuman Jurkat T cells\u001b[0m. In contrast, the p\n",
      "\n",
      "('epo', 'erythroid')\n",
      "GATA-1, response to \u001b[46m\u001b[30mEpo\u001b[0m and erythroid \u001b[46m\u001b[30mdifferentiation\u001b[0m, we analyzed the ex\n",
      "\n",
      "('lymphoid', 'pancreatic')\n",
      "dia is expressed in \u001b[46m\u001b[30mlymphoid\u001b[0m and pancreatic \u001b[46m\u001b[30mtissues\u001b[0m. A novel human home\n",
      "ne transcription in \u001b[46m\u001b[30mlymphoid\u001b[0m and pancreatic \u001b[46m\u001b[30mtissues\u001b[0m.\n",
      "\n",
      "('antiatherogenic', 'antiinflammatory')\n",
      "bute to some of its \u001b[46m\u001b[30mantiatherogenic\u001b[0m and antiinflammatory \u001b[46m\u001b[30mproperties\u001b[0m within the vessel w\n",
      "\n",
      "('ap-1', 'creb/atf')\n",
      "rs composed of both \u001b[46m\u001b[30mAP-1\u001b[0m and CREB/ATF \u001b[46m\u001b[30mproteins\u001b[0m. Copyright 1997 Aca\n",
      "\n",
      "('genistein', 'herbimycin')\n",
      "ly prevented by the \u001b[46m\u001b[30mprotein-tyrosine kinase inhibitors\u001b[0m genistein and \u001b[46m\u001b[30mherbimycin A\u001b[0m. Thus, tyrosine pho\n",
      "\n",
      "('p50', 'activity')\n",
      "s from the medulla. \u001b[46m\u001b[30mp65\u001b[0m, p50, and c-Rel \u001b[46m\u001b[30mactivities\u001b[0m were found in both \n",
      "\n",
      "('nf-e2', ',')\n",
      "4 demonstrated that \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem, inverted GATA \u001b[46m\u001b[30mbinding sites\u001b[0m are required for th\n",
      "\n",
      "('nf-e2', 'inverted')\n",
      "4 demonstrated that \u001b[46m\u001b[30mNF-E2\u001b[0m and tandem, inverted GATA \u001b[46m\u001b[30mbinding sites\u001b[0m are required for th\n",
      "\n",
      "('a', 'rp-camp-')\n",
      " occurred through a \u001b[46m\u001b[30mherbimycin A\u001b[0m and Rp-cAMP- \u001b[46m\u001b[30msensitive pathway\u001b[0m, suggesting phospho\n",
      "\n",
      "('-', 'il-3')\n",
      "at it can stimulate \u001b[46m\u001b[30mgranulocyte-macrophage colony-stimulating factor (GM-CSF)-\u001b[0m or interleukin-3 (IL-3)-\u001b[46m\u001b[30minduced GM colony formation\u001b[0m, but potently inhib\n",
      "\n",
      "('-', 'interleukin-3')\n",
      "at it can stimulate \u001b[46m\u001b[30mgranulocyte-macrophage colony-stimulating factor (GM-CSF)-\u001b[0m or interleukin-3 (IL-3)-\u001b[46m\u001b[30minduced GM colony formation\u001b[0m, but potently inhib\n",
      "\n",
      "('stat1', 'protein')\n",
      "omycin D. Increased \u001b[46m\u001b[30mStat1\u001b[0m and Stat3 mRNA and protein \u001b[46m\u001b[30mlevels\u001b[0m were detected, resp\n",
      "\n",
      "('stat3', 'level')\n",
      "omycin D. Increased \u001b[46m\u001b[30mStat1\u001b[0m and Stat3 mRNA and protein \u001b[46m\u001b[30mlevels\u001b[0m were detected, resp\n",
      "\n",
      "('mrna', 'level')\n",
      "omycin D. Increased \u001b[46m\u001b[30mStat1\u001b[0m and Stat3 mRNA and protein \u001b[46m\u001b[30mlevels\u001b[0m were detected, resp\n",
      "Increased Stat1 and \u001b[46m\u001b[30mStat3\u001b[0m mRNA and protein \u001b[46m\u001b[30mlevels\u001b[0m were detected, resp\n",
      "\n",
      "('and', 'level')\n",
      "omycin D. Increased \u001b[46m\u001b[30mStat1\u001b[0m and Stat3 mRNA and protein \u001b[46m\u001b[30mlevels\u001b[0m were detected, resp\n",
      "\n",
      "('p1', 'p9')\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      "\n",
      "('p4', 'p9')\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      "\n",
      "('p7', 'p9')\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      "\n",
      "('p6', 'p9')\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      "\n",
      "(',', 'p9')\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      " 437, 438, and 440 (\u001b[46m\u001b[30mposition\u001b[0m P1, P4, P6, P7, and \u001b[46m\u001b[30mP9\u001b[0m) contributed to DQ2\n",
      "\n",
      "('lymphocytic', 'mononuclear')\n",
      "ected cells of both \u001b[46m\u001b[30mT lymphocytic\u001b[0m and mononuclear phagocytic \u001b[46m\u001b[30mlineage\u001b[0m. Activated mononucl\n",
      "\n",
      "('lymphocytic', 'phagocytic')\n",
      "ected cells of both \u001b[46m\u001b[30mT lymphocytic\u001b[0m and mononuclear phagocytic \u001b[46m\u001b[30mlineage\u001b[0m. Activated mononucl\n",
      "\n",
      "('glucocorticoid-', 'fas-')\n",
      "tease inhibitors on \u001b[46m\u001b[30mglucocorticoid-\u001b[0m and Fas-\u001b[46m\u001b[30mmediated cytotoxicity\u001b[0m. Fas-mediated apopt\n",
      "\n",
      "('humoral', 'cell')\n",
      "riety of effects on \u001b[46m\u001b[30mhumoral\u001b[0m and cell mediated \u001b[46m\u001b[30mimmune responses\u001b[0m. The underlying mol\n",
      "\n",
      "('humoral', 'mediated')\n",
      "riety of effects on \u001b[46m\u001b[30mhumoral\u001b[0m and cell mediated \u001b[46m\u001b[30mimmune responses\u001b[0m. The underlying mol\n",
      "\n",
      "('cd44', 'factor')\n",
      " the interleukin-2, \u001b[46m\u001b[30mCD44\u001b[0m, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('cd44', 'necrosis')\n",
      " the interleukin-2, \u001b[46m\u001b[30mCD44\u001b[0m, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "('cd44', 'tumor')\n",
      " the interleukin-2, \u001b[46m\u001b[30mCD44\u001b[0m, ICAM-1, and tumor necrosis factor \u001b[46m\u001b[30mgenes\u001b[0m. The role of egr-1 \n",
      "\n",
      "(')', 'il-4')\n",
      " well described for \u001b[46m\u001b[30minterleukin-2 (IL-2)\u001b[0m and IL-4 \u001b[46m\u001b[30mgene transcription\u001b[0m in T cells. Costimu\n",
      "\n",
      "('c-jun-', 'gst-pi-')\n",
      "n was found between \u001b[46m\u001b[30mc-Jun-\u001b[0m and GST-pi-\u001b[46m\u001b[30mpositive plasma cells\u001b[0m. The expression of \n",
      "\n",
      "(')', 'high')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "\n",
      "(')', 'capacity')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "\n",
      "(')', ',')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "\n",
      "(')', 'ii')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "r alpha subunit and \u001b[46m\u001b[30mtumor necrosis factor (TNF) receptors\u001b[0m I (p55) and \u001b[46m\u001b[30mII (p75)\u001b[0m were also detected \n",
      "\n",
      "(')', 'low')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "\n",
      "(')', 'affinity')\n",
      "ate the presence of \u001b[46m\u001b[30mestrogen type I (high affinity, low capacity)\u001b[0m and type II (low affinity, high capacity) \u001b[46m\u001b[30mbinding sites\u001b[0m in human peripheral\n",
      "\n",
      "('heavy', 'kappa')\n",
      "motif found in both \u001b[46m\u001b[30mheavy\u001b[0m and kappa light \u001b[46m\u001b[30mchain enhancers\u001b[0m. The complementary \n",
      "if. Activity of the \u001b[46m\u001b[30mimmunoglobulin heavy\u001b[0m and kappa light \u001b[46m\u001b[30mchain gene enhancers\u001b[0m depends on a comple\n",
      "if. Activity of the \u001b[46m\u001b[30mimmunoglobulin\u001b[0m heavy and \u001b[46m\u001b[30mkappa light chain gene enhancers\u001b[0m depends on a comple\n",
      "\n",
      "('g1', 's')\n",
      " by PRL during both \u001b[46m\u001b[30mG1\u001b[0m and S \u001b[46m\u001b[30mphase\u001b[0m of the cell cycle. \n",
      "ve elements mediate \u001b[46m\u001b[30mG1\u001b[0m and S \u001b[46m\u001b[30mphase expression\u001b[0m of the interferon r\n",
      "\n",
      "(',', 'box')\n",
      "ctamer site and the \u001b[46m\u001b[30mY\u001b[0m, X1, and X2 \u001b[46m\u001b[30mboxes\u001b[0m. Class II antigen e\n",
      "ctamer site and the \u001b[46m\u001b[30mY\u001b[0m, X1, and X2 \u001b[46m\u001b[30mboxes\u001b[0m. Class II antigen e\n",
      "mer site and the Y, \u001b[46m\u001b[30mX1\u001b[0m, and X2 \u001b[46m\u001b[30mboxes\u001b[0m. Class II antigen e\n",
      "\n",
      "('x1', 'box')\n",
      "ctamer site and the \u001b[46m\u001b[30mY\u001b[0m, X1, and X2 \u001b[46m\u001b[30mboxes\u001b[0m. Class II antigen e\n",
      "\n",
      "('y', 'x2')\n",
      "ctamer site and the \u001b[46m\u001b[30mY\u001b[0m, X1, and X2 \u001b[46m\u001b[30mboxes\u001b[0m. Class II antigen e\n",
      "\n",
      "('and', 'cell')\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "\n",
      "('tam-treated', 'cell')\n",
      "d lysis of control, \u001b[46m\u001b[30mE2-treated\u001b[0m, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "\n",
      "(')', 'beta')\n",
      "ptional activity of \u001b[46m\u001b[30mcore binding factor-\u001b[0malpha (AML1) and \u001b[46m\u001b[30mbeta\u001b[0m subunits on murine \n",
      "\n",
      "('(', 'beta')\n",
      "ptional activity of \u001b[46m\u001b[30mcore binding factor-\u001b[0malpha (AML1) and \u001b[46m\u001b[30mbeta\u001b[0m subunits on murine \n",
      "\n",
      "('tata', 'a')\n",
      "gene lacks either a \u001b[46m\u001b[30mTATA\u001b[0m or a CAAT \u001b[46m\u001b[30mbox\u001b[0m and transcription i\n",
      "\n",
      "('-', 'sp1')\n",
      "nce they affect the \u001b[46m\u001b[30mnuclear factor kappa B (NF-kappa B)-\u001b[0m and Sp1\u001b[46m\u001b[30m-binding sites\u001b[0m and were expected t\n",
      "\n",
      "('u1b', 'u2')\n",
      " Sp3 is involved in \u001b[46m\u001b[30mU1B\u001b[0m and U2 \u001b[46m\u001b[30mformation\u001b[0m. EMS analyses perfo\n",
      "\n",
      "('recombinant', 'nuclear')\n",
      "tion by GM3 blocked \u001b[46m\u001b[30mrecombinant\u001b[0m and nuclear \u001b[46m\u001b[30mNF-kappaB proteins\u001b[0m binding to the GM-C\n",
      "\n",
      "('htlv-i', 'type')\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('atl-1k', 'type')\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('s-lb1', 'type')\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('mt-2', 'type')\n",
      "lines infected with \u001b[46m\u001b[30mhuman T-cell leukemia virus\u001b[0m type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and \u001b[46m\u001b[30mtype II (Mo)\u001b[0m. Another unexpected\n",
      "\n",
      "('myeloperoxidase', 'cd34')\n",
      "d repression of the \u001b[46m\u001b[30mmyeloperoxidase\u001b[0m and CD34 \u001b[46m\u001b[30mgenes\u001b[0m. Moreover, DEM abol\n",
      "\n",
      "('eu', 'thyroid')\n",
      "ol/microgram RNA in \u001b[46m\u001b[30mhypo\u001b[0m-, eu -and hyper\u001b[46m\u001b[30mthyroid patients\u001b[0m, respectively, corr\n",
      "\n",
      "(',', 'thyroid')\n",
      "ol/microgram RNA in \u001b[46m\u001b[30mhypo\u001b[0m-, eu -and hyper\u001b[46m\u001b[30mthyroid patients\u001b[0m, respectively, corr\n",
      "\n",
      "('unstimulated', 'lps-stimulated')\n",
      "eterodimers in both \u001b[46m\u001b[30munstimulated\u001b[0m and LPS-stimulated \u001b[46m\u001b[30mcells\u001b[0m. Maximal LPS induct\n",
      "\n",
      "('cd4(+)', 'cd8(+)')\n",
      "the surface of both \u001b[46m\u001b[30mCD4(+)\u001b[0m and CD8(+) \u001b[46m\u001b[30msubsets\u001b[0m of T cells are dire\n",
      "\n",
      "('il-12', 'b7.1')\n",
      "mor cells with both \u001b[46m\u001b[30mIL-12\u001b[0m and B7.1 \u001b[46m\u001b[30mcDNAs\u001b[0m, it may be possible\n",
      "\n",
      "('lps-free', 'serum-free')\n",
      "ding protein. Using \u001b[46m\u001b[30mLPS-free\u001b[0m and serum-free \u001b[46m\u001b[30mconditions\u001b[0m, constitutive NF-ka\n",
      "\n",
      "('ap2', 'sp1')\n",
      "istence of multiple \u001b[46m\u001b[30mAP2\u001b[0m and Sp1 \u001b[46m\u001b[30mbinding sites\u001b[0m in the 5'-untransla\n",
      "\n",
      "('tetra-', 'hexasaccharide')\n",
      "2/CD43 bore complex \u001b[46m\u001b[30msialylated tetra-\u001b[0m and hexasaccharide \u001b[46m\u001b[30mchains\u001b[0m. Treatment with sol\n",
      "\n",
      "('otf-1', 'nf-kappa')\n",
      "esponse: CREB, CTF, \u001b[46m\u001b[30mOTF-1\u001b[0m, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('otf-1', 'b')\n",
      "esponse: CREB, CTF, \u001b[46m\u001b[30mOTF-1\u001b[0m, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('tat-', 'mitogen-')\n",
      "rnatants to inhibit \u001b[46m\u001b[30mTat-\u001b[0m or mitogen-\u001b[46m\u001b[30mmediated LTR transcription\u001b[0m. However, the respo\n",
      "\n",
      "('n-terminal', 'stat1')\n",
      "tly with Stat1 (via \u001b[46m\u001b[30mE1A N-terminal\u001b[0m and Stat1 C-terminal \u001b[46m\u001b[30mresidues\u001b[0m) and block IFNgamma\n",
      "\n",
      "('n-terminal', 'c-terminal')\n",
      "tly with Stat1 (via \u001b[46m\u001b[30mE1A N-terminal\u001b[0m and Stat1 C-terminal \u001b[46m\u001b[30mresidues\u001b[0m) and block IFNgamma\n",
      "\n",
      "('cd3', 'cd28')\n",
      "ross-linking of the \u001b[46m\u001b[30mCD3\u001b[0m and CD28 \u001b[46m\u001b[30mmolecules\u001b[0m on T lymphocytes re\n",
      " activation via the \u001b[46m\u001b[30mCD3\u001b[0m and CD28 \u001b[46m\u001b[30mreceptors\u001b[0m. Expression of the \n",
      "\n",
      "('fibroblastic', 'keratinocyte-derived')\n",
      " -and E7-expressing \u001b[46m\u001b[30mhuman fibroblastic\u001b[0m or keratinocyte-derived human \u001b[46m\u001b[30mcells\u001b[0m to be selectively k\n",
      "\n",
      "('fibroblastic', 'human')\n",
      " -and E7-expressing \u001b[46m\u001b[30mhuman fibroblastic\u001b[0m or keratinocyte-derived human \u001b[46m\u001b[30mcells\u001b[0m to be selectively k\n",
      "\n",
      "('g', 'z-29')\n",
      "y virus promoter by \u001b[46m\u001b[30mhuman herpesvirus 6 (HHV-6) strains\u001b[0m GS and \u001b[46m\u001b[30mZ-29\u001b[0m in primary human T \n",
      "\n",
      "('rest', 'activate')\n",
      " gene expression in \u001b[46m\u001b[30mresting\u001b[0m and activated \u001b[46m\u001b[30mT cells\u001b[0m.\n",
      "\n",
      "(')', '99-bp')\n",
      "cribe the effect of \u001b[46m\u001b[30m383-bp (delta383)\u001b[0m and 99-bp (delta99) \u001b[46m\u001b[30msequences\u001b[0m containing the PYBF\n",
      "\n",
      "(')', 'delta99')\n",
      "cribe the effect of \u001b[46m\u001b[30m383-bp (delta383)\u001b[0m and 99-bp (delta99) \u001b[46m\u001b[30msequences\u001b[0m containing the PYBF\n",
      "\n",
      "('only', 'but')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also \u001b[46m\u001b[30mconstitutive\u001b[0m, HIV-enhancer activ\n",
      "\n",
      "('only', ',')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also \u001b[46m\u001b[30mconstitutive\u001b[0m, HIV-enhancer activ\n",
      "\n",
      "('only', 'induced')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also \u001b[46m\u001b[30mconstitutive\u001b[0m, HIV-enhancer activ\n",
      "\n",
      "('only', 'constitutive')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "\n",
      "('only', 'also')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also \u001b[46m\u001b[30mconstitutive\u001b[0m, HIV-enhancer activ\n",
      "\n",
      "('pma-', 'hiv-enhancer')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also constitutive, \u001b[46m\u001b[30mHIV-enhancer activity\u001b[0m concomitant to an i\n",
      "\n",
      "('lymphoid-restricted', 'structurally')\n",
      "e role of Aiolos, a \u001b[46m\u001b[30mlymphoid-restricted\u001b[0m and structurally related \u001b[46m\u001b[30mgene\u001b[0m, in lymphoid differ\n",
      "\n",
      "('lymphoid-restricted', 'related')\n",
      "e role of Aiolos, a \u001b[46m\u001b[30mlymphoid-restricted\u001b[0m and structurally related \u001b[46m\u001b[30mgene\u001b[0m, in lymphoid differ\n",
      "\n",
      "('b-cell-specific', 'interferon-inducible')\n",
      " are regulated in a \u001b[46m\u001b[30mB-cell-specific\u001b[0m and gamma interferon-inducible \u001b[46m\u001b[30mfashion\u001b[0m. The master switch \n",
      "\n",
      "('b-cell-specific', 'gamma')\n",
      " are regulated in a \u001b[46m\u001b[30mB-cell-specific\u001b[0m and gamma interferon-inducible \u001b[46m\u001b[30mfashion\u001b[0m. The master switch \n",
      "\n",
      "('etoposide-', 'glucocorticoid-')\n",
      " apoptosis, whereas \u001b[46m\u001b[30metoposide-\u001b[0m and glucocorticoid-\u001b[46m\u001b[30minduced cytotoxicity\u001b[0m was potently inhibi\n",
      "\n",
      "('cytokine', 'viral')\n",
      "f immunoregulatory, \u001b[46m\u001b[30mcytokine\u001b[0m and viral \u001b[46m\u001b[30mgene expression\u001b[0m. In this report, we\n",
      "\n",
      "('interleukin-3-dependent', 'p53-mediated')\n",
      "otein reversed both \u001b[46m\u001b[30minterleukin-3-dependent\u001b[0m and p53-mediated \u001b[46m\u001b[30mapoptosis\u001b[0m. The close homology\n",
      "\n",
      "(',', '440')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "\n",
      "('437', '440')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "\n",
      "('438', '440')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "\n",
      "('435', '440')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "\n",
      "('432', '440')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, 438, and \u001b[46m\u001b[30m440\u001b[0m (position P1, P4, P\n",
      "\n",
      "('lineage-', 'stage-')\n",
      "upied in vivo in an \u001b[46m\u001b[30merythroid lineage-\u001b[0m and developmental stage-\u001b[46m\u001b[30mspecific manner\u001b[0m. We have systematic\n",
      "o suggests that the \u001b[46m\u001b[30merythroid lineage-\u001b[0m and developmental stage-\u001b[46m\u001b[30mspecific regulation\u001b[0m of human alpha-like\n",
      "\n",
      "('lineage-', 'developmental')\n",
      "upied in vivo in an \u001b[46m\u001b[30merythroid lineage-\u001b[0m and developmental stage-\u001b[46m\u001b[30mspecific manner\u001b[0m. We have systematic\n",
      "o suggests that the \u001b[46m\u001b[30merythroid lineage-\u001b[0m and developmental stage-\u001b[46m\u001b[30mspecific regulation\u001b[0m of human alpha-like\n",
      "\n",
      "('ap-2', 'sequence')\n",
      "specifically to the \u001b[46m\u001b[30mAP-1\u001b[0m, AP-2, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "\n",
      "('ap-1', 'b')\n",
      "specifically to the \u001b[46m\u001b[30mAP-1\u001b[0m, AP-2, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "\n",
      "('ap-1', 'nf')\n",
      "specifically to the \u001b[46m\u001b[30mAP-1\u001b[0m, AP-2, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "\n",
      "('ap-1', 'kappa')\n",
      "specifically to the \u001b[46m\u001b[30mAP-1\u001b[0m, AP-2, and NF kappa B \u001b[46m\u001b[30msequence\u001b[0m located within the \n",
      "The \u001b[46m\u001b[30minterleukin-8 AP-1\u001b[0m and kappa B-like \u001b[46m\u001b[30msites\u001b[0m are genetic end tar\n",
      "\n",
      "('monocytic', 'neutrophilic')\n",
      "ifferentiate to the \u001b[46m\u001b[30mmonocytic\u001b[0m or neutrophilic \u001b[46m\u001b[30mlineages\u001b[0m in response to PMA \n",
      "s U937 and HL-60 to \u001b[46m\u001b[30mmonocytic\u001b[0m and neutrophilic \u001b[46m\u001b[30mcells\u001b[0m. PU.1 is expressed \n",
      "\n",
      "('immune', 'endocrine')\n",
      "d to a link between \u001b[46m\u001b[30mimmune\u001b[0m and endocrine \u001b[46m\u001b[30msystems\u001b[0m, including a regula\n",
      "\n",
      "('interleukin-13', 'interleukin-4')\n",
      "Coexpression of the \u001b[46m\u001b[30minterleukin-13\u001b[0m and interleukin-4 \u001b[46m\u001b[30mgenes\u001b[0m correlates with the\n",
      "\n",
      "('il-6', 'tnf-alpha')\n",
      "1 alpha, IL-1 beta, \u001b[46m\u001b[30mIL-6\u001b[0m, IL-8, and TNF-alpha \u001b[46m\u001b[30mgene expression\u001b[0m in monocytes stimul\n",
      "\n",
      "('gamma', 'beta')\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not alpha or \u001b[46m\u001b[30mbeta\u001b[0m, induces maturation\n",
      "\n",
      "('interferon', 'or')\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not alpha or \u001b[46m\u001b[30mbeta\u001b[0m, induces maturation\n",
      "\n",
      "(',', 'beta')\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not alpha or \u001b[46m\u001b[30mbeta\u001b[0m, induces maturation\n",
      "\n",
      "('interferon', 'alpha')\n",
      " and, finally, that \u001b[46m\u001b[30minterferon\u001b[0m gamma, but not alpha or \u001b[46m\u001b[30mbeta\u001b[0m, induces maturation\n",
      "\n",
      "('mab/il-2-', 'pha-')\n",
      "lls, IL-13 inhibits \u001b[46m\u001b[30manti-CD3 mAb/IL-2-\u001b[0m or PHA-\u001b[46m\u001b[30mmediated IFN-gamma production\u001b[0m and enhances cytoly\n",
      "\n",
      "('tnf-', 'anti-fas-')\n",
      "-xL as it inhibited \u001b[46m\u001b[30mTNF-\u001b[0m and anti-Fas-\u001b[46m\u001b[30minduced activation\u001b[0m of two enzymes part\n",
      "infected cells from \u001b[46m\u001b[30mTNF-\u001b[0m and/or anti-Fas- \u001b[46m\u001b[30minduced cell death\u001b[0m in order to maximiz\n",
      "\n",
      "('1', '6')\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "\n",
      "('5', '6')\n",
      "action of RANK with \u001b[46m\u001b[30mtumor necrosis factor receptor-associated factors (TRAFs)\u001b[0m 1, 2, 3, 5, and \u001b[46m\u001b[30m6\u001b[0m both in vitro and i\n",
      "\n",
      "('basal', 'pma')\n",
      "sulted in augmented \u001b[46m\u001b[30mbasal\u001b[0m and PMA-induced \u001b[46m\u001b[30mpromoter activity\u001b[0m.\n",
      "ed several peaks of \u001b[46m\u001b[30mbasal\u001b[0m and PMA induced \u001b[46m\u001b[30mactivity\u001b[0m suggesting the pres\n",
      "\n",
      "('t', 'small')\n",
      "he stability of the \u001b[46m\u001b[30mbig T\u001b[0m and small t \u001b[46m\u001b[30mallele\u001b[0m in normal heterozyg\n",
      "\n",
      "('t', 't')\n",
      "he stability of the \u001b[46m\u001b[30mbig T\u001b[0m and small t \u001b[46m\u001b[30mallele\u001b[0m in normal heterozyg\n",
      "\n",
      "('myelomonocytic', 'glial')\n",
      "tion in H9 T cells, \u001b[46m\u001b[30mmyelomonocytic\u001b[0m, and glial \u001b[46m\u001b[30mcell lines\u001b[0m. In vivo occupancy \n",
      "\n",
      "('extracellular', 'intracellular')\n",
      "d decreases in both \u001b[46m\u001b[30mextracellular\u001b[0m and intracellular \u001b[46m\u001b[30mpH\u001b[0m. We conclude from t\n",
      "\n",
      "('ca(2+)-', 'pkc-')\n",
      "eviously shown that \u001b[46m\u001b[30mCa(2+)-\u001b[0m and PKC-\u001b[46m\u001b[30mdependent pathways\u001b[0m synergize by accele\n",
      "\n",
      "('macrophage', 'fibrosarcoma')\n",
      "ene was observed in \u001b[46m\u001b[30mmouse macrophage\u001b[0m and fibrosarcoma \u001b[46m\u001b[30mcell lines\u001b[0m, when the cells wer\n",
      "ene was observed in \u001b[46m\u001b[30mmouse\u001b[0m macrophage and \u001b[46m\u001b[30mfibrosarcoma cell lines\u001b[0m, when the cells wer\n",
      "\n",
      "('cd4-', 'cd8-')\n",
      " were found in both \u001b[46m\u001b[30mCD4-\u001b[0m and CD8-\u001b[46m\u001b[30mpositive thymocytes\u001b[0m. These observations\n",
      "\n",
      "('hematopoietic', 'trophoblast')\n",
      "ssed exclusively in \u001b[46m\u001b[30mhematopoietic\u001b[0m and trophoblast \u001b[46m\u001b[30mcells\u001b[0m. It contains a numb\n",
      "\n",
      "('immune', 'cytokine')\n",
      "\u001b[46m\u001b[30mCellular immune\u001b[0m and cytokine \u001b[46m\u001b[30mpathways\u001b[0m resulting in tissue\n",
      "\u001b[46m\u001b[30mCellular\u001b[0m immune and \u001b[46m\u001b[30mcytokine pathways\u001b[0m resulting in tissue\n",
      "\n",
      "('-2', 'gene')\n",
      "lines co-expressing \u001b[46m\u001b[30mGATA-1\u001b[0m and -2 or GATA-1 and -3 \u001b[46m\u001b[30mgene products\u001b[0m. This pattern of di\n",
      "\n",
      "('p40', 'p35')\n",
      "e B cells expressed \u001b[46m\u001b[30mp40\u001b[0m and p35 \u001b[46m\u001b[30mmRNA\u001b[0m, and phorbol myrist\n",
      "\n",
      "('autocrine', 'paracrine')\n",
      " independent of the \u001b[46m\u001b[30mautocrine\u001b[0m or paracrine \u001b[46m\u001b[30maction\u001b[0m of endogenous TNF-a\n",
      "ory mediators in an \u001b[46m\u001b[30mautocrine\u001b[0m and paracrine \u001b[46m\u001b[30mfashion\u001b[0m. The mechanism(s) r\n",
      "\n",
      "('exocrine', 'endocrine')\n",
      "composed of ductal, \u001b[46m\u001b[30mexocrine\u001b[0m and endocrine \u001b[46m\u001b[30mcompartments\u001b[0m. Early buds are cha\n",
      "\n",
      "('constitutive', 'inducible')\n",
      "factor for both the \u001b[46m\u001b[30mconstitutive\u001b[0m and IFN inducible \u001b[46m\u001b[30mexpression\u001b[0m of MHC class II gen\n",
      "s that regulate the \u001b[46m\u001b[30mconstitutive\u001b[0m and inducible \u001b[46m\u001b[30mexpression\u001b[0m of CD69 by leukocyt\n",
      "\n",
      "('constitutive', 'ifn')\n",
      "factor for both the \u001b[46m\u001b[30mconstitutive\u001b[0m and IFN inducible \u001b[46m\u001b[30mexpression\u001b[0m of MHC class II gen\n",
      "\n",
      "('stat5-', 'stat1-')\n",
      "rshift experiments. \u001b[46m\u001b[30mSTAT5-\u001b[0m and STAT1-\u001b[46m\u001b[30mrelated factors\u001b[0m were detected in AL\n",
      "\n",
      "('medium', 'large')\n",
      "ferentially affects \u001b[46m\u001b[30mmedium\u001b[0m and large\u001b[46m\u001b[30m-sized arteries\u001b[0m. Glucocorticoid the\n",
      "\n",
      "(')', 'productive')\n",
      " can establish both \u001b[46m\u001b[30mnonproductive (latent)\u001b[0m and productive (lytic) \u001b[46m\u001b[30minfections\u001b[0m. Although the CD8+ \n",
      "\n",
      "(')', 'lytic')\n",
      " can establish both \u001b[46m\u001b[30mnonproductive (latent)\u001b[0m and productive (lytic) \u001b[46m\u001b[30minfections\u001b[0m. Although the CD8+ \n",
      "\n",
      "('lef-1', 'distal')\n",
      "located between the \u001b[46m\u001b[30mLEF-1\u001b[0m and distal NF-kappaB transcription factor \u001b[46m\u001b[30mbinding sites\u001b[0m) that we identified\n",
      "\n",
      "('lef-1', 'factor')\n",
      "located between the \u001b[46m\u001b[30mLEF-1\u001b[0m and distal NF-kappaB transcription factor \u001b[46m\u001b[30mbinding sites\u001b[0m) that we identified\n",
      "\n",
      "('lef-1', 'transcription')\n",
      "located between the \u001b[46m\u001b[30mLEF-1\u001b[0m and distal NF-kappaB transcription factor \u001b[46m\u001b[30mbinding sites\u001b[0m) that we identified\n",
      "\n",
      "('lef-1', 'nf-kappab')\n",
      "located between the \u001b[46m\u001b[30mLEF-1\u001b[0m and distal NF-kappaB transcription factor \u001b[46m\u001b[30mbinding sites\u001b[0m) that we identified\n",
      "\n",
      "('c-fos', 'fos-b')\n",
      "-jun, jun-B, jun-D, \u001b[46m\u001b[30mc-fos\u001b[0m, or Fos-B \u001b[46m\u001b[30mexpression vectors\u001b[0m partially substitut\n",
      "\n",
      "('splenic', 'brain')\n",
      " kDs) isolated from \u001b[46m\u001b[30msplenic\u001b[0m and brain \u001b[46m\u001b[30mcells\u001b[0m of immunized rats w\n",
      "\n",
      "('1a', '1b')\n",
      "ress tal-1 from the \u001b[46m\u001b[30mpromoters\u001b[0m 1a and \u001b[46m\u001b[30m1b\u001b[0m. HS II was weak in \n",
      "\n",
      "(')', 'tsh')\n",
      "te the influence of \u001b[46m\u001b[30mserum thyroxine (T4)\u001b[0m and thyrotropin (TSH) \u001b[46m\u001b[30mlevels\u001b[0m on receptor kinetic\n",
      "\n",
      "(')', 'thyrotropin')\n",
      "te the influence of \u001b[46m\u001b[30mserum thyroxine (T4)\u001b[0m and thyrotropin (TSH) \u001b[46m\u001b[30mlevels\u001b[0m on receptor kinetic\n",
      "te the influence of \u001b[46m\u001b[30mserum\u001b[0m thyroxine (T4) and \u001b[46m\u001b[30mthyrotropin (TSH) levels\u001b[0m on receptor kinetic\n",
      "\n",
      "('pma-', 'ra-')\n",
      "ppressed the basal, \u001b[46m\u001b[30mPMA-\u001b[0m, and RA-\u001b[46m\u001b[30minducible CD23 expression\u001b[0m in a dose-dependent\n",
      "\n",
      "('-4', '-13')\n",
      "\u001b[46m\u001b[30mInterleukin\u001b[0m-4 and \u001b[46m\u001b[30m-13\u001b[0m induce upregulation\n",
      "xpressed cytokines [\u001b[46m\u001b[30mhuman interleukin\u001b[0m-2, -4, -5 and \u001b[46m\u001b[30m-13\u001b[0m and human and mouse\n",
      "\n",
      "('w-x-y', 'x-y')\n",
      " class II conserved \u001b[46m\u001b[30mW-X-Y\u001b[0m or X-Y \u001b[46m\u001b[30mregulatory elements\u001b[0m was determined. Two\n",
      "\n",
      "('nonhematopoietic', 'hematopoietic')\n",
      " promoter into both \u001b[46m\u001b[30mnonhematopoietic\u001b[0m and hematopoietic \u001b[46m\u001b[30mcell lines\u001b[0m. As with the hetero\n",
      "\n",
      "('ku812', 'cell')\n",
      " differentiation of \u001b[46m\u001b[30mHEL\u001b[0m, KU812 and K562 \u001b[46m\u001b[30mcells\u001b[0m, but not the induct\n",
      "\n",
      "('hel', 'k562')\n",
      " differentiation of \u001b[46m\u001b[30mHEL\u001b[0m, KU812 and K562 \u001b[46m\u001b[30mcells\u001b[0m, but not the induct\n",
      "\n",
      "('mitogenic', 'alloantigenic')\n",
      "se are inducible by \u001b[46m\u001b[30mmitogenic\u001b[0m or alloantigenic \u001b[46m\u001b[30mstimuli\u001b[0m.\n",
      "\n",
      "('stat3', 'protein')\n",
      "Increased Stat1 and \u001b[46m\u001b[30mStat3\u001b[0m mRNA and protein \u001b[46m\u001b[30mlevels\u001b[0m were detected, resp\n",
      " chain and activate \u001b[46m\u001b[30mSTAT6\u001b[0m, STAT3 and STAT5 \u001b[46m\u001b[30mproteins\u001b[0m in normal human B c\n",
      "\n",
      "('lps-', 'il-1beta-')\n",
      "ated enhancement of \u001b[46m\u001b[30mLPS-\u001b[0m and IL-1beta-\u001b[46m\u001b[30minduced IL-6 production\u001b[0m. Indomethacin block\n",
      "\n",
      "('neuroglial', 'lymphocytic')\n",
      "nalyses in cells of \u001b[46m\u001b[30mneuroglial\u001b[0m and lymphocytic \u001b[46m\u001b[30morigin\u001b[0m demonstrated that s\n",
      "\n",
      "('ap-2-', 'ap-1-')\n",
      "this region, single \u001b[46m\u001b[30mAP-2-\u001b[0m and AP-1- \u001b[46m\u001b[30mlike consensus sequences\u001b[0m were noted. These A\n",
      "\n",
      "('cd11b', 'receptor')\n",
      "kaline phosphatase, \u001b[46m\u001b[30mCD11b\u001b[0m, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "('cd11b', 'g-csf')\n",
      "kaline phosphatase, \u001b[46m\u001b[30mCD11b\u001b[0m, CD33, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "('growth', 'development')\n",
      "n important role in \u001b[46m\u001b[30mB-cell\u001b[0m growth and \u001b[46m\u001b[30mdevelopment\u001b[0m.\n",
      "\n",
      "('stat3', 'stat5')\n",
      "and activate STAT6, \u001b[46m\u001b[30mSTAT3\u001b[0m and STAT5 \u001b[46m\u001b[30mproteins\u001b[0m in normal human B c\n",
      "\n",
      "('jak2', 'fe')\n",
      "olecules. The Jak1, \u001b[46m\u001b[30mJak2\u001b[0m, Jak3, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "\n",
      "('activate', 'anergized')\n",
      " nuclei of resting, \u001b[46m\u001b[30mactivated\u001b[0m, and anergized \u001b[46m\u001b[30mcells\u001b[0m. The inducible fact\n",
      "\n",
      "('cord', 'adult')\n",
      " mRNA expression in \u001b[46m\u001b[30mactivated cord\u001b[0m and adult \u001b[46m\u001b[30mlymphocytes\u001b[0m: an analysis by Nor\n",
      "\n",
      "('neutrophilic', 'eosinophilic')\n",
      "ate of apoptosis in \u001b[46m\u001b[30mneutrophilic\u001b[0m and eosinophilic \u001b[46m\u001b[30mgranulocytes\u001b[0m. Eosinophils and ne\n",
      "\n",
      "('normal', 'neoplastic')\n",
      "iquely expressed in \u001b[46m\u001b[30mnormal\u001b[0m and neoplastic \u001b[46m\u001b[30mT-lineage lymphocytes\u001b[0m. The TCF-1 gene enc\n",
      "\n",
      "('upstream', 'downstream')\n",
      "contained extensive \u001b[46m\u001b[30mupstream\u001b[0m and downstream \u001b[46m\u001b[30msequences\u001b[0m. A TATA-like motif \n",
      " the actions of the \u001b[46m\u001b[30mupstream\u001b[0m and downstream \u001b[46m\u001b[30mpositive regulatory elements\u001b[0m. This is the first \n",
      " be divided into an \u001b[46m\u001b[30mupstream\u001b[0m and a downstream \u001b[46m\u001b[30mregulatory region\u001b[0m. The downstream reg\n",
      "\n",
      "('expression', 'replication')\n",
      "hat is critical for \u001b[46m\u001b[30mviral gene\u001b[0m expression and \u001b[46m\u001b[30mreplication\u001b[0m, transactivates the\n",
      "\n",
      "('kappa', 'lambda')\n",
      "cy rearrangement of \u001b[46m\u001b[30mkappa\u001b[0m and lambda \u001b[46m\u001b[30mlight-chain genes\u001b[0m. These events are a\n",
      "ase in steady state \u001b[46m\u001b[30mkappa\u001b[0m and lambda \u001b[46m\u001b[30mL chain mRNA levels\u001b[0m. Furthermore, a sig\n",
      "\n",
      "('1', 'p5')\n",
      " 433, 434, and 436 (\u001b[46m\u001b[30mpositions\u001b[0m P 1, P2, P3, and \u001b[46m\u001b[30mP5\u001b[0m) contributed to TCR\n",
      "\n",
      "('p3', 'p5')\n",
      " 433, 434, and 436 (\u001b[46m\u001b[30mpositions\u001b[0m P 1, P2, P3, and \u001b[46m\u001b[30mP5\u001b[0m) contributed to TCR\n",
      "\n",
      "('p2', 'p5')\n",
      " 433, 434, and 436 (\u001b[46m\u001b[30mpositions\u001b[0m P 1, P2, P3, and \u001b[46m\u001b[30mP5\u001b[0m) contributed to TCR\n",
      "\n",
      "('p', 'p5')\n",
      " 433, 434, and 436 (\u001b[46m\u001b[30mpositions\u001b[0m P 1, P2, P3, and \u001b[46m\u001b[30mP5\u001b[0m) contributed to TCR\n",
      "\n",
      "(',', 'p5')\n",
      " 433, 434, and 436 (\u001b[46m\u001b[30mpositions\u001b[0m P 1, P2, P3, and \u001b[46m\u001b[30mP5\u001b[0m) contributed to TCR\n",
      " 433, 434, and 436 (\u001b[46m\u001b[30mpositions\u001b[0m P 1, P2, P3, and \u001b[46m\u001b[30mP5\u001b[0m) contributed to TCR\n",
      " 433, 434, and 436 (\u001b[46m\u001b[30mpositions\u001b[0m P 1, P2, P3, and \u001b[46m\u001b[30mP5\u001b[0m) contributed to TCR\n",
      "\n",
      "('eosinophil', 'neutrophil')\n",
      "5 and GM-CSF during \u001b[46m\u001b[30meosinophil\u001b[0m and neutrophil \u001b[46m\u001b[30mdifferentiation\u001b[0m from human CD34+ he\n",
      "\n",
      "('gm-csf', 'egr-1')\n",
      "expression of IL-3, \u001b[46m\u001b[30mGM-CSF\u001b[0m, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "\n",
      "('fm', 'gene')\n",
      "expression of IL-3, \u001b[46m\u001b[30mGM-CSF\u001b[0m, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "d (3) expression of \u001b[46m\u001b[30mIL-3\u001b[0m, GM-CSF, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "\n",
      "('element-specific', 'common')\n",
      "e elements revealed \u001b[46m\u001b[30melement-specific\u001b[0m and common \u001b[46m\u001b[30mcomplexes\u001b[0m. Six tandem repeats\n",
      "\n",
      "('cardiac', 'adrenergic')\n",
      "er or exophthalmos. \u001b[46m\u001b[30mCardiac\u001b[0m and adrenergic \u001b[46m\u001b[30mdiseases\u001b[0m were excluded. The \n",
      "\n",
      "('-10', 'il-6')\n",
      "Receptors for \u001b[46m\u001b[30minterleukin (IL)-10\u001b[0m and IL-6\u001b[46m\u001b[30m-type cytokines\u001b[0m use similar signali\n",
      "\n",
      "('igd', 'chain')\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('igd', 'lambda')\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('igd', 'l')\n",
      "B cell surface IgM, \u001b[46m\u001b[30mIgD\u001b[0m, kappa L chain, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('p105', 'p100')\n",
      ". No degradation of \u001b[46m\u001b[30mp105\u001b[0m and p100 \u001b[46m\u001b[30minhibitors\u001b[0m was observed under \n",
      "\n",
      "('beta', 'phorbol')\n",
      " assays. TNF-alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('beta', ')')\n",
      " assays. TNF-alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('beta', 'acetate')\n",
      " assays. TNF-alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('beta', '(')\n",
      " assays. TNF-alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('beta', 'pma')\n",
      " assays. TNF-alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('beta', 'myristate')\n",
      " assays. TNF-alpha, \u001b[46m\u001b[30mIL-1 beta\u001b[0m and phorbol myristate acetate (PMA) \u001b[46m\u001b[30mtreatment\u001b[0m increased AP-1 and \n",
      "\n",
      "('ap-1', 'b-like')\n",
      "The \u001b[46m\u001b[30minterleukin-8 AP-1\u001b[0m and kappa B-like \u001b[46m\u001b[30msites\u001b[0m are genetic end tar\n",
      "\n",
      "('cortisol', 'aldosterone')\n",
      "eukocytes in aging. \u001b[46m\u001b[30mPlasma cortisol\u001b[0m and aldosterone \u001b[46m\u001b[30mlevels\u001b[0m and number of relat\n",
      "\n",
      "('u3', 'r')\n",
      "not detected in the \u001b[46m\u001b[30mU3\u001b[0m and R \u001b[46m\u001b[30mregions\u001b[0m of proviral DNA fro\n",
      "\n",
      "('c', 'vimentin')\n",
      "creases in lamin A, \u001b[46m\u001b[30mlamin C\u001b[0m, and vimentin \u001b[46m\u001b[30mtranscripts\u001b[0m. Other studies have\n",
      "\n",
      "(',', 'transcript')\n",
      "creases in lamin A, \u001b[46m\u001b[30mlamin C\u001b[0m, and vimentin \u001b[46m\u001b[30mtranscripts\u001b[0m. Other studies have\n",
      "nduced increases in \u001b[46m\u001b[30mlamin A\u001b[0m, lamin C, and vimentin \u001b[46m\u001b[30mtranscripts\u001b[0m. Other studies have\n",
      "nduced increases in \u001b[46m\u001b[30mlamin A\u001b[0m, lamin C, and vimentin \u001b[46m\u001b[30mtranscripts\u001b[0m. Other studies have\n",
      "\n",
      "('rrna', 'trna')\n",
      "rt higher levels of \u001b[46m\u001b[30m5S rRNA\u001b[0m and tRNA \u001b[46m\u001b[30mgene transcription\u001b[0m than chromatin or e\n",
      "\n",
      "('ku812', 'k562')\n",
      "erentiation of HEL, \u001b[46m\u001b[30mKU812\u001b[0m and K562 \u001b[46m\u001b[30mcells\u001b[0m, but not the induct\n",
      "\n",
      "('mel', 'nih3t3')\n",
      "ike element between \u001b[46m\u001b[30mMEL\u001b[0m and NIH3T3 \u001b[46m\u001b[30mcells\u001b[0m. These results prov\n",
      "\n",
      "('p53', 'expression')\n",
      "distinct changes in \u001b[46m\u001b[30mP-glycoprotein\u001b[0m, steroid receptors, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      " in P-glycoprotein, \u001b[46m\u001b[30msteroid receptors\u001b[0m, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "\n",
      "('receptor', 'expression')\n",
      "distinct changes in \u001b[46m\u001b[30mP-glycoprotein\u001b[0m, steroid receptors, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "\n",
      "('p-glycoprotein', 'bcl-2')\n",
      "distinct changes in \u001b[46m\u001b[30mP-glycoprotein\u001b[0m, steroid receptors, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "\n",
      "('steroid', 'expression')\n",
      "distinct changes in \u001b[46m\u001b[30mP-glycoprotein\u001b[0m, steroid receptors, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "\n",
      "('cellular', 'molecular')\n",
      "\u001b[46m\u001b[30mCellular\u001b[0m and molecular \u001b[46m\u001b[30mmechanisms\u001b[0m of IFN-gamma produc\n",
      "\n",
      "('p50', ')')\n",
      "s of NF-kappa B the \u001b[46m\u001b[30mp50\u001b[0m and RelA (p65) \u001b[46m\u001b[30mproteins\u001b[0m, indicated that the\n",
      "\n",
      "('p50', 'rela')\n",
      "s of NF-kappa B the \u001b[46m\u001b[30mp50\u001b[0m and RelA (p65) \u001b[46m\u001b[30mproteins\u001b[0m, indicated that the\n",
      "\n",
      "('p50', '(')\n",
      "s of NF-kappa B the \u001b[46m\u001b[30mp50\u001b[0m and RelA (p65) \u001b[46m\u001b[30mproteins\u001b[0m, indicated that the\n",
      "\n",
      "('cd11b', 'gene')\n",
      "de sequences of the \u001b[46m\u001b[30mCD11a\u001b[0m, CD11b, and CD11c \u001b[46m\u001b[30mgene promoters\u001b[0m to identify common \n",
      "\n",
      "('cd11a', 'cd11c')\n",
      "de sequences of the \u001b[46m\u001b[30mCD11a\u001b[0m, CD11b, and CD11c \u001b[46m\u001b[30mgene promoters\u001b[0m to identify common \n",
      "\n",
      "('cytogenetic', 'data')\n",
      "9. Here, we present \u001b[46m\u001b[30mclinical\u001b[0m, cytogenetic, and molecular \u001b[46m\u001b[30mdata\u001b[0m from a new CMPD1/SR\n",
      "\n",
      "('x1', 'x2')\n",
      "mer site and the Y, \u001b[46m\u001b[30mX1\u001b[0m, and X2 \u001b[46m\u001b[30mboxes\u001b[0m. Class II antigen e\n",
      "allel, up-regulates \u001b[46m\u001b[30mX1\u001b[0m and X2 \u001b[46m\u001b[30mbox protein-DNA interactions\u001b[0m, while all other in\n",
      "\n",
      "('cd8+', 'cd4+')\n",
      "tor-bearing subset, \u001b[46m\u001b[30mCD8+\u001b[0m and CD4+ \u001b[46m\u001b[30mcells\u001b[0m were depleted by co\n",
      "ell types including \u001b[46m\u001b[30mCD8+\u001b[0m and CD4+ \u001b[46m\u001b[30mT cells\u001b[0m as well as monocyte\n",
      "\n",
      "('p50/p65', 'p50/relb')\n",
      "criptionally active \u001b[46m\u001b[30mp50/p65\u001b[0m and p50/RelB \u001b[46m\u001b[30mheterodimers\u001b[0m. As in MDMs, AMs co\n",
      "\n",
      "(')', 'cn')\n",
      "on of the cDNAs for \u001b[46m\u001b[30mCN A (catalytic)\u001b[0m and CN B (regulatory) \u001b[46m\u001b[30msubunits\u001b[0m also augments trans\n",
      "\n",
      "(')', 'regulatory')\n",
      "on of the cDNAs for \u001b[46m\u001b[30mCN A (catalytic)\u001b[0m and CN B (regulatory) \u001b[46m\u001b[30msubunits\u001b[0m also augments trans\n",
      "\n",
      "('western', 'supershift')\n",
      "reated fibroblasts. \u001b[46m\u001b[30mWestern\u001b[0m and supershift \u001b[46m\u001b[30manalyses\u001b[0m indicated that func\n",
      "\n",
      "('v.cholera.', 'c.botulinum')\n",
      "t with B.pertussis, \u001b[46m\u001b[30mV.cholera.\u001b[0m or C.botulinum \u001b[46m\u001b[30mtoxin\u001b[0m did not influence h\n",
      "\n",
      "('nfat-', 'interleukin-2-')\n",
      "ulation in inducing \u001b[46m\u001b[30mNFAT-\u001b[0m and interleukin-2-\u001b[46m\u001b[30mdependent transcription\u001b[0m. In contrast, NFAT \n",
      "\n",
      "('type-', 'differentiation-')\n",
      "er that confer cell \u001b[46m\u001b[30mtype-\u001b[0m and differentiation-\u001b[46m\u001b[30mspecific expression\u001b[0m in the B cells of b\n",
      "\n",
      "('human', 'simian')\n",
      "inding sites in the \u001b[46m\u001b[30mhuman\u001b[0m and simian \u001b[46m\u001b[30mEpstein-Barr virus oncogene LMP1\u001b[0m. Nonhuman primates \n",
      "\n",
      "('small', 'large')\n",
      "ases of follicular, \u001b[46m\u001b[30mmixed small\u001b[0m and large \u001b[46m\u001b[30mcell lymphomas\u001b[0m showed LAZ3/BCL6 ex\n",
      "\n",
      "('lymphoid', 'nonlymphoid')\n",
      "vator properties in \u001b[46m\u001b[30mlymphoid\u001b[0m and nonlymphoid \u001b[46m\u001b[30mcells\u001b[0m on reporter genes c\n",
      "\n",
      "('monocytic', 'granulocytic')\n",
      "ot the induction of \u001b[46m\u001b[30mmonocytic\u001b[0m or granulocytic \u001b[46m\u001b[30mdifferentiation\u001b[0m of HL-60, U937 and \n",
      "ession is common in \u001b[46m\u001b[30mmonocytic\u001b[0m and granulocytic \u001b[46m\u001b[30mmaturation\u001b[0m of myeloid leukemia\n",
      "\n",
      "('t-', 'nk-')\n",
      "ukocytes of the B-, \u001b[46m\u001b[30mT-\u001b[0m, and NK-\u001b[46m\u001b[30mcell lineages\u001b[0m were treated with e\n",
      "\n",
      "('ine', 'gsh')\n",
      "rage, significantly \u001b[46m\u001b[30mdecreased plasma cyst(e)ine\u001b[0m and intracellular GSH \u001b[46m\u001b[30mlevels\u001b[0m, we also hypothesiz\n",
      "\n",
      "('ine', 'intracellular')\n",
      "rage, significantly \u001b[46m\u001b[30mdecreased plasma cyst(e)ine\u001b[0m and intracellular GSH \u001b[46m\u001b[30mlevels\u001b[0m, we also hypothesiz\n",
      "\n",
      "('ap-1-', 'nf-kappab-')\n",
      "ing concurrently on \u001b[46m\u001b[30mAP-1-\u001b[0m and NF-kappaB-\u001b[46m\u001b[30mbinding sites\u001b[0m of the interleukin-\n",
      "\n",
      "('growth-', 'cycle-')\n",
      "romoters of certain \u001b[46m\u001b[30mgrowth-\u001b[0m and cell cycle-\u001b[46m\u001b[30mcontrolling genes\u001b[0m and forms distinct \n",
      "\n",
      "('growth-', 'cell')\n",
      "romoters of certain \u001b[46m\u001b[30mgrowth-\u001b[0m and cell cycle-\u001b[46m\u001b[30mcontrolling genes\u001b[0m and forms distinct \n",
      "\n",
      "('ri-', 'sie')\n",
      "ns when C epsilon-, \u001b[46m\u001b[30mFc gamma RI-\u001b[0m, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "\n",
      "(',', 'gas')\n",
      "ns when C epsilon-, \u001b[46m\u001b[30mFc gamma RI-\u001b[0m, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "nding patterns when \u001b[46m\u001b[30mC epsilon-\u001b[0m, Fc gamma RI-, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "nding patterns when \u001b[46m\u001b[30mC epsilon-\u001b[0m, Fc gamma RI-, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "\n",
      "('u937', 'thp-1')\n",
      "cantly expressed in \u001b[46m\u001b[30mU937\u001b[0m and THP-1 \u001b[46m\u001b[30mcells\u001b[0m, weakly expressed i\n",
      "\n",
      "('basal', 't3')\n",
      "50% lower than both \u001b[46m\u001b[30mbasal\u001b[0m and T3\u001b[46m\u001b[30m-values\u001b[0m. The log10Kd increa\n",
      "\n",
      "(')', 'naive')\n",
      "appaB) in activated \u001b[46m\u001b[30mmemory (CD45RO+)\u001b[0m and naive (CD45RA+) \u001b[46m\u001b[30mT cell subsets\u001b[0m from young and elde\n",
      "\n",
      "(')', 'cd45ra+')\n",
      "appaB) in activated \u001b[46m\u001b[30mmemory (CD45RO+)\u001b[0m and naive (CD45RA+) \u001b[46m\u001b[30mT cell subsets\u001b[0m from young and elde\n",
      "\n",
      "('estrogen', 'progesterone')\n",
      "Demonstration of \u001b[46m\u001b[30mestrogen\u001b[0m and progesterone \u001b[46m\u001b[30mreceptors\u001b[0m as well as Ki-67 an\n",
      "\n",
      "('c-jun', 'fra-1')\n",
      "entration of c-fos, \u001b[46m\u001b[30mc-jun\u001b[0m, c-myc, junB, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "\n",
      "('proximal', 'remote')\n",
      " transcription from \u001b[46m\u001b[30mproximal\u001b[0m and remote \u001b[46m\u001b[30mpositions\u001b[0m. Furthermore, we id\n",
      "\n",
      "('producing', 't-')\n",
      "GH/PRL- and insulin-\u001b[46m\u001b[30mproducing\u001b[0m, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "('t-', '-')\n",
      "is also involved in \u001b[46m\u001b[30mT-\u001b[0m acute and- \u001b[46m\u001b[30mchronic leukemias\u001b[0m arising in cases of\n",
      "\n",
      "('75', 'kda')\n",
      "binding proteins of \u001b[46m\u001b[30m85\u001b[0m, 75, and 54 \u001b[46m\u001b[30mkDa\u001b[0m, whereas in Tax exp\n",
      "\n",
      "('85', '54')\n",
      "binding proteins of \u001b[46m\u001b[30m85\u001b[0m, 75, and 54 \u001b[46m\u001b[30mkDa\u001b[0m, whereas in Tax exp\n",
      "\n",
      "('squirrel', 'receptor')\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "('human', 'cotton-top')\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "('human', 'tamarin')\n",
      "ely conserved among \u001b[46m\u001b[30mhuman\u001b[0m, squirrel monkey, owl monkey, and cotton-top tamarin \u001b[46m\u001b[30mreceptors\u001b[0m. Twenty-two differe\n",
      "\n",
      "(')', 'rare')\n",
      "ing to analyze both \u001b[46m\u001b[30mIg-silenced (common)\u001b[0m and Ig-expressing (rare) \u001b[46m\u001b[30mhybrids\u001b[0m. Although no single\n",
      "\n",
      "(')', 'ig-expressing')\n",
      "ing to analyze both \u001b[46m\u001b[30mIg-silenced (common)\u001b[0m and Ig-expressing (rare) \u001b[46m\u001b[30mhybrids\u001b[0m. Although no single\n",
      "\n",
      "('il-2', 'il-2r')\n",
      "enes, including the \u001b[46m\u001b[30mIL-2\u001b[0m and IL-2R \u001b[46m\u001b[30mgenes\u001b[0m. Co-ligation of the\n",
      "\n",
      "('pkc-dependent', 'pkc-independent')\n",
      "eam events via both \u001b[46m\u001b[30mPKC-dependent\u001b[0m and PKC-independent \u001b[46m\u001b[30mpathways\u001b[0m, and that multiple \n",
      "\n",
      "('il-1', 'il-4')\n",
      "ma activity but not \u001b[46m\u001b[30mIL-1\u001b[0m, IL-2, or IL-4 \u001b[46m\u001b[30mactivity\u001b[0m was present in cult\n",
      "\n",
      "('il-2', 'activity')\n",
      "ma activity but not \u001b[46m\u001b[30mIL-1\u001b[0m, IL-2, or IL-4 \u001b[46m\u001b[30mactivity\u001b[0m was present in cult\n",
      "\n",
      "('proliferation', 'cytotoxicity')\n",
      "resented antigen in \u001b[46m\u001b[30mproliferation\u001b[0m and cytotoxicity \u001b[46m\u001b[30massays\u001b[0m much more efficient\n",
      "\n",
      "('egr-1', 'c-fos')\n",
      "nd the induction of \u001b[46m\u001b[30mEgr-1\u001b[0m and c-fos \u001b[46m\u001b[30mmRNA expression\u001b[0m by sIgM- and sIgD-c\n",
      "n and expression of \u001b[46m\u001b[30mEgr-1\u001b[0m and c-fos \u001b[46m\u001b[30mmRNA\u001b[0m, although sIgM-cros\n",
      "\n",
      "('ki-67', 'p-145')\n",
      "eceptors as well as \u001b[46m\u001b[30mKi-67\u001b[0m and p-145 \u001b[46m\u001b[30mantigens\u001b[0m in single tumor cel\n",
      "\n",
      "('hcmv', 'mie')\n",
      " motif found in the \u001b[46m\u001b[30mHCMV\u001b[0m and chimpanzee CMV MIE \u001b[46m\u001b[30menhancers\u001b[0m, we have examined t\n",
      "\n",
      "('hcmv', 'cmv')\n",
      " motif found in the \u001b[46m\u001b[30mHCMV\u001b[0m and chimpanzee CMV MIE \u001b[46m\u001b[30menhancers\u001b[0m, we have examined t\n",
      "\n",
      "('hcmv', 'chimpanzee')\n",
      " motif found in the \u001b[46m\u001b[30mHCMV\u001b[0m and chimpanzee CMV MIE \u001b[46m\u001b[30menhancers\u001b[0m, we have examined t\n",
      "\n",
      "('m-tat/epo', 'm-tat/scf')\n",
      " are referred to as \u001b[46m\u001b[30mM-TAT/EPO\u001b[0m, M-TAT/GM-CSF, and M-TAT/SCF \u001b[46m\u001b[30mcells\u001b[0m, respectively. Hemo\n",
      "\n",
      "('m-tat/gm-csf', 'cell')\n",
      " are referred to as \u001b[46m\u001b[30mM-TAT/EPO\u001b[0m, M-TAT/GM-CSF, and M-TAT/SCF \u001b[46m\u001b[30mcells\u001b[0m, respectively. Hemo\n",
      "\n",
      "('th0', 'th2')\n",
      "vation apoptosis in \u001b[46m\u001b[30mTh0\u001b[0m, Th1, and Th2 \u001b[46m\u001b[30mclones\u001b[0m. We also found that\n",
      "\n",
      "('th1', 'clone')\n",
      "vation apoptosis in \u001b[46m\u001b[30mTh0\u001b[0m, Th1, and Th2 \u001b[46m\u001b[30mclones\u001b[0m. We also found that\n",
      "\n",
      "('lps-', 'zymosan-')\n",
      "were sufficient for \u001b[46m\u001b[30mLPS-\u001b[0m or zymosan-\u001b[46m\u001b[30mmediated transcriptional induction\u001b[0m, whereas phorbol in\n",
      "\n",
      "('ap-1-', 'nf-at-')\n",
      " among NF-kappa B-, \u001b[46m\u001b[30mAP-1-\u001b[0m and NF-AT-\u001b[46m\u001b[30mbinding sequences\u001b[0m is required for ind\n",
      "\n",
      "('c-fos', 'the')\n",
      "s were examined for \u001b[46m\u001b[30mc-fos\u001b[0m, c-myc, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "ctivation, both the \u001b[46m\u001b[30mc-fos\u001b[0m and the c-jun \u001b[46m\u001b[30mmRNA expression\u001b[0m was decreased. The \n",
      "\n",
      "('c-fos', 'hybrid')\n",
      "s were examined for \u001b[46m\u001b[30mc-fos\u001b[0m, c-myc, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('c-fos', 'bcr/abl')\n",
      "s were examined for \u001b[46m\u001b[30mc-fos\u001b[0m, c-myc, p53 and the hybrid bcr/abl \u001b[46m\u001b[30mmRNA levels\u001b[0m. Results indicated \n",
      "\n",
      "('cell-type-specific', 'ubiquitous')\n",
      "cognized by several \u001b[46m\u001b[30mcell-type-specific\u001b[0m and ubiquitous \u001b[46m\u001b[30mtranscriptional regulators\u001b[0m that integrate info\n",
      "\n",
      "('s', 'j')\n",
      "to require both the \u001b[46m\u001b[30mS\u001b[0m and J \u001b[46m\u001b[30melements\u001b[0m, which are separate\n",
      "\n",
      "('usf-', 'sp1-')\n",
      "he transcription of \u001b[46m\u001b[30mUSF-\u001b[0m and Sp1-\u001b[46m\u001b[30mregulated promoters\u001b[0m. Taken together, ou\n",
      "\n",
      "('102', '104')\n",
      "rylation of JunB at \u001b[46m\u001b[30mThr\u001b[0m102 and- \u001b[46m\u001b[30m104\u001b[0m by JNK MAP kinase. \n",
      "\n",
      "('thr', '-')\n",
      "rylation of JunB at \u001b[46m\u001b[30mThr\u001b[0m102 and- \u001b[46m\u001b[30m104\u001b[0m by JNK MAP kinase. \n",
      "\n",
      "('t', 'monocytic')\n",
      "ulation of c-Fos in \u001b[46m\u001b[30mactivated\u001b[0m T lymphoid and \u001b[46m\u001b[30mmonocytic cells\u001b[0m by human immunodefi\n",
      " repeat activity in \u001b[46m\u001b[30mhuman T\u001b[0m and monocytic \u001b[46m\u001b[30mcell lines\u001b[0m. We have tested the\n",
      "onsive cells of the \u001b[46m\u001b[30mT\u001b[0m and monocytic \u001b[46m\u001b[30mlineages\u001b[0m. Although resting t\n",
      "\n",
      "('g1-', 'g2/m-')\n",
      "ore strongly in the \u001b[46m\u001b[30mG1-\u001b[0m and G2/M-\u001b[46m\u001b[30mphase\u001b[0m enriched samples th\n",
      "\n",
      "('tnf-', 'cytokine-')\n",
      "ays mediated by the \u001b[46m\u001b[30mTNF-\u001b[0m and cytokine-\u001b[46m\u001b[30mreceptor\u001b[0m families target a c\n",
      "\n",
      "('transcription', 'proliferation')\n",
      "pression of certain \u001b[46m\u001b[30mtranscription\u001b[0m, differentiation and proliferation \u001b[46m\u001b[30mfactors\u001b[0m. Many of these gene\n",
      "\n",
      "(',', 'factor')\n",
      "pression of certain \u001b[46m\u001b[30mtranscription\u001b[0m, differentiation and proliferation \u001b[46m\u001b[30mfactors\u001b[0m. Many of these gene\n",
      "\n",
      "('differentiation', 'factor')\n",
      "pression of certain \u001b[46m\u001b[30mtranscription\u001b[0m, differentiation and proliferation \u001b[46m\u001b[30mfactors\u001b[0m. Many of these gene\n",
      "\n",
      "('prdii', 'tetrahexamer')\n",
      "tion. When purified \u001b[46m\u001b[30mPRDII\u001b[0m and tetrahexamer \u001b[46m\u001b[30mbinding proteins\u001b[0m were added to the i\n",
      "\n",
      "('natural', 'synthetic')\n",
      "ors. The binding of \u001b[46m\u001b[30mnatural\u001b[0m or synthetic \u001b[46m\u001b[30mligands\u001b[0m to nuclear receptor\n",
      "\n",
      "('plasma', 'urinary')\n",
      "ction and increased \u001b[46m\u001b[30mplasma\u001b[0m and urinary \u001b[46m\u001b[30mcortisol concentrations\u001b[0m. As cortisol is inv\n",
      "\n",
      "('91', '84')\n",
      "ted stat1 proteins (\u001b[46m\u001b[30m91\u001b[0m and 84 \u001b[46m\u001b[30mkDa proteins\u001b[0m) were translocated \n",
      "\n",
      "('e1a', 'hexon')\n",
      "ed sequences in the \u001b[46m\u001b[30madenovirus E1A\u001b[0m and hexon \u001b[46m\u001b[30mgenes\u001b[0m. The E1A and hexon \n",
      "nd hexon genes. The \u001b[46m\u001b[30mE1A\u001b[0m and hexon \u001b[46m\u001b[30mprimers\u001b[0m amplified DNA from \n",
      "\n",
      "('1q12', '1p36')\n",
      "s, specific for the \u001b[46m\u001b[30m1q12\u001b[0m and 1p36 \u001b[46m\u001b[30mregions\u001b[0m, respectively. Abno\n",
      "\n",
      "('membrane-bound', 'cytosolic')\n",
      "r 48) of the total, \u001b[46m\u001b[30mmembrane-bound\u001b[0m and cytosolic \u001b[46m\u001b[30menzyme\u001b[0m. By contrast, ICRF-\n",
      "\n",
      "('cd3', 'cd2')\n",
      "ter ligation of the \u001b[46m\u001b[30mCD3\u001b[0m and CD2 \u001b[46m\u001b[30mreceptors\u001b[0m in Jurkat and norma\n",
      "mphocytes following \u001b[46m\u001b[30mCD3\u001b[0m and CD2 \u001b[46m\u001b[30mreceptor stimulation\u001b[0m or activation by ph\n",
      "\n",
      "('inflammatory', 'immunoregulatory')\n",
      "hat are involved in \u001b[46m\u001b[30minflammatory\u001b[0m and immunoregulatory \u001b[46m\u001b[30mresponses\u001b[0m plays a critical ro\n",
      "\n",
      "('p55', 'ii')\n",
      "r alpha subunit and \u001b[46m\u001b[30mtumor necrosis factor (TNF) receptors\u001b[0m I (p55) and \u001b[46m\u001b[30mII (p75)\u001b[0m were also detected \n",
      "\n",
      "('(', 'ii')\n",
      "r alpha subunit and \u001b[46m\u001b[30mtumor necrosis factor (TNF) receptors\u001b[0m I (p55) and \u001b[46m\u001b[30mII (p75)\u001b[0m were also detected \n",
      "\n",
      "('cd33', 'receptor')\n",
      "phosphatase, CD11b, \u001b[46m\u001b[30mCD33\u001b[0m, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "('cd33', 'g-csf')\n",
      "phosphatase, CD11b, \u001b[46m\u001b[30mCD33\u001b[0m, and G-CSF receptor \u001b[46m\u001b[30mmRNA\u001b[0m, at concentrations \n",
      "\n",
      "('stat1', 'stat3')\n",
      " altered balance of \u001b[46m\u001b[30mStat1\u001b[0m and Stat3 \u001b[46m\u001b[30mtranscriptional activity\u001b[0m in the regulation o\n",
      "\n",
      "('proline-rich', 'glutamine-rich')\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, proline-rich, or \u001b[46m\u001b[30mglutamine-rich activation domain\u001b[0m. ZEBRA activation d\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, \u001b[46m\u001b[30mproline-rich\u001b[0m, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, \u001b[46m\u001b[30mproline-rich\u001b[0m, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "\n",
      "(',', 'glutamine-rich')\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, proline-rich, or \u001b[46m\u001b[30mglutamine-rich activation domain\u001b[0m. ZEBRA activation d\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, proline-rich, or \u001b[46m\u001b[30mglutamine-rich activation domain\u001b[0m. ZEBRA activation d\n",
      "\n",
      "(',', 'proto-oncogene')\n",
      ". The expression of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun and jun B \u001b[46m\u001b[30mproto-oncogenes\u001b[0m was studied in phyt\n",
      "\n",
      "('c-jun', 'proto-oncogene')\n",
      ". The expression of \u001b[46m\u001b[30mc-fos\u001b[0m, c-jun and jun B \u001b[46m\u001b[30mproto-oncogenes\u001b[0m was studied in phyt\n",
      "\n",
      "('(', 'thyrotropin')\n",
      "te the influence of \u001b[46m\u001b[30mserum\u001b[0m thyroxine (T4) and \u001b[46m\u001b[30mthyrotropin (TSH) levels\u001b[0m on receptor kinetic\n",
      "\n",
      "('thyroxine', 'thyrotropin')\n",
      "te the influence of \u001b[46m\u001b[30mserum\u001b[0m thyroxine (T4) and \u001b[46m\u001b[30mthyrotropin (TSH) levels\u001b[0m on receptor kinetic\n",
      "\n",
      "('t4', 'thyrotropin')\n",
      "te the influence of \u001b[46m\u001b[30mserum\u001b[0m thyroxine (T4) and \u001b[46m\u001b[30mthyrotropin (TSH) levels\u001b[0m on receptor kinetic\n",
      "\n",
      "('promoter-', 'specific')\n",
      "est that OCA-B is a \u001b[46m\u001b[30mtissue-\u001b[0m, promoter-, and factor-\u001b[46m\u001b[30mspecific coactivator\u001b[0m and that OCA-B may \n",
      "\n",
      "('tissue-', 'factor-')\n",
      "est that OCA-B is a \u001b[46m\u001b[30mtissue-\u001b[0m, promoter-, and factor-\u001b[46m\u001b[30mspecific coactivator\u001b[0m and that OCA-B may \n",
      "\n",
      "('calm', 'mll')\n",
      "(p13;q14) indicates \u001b[46m\u001b[30mCALM\u001b[0m and MLL \u001b[46m\u001b[30mrearrangements\u001b[0m in morphologically \n",
      "\n",
      "('rest', 'stimulate')\n",
      "scription factor in \u001b[46m\u001b[30mresting\u001b[0m and stimulated \u001b[46m\u001b[30mgranulocytes\u001b[0m. A reduction in the\n",
      "\n",
      "('encode', 'cellular')\n",
      " a complex array of \u001b[46m\u001b[30mvirally encoded\u001b[0m and cellular \u001b[46m\u001b[30mproteins\u001b[0m. A wide spectrum of\n",
      "\n",
      "('acetaminophen-', 'ccl4-')\n",
      " to protect against \u001b[46m\u001b[30macetaminophen-\u001b[0m and CCl4-\u001b[46m\u001b[30minduced hepatotoxicity\u001b[0m, lipid peroxidation\n",
      "\n",
      "('mue3', 'site')\n",
      "ncer containing the \u001b[46m\u001b[30mmuA\u001b[0m, muE3, and muB \u001b[46m\u001b[30msites\u001b[0m is transactivated b\n",
      "\n",
      "('cell-cell', 'cell-matrix')\n",
      "mation in promoting \u001b[46m\u001b[30mcell-cell\u001b[0m and cell-matrix \u001b[46m\u001b[30minteractions\u001b[0m. We observed that i\n",
      "\n",
      "('46,xx', '46,xy')\n",
      "ssays; 12 cases had \u001b[46m\u001b[30m46,XX\u001b[0m or 46,XY \u001b[46m\u001b[30mkaryotypes\u001b[0m, whereas 2 cases ha\n",
      "\n",
      "('vi', 'not')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('vi', 'but')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('vi', 'iii')\n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "etween the cells of \u001b[46m\u001b[30mCategories\u001b[0m Va, \u001b[46m\u001b[30mVI\u001b[0m and DFR but not Category III \u001b[46m\u001b[30mcells\u001b[0m. Cells within each \n",
      "\n",
      "('junb', 'fra-1')\n",
      "-fos, c-jun, c-myc, \u001b[46m\u001b[30mjunB\u001b[0m, and fra-1 \u001b[46m\u001b[30mmRNAs\u001b[0m was increased in ac\n",
      "\n",
      "('40', '130')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass 40\u001b[0m, 42, 70, 120, and 130 \u001b[46m\u001b[30mkDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "\n",
      "('p53', 'bak')\n",
      "ut had no effect on \u001b[46m\u001b[30mp53\u001b[0m, Bax, or Bak \u001b[46m\u001b[30mgene expression\u001b[0m. Mechanisms for tra\n",
      "\n",
      "('bax', 'gene')\n",
      "ut had no effect on \u001b[46m\u001b[30mp53\u001b[0m, Bax, or Bak \u001b[46m\u001b[30mgene expression\u001b[0m. Mechanisms for tra\n",
      "\n",
      "('jak3', 'fe')\n",
      "es. The Jak1, Jak2, \u001b[46m\u001b[30mJak3\u001b[0m, and Fes \u001b[46m\u001b[30mtyrosine kinases\u001b[0m have been demonstra\n",
      "\n",
      "('1', 'gamma')\n",
      "for GATA-1, and for \u001b[46m\u001b[30malpha 1\u001b[0m, alpha 2 and gamma \u001b[46m\u001b[30mglobin genes\u001b[0m. These results indi\n",
      "\n",
      "(',', 'globin')\n",
      "for GATA-1, and for \u001b[46m\u001b[30malpha 1\u001b[0m, alpha 2 and gamma \u001b[46m\u001b[30mglobin genes\u001b[0m. These results indi\n",
      "\n",
      "('2', 'globin')\n",
      "for GATA-1, and for \u001b[46m\u001b[30malpha 1\u001b[0m, alpha 2 and gamma \u001b[46m\u001b[30mglobin genes\u001b[0m. These results indi\n",
      "\n",
      "('alpha', 'globin')\n",
      "for GATA-1, and for \u001b[46m\u001b[30malpha 1\u001b[0m, alpha 2 and gamma \u001b[46m\u001b[30mglobin genes\u001b[0m. These results indi\n",
      "\n",
      "('rel', 'p65')\n",
      "te bound translated \u001b[46m\u001b[30mc-Rel\u001b[0m and p65 \u001b[46m\u001b[30mhomodimers\u001b[0m but not p50/p65 het\n",
      "\n",
      "('creb', 'atf1')\n",
      " CRE interacts with \u001b[46m\u001b[30mCREB\u001b[0m and ATF1 \u001b[46m\u001b[30mproteins\u001b[0m present in B cell n\n",
      "\n",
      "('erythroid', 't-cell')\n",
      "-1 transcription in \u001b[46m\u001b[30merythroid\u001b[0m and T-cell \u001b[46m\u001b[30mlines\u001b[0m. The tal-1 gene, fr\n",
      "\n",
      "('endocrine', 'nonendocrine')\n",
      "xamine a variety of \u001b[46m\u001b[30mendocrine\u001b[0m and nonendocrine \u001b[46m\u001b[30mcell lineages\u001b[0m for differences in \n",
      "\n",
      "('nf-kappab', 'four')\n",
      "ntirely missing the \u001b[46m\u001b[30mNF-kappaB\u001b[0m and four Spl \u001b[46m\u001b[30mbinding elements\u001b[0m, replicated with wi\n",
      "\n",
      "('nf-kappab', 'spl')\n",
      "ntirely missing the \u001b[46m\u001b[30mNF-kappaB\u001b[0m and four Spl \u001b[46m\u001b[30mbinding elements\u001b[0m, replicated with wi\n",
      "\n",
      "('b', 'l')\n",
      "and S2' subsites of \u001b[46m\u001b[30mcathepsin\u001b[0m B and \u001b[46m\u001b[30mL\u001b[0m, and not in the S1 \n",
      "\n",
      "('protein', 'mrna')\n",
      " down-regulation of \u001b[46m\u001b[30mStat1 protein\u001b[0m and mRNA \u001b[46m\u001b[30mlevels\u001b[0m. Our results demons\n",
      "gulated at both the \u001b[46m\u001b[30mprotein\u001b[0m and mRNA \u001b[46m\u001b[30mlevels\u001b[0m. To understand the \n",
      " down-regulation of \u001b[46m\u001b[30mStat1\u001b[0m protein and \u001b[46m\u001b[30mmRNA levels\u001b[0m. Our results demons\n",
      "\n",
      "('infectious', 'neoplastic')\n",
      "toimmune, allergic, \u001b[46m\u001b[30minfectious\u001b[0m, or neoplastic \u001b[46m\u001b[30mdiseases\u001b[0m.\n",
      "\n",
      "('sequence-', 'pituitary-')\n",
      "moter activity in a \u001b[46m\u001b[30mDNA sequence-\u001b[0m and pituitary-\u001b[46m\u001b[30mspecific manner\u001b[0m. The transcription \n",
      "\n",
      "('control', 'er-')\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "\n",
      "('e2-treated', 'cell')\n",
      "l-mediated lysis of \u001b[46m\u001b[30mcontrol\u001b[0m, E2-treated, and TAM-treated \u001b[46m\u001b[30mER+\u001b[0m and ER- \u001b[46m\u001b[30mcells\u001b[0m. These in vitro res\n",
      "\n",
      "('dp', 'alpha')\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('-beta', 'alpha')\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('dp', 'dq')\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('-beta', 'dq')\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP\u001b[0m alpha and \u001b[46m\u001b[30m-beta\u001b[0m, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('estrogen-dependent', 'tissue-specific')\n",
      "imary cultures. The \u001b[46m\u001b[30mestrogen-dependent\u001b[0m and tissue-specific \u001b[46m\u001b[30mregulation\u001b[0m of the Xenopus laev\n",
      "\n",
      "('a', 'with')\n",
      " were infected with \u001b[46m\u001b[30mtype A\u001b[0m and one with type B \u001b[46m\u001b[30mEBV\u001b[0m. Polyclonal and clo\n",
      "\n",
      "('a', 'one')\n",
      " were infected with \u001b[46m\u001b[30mtype A\u001b[0m and one with type B \u001b[46m\u001b[30mEBV\u001b[0m. Polyclonal and clo\n",
      "\n",
      "('sp1', 'ap2')\n",
      "is reveals putative \u001b[46m\u001b[30mSp1\u001b[0m and Ap2 \u001b[46m\u001b[30mbinding site/s\u001b[0m and absence of TATA\n",
      "\n",
      "('mature', 'immature')\n",
      "dantly expressed in \u001b[46m\u001b[30mmature\u001b[0m and immature \u001b[46m\u001b[30mT-cell lines\u001b[0m (Jurkat, CCRF-CEM) \n",
      "\n",
      "('oct-1', 'oca-b')\n",
      "on severely impairs \u001b[46m\u001b[30mOct-1\u001b[0m and OCA-B \u001b[46m\u001b[30mfunction\u001b[0m in a cell-free syst\n",
      "\n",
      "('oct-1', 'oct-2')\n",
      "en T cells, whereas \u001b[46m\u001b[30mOct-1\u001b[0m and Oct-2 \u001b[46m\u001b[30mDNA binding activity\u001b[0m was similar in both\n",
      "\n",
      "('tissue-specific', 'developmental')\n",
      "enes are subject to \u001b[46m\u001b[30mtissue-specific\u001b[0m and developmental stage-specific \u001b[46m\u001b[30mregulation\u001b[0m. A switch from huma\n",
      "\n",
      "('tissue-specific', 'stage-specific')\n",
      "enes are subject to \u001b[46m\u001b[30mtissue-specific\u001b[0m and developmental stage-specific \u001b[46m\u001b[30mregulation\u001b[0m. A switch from huma\n",
      "\n",
      "(')', 'fcs-')\n",
      "eripheral blood. In \u001b[46m\u001b[30mclonogenetic fetal calf serum-supplemented (FCS+)\u001b[0m or -nonsupplemented (FCS-) \u001b[46m\u001b[30mculture\u001b[0m treated with satura\n",
      "\n",
      "('u-937', 'tur')\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not \u001b[46m\u001b[30mTUR\u001b[0m, cells. Okadaic aci\n",
      "\n",
      "('tpa-treated', 'not')\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not \u001b[46m\u001b[30mTUR\u001b[0m, cells. Okadaic aci\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not TUR, \u001b[46m\u001b[30mcells\u001b[0m. Okadaic acid treat\n",
      "\n",
      "(',', 'tur')\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not \u001b[46m\u001b[30mTUR\u001b[0m, cells. Okadaic aci\n",
      "\n",
      "('/csa', '/fk506')\n",
      "lock binding by the \u001b[46m\u001b[30mcyclophilin A/CsA\u001b[0m or FKBP12/FK506 \u001b[46m\u001b[30mcomplexes\u001b[0m and thereby render \n",
      "\n",
      "('/csa', 'fkbp12')\n",
      "lock binding by the \u001b[46m\u001b[30mcyclophilin A/CsA\u001b[0m or FKBP12/FK506 \u001b[46m\u001b[30mcomplexes\u001b[0m and thereby render \n",
      "\n",
      "(')', 'gamma')\n",
      "alpha)), as well as \u001b[46m\u001b[30mIFN(\u001b[0mbeta) and \u001b[46m\u001b[30mgamma\u001b[0m, results in an incr\n",
      "\n",
      "('resident', 'inflammatory')\n",
      "teinase produced by \u001b[46m\u001b[30mresident\u001b[0m and inflammatory \u001b[46m\u001b[30mcells\u001b[0m during connective t\n",
      "\n",
      "('deltaspi-b', 'spi-b')\n",
      "n B lymphoid cells, \u001b[46m\u001b[30mdeltaspi-B\u001b[0m and spi-B \u001b[46m\u001b[30mmRNAs\u001b[0m were present simult\n",
      "\n",
      "('1367', '1419')\n",
      " the E1a region (at \u001b[46m\u001b[30mnt\u001b[0m 1333, 1367, or \u001b[46m\u001b[30m1419\u001b[0m). There was not any\n",
      "\n",
      "(',', '1419')\n",
      " the E1a region (at \u001b[46m\u001b[30mnt\u001b[0m 1333, 1367, or \u001b[46m\u001b[30m1419\u001b[0m). There was not any\n",
      " the E1a region (at \u001b[46m\u001b[30mnt\u001b[0m 1333, 1367, or \u001b[46m\u001b[30m1419\u001b[0m). There was not any\n",
      "\n",
      "('1333', '1419')\n",
      " the E1a region (at \u001b[46m\u001b[30mnt\u001b[0m 1333, 1367, or \u001b[46m\u001b[30m1419\u001b[0m). There was not any\n",
      "\n",
      "('creb/atf', 'sp1')\n",
      " further induced by \u001b[46m\u001b[30mCREB/ATF\u001b[0m and Sp1 \u001b[46m\u001b[30mfactors\u001b[0m through proximal up\n",
      "\n",
      "('-', '-selected')\n",
      "rter construct, the \u001b[46m\u001b[30mp65\u001b[0m -and p50\u001b[46m\u001b[30m-selected motifs\u001b[0m were activated only\n",
      "\n",
      "('p65', 'p50')\n",
      "rter construct, the \u001b[46m\u001b[30mp65\u001b[0m -and p50\u001b[46m\u001b[30m-selected motifs\u001b[0m were activated only\n",
      "\n",
      "('granulocyte', 'monocyte')\n",
      "d cell features and \u001b[46m\u001b[30mgranulocyte\u001b[0m or monocyte \u001b[46m\u001b[30mdifferentiation\u001b[0m could be induced in\n",
      "\n",
      "('hla-dra', 'dqb')\n",
      "ent transfection of \u001b[46m\u001b[30mHLA-DRA\u001b[0m and DQB \u001b[46m\u001b[30mreporter constructs\u001b[0m indicated that the \n",
      "\n",
      "('tpa-treated', 'tur')\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not TUR, \u001b[46m\u001b[30mcells\u001b[0m. Okadaic acid treat\n",
      "\n",
      "('tpa-treated', ',')\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not TUR, \u001b[46m\u001b[30mcells\u001b[0m. Okadaic acid treat\n",
      "\n",
      "('u-937', 'cell')\n",
      "n of this kinase in \u001b[46m\u001b[30mTPA-treated\u001b[0m U-937, and not TUR, \u001b[46m\u001b[30mcells\u001b[0m. Okadaic acid treat\n",
      "\n",
      "('megakaryocytic', 'mastocytic/basophilic')\n",
      " for the erythroid, \u001b[46m\u001b[30mmegakaryocytic\u001b[0m, and mastocytic/basophilic \u001b[46m\u001b[30mlineages\u001b[0m, we studied GATA-1 \n",
      "\n",
      "('pthrp', 'il2r')\n",
      "ivation of both the \u001b[46m\u001b[30mPTHrP\u001b[0m and IL2R alpha \u001b[46m\u001b[30mpromoters\u001b[0m but not the HTLV-I \n",
      "\n",
      "('pthrp', 'alpha')\n",
      "ivation of both the \u001b[46m\u001b[30mPTHrP\u001b[0m and IL2R alpha \u001b[46m\u001b[30mpromoters\u001b[0m but not the HTLV-I \n",
      "\n",
      "('thymus', 't')\n",
      "nd primarily in the \u001b[46m\u001b[30mthymus\u001b[0m or T \u001b[46m\u001b[30mcell lines\u001b[0m. The immature CEM T\n",
      "\n",
      "('maternal', 'biallelic')\n",
      "revious findings of \u001b[46m\u001b[30mmaternal\u001b[0m or biallelic \u001b[46m\u001b[30mexpression\u001b[0m in placentae and br\n",
      "\n",
      "('cytometric', 'morphological')\n",
      "psilon transcripts. \u001b[46m\u001b[30mFlow cytometric\u001b[0m and morphological \u001b[46m\u001b[30manalyses\u001b[0m demonstrated that t\n",
      "\n",
      "('traf2', 'traf6')\n",
      "tive mutants of the \u001b[46m\u001b[30mTRAF2\u001b[0m and TRAF6 \u001b[46m\u001b[30madaptors\u001b[0m, which effectively \n",
      "\n",
      "('55-', '85-')\n",
      "ation of binding of \u001b[46m\u001b[30m55-\u001b[0m and 85-\u001b[46m\u001b[30mkDa proteins\u001b[0m to the kappa B enha\n",
      "\n",
      "('polyclonal', 'clonal')\n",
      "re detected in both \u001b[46m\u001b[30mpolyclonal\u001b[0m and clonal \u001b[46m\u001b[30mCD3-CD16+ natural killer(NK) cell lines\u001b[0m. Two unrearranged T\n",
      "ne with type B EBV. \u001b[46m\u001b[30mPolyclonal\u001b[0m and clonal \u001b[46m\u001b[30mCTL\u001b[0m that were generated\n",
      "\n",
      "('prl-', 'il-2-')\n",
      "able for one of the \u001b[46m\u001b[30mPRL-\u001b[0m and IL-2-\u001b[46m\u001b[30minduced factors\u001b[0m. A transcription fa\n",
      "\n",
      "('androgen-', 'antiandrogen-')\n",
      "lated in vitro, and \u001b[46m\u001b[30mandrogen-\u001b[0m and antiandrogen-\u001b[46m\u001b[30mbound receptor complexes\u001b[0m were studied using \n",
      "\n",
      "('-alpha', '-beta')\n",
      "nt study shows that \u001b[46m\u001b[30mIFN\u001b[0m-alpha and \u001b[46m\u001b[30m-beta\u001b[0m mediate anti-apopto\n",
      "\n",
      "('alpha-induced', 'pkc')\n",
      "echanism, including \u001b[46m\u001b[30mtumor necrosis factor alpha-induced\u001b[0m and protein kinase C (PKC)-dependent \u001b[46m\u001b[30mactivation\u001b[0m of NF-kappa B, and \n",
      "\n",
      "('alpha-induced', '-dependent')\n",
      "echanism, including \u001b[46m\u001b[30mtumor necrosis factor alpha-induced\u001b[0m and protein kinase C (PKC)-dependent \u001b[46m\u001b[30mactivation\u001b[0m of NF-kappa B, and \n",
      "\n",
      "('alpha-induced', 'protein')\n",
      "echanism, including \u001b[46m\u001b[30mtumor necrosis factor alpha-induced\u001b[0m and protein kinase C (PKC)-dependent \u001b[46m\u001b[30mactivation\u001b[0m of NF-kappa B, and \n",
      "\n",
      "('alpha-induced', '(')\n",
      "echanism, including \u001b[46m\u001b[30mtumor necrosis factor alpha-induced\u001b[0m and protein kinase C (PKC)-dependent \u001b[46m\u001b[30mactivation\u001b[0m of NF-kappa B, and \n",
      "\n",
      "('alpha-induced', 'c')\n",
      "echanism, including \u001b[46m\u001b[30mtumor necrosis factor alpha-induced\u001b[0m and protein kinase C (PKC)-dependent \u001b[46m\u001b[30mactivation\u001b[0m of NF-kappa B, and \n",
      "\n",
      "('alpha-induced', 'kinase')\n",
      "echanism, including \u001b[46m\u001b[30mtumor necrosis factor alpha-induced\u001b[0m and protein kinase C (PKC)-dependent \u001b[46m\u001b[30mactivation\u001b[0m of NF-kappa B, and \n",
      "\n",
      "('alpha-induced', ')')\n",
      "echanism, including \u001b[46m\u001b[30mtumor necrosis factor alpha-induced\u001b[0m and protein kinase C (PKC)-dependent \u001b[46m\u001b[30mactivation\u001b[0m of NF-kappa B, and \n",
      "\n",
      "(',', 'tumor')\n",
      "n normal epidermis, \u001b[46m\u001b[30mbenign\u001b[0m, and malignant \u001b[46m\u001b[30mtumors\u001b[0m originating from ep\n",
      "\n",
      "('benign', 'malignant')\n",
      "n normal epidermis, \u001b[46m\u001b[30mbenign\u001b[0m, and malignant \u001b[46m\u001b[30mtumors\u001b[0m originating from ep\n",
      "\n",
      "('heterologous', 'glutamine-rich')\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, \u001b[46m\u001b[30mproline-rich\u001b[0m, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "\n",
      "('acidic', 'activation')\n",
      "an be replaced by a \u001b[46m\u001b[30mheterologous\u001b[0m acidic, \u001b[46m\u001b[30mproline-rich\u001b[0m, or glutamine-rich \u001b[46m\u001b[30mactivation domain\u001b[0m. ZEBRA activation d\n",
      "\n",
      "('il-4', 'il-13')\n",
      "o P elements of the \u001b[46m\u001b[30mIL-4\u001b[0m and IL-13 \u001b[46m\u001b[30mpromoters\u001b[0m, than do freshly-is\n",
      "\n",
      "('-8', '-6')\n",
      "pha, the chemokines \u001b[46m\u001b[30minterleukin (IL)\u001b[0m-8 and \u001b[46m\u001b[30m-6\u001b[0m, and matrix metallo\n",
      "\n",
      "('ctf', 'gene')\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('creb', 'nf-kappa')\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('creb', 'b')\n",
      "ferential response: \u001b[46m\u001b[30mCREB\u001b[0m, CTF, OTF-1, OFT-2, and NF-kappa B \u001b[46m\u001b[30mgenes\u001b[0m were strongly induc\n",
      "\n",
      "('mrl-lpr/lpr', 'cd4(-)')\n",
      "orter constructs in \u001b[46m\u001b[30mMRL-lpr/lpr\u001b[0m and C3H-gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m were constitutively\n",
      " fasL. Unstimulated \u001b[46m\u001b[30mMRL-lpr/lpr\u001b[0m and C3H-gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m constitutively cont\n",
      "\n",
      "('mrl-lpr/lpr', 'c3h-gld/gld')\n",
      "orter constructs in \u001b[46m\u001b[30mMRL-lpr/lpr\u001b[0m and C3H-gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m were constitutively\n",
      " fasL. Unstimulated \u001b[46m\u001b[30mMRL-lpr/lpr\u001b[0m and C3H-gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m constitutively cont\n",
      "\n",
      "('mrl-lpr/lpr', 'cd8(-)')\n",
      "orter constructs in \u001b[46m\u001b[30mMRL-lpr/lpr\u001b[0m and C3H-gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m were constitutively\n",
      " fasL. Unstimulated \u001b[46m\u001b[30mMRL-lpr/lpr\u001b[0m and C3H-gld/gld CD4(-)CD8(-) \u001b[46m\u001b[30mT cells\u001b[0m constitutively cont\n",
      "\n",
      "('transform', 'normal')\n",
      "rotein TBP. In both \u001b[46m\u001b[30mtransformed\u001b[0m and normal \u001b[46m\u001b[30mlymphocytes\u001b[0m, OKA stimulation in\n",
      "\n",
      "('cell-cell', 'cell-extracellular')\n",
      "4 integrins mediate \u001b[46m\u001b[30mcell-cell\u001b[0m and cell-extracellular matrix \u001b[46m\u001b[30minteractions\u001b[0m that are critical f\n",
      "\n",
      "('cell-cell', 'matrix')\n",
      "4 integrins mediate \u001b[46m\u001b[30mcell-cell\u001b[0m and cell-extracellular matrix \u001b[46m\u001b[30minteractions\u001b[0m that are critical f\n",
      "\n",
      "('-', 'myelin')\n",
      "e peptide ligand of \u001b[46m\u001b[30mtetanus toxoid (TT)-\u001b[0m and myelin basic protein (MBP)-\u001b[46m\u001b[30mspecific human T cell lines\u001b[0m. The TT-selected T \n",
      "\n",
      "('-', 'protein')\n",
      "e peptide ligand of \u001b[46m\u001b[30mtetanus toxoid (TT)-\u001b[0m and myelin basic protein (MBP)-\u001b[46m\u001b[30mspecific human T cell lines\u001b[0m. The TT-selected T \n",
      "\n",
      "('-', 'mbp')\n",
      "e peptide ligand of \u001b[46m\u001b[30mtetanus toxoid (TT)-\u001b[0m and myelin basic protein (MBP)-\u001b[46m\u001b[30mspecific human T cell lines\u001b[0m. The TT-selected T \n",
      "\n",
      "('-', 'basic')\n",
      "e peptide ligand of \u001b[46m\u001b[30mtetanus toxoid (TT)-\u001b[0m and myelin basic protein (MBP)-\u001b[46m\u001b[30mspecific human T cell lines\u001b[0m. The TT-selected T \n",
      "\n",
      "('lamin', 'transcript')\n",
      "nduced increases in \u001b[46m\u001b[30mlamin A\u001b[0m, lamin C, and vimentin \u001b[46m\u001b[30mtranscripts\u001b[0m. Other studies have\n",
      "\n",
      "('c', 'transcript')\n",
      "nduced increases in \u001b[46m\u001b[30mlamin A\u001b[0m, lamin C, and vimentin \u001b[46m\u001b[30mtranscripts\u001b[0m. Other studies have\n",
      "\n",
      "('a', 'vimentin')\n",
      "nduced increases in \u001b[46m\u001b[30mlamin A\u001b[0m, lamin C, and vimentin \u001b[46m\u001b[30mtranscripts\u001b[0m. Other studies have\n",
      "\n",
      "('humoral', 'cell-mediated')\n",
      "nic response toward \u001b[46m\u001b[30mhumoral\u001b[0m or cell-mediated \u001b[46m\u001b[30mimmunity\u001b[0m. Although lymphokin\n",
      "\n",
      "('k-562', 'hela')\n",
      " abundant in U-937, \u001b[46m\u001b[30mK-562\u001b[0m, and HeLa \u001b[46m\u001b[30mcell extracts\u001b[0m than in Raji, HF, B\n",
      "\n",
      "('fo', 'protein')\n",
      "Involvement of \u001b[46m\u001b[30mRel\u001b[0m, Fos, and Jun \u001b[46m\u001b[30mproteins\u001b[0m in binding activity\n",
      "\n",
      "('rel', 'jun')\n",
      "Involvement of \u001b[46m\u001b[30mRel\u001b[0m, Fos, and Jun \u001b[46m\u001b[30mproteins\u001b[0m in binding activity\n",
      "\n",
      "('ap-1-', 'nf-at/ap-1-')\n",
      "f deltorphin to the \u001b[46m\u001b[30mAP-1-\u001b[0m and NF-AT/AP-1-\u001b[46m\u001b[30mbinding sites\u001b[0m of the IL-2 promote\n",
      "\n",
      "('physico-chemical', 'functional')\n",
      " was discussed. The \u001b[46m\u001b[30mphysico-chemical\u001b[0m and functional \u001b[46m\u001b[30mparameters\u001b[0m of the low molecula\n",
      "\n",
      "('beta', 'kappa')\n",
      "e increases in both \u001b[46m\u001b[30mIL-1 beta\u001b[0m and I kappa B alpha/MAD-3 mRNA \u001b[46m\u001b[30mlevels\u001b[0m were detected in nu\n",
      "\n",
      "('beta', 'i')\n",
      "e increases in both \u001b[46m\u001b[30mIL-1 beta\u001b[0m and I kappa B alpha/MAD-3 mRNA \u001b[46m\u001b[30mlevels\u001b[0m were detected in nu\n",
      "\n",
      "('beta', 'mrna')\n",
      "e increases in both \u001b[46m\u001b[30mIL-1 beta\u001b[0m and I kappa B alpha/MAD-3 mRNA \u001b[46m\u001b[30mlevels\u001b[0m were detected in nu\n",
      "\n",
      "('beta', 'alpha/mad-3')\n",
      "e increases in both \u001b[46m\u001b[30mIL-1 beta\u001b[0m and I kappa B alpha/MAD-3 mRNA \u001b[46m\u001b[30mlevels\u001b[0m were detected in nu\n",
      "\n",
      "('beta', 'b')\n",
      "e increases in both \u001b[46m\u001b[30mIL-1 beta\u001b[0m and I kappa B alpha/MAD-3 mRNA \u001b[46m\u001b[30mlevels\u001b[0m were detected in nu\n",
      "\n",
      "('lps-', 'stimulated')\n",
      "ear protein(s) from \u001b[46m\u001b[30mLAM-\u001b[0m, LPS-, or TNF-alpha- \u001b[46m\u001b[30mstimulated THP-1 cells\u001b[0m to the NF-IL6 motif\n",
      "\n",
      "('lam-', 'tnf-alpha-')\n",
      "ear protein(s) from \u001b[46m\u001b[30mLAM-\u001b[0m, LPS-, or TNF-alpha- \u001b[46m\u001b[30mstimulated THP-1 cells\u001b[0m to the NF-IL6 motif\n",
      "\n",
      "('-585', '-650')\n",
      "to two sites around \u001b[46m\u001b[30mpositions\u001b[0m -585 and \u001b[46m\u001b[30m-650\u001b[0m located upstream of\n",
      "\n",
      "('acetate-', 'lipopolysaccharide-')\n",
      "ts the HIV -but not \u001b[46m\u001b[30mphorbol myristate acetate-\u001b[0m or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('creb/atf', 'srf')\n",
      ", activation of the \u001b[46m\u001b[30mCREB/ATF\u001b[0m and SRF \u001b[46m\u001b[30mpathways\u001b[0m is also required.\n",
      "\n",
      "('0', '2')\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper\u001b[0m 0 (Th0) and \u001b[46m\u001b[30m2 (Th2) subset\u001b[0m, was originally des\n",
      "\n",
      "('(', '2')\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper\u001b[0m 0 (Th0) and \u001b[46m\u001b[30m2 (Th2) subset\u001b[0m, was originally des\n",
      "\n",
      "('th0', '2')\n",
      "4, a product of the \u001b[46m\u001b[30mT-helper\u001b[0m 0 (Th0) and \u001b[46m\u001b[30m2 (Th2) subset\u001b[0m, was originally des\n",
      "\n",
      "(\"s1'\", \"s2'\")\n",
      " any of the S2, S1, \u001b[46m\u001b[30mS1'\u001b[0m, and S2' \u001b[46m\u001b[30msubsites\u001b[0m of cathepsin B and \n",
      "\n",
      "('tgf-alpha', 'tgf-beta1')\n",
      "ndent regulation of \u001b[46m\u001b[30mTGF-alpha\u001b[0m and TGF-beta1 \u001b[46m\u001b[30mexpression\u001b[0m in human eosinophil\n",
      "\n",
      "('n', 'the')\n",
      "tion domains at the \u001b[46m\u001b[30mN\u001b[0m and the C \u001b[46m\u001b[30mtermini\u001b[0m. The transcriptiona\n",
      "\n",
      "('fo', 'ets')\n",
      "NF-AT, but not Jun, \u001b[46m\u001b[30mFos\u001b[0m, NF-kappaB, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n",
      "('gm-csf', 'gene')\n",
      "d (3) expression of \u001b[46m\u001b[30mIL-3\u001b[0m, GM-CSF, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "\n",
      "('il-3', 'egr-1')\n",
      "d (3) expression of \u001b[46m\u001b[30mIL-3\u001b[0m, GM-CSF, FMS and EGR-1 \u001b[46m\u001b[30mgenes\u001b[0m which are all locat\n",
      "\n",
      "('il-5', 'il-4')\n",
      "sponsiveness of the \u001b[46m\u001b[30mIL-5\u001b[0m and IL-4 \u001b[46m\u001b[30mgenes\u001b[0m to transcription fa\n",
      "\n",
      "('b-', 'nk-')\n",
      ", leukocytes of the \u001b[46m\u001b[30mB-\u001b[0m, T-, and NK-\u001b[46m\u001b[30mcell lineages\u001b[0m were treated with e\n",
      "\n",
      "('t-', 'cell')\n",
      ", leukocytes of the \u001b[46m\u001b[30mB-\u001b[0m, T-, and NK-\u001b[46m\u001b[30mcell lineages\u001b[0m were treated with e\n",
      "\n",
      "('specific', 'non-specific')\n",
      "r components of the \u001b[46m\u001b[30mspecific\u001b[0m and non-specific \u001b[46m\u001b[30mimmunoreaction\u001b[0m. MRP14 (Macrophage \n",
      "\n",
      "('upstream', 'a')\n",
      " be divided into an \u001b[46m\u001b[30mupstream\u001b[0m and a downstream \u001b[46m\u001b[30mregulatory region\u001b[0m. The downstream reg\n",
      "\n",
      "('cd3', 'cd45')\n",
      " lines deficient in \u001b[46m\u001b[30mCD3\u001b[0m or CD45 \u001b[46m\u001b[30mexpression\u001b[0m also gave impaired \n",
      "\n",
      "('ap-1', 'site')\n",
      "rs that bind to the \u001b[46m\u001b[30mNF-AT1\u001b[0m, AP-1, and NF-kB \u001b[46m\u001b[30msites\u001b[0m located in the prom\n",
      "\n",
      "('nf-at1', 'nf-kb')\n",
      "rs that bind to the \u001b[46m\u001b[30mNF-AT1\u001b[0m, AP-1, and NF-kB \u001b[46m\u001b[30msites\u001b[0m located in the prom\n",
      "\n",
      "('residue', ',')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, \u001b[46m\u001b[30m438\u001b[0m, and 440 (position \n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, \u001b[46m\u001b[30m438\u001b[0m, and 440 (position \n",
      "\n",
      "('residue', '437')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, \u001b[46m\u001b[30m438\u001b[0m, and 440 (position \n",
      "\n",
      "('residue', '435')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, \u001b[46m\u001b[30m438\u001b[0m, and 440 (position \n",
      "\n",
      "('432', '438')\n",
      "QA1*0201/DQB1*0201. \u001b[46m\u001b[30mResidues\u001b[0m 432, 435, 437, \u001b[46m\u001b[30m438\u001b[0m, and 440 (position \n",
      "\n",
      "('-', '-induced')\n",
      "n. Furthermore, the \u001b[46m\u001b[30mVitD3\u001b[0m -and the PMA\u001b[46m\u001b[30m-induced CD14 expression\u001b[0m was inhibited as a \n",
      "\n",
      "('vitd3', 'the')\n",
      "n. Furthermore, the \u001b[46m\u001b[30mVitD3\u001b[0m -and the PMA\u001b[46m\u001b[30m-induced CD14 expression\u001b[0m was inhibited as a \n",
      "\n",
      "('vitd3', 'pma')\n",
      "n. Furthermore, the \u001b[46m\u001b[30mVitD3\u001b[0m -and the PMA\u001b[46m\u001b[30m-induced CD14 expression\u001b[0m was inhibited as a \n",
      "\n",
      "('b-cell', 't-cell')\n",
      " at early stages of \u001b[46m\u001b[30mB-cell\u001b[0m and T-cell \u001b[46m\u001b[30mdifferentiation\u001b[0m. The expression of \n",
      "\n",
      "('ferritin', 'transferrin')\n",
      "RE transcripts from \u001b[46m\u001b[30mferritin\u001b[0m or transferrin \u001b[46m\u001b[30mreceptor mRNAs\u001b[0m. A transcript of th\n",
      "\n",
      "('young', 'aged')\n",
      "clear leukocytes of \u001b[46m\u001b[30myoung\u001b[0m and aged \u001b[46m\u001b[30msubjects\u001b[0m. The dexamethasone \n",
      "\n",
      "('akv', 'murine')\n",
      "tory regions of the \u001b[46m\u001b[30mlymphomagenic Akv\u001b[0m and SL3-3 murine leukemia \u001b[46m\u001b[30mretroviruses\u001b[0m (MLVs) contain two \n",
      "\n",
      "('akv', 'sl3-3')\n",
      "tory regions of the \u001b[46m\u001b[30mlymphomagenic Akv\u001b[0m and SL3-3 murine leukemia \u001b[46m\u001b[30mretroviruses\u001b[0m (MLVs) contain two \n",
      "\n",
      "('akv', 'leukemia')\n",
      "tory regions of the \u001b[46m\u001b[30mlymphomagenic Akv\u001b[0m and SL3-3 murine leukemia \u001b[46m\u001b[30mretroviruses\u001b[0m (MLVs) contain two \n",
      "\n",
      "('basal', 'induced')\n",
      "ed several peaks of \u001b[46m\u001b[30mbasal\u001b[0m and PMA induced \u001b[46m\u001b[30mactivity\u001b[0m suggesting the pres\n",
      "\n",
      "('cortisol', 'cortisol')\n",
      "ybridization assay. \u001b[46m\u001b[30mSerum cortisol\u001b[0m, osteocalcin and urinary cortisol \u001b[46m\u001b[30mlevels\u001b[0m were also determine\n",
      "\n",
      "('cortisol', 'urinary')\n",
      "ybridization assay. \u001b[46m\u001b[30mSerum cortisol\u001b[0m, osteocalcin and urinary cortisol \u001b[46m\u001b[30mlevels\u001b[0m were also determine\n",
      "\n",
      "(',', 'level')\n",
      "ybridization assay. \u001b[46m\u001b[30mSerum cortisol\u001b[0m, osteocalcin and urinary cortisol \u001b[46m\u001b[30mlevels\u001b[0m were also determine\n",
      "\n",
      "('osteocalcin', 'level')\n",
      "ybridization assay. \u001b[46m\u001b[30mSerum cortisol\u001b[0m, osteocalcin and urinary cortisol \u001b[46m\u001b[30mlevels\u001b[0m were also determine\n",
      "\n",
      "('humoral', 'cd8')\n",
      "ion, and support of \u001b[46m\u001b[30mhumoral\u001b[0m and CD8 \u001b[46m\u001b[30mresponses\u001b[0m. The antigens recog\n",
      "\n",
      "('redundancy', 'pleiotropy')\n",
      "molecular bases for \u001b[46m\u001b[30mcytokine\u001b[0m redundancy and \u001b[46m\u001b[30mpleiotropy\u001b[0m, we have compared t\n",
      "\n",
      "('mbp-', 'gst-')\n",
      "ubation of purified \u001b[46m\u001b[30mMBP-\u001b[0m or GST-\u001b[46m\u001b[30mHBD\u001b[0m with rabbit reticul\n",
      "\n",
      "('nb2', 'c196')\n",
      "binding proteins in \u001b[46m\u001b[30mNb2\u001b[0m and C196 \u001b[46m\u001b[30mT cell lines\u001b[0m were investigated. \n",
      "\n",
      "('t', 'mitogenesis')\n",
      "are not involved in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocyte\u001b[0m activation and \u001b[46m\u001b[30mmitogenesis\u001b[0m.\n",
      "\n",
      "('and', 'mitogenesis')\n",
      "are not involved in \u001b[46m\u001b[30mB\u001b[0m and T \u001b[46m\u001b[30mlymphocyte\u001b[0m activation and \u001b[46m\u001b[30mmitogenesis\u001b[0m.\n",
      "\n",
      "('cd14', 'cd23')\n",
      " inverse effects on \u001b[46m\u001b[30mCD14\u001b[0m and CD23 \u001b[46m\u001b[30mgene expression\u001b[0m.\n",
      "n the regulation of \u001b[46m\u001b[30mCD14\u001b[0m and CD23 \u001b[46m\u001b[30mexpression\u001b[0m during monocytic di\n",
      "\n",
      "('hiv', 'myristate')\n",
      "tively inhibits the \u001b[46m\u001b[30mHIV\u001b[0m -but not phorbol myristate acetate- or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('hiv', 'phorbol')\n",
      "tively inhibits the \u001b[46m\u001b[30mHIV\u001b[0m -but not phorbol myristate acetate- or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('hiv', 'acetate-')\n",
      "tively inhibits the \u001b[46m\u001b[30mHIV\u001b[0m -but not phorbol myristate acetate- or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('hiv', 'or')\n",
      "tively inhibits the \u001b[46m\u001b[30mHIV\u001b[0m -but not phorbol myristate acetate- or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('-', 'mediated')\n",
      "tively inhibits the \u001b[46m\u001b[30mHIV\u001b[0m -but not phorbol myristate acetate- or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('hiv', 'not')\n",
      "tively inhibits the \u001b[46m\u001b[30mHIV\u001b[0m -but not phorbol myristate acetate- or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('hiv', 'lipopolysaccharide-')\n",
      "tively inhibits the \u001b[46m\u001b[30mHIV\u001b[0m -but not phorbol myristate acetate- or lipopolysaccharide-\u001b[46m\u001b[30mmediated activation\u001b[0m of NF-kappa B. That\n",
      "\n",
      "('alpha', 'delta')\n",
      "ing element between \u001b[46m\u001b[30malpha\u001b[0m and delta \u001b[46m\u001b[30mgene segments\u001b[0m within the human T \n",
      "\n",
      "('endocrine', 'exocrine')\n",
      "ithelium from which \u001b[46m\u001b[30mendocrine\u001b[0m and exocrine \u001b[46m\u001b[30mprecursor cells\u001b[0m bud to eventually f\n",
      "\n",
      "('epsilon-', 'sie')\n",
      "nding patterns when \u001b[46m\u001b[30mC epsilon-\u001b[0m, Fc gamma RI-, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "\n",
      "('fc', 'gas')\n",
      "nding patterns when \u001b[46m\u001b[30mC epsilon-\u001b[0m, Fc gamma RI-, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "\n",
      "('ri-', 'gas')\n",
      "nding patterns when \u001b[46m\u001b[30mC epsilon-\u001b[0m, Fc gamma RI-, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "\n",
      "('gamma', 'gas')\n",
      "nding patterns when \u001b[46m\u001b[30mC epsilon-\u001b[0m, Fc gamma RI-, and SIE \u001b[46m\u001b[30mGAS motif\u001b[0m containing oligonuc\n",
      "\n",
      "('u937', 'hel/s')\n",
      "entiation of HL-60, \u001b[46m\u001b[30mU937\u001b[0m and HEL/S \u001b[46m\u001b[30mcells\u001b[0m. The erythroid diff\n",
      "\n",
      "(',', '-zeta')\n",
      "ysis of the role of \u001b[46m\u001b[30mprotein kinase C\u001b[0m-alpha, -epsilon, and \u001b[46m\u001b[30m-zeta\u001b[0m in T cell activatio\n",
      "ysis of the role of \u001b[46m\u001b[30mprotein kinase C\u001b[0m-alpha, -epsilon, and \u001b[46m\u001b[30m-zeta\u001b[0m in T cell activatio\n",
      "mutationally active \u001b[46m\u001b[30mPKC\u001b[0m-alpha, -epsilon, or \u001b[46m\u001b[30m-zeta\u001b[0m have been transfect\n",
      "mutationally active \u001b[46m\u001b[30mPKC\u001b[0m-alpha, -epsilon, or \u001b[46m\u001b[30m-zeta\u001b[0m have been transfect\n",
      "\n",
      "('-alpha', '-zeta')\n",
      "ysis of the role of \u001b[46m\u001b[30mprotein kinase C\u001b[0m-alpha, -epsilon, and \u001b[46m\u001b[30m-zeta\u001b[0m in T cell activatio\n",
      "mutationally active \u001b[46m\u001b[30mPKC\u001b[0m-alpha, -epsilon, or \u001b[46m\u001b[30m-zeta\u001b[0m have been transfect\n",
      "\n",
      "('-epsilon', '-zeta')\n",
      "ysis of the role of \u001b[46m\u001b[30mprotein kinase C\u001b[0m-alpha, -epsilon, and \u001b[46m\u001b[30m-zeta\u001b[0m in T cell activatio\n",
      "mutationally active \u001b[46m\u001b[30mPKC\u001b[0m-alpha, -epsilon, or \u001b[46m\u001b[30m-zeta\u001b[0m have been transfect\n",
      "\n",
      "('pkc/ras-', 'cam/cn-')\n",
      "h the activation of \u001b[46m\u001b[30mPKC/Ras-\u001b[0m and CaM/CN-\u001b[46m\u001b[30mmediated pathways\u001b[0m play a central role\n",
      "\n",
      "('cytokine', 'immune')\n",
      "ansmit signals from \u001b[46m\u001b[30mcytokine\u001b[0m and immune \u001b[46m\u001b[30mreceptors\u001b[0m. Very little inform\n",
      "\n",
      "('chain', 'chain')\n",
      "l surface IgM, IgD, \u001b[46m\u001b[30mkappa L chain\u001b[0m, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('chain', 'lambda')\n",
      "l surface IgM, IgD, \u001b[46m\u001b[30mkappa L chain\u001b[0m, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('chain', 'l')\n",
      "l surface IgM, IgD, \u001b[46m\u001b[30mkappa L chain\u001b[0m, and lambda L chain \u001b[46m\u001b[30mexpression\u001b[0m. In contrast, TGF-b\n",
      "\n",
      "('creb-', 'nf-kappa')\n",
      " sites for at least \u001b[46m\u001b[30mCREB-\u001b[0m and NF-kappa B-\u001b[46m\u001b[30mlike factors\u001b[0m, which synergistica\n",
      "\n",
      "('creb-', 'b-')\n",
      " sites for at least \u001b[46m\u001b[30mCREB-\u001b[0m and NF-kappa B-\u001b[46m\u001b[30mlike factors\u001b[0m, which synergistica\n",
      "\n",
      "('il-4', 'il-5')\n",
      "n the regulation of \u001b[46m\u001b[30mIL-4\u001b[0m and IL-5 \u001b[46m\u001b[30mgenes\u001b[0m.\n",
      "\n",
      "('drosophila', 'human')\n",
      "ously characterized \u001b[46m\u001b[30mDrosophila\u001b[0m and human \u001b[46m\u001b[30mTAF subunits\u001b[0m that make up the co\n",
      "\n",
      "('primary', 'long-term')\n",
      "nd tat mutations in \u001b[46m\u001b[30mprimary\u001b[0m and long-term \u001b[46m\u001b[30mhuman lymphoid cells\u001b[0m. Tat is an essentia\n",
      "\n",
      "('pma-', 'constitutive')\n",
      "s found to suppress \u001b[46m\u001b[30mnot only\u001b[0m PMA- or TNF-induced, but also \u001b[46m\u001b[30mconstitutive\u001b[0m, HIV-enhancer activ\n",
      "\n",
      "('promyelocyte', 'late-myeloblast-like')\n",
      "ession occurring in \u001b[46m\u001b[30mpromyelocyte\u001b[0m and late-myeloblast-like \u001b[46m\u001b[30mcell lines\u001b[0m. Western blot and i\n",
      "\n",
      "('pro-b', 'b')\n",
      " lines representing \u001b[46m\u001b[30mpro-B\u001b[0m, pre-B, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      "\n",
      "('pre-b', 'cell')\n",
      " lines representing \u001b[46m\u001b[30mpro-B\u001b[0m, pre-B, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      "\n",
      "('pro-b', 'mature')\n",
      " lines representing \u001b[46m\u001b[30mpro-B\u001b[0m, pre-B, and mature B \u001b[46m\u001b[30mcells\u001b[0m. We could also show\n",
      "\n",
      "('p65-', 'mediated')\n",
      "pa B gamma inhibits \u001b[46m\u001b[30mp50-\u001b[0m, p65-, and c-Rel-\u001b[46m\u001b[30mmediated transactivation\u001b[0m and/or DNA binding,\n",
      "\n",
      "('receptor', 'bcl-2')\n",
      " in P-glycoprotein, \u001b[46m\u001b[30msteroid receptors\u001b[0m, p53 and Bcl-2 \u001b[46m\u001b[30mexpression\u001b[0m take place. In view\n",
      "\n",
      "('th1-', 'th2-')\n",
      "molecular basis for \u001b[46m\u001b[30mTh1-\u001b[0m and Th2- \u001b[46m\u001b[30mspecific gene expression\u001b[0m remains to be eluci\n",
      " which express both \u001b[46m\u001b[30mTh1-\u001b[0m and Th2-\u001b[46m\u001b[30mtype cytokines\u001b[0m. Our studies report\n",
      "\n",
      "('gh/prl-', 't-')\n",
      " of Pan proteins in \u001b[46m\u001b[30mGH/PRL-\u001b[0m and insulin-producing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "('and', 'lymphocyte')\n",
      " of Pan proteins in \u001b[46m\u001b[30mGH/PRL-\u001b[0m and insulin-producing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "('insulin-', 'lymphocyte')\n",
      " of Pan proteins in \u001b[46m\u001b[30mGH/PRL-\u001b[0m and insulin-producing, B- and T-\u001b[46m\u001b[30mlymphocyte cells\u001b[0m. IEF-1, a pancreati\n",
      "\n",
      "('promyelocytic', 'myeloblastic')\n",
      "nduction of CD38 in \u001b[46m\u001b[30macute promyelocytic\u001b[0m and acute myeloblastic \u001b[46m\u001b[30mleukemia cells\u001b[0m was independent of \n",
      "\n",
      "('promyelocytic', 'acute')\n",
      "nduction of CD38 in \u001b[46m\u001b[30macute promyelocytic\u001b[0m and acute myeloblastic \u001b[46m\u001b[30mleukemia cells\u001b[0m was independent of \n",
      "\n",
      "('cis-', 'trans-')\n",
      "acterization of the \u001b[46m\u001b[30mcis-\u001b[0m and trans-\u001b[46m\u001b[30macting elements\u001b[0m involved in the tis\n",
      "\n",
      "('(8;21)(q22;q22)', '(3;21)(q26;q22)')\n",
      "is disrupted in the \u001b[46m\u001b[30m(8;21)(q22;q22)\u001b[0m and (3;21)(q26;q22) \u001b[46m\u001b[30mtranslocations\u001b[0m associated with mye\n",
      "\n",
      "('antiinflammatory', 'antiinfectious')\n",
      "ncluding antitumor, \u001b[46m\u001b[30mantiinflammatory\u001b[0m, and antiinfectious \u001b[46m\u001b[30mactivities\u001b[0m. Although its preci\n",
      "\n",
      "('i', 'iv')\n",
      "ith thrombospondin, \u001b[46m\u001b[30mcollagens type\u001b[0m I and \u001b[46m\u001b[30mIV\u001b[0m, oxidized low densi\n",
      "\n",
      "('cd45-', 'cd3-')\n",
      "tion cascade. Using \u001b[46m\u001b[30mCD45-\u001b[0m or CD3-\u001b[46m\u001b[30mnegative variants\u001b[0m of the Jurkat leuke\n",
      "\n",
      "(')', 'kappa')\n",
      "-128). Finally, the \u001b[46m\u001b[30mAP-1 (-186 to -176)\u001b[0m and the kappa B \u001b[46m\u001b[30msites\u001b[0m (-206 to -195) resp\n",
      "\n",
      "(')', 'the')\n",
      "-128). Finally, the \u001b[46m\u001b[30mAP-1 (-186 to -176)\u001b[0m and the kappa B \u001b[46m\u001b[30msites\u001b[0m (-206 to -195) resp\n",
      "\n",
      "('tal1-', 'lmo-')\n",
      " sufficient for the \u001b[46m\u001b[30mTAL1-\u001b[0m and LMO-\u001b[46m\u001b[30mdependent transcriptional activation\u001b[0m, and GATA3 binds to\n",
      "\n",
      "('erythroid', 'basosophilic')\n",
      "ferentiation of the \u001b[46m\u001b[30merythroid\u001b[0m, megakaryocytic, and basosophilic \u001b[46m\u001b[30mlineages\u001b[0m.\n",
      "\n",
      "('stat6', 'stat5')\n",
      " chain and activate \u001b[46m\u001b[30mSTAT6\u001b[0m, STAT3 and STAT5 \u001b[46m\u001b[30mproteins\u001b[0m in normal human B c\n",
      "\n",
      "('ap-1-', 'octamer-')\n",
      "ymphocytes. Role of \u001b[46m\u001b[30mAP-1-\u001b[0m and octamer-\u001b[46m\u001b[30mbinding proteins\u001b[0m in control of IL3 g\n",
      "\n",
      "('8', '18')\n",
      "cell shape changes, \u001b[46m\u001b[30mcytokeratins\u001b[0m 8 and \u001b[46m\u001b[30m18\u001b[0m, associated with di\n",
      "\n",
      "('-5', '-13')\n",
      "xpressed cytokines [\u001b[46m\u001b[30mhuman interleukin\u001b[0m-2, -4, -5 and \u001b[46m\u001b[30m-13\u001b[0m and human and mouse\n",
      "\n",
      "(',', '-13')\n",
      "xpressed cytokines [\u001b[46m\u001b[30mhuman interleukin\u001b[0m-2, -4, -5 and \u001b[46m\u001b[30m-13\u001b[0m and human and mouse\n",
      "xpressed cytokines [\u001b[46m\u001b[30mhuman interleukin\u001b[0m-2, -4, -5 and \u001b[46m\u001b[30m-13\u001b[0m and human and mouse\n",
      "\n",
      "('-2', '-13')\n",
      "xpressed cytokines [\u001b[46m\u001b[30mhuman interleukin\u001b[0m-2, -4, -5 and \u001b[46m\u001b[30m-13\u001b[0m and human and mouse\n",
      "\n",
      "('65-75', '120-125')\n",
      "f proteins of about \u001b[46m\u001b[30m65-75\u001b[0m and 120-125 \u001b[46m\u001b[30mkDa\u001b[0m. In addition, integ\n",
      "\n",
      "('granulocyte', 't-cell')\n",
      " 880 comparisons of \u001b[46m\u001b[30mgranulocyte\u001b[0m and T-cell \u001b[46m\u001b[30mDNA\u001b[0m. Granulocyte DNA fr\n",
      "\n",
      "(')', 'j774')\n",
      "siently transfected \u001b[46m\u001b[30mhuman (U937)\u001b[0m and murine (J774) \u001b[46m\u001b[30mmonocytic cell lines\u001b[0m. Deletion construct\n",
      "\n",
      "(')', 'murine')\n",
      "siently transfected \u001b[46m\u001b[30mhuman (U937)\u001b[0m and murine (J774) \u001b[46m\u001b[30mmonocytic cell lines\u001b[0m. Deletion construct\n",
      "\n",
      "('il-1-', 'il-18-')\n",
      " results in loss of \u001b[46m\u001b[30mIL-1-\u001b[0m and IL-18-\u001b[46m\u001b[30mmediated function\u001b[0m. MyD88, originally \n",
      "\n",
      "('cd3', 'cd25')\n",
      "A treatment induced \u001b[46m\u001b[30mCD3\u001b[0m and CD25 (IL-2R) \u001b[46m\u001b[30mreceptors\u001b[0m on the parental lin\n",
      "\n",
      "('cd3', ')')\n",
      "A treatment induced \u001b[46m\u001b[30mCD3\u001b[0m and CD25 (IL-2R) \u001b[46m\u001b[30mreceptors\u001b[0m on the parental lin\n",
      "\n",
      "('cd3', 'il-2r')\n",
      "A treatment induced \u001b[46m\u001b[30mCD3\u001b[0m and CD25 (IL-2R) \u001b[46m\u001b[30mreceptors\u001b[0m on the parental lin\n",
      "\n",
      "('cd3', '(')\n",
      "A treatment induced \u001b[46m\u001b[30mCD3\u001b[0m and CD25 (IL-2R) \u001b[46m\u001b[30mreceptors\u001b[0m on the parental lin\n",
      "\n",
      "('development', 'homeostasis')\n",
      " the Ikaros gene in \u001b[46m\u001b[30mlymphocyte\u001b[0m development and \u001b[46m\u001b[30mhomeostasis\u001b[0m. The Ikaros gene, w\n",
      "\n",
      "('binding', 'recognition')\n",
      " 57 is critical for \u001b[46m\u001b[30mpeptide\u001b[0m binding and \u001b[46m\u001b[30mrecognition\u001b[0m. The association of\n",
      "\n",
      "(',', '130')\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "several proteins of \u001b[46m\u001b[30mmolecular mass\u001b[0m 40, 42, 70, 120, and \u001b[46m\u001b[30m130 kDa\u001b[0m. There was a good c\n",
      "\n",
      "('core-', 'o-side')\n",
      "lood monocytes. LPS \u001b[46m\u001b[30mcore-\u001b[0m and O-side chain-\u001b[46m\u001b[30mspecific mAbs\u001b[0m inhibited mCD14-med\n",
      "\n",
      "('core-', 'chain-')\n",
      "lood monocytes. LPS \u001b[46m\u001b[30mcore-\u001b[0m and O-side chain-\u001b[46m\u001b[30mspecific mAbs\u001b[0m inhibited mCD14-med\n",
      "\n",
      "('hlf', 'c/ebp')\n",
      "er genes containing \u001b[46m\u001b[30mHLF\u001b[0m or C/EBP \u001b[46m\u001b[30mconsensus binding sites\u001b[0m. But on reporter ge\n",
      "\n",
      "('hormone', 'prolactin')\n",
      "ivates promoters of \u001b[46m\u001b[30mgrowth hormone\u001b[0m and prolactin \u001b[46m\u001b[30mgenes\u001b[0m. In three unrelated\n",
      "\n",
      "('2.7', '4.5')\n",
      "two mRNA species of \u001b[46m\u001b[30m2.7\u001b[0m and 4.5 \u001b[46m\u001b[30mkilobase pairs\u001b[0m, while an NFATc.bet\n",
      "\n",
      "('lyn', 'jak2')\n",
      "teraction activates \u001b[46m\u001b[30mLyn\u001b[0m and Jak2 \u001b[46m\u001b[30mtyrosine kinases\u001b[0m and propagates sign\n",
      "\n",
      "(',', 'experiment')\n",
      "ls. On the basis of \u001b[46m\u001b[30mbinding\u001b[0m, reconstitution and cotransfection \u001b[46m\u001b[30mexperiments\u001b[0m, we propose that ac\n",
      "\n",
      "('reconstitution', 'experiment')\n",
      "ls. On the basis of \u001b[46m\u001b[30mbinding\u001b[0m, reconstitution and cotransfection \u001b[46m\u001b[30mexperiments\u001b[0m, we propose that ac\n",
      "\n",
      "('binding', 'cotransfection')\n",
      "ls. On the basis of \u001b[46m\u001b[30mbinding\u001b[0m, reconstitution and cotransfection \u001b[46m\u001b[30mexperiments\u001b[0m, we propose that ac\n",
      "\n",
      "(',', '-1011')\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "\n",
      "('-178', '-1011')\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "\n",
      "('-875', '-1011')\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "\n",
      "('-153', '-1011')\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "\n",
      "('-286', '-1011')\n",
      "and NFkB located at \u001b[46m\u001b[30mpositions\u001b[0m -153, -178, -286, -875, and \u001b[46m\u001b[30m-1011\u001b[0m, respectively. To a\n",
      "\n",
      "('stat1-', 'stat5-')\n",
      "detected in ALL and \u001b[46m\u001b[30mSTAT1-\u001b[0m, STAT3-, and STAT5-\u001b[46m\u001b[30mrelated proteins\u001b[0m were present in nuc\n",
      "\n",
      "('stat3-', 'related')\n",
      "detected in ALL and \u001b[46m\u001b[30mSTAT1-\u001b[0m, STAT3-, and STAT5-\u001b[46m\u001b[30mrelated proteins\u001b[0m were present in nuc\n",
      "\n",
      "('ifn-gamma', 'il-2')\n",
      "ter gene construct, \u001b[46m\u001b[30mIFN-gamma\u001b[0m and IL-2 \u001b[46m\u001b[30mmRNA accumulation\u001b[0m, and IFN-gamma prod\n",
      "\n",
      "('early', 'transient')\n",
      "ytes demonstrate an \u001b[46m\u001b[30mearly\u001b[0m and transient \u001b[46m\u001b[30mhyperpolarization\u001b[0m after ligand bindin\n",
      "\n",
      "(')', 'nf-kappa')\n",
      "the products of the \u001b[46m\u001b[30mNF-kappa B2 (p100)\u001b[0m and NF-kappa B1 (p105) \u001b[46m\u001b[30mgenes\u001b[0m; (ii) in contrast t\n",
      "\n",
      "(')', 'p105')\n",
      "the products of the \u001b[46m\u001b[30mNF-kappa B2 (p100)\u001b[0m and NF-kappa B1 (p105) \u001b[46m\u001b[30mgenes\u001b[0m; (ii) in contrast t\n",
      "\n",
      "(')', 'b1')\n",
      "the products of the \u001b[46m\u001b[30mNF-kappa B2 (p100)\u001b[0m and NF-kappa B1 (p105) \u001b[46m\u001b[30mgenes\u001b[0m; (ii) in contrast t\n",
      "\n",
      "('differentiation', 'activation')\n",
      " to be critical for \u001b[46m\u001b[30mT lymphocyte\u001b[0m differentiation and \u001b[46m\u001b[30mactivation\u001b[0m. Hence in the absen\n",
      "\n",
      "('myeloid', 'lymphoid')\n",
      "tment to erythroid, \u001b[46m\u001b[30mmyeloid\u001b[0m and lymphoid \u001b[46m\u001b[30mcell types\u001b[0m is summarized.\n",
      "\n",
      "('sh2', 'sh3')\n",
      "ruct containing the \u001b[46m\u001b[30mSH2\u001b[0m and SH3 \u001b[46m\u001b[30mdomains\u001b[0m of phospholipase C \n",
      "\n",
      "('alpha', 'dq')\n",
      "DNA of the DR beta, \u001b[46m\u001b[30mDP alpha\u001b[0m and -beta, and DQ alpha \u001b[46m\u001b[30mgenes\u001b[0m, always located dow\n",
      "\n",
      "('monocyte', 't-')\n",
      "transient assays in \u001b[46m\u001b[30mmonocyte\u001b[0m and T-\u001b[46m\u001b[30mcell types\u001b[0m. The SCMV SNE sites\n",
      "\n",
      "('beta', 'the')\n",
      "1 to +12), both the \u001b[46m\u001b[30mproIL-1 beta\u001b[0m and the simian virus 40 \u001b[46m\u001b[30menhancer elements\u001b[0m functioned more eff\n",
      "\n",
      "('beta', '40')\n",
      "1 to +12), both the \u001b[46m\u001b[30mproIL-1 beta\u001b[0m and the simian virus 40 \u001b[46m\u001b[30menhancer elements\u001b[0m functioned more eff\n",
      "\n",
      "('beta', 'simian')\n",
      "1 to +12), both the \u001b[46m\u001b[30mproIL-1 beta\u001b[0m and the simian virus 40 \u001b[46m\u001b[30menhancer elements\u001b[0m functioned more eff\n",
      "\n",
      "('beta', 'virus')\n",
      "1 to +12), both the \u001b[46m\u001b[30mproIL-1 beta\u001b[0m and the simian virus 40 \u001b[46m\u001b[30menhancer elements\u001b[0m functioned more eff\n",
      "\n",
      "('htlv-i', 'htlv-ii')\n",
      " responsive to both \u001b[46m\u001b[30mHTLV-I\u001b[0m and HTLV-II \u001b[46m\u001b[30mTax\u001b[0m as well as the AP1/\n",
      "\n",
      "('a', 'alpha')\n",
      "ic development. The \u001b[46m\u001b[30mPEBP2 alpha A\u001b[0m and PEBP2 alpha B \u001b[46m\u001b[30mgenes\u001b[0m encode the DNA-bind\n",
      "\n",
      "('a', 'pebp2')\n",
      "ic development. The \u001b[46m\u001b[30mPEBP2 alpha A\u001b[0m and PEBP2 alpha B \u001b[46m\u001b[30mgenes\u001b[0m encode the DNA-bind\n",
      "\n",
      "('ap-1', 'sp1')\n",
      " interact with both \u001b[46m\u001b[30mAP-1\u001b[0m and Sp1 \u001b[46m\u001b[30mproteins\u001b[0m. In this study, we \n",
      "\n",
      "('mue3', 'mub')\n",
      "containing the muA, \u001b[46m\u001b[30mmuE3\u001b[0m, and muB \u001b[46m\u001b[30msites\u001b[0m is transactivated b\n",
      "\n",
      "('anti-inflammatory', 'proinflammatory')\n",
      "ic Abs thus mediate \u001b[46m\u001b[30manti-inflammatory\u001b[0m and proinflammatory \u001b[46m\u001b[30mfunctions\u001b[0m, respectively, by p\n",
      "\n",
      "('nf-kappab', 'ets')\n",
      ", but not Jun, Fos, \u001b[46m\u001b[30mNF-kappaB\u001b[0m, Oct or Ets \u001b[46m\u001b[30mfamily members\u001b[0m, renders the interl\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for fb, sample in false_bridges.items():\n",
    "    print(fb)\n",
    "    for dc in sample:\n",
    "        print(dc.get_context())\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 158,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_dict = {'bigram': [], 'freq': [], 'pmi': [], 'll': [], 'type': []}\n",
    "\n",
    "all_bigrams = set.union(set(gap_bigrams.keys()), set(cont_bigrams.keys()), set(false_bridges.keys()))\n",
    "for bigram in all_bigrams:\n",
    "    # skip if not frequent enough\n",
    "    if model.freq(bigram) < FREQ_THRESHOLD and (bigram not in false_bridges or model.freq(bigram) < FREQ_THRESHOLD - 1):\n",
    "        continue\n",
    "\n",
    "    data_dict['bigram'].append(bigram)\n",
    "    data_dict['freq'].append(model.freq(bigram))\n",
    "\n",
    "    contingency_table = model.contingency_table(bigram[0], bigram[1])\n",
    "    pmi = conceptstats.pointwise_mutual_information(contingency_table)\n",
    "    data_dict['pmi'].append(pmi)\n",
    "    ll = conceptstats.log_likelihood_ratio(contingency_table)\n",
    "    data_dict['ll'].append(ll)\n",
    "\n",
    "    # how it occurs\n",
    "    if bigram in gap_bigrams:\n",
    "        if bigram in cont_bigrams: \n",
    "            type_ = 'both'\n",
    "        else:\n",
    "            type_ = 'only_gap'\n",
    "    elif bigram in cont_bigrams:\n",
    "        type_ = 'only_cont'\n",
    "    else:\n",
    "        type_ = 'false'\n",
    "    data_dict['type'].append(type_)\n",
    "\n",
    "data = pd.DataFrame(data_dict)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### NOTE\n",
    "\n",
    "That a bigram occurs as `only_gap` means that it occurs only in gap position for DC's. However, those bigrams can just as well occur in CC's as well, thereby getting a high association."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 159,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd4e22ad30>"
      ]
     },
     "execution_count": 159,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.boxplot(x='type', y='pmi', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 150,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "288"
      ]
     },
     "execution_count": 150,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data[data['type'] == 'only_gap'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 151,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Source</th>\n",
       "      <th>ddof1</th>\n",
       "      <th>H</th>\n",
       "      <th>p-unc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Kruskal</th>\n",
       "      <td>type</td>\n",
       "      <td>3</td>\n",
       "      <td>140.1</td>\n",
       "      <td>3.596371e-30</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        Source  ddof1      H         p-unc\n",
       "Kruskal   type      3  140.1  3.596371e-30"
      ]
     },
     "execution_count": 151,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pingouin.kruskal(data, 'pmi', 'type')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 152,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd4e003160>"
      ]
     },
     "execution_count": 152,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.boxplot(x='type', y='ll', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>bigram</th>\n",
       "      <th>freq</th>\n",
       "      <th>pmi</th>\n",
       "      <th>ll</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>620</th>\n",
       "      <td>(pma-, induced)</td>\n",
       "      <td>3</td>\n",
       "      <td>7.791787</td>\n",
       "      <td>56.290853</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>(gamma, delta)</td>\n",
       "      <td>6</td>\n",
       "      <td>5.486072</td>\n",
       "      <td>63.933485</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>(nm23, protein)</td>\n",
       "      <td>4</td>\n",
       "      <td>3.714515</td>\n",
       "      <td>28.708191</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>538</th>\n",
       "      <td>(alpha, globin)</td>\n",
       "      <td>4</td>\n",
       "      <td>3.573091</td>\n",
       "      <td>26.408233</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>(dna-binding, protein)</td>\n",
       "      <td>33</td>\n",
       "      <td>3.211070</td>\n",
       "      <td>158.562848</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>522</th>\n",
       "      <td>(), pml-rar)</td>\n",
       "      <td>3</td>\n",
       "      <td>2.679252</td>\n",
       "      <td>14.699582</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>871</th>\n",
       "      <td>(and, mitogenesis)</td>\n",
       "      <td>3</td>\n",
       "      <td>2.429193</td>\n",
       "      <td>13.310525</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>((, 2)</td>\n",
       "      <td>26</td>\n",
       "      <td>1.876630</td>\n",
       "      <td>57.419386</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>(basal, expression)</td>\n",
       "      <td>3</td>\n",
       "      <td>1.874854</td>\n",
       "      <td>8.356068</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>526</th>\n",
       "      <td>(beta, ()</td>\n",
       "      <td>21</td>\n",
       "      <td>1.736794</td>\n",
       "      <td>41.373830</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>(il-1, ))</td>\n",
       "      <td>9</td>\n",
       "      <td>1.684238</td>\n",
       "      <td>17.892525</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>(beta, ))</td>\n",
       "      <td>19</td>\n",
       "      <td>1.636119</td>\n",
       "      <td>34.184787</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>(), ;)</td>\n",
       "      <td>23</td>\n",
       "      <td>1.607451</td>\n",
       "      <td>39.883186</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>(alpha, kappa)</td>\n",
       "      <td>5</td>\n",
       "      <td>1.463490</td>\n",
       "      <td>8.397770</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>(or, proliferation)</td>\n",
       "      <td>3</td>\n",
       "      <td>1.402986</td>\n",
       "      <td>5.229621</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>780</th>\n",
       "      <td>((, ii)</td>\n",
       "      <td>17</td>\n",
       "      <td>1.375284</td>\n",
       "      <td>23.177056</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>(), ,)</td>\n",
       "      <td>662</td>\n",
       "      <td>1.277775</td>\n",
       "      <td>803.710056</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>(p50, ))</td>\n",
       "      <td>7</td>\n",
       "      <td>1.235138</td>\n",
       "      <td>8.606633</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>529</th>\n",
       "      <td>(,, thyroid)</td>\n",
       "      <td>4</td>\n",
       "      <td>1.066641</td>\n",
       "      <td>4.352261</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>(residue, ,)</td>\n",
       "      <td>7</td>\n",
       "      <td>1.042987</td>\n",
       "      <td>6.698730</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>741</th>\n",
       "      <td>(,, 3)</td>\n",
       "      <td>13</td>\n",
       "      <td>0.787353</td>\n",
       "      <td>7.144122</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>825</th>\n",
       "      <td>(alpha, b)</td>\n",
       "      <td>9</td>\n",
       "      <td>0.629450</td>\n",
       "      <td>3.282284</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>(b, and)</td>\n",
       "      <td>112</td>\n",
       "      <td>0.508793</td>\n",
       "      <td>25.902153</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>(,, 6)</td>\n",
       "      <td>6</td>\n",
       "      <td>0.508329</td>\n",
       "      <td>1.609007</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>(), low)</td>\n",
       "      <td>3</td>\n",
       "      <td>0.285695</td>\n",
       "      <td>0.302052</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>812</th>\n",
       "      <td>((, beta)</td>\n",
       "      <td>4</td>\n",
       "      <td>0.255189</td>\n",
       "      <td>0.304165</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>(a, one)</td>\n",
       "      <td>7</td>\n",
       "      <td>0.252044</td>\n",
       "      <td>0.478263</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>537</th>\n",
       "      <td>(,, 5)</td>\n",
       "      <td>3</td>\n",
       "      <td>0.205009</td>\n",
       "      <td>0.163662</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>723</th>\n",
       "      <td>(b, signal)</td>\n",
       "      <td>3</td>\n",
       "      <td>0.104714</td>\n",
       "      <td>0.042719</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>869</th>\n",
       "      <td>(,, nfat)</td>\n",
       "      <td>8</td>\n",
       "      <td>0.092929</td>\n",
       "      <td>0.078377</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>(,, gamma)</td>\n",
       "      <td>6</td>\n",
       "      <td>0.088475</td>\n",
       "      <td>0.055326</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>(), regulatory)</td>\n",
       "      <td>3</td>\n",
       "      <td>-0.060051</td>\n",
       "      <td>0.014921</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>(,, tumor)</td>\n",
       "      <td>10</td>\n",
       "      <td>-0.075497</td>\n",
       "      <td>0.066743</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>870</th>\n",
       "      <td>(), type)</td>\n",
       "      <td>5</td>\n",
       "      <td>-0.077337</td>\n",
       "      <td>0.037351</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>(,, treatment)</td>\n",
       "      <td>11</td>\n",
       "      <td>-0.121245</td>\n",
       "      <td>0.190635</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>(,, experiment)</td>\n",
       "      <td>3</td>\n",
       "      <td>-0.240829</td>\n",
       "      <td>0.260718</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>((, type)</td>\n",
       "      <td>4</td>\n",
       "      <td>-0.254293</td>\n",
       "      <td>0.357267</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>(,, beta)</td>\n",
       "      <td>7</td>\n",
       "      <td>-0.310301</td>\n",
       "      <td>0.886587</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370</th>\n",
       "      <td>(,, tyrosine)</td>\n",
       "      <td>8</td>\n",
       "      <td>-0.361893</td>\n",
       "      <td>1.380983</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>(,, transcript)</td>\n",
       "      <td>3</td>\n",
       "      <td>-0.515841</td>\n",
       "      <td>1.315326</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>770</th>\n",
       "      <td>(and, lymphocyte)</td>\n",
       "      <td>13</td>\n",
       "      <td>-0.520438</td>\n",
       "      <td>4.661792</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>368</th>\n",
       "      <td>(a, type)</td>\n",
       "      <td>4</td>\n",
       "      <td>-0.616393</td>\n",
       "      <td>2.398182</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>(,, clone)</td>\n",
       "      <td>4</td>\n",
       "      <td>-0.721566</td>\n",
       "      <td>3.465561</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>771</th>\n",
       "      <td>(,, dna)</td>\n",
       "      <td>10</td>\n",
       "      <td>-0.724473</td>\n",
       "      <td>7.699520</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>562</th>\n",
       "      <td>(or, gene)</td>\n",
       "      <td>3</td>\n",
       "      <td>-0.815308</td>\n",
       "      <td>3.585535</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>(,, activation)</td>\n",
       "      <td>30</td>\n",
       "      <td>-0.843435</td>\n",
       "      <td>30.822860</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>(only, ,)</td>\n",
       "      <td>4</td>\n",
       "      <td>-0.845263</td>\n",
       "      <td>4.979521</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>((, b)</td>\n",
       "      <td>12</td>\n",
       "      <td>-0.918649</td>\n",
       "      <td>15.500896</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>523</th>\n",
       "      <td>(,, specific)</td>\n",
       "      <td>4</td>\n",
       "      <td>-1.062097</td>\n",
       "      <td>8.543260</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>486</th>\n",
       "      <td>(,, type)</td>\n",
       "      <td>5</td>\n",
       "      <td>-1.107466</td>\n",
       "      <td>11.348271</td>\n",
       "      <td>false</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                     bigram  freq       pmi          ll   type\n",
       "620         (pma-, induced)     3  7.791787   56.290853  false\n",
       "239          (gamma, delta)     6  5.486072   63.933485  false\n",
       "426         (nm23, protein)     4  3.714515   28.708191  false\n",
       "538         (alpha, globin)     4  3.573091   26.408233  false\n",
       "341  (dna-binding, protein)    33  3.211070  158.562848  false\n",
       "522            (), pml-rar)     3  2.679252   14.699582  false\n",
       "871      (and, mitogenesis)     3  2.429193   13.310525  false\n",
       "581                  ((, 2)    26  1.876630   57.419386  false\n",
       "405     (basal, expression)     3  1.874854    8.356068  false\n",
       "526               (beta, ()    21  1.736794   41.373830  false\n",
       "108               (il-1, ))     9  1.684238   17.892525  false\n",
       "351               (beta, ))    19  1.636119   34.184787  false\n",
       "302                  (), ;)    23  1.607451   39.883186  false\n",
       "494          (alpha, kappa)     5  1.463490    8.397770  false\n",
       "374     (or, proliferation)     3  1.402986    5.229621  false\n",
       "780                 ((, ii)    17  1.375284   23.177056  false\n",
       "407                  (), ,)   662  1.277775  803.710056  false\n",
       "497                (p50, ))     7  1.235138    8.606633  false\n",
       "529            (,, thyroid)     4  1.066641    4.352261  false\n",
       "427            (residue, ,)     7  1.042987    6.698730  false\n",
       "741                  (,, 3)    13  0.787353    7.144122  false\n",
       "825              (alpha, b)     9  0.629450    3.282284  false\n",
       "308                (b, and)   112  0.508793   25.902153  false\n",
       "646                  (,, 6)     6  0.508329    1.609007  false\n",
       "95                 (), low)     3  0.285695    0.302052  false\n",
       "812               ((, beta)     4  0.255189    0.304165  false\n",
       "336                (a, one)     7  0.252044    0.478263  false\n",
       "537                  (,, 5)     3  0.205009    0.163662  false\n",
       "723             (b, signal)     3  0.104714    0.042719  false\n",
       "869               (,, nfat)     8  0.092929    0.078377  false\n",
       "304              (,, gamma)     6  0.088475    0.055326  false\n",
       "32          (), regulatory)     3 -0.060051    0.014921  false\n",
       "171              (,, tumor)    10 -0.075497    0.066743  false\n",
       "870               (), type)     5 -0.077337    0.037351  false\n",
       "329          (,, treatment)    11 -0.121245    0.190635  false\n",
       "209         (,, experiment)     3 -0.240829    0.260718  false\n",
       "644               ((, type)     4 -0.254293    0.357267  false\n",
       "401               (,, beta)     7 -0.310301    0.886587  false\n",
       "370           (,, tyrosine)     8 -0.361893    1.380983  false\n",
       "311         (,, transcript)     3 -0.515841    1.315326  false\n",
       "770       (and, lymphocyte)    13 -0.520438    4.661792  false\n",
       "368               (a, type)     4 -0.616393    2.398182  false\n",
       "233              (,, clone)     4 -0.721566    3.465561  false\n",
       "771                (,, dna)    10 -0.724473    7.699520  false\n",
       "562              (or, gene)     3 -0.815308    3.585535  false\n",
       "98          (,, activation)    30 -0.843435   30.822860  false\n",
       "343               (only, ,)     4 -0.845263    4.979521  false\n",
       "456                  ((, b)    12 -0.918649   15.500896  false\n",
       "523           (,, specific)     4 -1.062097    8.543260  false\n",
       "486               (,, type)     5 -1.107466   11.348271  false"
      ]
     },
     "execution_count": 155,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data[data['type'] == 'false'].sort_values(['pmi', 'll'], ascending=False).head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Question 4: What is the full-term unithood?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<seaborn.axisgrid.FacetGrid at 0x7fdd5ab3f2b0>"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.lmplot('freq', 'll', data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [],
   "source": [
    "all_concepts = disc_concepts.union(cont_concepts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_dict = {'concept': [], 'type': [],  'pmi_nl': [], 'tc': [], 'freq': [], 'len': []}\n",
    "\n",
    "for concept in all_concepts:\n",
    "    \n",
    "    if model[concept] < FREQ_THRESHOLD:\n",
    "        continue\n",
    "    \n",
    "    data_dict['concept'].append(concept)\n",
    "    \n",
    "    data_dict['freq'].append(model[concept])\n",
    "    \n",
    "    if concept in disc_concepts:\n",
    "        if concept in cont_concepts:\n",
    "            concept_type = 'both'\n",
    "        else:\n",
    "            concept_type = 'only_DC'\n",
    "    else:\n",
    "        concept_type = 'only_CC'\n",
    "    data_dict['type'].append(concept_type)\n",
    "    \n",
    "    data_dict['pmi_nl'].append(conceptstats.length_normalized_pmi(concept, model))\n",
    "    data_dict['tc'].append(conceptstats.term_coherence(concept, model))\n",
    "    \n",
    "    data_dict['len'].append(len(concept))\n",
    "\n",
    "\n",
    "data = pd.DataFrame(data_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>concept</th>\n",
       "      <th>type</th>\n",
       "      <th>pmi_nl</th>\n",
       "      <th>tc</th>\n",
       "      <th>freq</th>\n",
       "      <th>len</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4009</th>\n",
       "      <td>(nf-kappa, b)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>4.990988</td>\n",
       "      <td>1.797796</td>\n",
       "      <td>1077</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4173</th>\n",
       "      <td>(peripheral, blood)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>6.668685</td>\n",
       "      <td>1.742202</td>\n",
       "      <td>257</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1841</th>\n",
       "      <td>(mobility, shift)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.380431</td>\n",
       "      <td>1.694980</td>\n",
       "      <td>148</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2644</th>\n",
       "      <td>(electrophoretic, mobility)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.650202</td>\n",
       "      <td>1.640819</td>\n",
       "      <td>118</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4064</th>\n",
       "      <td>(12-myristate, 13-acetate)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.795946</td>\n",
       "      <td>1.522634</td>\n",
       "      <td>48</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3920</th>\n",
       "      <td>(zinc, finger)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.663115</td>\n",
       "      <td>1.512410</td>\n",
       "      <td>52</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1478</th>\n",
       "      <td>(transcription, factor)</td>\n",
       "      <td>both</td>\n",
       "      <td>4.509866</td>\n",
       "      <td>1.435554</td>\n",
       "      <td>980</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3618</th>\n",
       "      <td>(bone, marrow)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.819017</td>\n",
       "      <td>1.404783</td>\n",
       "      <td>43</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>(phorbol, ester)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.391776</td>\n",
       "      <td>1.395424</td>\n",
       "      <td>119</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3729</th>\n",
       "      <td>(electrophoretic, mobility, shift)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.555339</td>\n",
       "      <td>1.333979</td>\n",
       "      <td>110</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1845</th>\n",
       "      <td>(long, terminal, repeat)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.591147</td>\n",
       "      <td>1.258394</td>\n",
       "      <td>99</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4107</th>\n",
       "      <td>(lymph, node)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.967909</td>\n",
       "      <td>1.255273</td>\n",
       "      <td>18</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1589</th>\n",
       "      <td>(chloramphenicol, acetyltransferase)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.800798</td>\n",
       "      <td>1.170119</td>\n",
       "      <td>34</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3568</th>\n",
       "      <td>(cyclic, amp)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.277528</td>\n",
       "      <td>1.145852</td>\n",
       "      <td>25</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3395</th>\n",
       "      <td>(natural, killer)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.460087</td>\n",
       "      <td>1.145823</td>\n",
       "      <td>42</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1248</th>\n",
       "      <td>(t, cell)</td>\n",
       "      <td>both</td>\n",
       "      <td>3.769901</td>\n",
       "      <td>1.135449</td>\n",
       "      <td>1575</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4020</th>\n",
       "      <td>(herpes, simplex)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.863101</td>\n",
       "      <td>1.130683</td>\n",
       "      <td>17</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3984</th>\n",
       "      <td>(pyrrolidine, dithiocarbamate)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.758293</td>\n",
       "      <td>1.129745</td>\n",
       "      <td>18</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2308</th>\n",
       "      <td>(situ, hybridization)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.435617</td>\n",
       "      <td>1.104869</td>\n",
       "      <td>40</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4180</th>\n",
       "      <td>(nitric, oxide)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.814548</td>\n",
       "      <td>1.100928</td>\n",
       "      <td>17</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3746</th>\n",
       "      <td>(heat, shock)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.725055</td>\n",
       "      <td>1.089369</td>\n",
       "      <td>33</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1457</th>\n",
       "      <td>(flow, cytometry)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.250204</td>\n",
       "      <td>1.086068</td>\n",
       "      <td>24</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>(germinal, center)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.528051</td>\n",
       "      <td>1.084192</td>\n",
       "      <td>20</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1731</th>\n",
       "      <td>(breast, cancer)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.117351</td>\n",
       "      <td>1.075994</td>\n",
       "      <td>48</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1867</th>\n",
       "      <td>(hydrogen, peroxide)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.967909</td>\n",
       "      <td>1.002862</td>\n",
       "      <td>14</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3251</th>\n",
       "      <td>(amino, acid)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.005853</td>\n",
       "      <td>1.002616</td>\n",
       "      <td>109</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1312</th>\n",
       "      <td>(mobility, shift, assay)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.005318</td>\n",
       "      <td>1.002515</td>\n",
       "      <td>131</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3823</th>\n",
       "      <td>(open, reading, frame)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.717699</td>\n",
       "      <td>0.996078</td>\n",
       "      <td>17</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1586</th>\n",
       "      <td>(northern, blot)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.031681</td>\n",
       "      <td>0.985358</td>\n",
       "      <td>45</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1523</th>\n",
       "      <td>(vitamin, d)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.026404</td>\n",
       "      <td>0.970630</td>\n",
       "      <td>44</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>(dissociation, constant)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.851547</td>\n",
       "      <td>0.968140</td>\n",
       "      <td>26</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3249</th>\n",
       "      <td>(tyrosine, phosphorylation)</td>\n",
       "      <td>both</td>\n",
       "      <td>6.116899</td>\n",
       "      <td>0.962208</td>\n",
       "      <td>162</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>909</th>\n",
       "      <td>(squirrel, monkey)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.768243</td>\n",
       "      <td>0.953588</td>\n",
       "      <td>15</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1229</th>\n",
       "      <td>(leukotriene, b4)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>10.456876</td>\n",
       "      <td>0.952381</td>\n",
       "      <td>10</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3228</th>\n",
       "      <td>(signal, transduction)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>6.414016</td>\n",
       "      <td>0.918291</td>\n",
       "      <td>153</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>(immunodeficiency, virus)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>6.322930</td>\n",
       "      <td>0.918126</td>\n",
       "      <td>157</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>503</th>\n",
       "      <td>(rheumatoid, arthritis)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.775005</td>\n",
       "      <td>0.916902</td>\n",
       "      <td>14</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2370</th>\n",
       "      <td>(retinoic, acid)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.014805</td>\n",
       "      <td>0.870770</td>\n",
       "      <td>94</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1551</th>\n",
       "      <td>(raw, 264.7)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>10.903726</td>\n",
       "      <td>0.845098</td>\n",
       "      <td>7</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>966</th>\n",
       "      <td>(electrophoretic, mobility, shift, assay)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.252517</td>\n",
       "      <td>0.826644</td>\n",
       "      <td>99</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2675</th>\n",
       "      <td>(mechanical, ventilation)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>10.771957</td>\n",
       "      <td>0.788758</td>\n",
       "      <td>7</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2272</th>\n",
       "      <td>(e., chaffeensis)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.626161</td>\n",
       "      <td>0.782771</td>\n",
       "      <td>13</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2185</th>\n",
       "      <td>(escherichia, coli)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>10.291209</td>\n",
       "      <td>0.780744</td>\n",
       "      <td>9</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3301</th>\n",
       "      <td>(ru, 486)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>10.456876</td>\n",
       "      <td>0.760497</td>\n",
       "      <td>8</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1706</th>\n",
       "      <td>(monoclonal, antibody)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>7.123586</td>\n",
       "      <td>0.733414</td>\n",
       "      <td>69</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3588</th>\n",
       "      <td>(nih, 3t3)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>10.903726</td>\n",
       "      <td>0.718293</td>\n",
       "      <td>6</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2229</th>\n",
       "      <td>(ulcerative, colitis)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>11.234580</td>\n",
       "      <td>0.698970</td>\n",
       "      <td>5</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1395</th>\n",
       "      <td>(tetanus, toxoid)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>11.234580</td>\n",
       "      <td>0.698970</td>\n",
       "      <td>5</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2757</th>\n",
       "      <td>(phorbol, 12-myristate, 13-acetate)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>8.095795</td>\n",
       "      <td>0.697532</td>\n",
       "      <td>47</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1854</th>\n",
       "      <td>(site-directed, mutagenesis)</td>\n",
       "      <td>only_CC</td>\n",
       "      <td>9.210140</td>\n",
       "      <td>0.691818</td>\n",
       "      <td>15</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        concept     type     pmi_nl        tc  \\\n",
       "4009                              (nf-kappa, b)  only_CC   4.990988  1.797796   \n",
       "4173                        (peripheral, blood)  only_CC   6.668685  1.742202   \n",
       "1841                          (mobility, shift)  only_CC   7.380431  1.694980   \n",
       "2644                (electrophoretic, mobility)  only_CC   7.650202  1.640819   \n",
       "4064                 (12-myristate, 13-acetate)  only_CC   8.795946  1.522634   \n",
       "3920                             (zinc, finger)  only_CC   8.663115  1.512410   \n",
       "1478                    (transcription, factor)     both   4.509866  1.435554   \n",
       "3618                             (bone, marrow)  only_CC   8.819017  1.404783   \n",
       "309                            (phorbol, ester)  only_CC   7.391776  1.395424   \n",
       "3729         (electrophoretic, mobility, shift)  only_CC   7.555339  1.333979   \n",
       "1845                   (long, terminal, repeat)  only_CC   7.591147  1.258394   \n",
       "4107                              (lymph, node)  only_CC   9.967909  1.255273   \n",
       "1589       (chloramphenicol, acetyltransferase)  only_CC   8.800798  1.170119   \n",
       "3568                              (cyclic, amp)  only_CC   9.277528  1.145852   \n",
       "3395                          (natural, killer)  only_CC   8.460087  1.145823   \n",
       "1248                                  (t, cell)     both   3.769901  1.135449   \n",
       "4020                          (herpes, simplex)  only_CC   9.863101  1.130683   \n",
       "3984             (pyrrolidine, dithiocarbamate)  only_CC   9.758293  1.129745   \n",
       "2308                      (situ, hybridization)  only_CC   8.435617  1.104869   \n",
       "4180                            (nitric, oxide)  only_CC   9.814548  1.100928   \n",
       "3746                              (heat, shock)  only_CC   8.725055  1.089369   \n",
       "1457                          (flow, cytometry)  only_CC   9.250204  1.086068   \n",
       "650                          (germinal, center)  only_CC   9.528051  1.084192   \n",
       "1731                           (breast, cancer)  only_CC   8.117351  1.075994   \n",
       "1867                       (hydrogen, peroxide)  only_CC   9.967909  1.002862   \n",
       "3251                              (amino, acid)  only_CC   7.005853  1.002616   \n",
       "1312                   (mobility, shift, assay)  only_CC   7.005318  1.002515   \n",
       "3823                     (open, reading, frame)  only_CC   9.717699  0.996078   \n",
       "1586                           (northern, blot)  only_CC   8.031681  0.985358   \n",
       "1523                               (vitamin, d)  only_CC   8.026404  0.970630   \n",
       "82                     (dissociation, constant)  only_CC   8.851547  0.968140   \n",
       "3249                (tyrosine, phosphorylation)     both   6.116899  0.962208   \n",
       "909                          (squirrel, monkey)  only_CC   9.768243  0.953588   \n",
       "1229                          (leukotriene, b4)  only_CC  10.456876  0.952381   \n",
       "3228                     (signal, transduction)  only_CC   6.414016  0.918291   \n",
       "354                   (immunodeficiency, virus)  only_CC   6.322930  0.918126   \n",
       "503                     (rheumatoid, arthritis)  only_CC   9.775005  0.916902   \n",
       "2370                           (retinoic, acid)  only_CC   7.014805  0.870770   \n",
       "1551                               (raw, 264.7)  only_CC  10.903726  0.845098   \n",
       "966   (electrophoretic, mobility, shift, assay)  only_CC   7.252517  0.826644   \n",
       "2675                  (mechanical, ventilation)  only_CC  10.771957  0.788758   \n",
       "2272                          (e., chaffeensis)  only_CC   9.626161  0.782771   \n",
       "2185                        (escherichia, coli)  only_CC  10.291209  0.780744   \n",
       "3301                                  (ru, 486)  only_CC  10.456876  0.760497   \n",
       "1706                     (monoclonal, antibody)  only_CC   7.123586  0.733414   \n",
       "3588                                 (nih, 3t3)  only_CC  10.903726  0.718293   \n",
       "2229                      (ulcerative, colitis)  only_CC  11.234580  0.698970   \n",
       "1395                          (tetanus, toxoid)  only_CC  11.234580  0.698970   \n",
       "2757        (phorbol, 12-myristate, 13-acetate)  only_CC   8.095795  0.697532   \n",
       "1854               (site-directed, mutagenesis)  only_CC   9.210140  0.691818   \n",
       "\n",
       "      freq  len  \n",
       "4009  1077    2  \n",
       "4173   257    2  \n",
       "1841   148    2  \n",
       "2644   118    2  \n",
       "4064    48    2  \n",
       "3920    52    2  \n",
       "1478   980    2  \n",
       "3618    43    2  \n",
       "309    119    2  \n",
       "3729   110    3  \n",
       "1845    99    3  \n",
       "4107    18    2  \n",
       "1589    34    2  \n",
       "3568    25    2  \n",
       "3395    42    2  \n",
       "1248  1575    2  \n",
       "4020    17    2  \n",
       "3984    18    2  \n",
       "2308    40    2  \n",
       "4180    17    2  \n",
       "3746    33    2  \n",
       "1457    24    2  \n",
       "650     20    2  \n",
       "1731    48    2  \n",
       "1867    14    2  \n",
       "3251   109    2  \n",
       "1312   131    3  \n",
       "3823    17    3  \n",
       "1586    45    2  \n",
       "1523    44    2  \n",
       "82      26    2  \n",
       "3249   162    2  \n",
       "909     15    2  \n",
       "1229    10    2  \n",
       "3228   153    2  \n",
       "354    157    2  \n",
       "503     14    2  \n",
       "2370    94    2  \n",
       "1551     7    2  \n",
       "966     99    4  \n",
       "2675     7    2  \n",
       "2272    13    2  \n",
       "2185     9    2  \n",
       "3301     8    2  \n",
       "1706    69    2  \n",
       "3588     6    2  \n",
       "2229     5    2  \n",
       "1395     5    2  \n",
       "2757    47    3  \n",
       "1854    15    2  "
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.sort_values('tc', ascending=False).head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.06840468787371443"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data[(data['pmi_nl'] < 2) & (data['len'] == 2)]) / len(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd54ee6ac8>"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.boxplot(x='type', y='tc', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_dict = {'ngram': [], 'freq': [], 'type': [], 'tc': [], 'pmi_nl': [], 'len': []}\n",
    "\n",
    "for n in range(2, 11):\n",
    "    for ngram, count in model.iterate(n, FREQ_THRESHOLD):\n",
    "        \n",
    "        ngram = tuple(ngram.split())\n",
    "\n",
    "        data_dict['ngram'].append(ngram)\n",
    "\n",
    "        data_dict['freq'].append(model[ngram])\n",
    "\n",
    "        if ngram in disc_concepts:\n",
    "            if ngram in cont_concepts:\n",
    "                ngram_type = 'both'\n",
    "            else:\n",
    "                ngram_type = 'only_DC'\n",
    "        elif ngram in cont_concepts:\n",
    "            ngram_type = 'only_CC'\n",
    "        else:\n",
    "            ngram_type = 'neither'\n",
    "            \n",
    "        data_dict['type'].append(ngram_type)\n",
    "\n",
    "        data_dict['pmi_nl'].append(conceptstats.length_normalized_pmi(ngram, model, smoothing=.1))\n",
    "        data_dict['tc'].append(conceptstats.term_coherence(ngram, model))\n",
    "\n",
    "        data_dict['len'].append(len(ngram))\n",
    "        \n",
    "data = pd.DataFrame(data_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fdd52e66668>"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.boxplot(x='type', y='pmi_nl', data=data, showfliers=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<function pingouin.pairwise.pairwise_ttests(data=None, dv=None, between=None, within=None, subject=None, parametric=True, marginal=True, alpha=0.05, tail='two-sided', padjust='none', effsize='hedges', correction='auto', nan_policy='listwise', return_desc=False, interaction=True)>"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pingouin.pairwise_ttests"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
